
<html lang="en"     class="pb-page"  data-request-id="1c258ca7-1ef7-4b7e-9c0b-1c7d08188591"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-23;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01308;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors" /></meta><meta name="dc.Creator" content="Agustin  Casimiro-Garcia" /></meta><meta name="dc.Creator" content="John I.  Trujillo" /></meta><meta name="dc.Creator" content="Felix  Vajdos" /></meta><meta name="dc.Creator" content="Brian  Juba" /></meta><meta name="dc.Creator" content="Mary Ellen  Banker" /></meta><meta name="dc.Creator" content="Ann  Aulabaugh" /></meta><meta name="dc.Creator" content="Paul  Balbo" /></meta><meta name="dc.Creator" content="Jonathan  Bauman" /></meta><meta name="dc.Creator" content="Jill  Chrencik" /></meta><meta name="dc.Creator" content="Jotham W.  Coe" /></meta><meta name="dc.Creator" content="Robert  Czerwinski" /></meta><meta name="dc.Creator" content="Martin  Dowty" /></meta><meta name="dc.Creator" content="John D.  Knafels" /></meta><meta name="dc.Creator" content="Soojin  Kwon" /></meta><meta name="dc.Creator" content="Louis  Leung" /></meta><meta name="dc.Creator" content="Sidney  Liang" /></meta><meta name="dc.Creator" content="Ralph P.  Robinson" /></meta><meta name="dc.Creator" content="Jean-Baptiste  Telliez" /></meta><meta name="dc.Creator" content="Ray  Unwalla" /></meta><meta name="dc.Creator" content="Xin  Yang" /></meta><meta name="dc.Creator" content="Atli  Thorarensen" /></meta><meta name="dc.Description" content="Ongoing interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage the JAK3 residue Cys909 by cyanamide, a structurally and mechanistically differ..." /></meta><meta name="Description" content="Ongoing interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage the JAK3 residue Cys909 by cyanamide, a structurally and mechanistically differ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 13, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01308" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01308" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01308" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01308" /></link>
        
    
    

<title>Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01308" /></meta><meta property="og:title" content="Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0027.jpeg" /></meta><meta property="og:description" content="Ongoing interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage the JAK3 residue Cys909 by cyanamide, a structurally and mechanistically differentiated electrophile from other cysteine reacting groups previously incorporated in JAK3 covalent inhibitors. Through crystallography, kinetic, and computational studies, interaction of cyanamide 12 with Cys909 was optimized leading to potent and selective JAK3 inhibitors as exemplified by 32. In relevant cell-based assays and in agreement with previous results from this group, 32 demonstrated that selective inhibition of JAK3 is sufficient to drive JAK1/JAK3-mediated cellular responses. The contribution from extrahepatic processes to the clearance of cyanamide-based covalent inhibitors was also characterized using metabolic and pharmacokinetic data for 12. This work also gave key insights into a productive approach to decrease glutathione/glutathione S-transferase-mediated clearance, a challenge typically encountered during the discovery of covalent kinase inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01308"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01308">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01308&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01308&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01308&amp;href=/doi/10.1021/acs.jmedchem.8b01308" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10665-10699</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01293" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01326" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Agustin Casimiro-Garcia</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agustin Casimiro-Garcia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (617) 665-5673. E-mail: <a href="/cdn-cgi/l/email-protection#bddcdac8cec9d4d393dedcced4d0d4cfd290dadccfded4dcfdcddbd4c7d8cf93ded2d0"><span class="__cf_email__" data-cfemail="58393f2d2b2c3136763b392b3135312a37753f392a3b313918283e31223d2a763b3735">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agustin++Casimiro-Garcia">Agustin Casimiro-Garcia</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9618-2547" title="Orcid link">http://orcid.org/0000-0001-9618-2547</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John I. Trujillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John I. Trujillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+I.++Trujillo">John I. Trujillo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Felix Vajdos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Felix Vajdos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Vajdos">Felix Vajdos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian Juba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian Juba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Inflammation and Immunology Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Juba">Brian Juba</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary Ellen Banker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary Ellen Banker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ellen++Banker">Mary Ellen Banker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ann Aulabaugh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ann Aulabaugh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Aulabaugh">Ann Aulabaugh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Balbo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Balbo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Inflammation and Immunology Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Balbo">Paul Balbo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan Bauman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Bauman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Bauman">Jonathan Bauman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jill Chrencik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jill Chrencik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jill++Chrencik">Jill Chrencik</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jotham W. Coe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jotham W. Coe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jotham+W.++Coe">Jotham W. Coe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Czerwinski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Czerwinski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Inflammation and Immunology Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Czerwinski">Robert Czerwinski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Dowty</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Dowty</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 1 Burtt Road, Andover, Massachusetts 01810, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Dowty">Martin Dowty</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John D. Knafels</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John D. Knafels</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Knafels">John D. Knafels</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Soojin Kwon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Soojin Kwon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Soojin++Kwon">Soojin Kwon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louis Leung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louis Leung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louis++Leung">Louis Leung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sidney Liang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sidney Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sidney++Liang">Sidney Liang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ralph P. Robinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ralph P. Robinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ralph+P.++Robinson">Ralph P. Robinson</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4066-5299" title="Orcid link">http://orcid.org/0000-0002-4066-5299</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Baptiste Telliez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Baptiste Telliez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Inflammation and Immunology Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Baptiste++Telliez">Jean-Baptiste Telliez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ray Unwalla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ray Unwalla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ray++Unwalla">Ray Unwalla</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5789-7336" title="Orcid link">http://orcid.org/0000-0002-5789-7336</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xin Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Yang">Xin Yang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Atli Thorarensen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Atli Thorarensen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Atli++Thorarensen">Atli Thorarensen</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01308&amp;href=/doi/10.1021%2Facs.jmedchem.8b01308" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10665–10699</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 13, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 August 2018</li><li><span class="item_label"><b>Published</b> online</span>13 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01308" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01308</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10665%26pageCount%3D35%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAgustin%2BCasimiro-Garcia%252C%2BJohn%2BI.%2BTrujillo%252C%2BFelix%2BVajdos%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D23%26contentID%3Dacs.jmedchem.8b01308%26title%3DIdentification%2Bof%2BCyanamide-Based%2BJanus%2BKinase%2B3%2B%2528JAK3%2529%2BCovalent%2BInhibitors%26numPages%3D35%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10699%26publicationDate%3DDecember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01308"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3963</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01308" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Agustin&quot;,&quot;last_name&quot;:&quot;Casimiro-Garcia&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;I. Trujillo&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Vajdos&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Juba&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ellen Banker&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Aulabaugh&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Balbo&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Bauman&quot;},{&quot;first_name&quot;:&quot;Jill&quot;,&quot;last_name&quot;:&quot;Chrencik&quot;},{&quot;first_name&quot;:&quot;Jotham&quot;,&quot;last_name&quot;:&quot;W. Coe&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Czerwinski&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Dowty&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Knafels&quot;},{&quot;first_name&quot;:&quot;Soojin&quot;,&quot;last_name&quot;:&quot;Kwon&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;Leung&quot;},{&quot;first_name&quot;:&quot;Sidney&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;P. Robinson&quot;},{&quot;first_name&quot;:&quot;Jean-Baptiste&quot;,&quot;last_name&quot;:&quot;Telliez&quot;},{&quot;first_name&quot;:&quot;Ray&quot;,&quot;last_name&quot;:&quot;Unwalla&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Atli&quot;,&quot;last_name&quot;:&quot;Thorarensen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10665-10699&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01308&quot;},&quot;abstract&quot;:&quot;Ongoing interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage the JAK3 residue Cys909 by cyanamide, a structurally and mechanistically differentiated electrophile from other cysteine reacting groups previously incorporated in JAK3 covalent inhibitors. Through crystallography, kinetic, and computational studies, interaction of cyanamide 12 with Cys909 was optimized leading to potent and selective JAK3 inhibitors as exemplified by 32. In relevant cell-based assays and in agreement with previous results from this group, 32 demonstrated that selective inhibition of JAK3 is sufficient to drive JAK1/JAK3-mediated cellular responses. The contribution from extrahepatic processes to the clearance of cyanamide-based covalent inhibitors was also characterized using metabolic and pharmacokinetic data for 12. This work also gave key insights into a productive approach to decrease glutathione/glutathione S-transferase-mediated clearance, a challenge typically encounte&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01308&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01308" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01308&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01308" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01308&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01308" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01308&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01308&amp;href=/doi/10.1021/acs.jmedchem.8b01308" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01308" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01308" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01308%26sid%3Dliteratum%253Aachs%26pmid%3D30423248%26genre%3Darticle%26aulast%3DCasimiro-Garcia%26date%3D2018%26atitle%3DIdentification%2Bof%2BCyanamide-Based%2BJanus%2BKinase%2B3%2B%2528JAK3%2529%2BCovalent%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D23%26spage%3D10665%26epage%3D10699%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/jmcmar.2018.61.issue-23/20181213/jmcmar.2018.61.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Ongoing interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage the JAK3 residue Cys909 by cyanamide, a structurally and mechanistically differentiated electrophile from other cysteine reacting groups previously incorporated in JAK3 covalent inhibitors. Through crystallography, kinetic, and computational studies, interaction of cyanamide <b>12</b> with Cys909 was optimized leading to potent and selective JAK3 inhibitors as exemplified by <b>32</b>. In relevant cell-based assays and in agreement with previous results from this group, <b>32</b> demonstrated that selective inhibition of JAK3 is sufficient to drive JAK1/JAK3-mediated cellular responses. The contribution from extrahepatic processes to the clearance of cyanamide-based covalent inhibitors was also characterized using metabolic and pharmacokinetic data for <b>12</b>. This work also gave key insights into a productive approach to decrease glutathione/glutathione <i>S</i>-transferase-mediated clearance, a challenge typically encountered during the discovery of covalent kinase inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that have a central role in the signaling process of many cytokine receptors. Along with their downstream effectors, signal transducer, and activator of transcription proteins (STATs), JAKs form a signaling pathway of fundamental importance in innate immunity, inflammation, and hematopoiesis.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Dysregulation of this pathway has been implicated in the pathogenesis of immune diseases and cancers, and thus JAKs are attractive targets for the treatment of a number of therapeutic indications.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> The JAK kinases include four family members JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2), each selectively associated with the intracellular domain of different receptors subunits. The pairing of the JAK kinases to mediate signaling from a given cytokine receptor is an important element of their function. For example, JAK3 is always paired to JAK1 and this arrangement controls the signaling for the γ-common chain (γ<sub>c</sub>) cytokines interleukin 2 (IL-2), IL-4, IL-7, IL-9, IL-15, and IL-21.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Another feature of the JAKs is their high degree of sequence homology, particularly in the catalytic domain, which has made challenging the identification of selective JAK inhibitors. JAK3 was the first of the JAKs to attract interest because of its essential role in immune signaling and predominant expression in the hematopoietic system.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Validation of its critical role in the immune system has come from human JAK3 deficiencies. Loss-of-function mutations in γ<sub>c</sub> or JAK3 confer a severe combined immunodeficiency in humans (SCID).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This strong rationale has led to the search of JAK3 inhibitors as therapeutic agents for the treatment of autoimmune and inflammatory diseases. The approval of tofacitinib (<b>1</b>) for the treatment of rheumatoid arthritis (RA) by the U.S. Food and Drug Administration in 2012 was an important milestone for JAK inhibition for the treatment of RA.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This agent was originally reported as a selective JAK3 inhibitor<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> but in more recent screens was demonstrated to be a pan-JAK inhibitor, with predominant JAK1 inhibition.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> There are now several JAK inhibitors in development for the treatment of inflammatory indications,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> but none of them are a JAK3 specific inhibitor,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> with the exception of PF-06651600 (<b>6</b>), as further detailed below.</div><div class="NLM_p">The identification of selective JAK3 inhibitors has continued to attract the attention of both industrial and academic groups. In addition to the potential of providing safer immunotherapeutic agents due to the restricted expression of JAK3, highly selective JAK3 inhibitors are important to dissect the complex signaling pathways involving JAK1/JAK3. These efforts have targeted the ATP binding site of the kinase for identification of selective agents. Two approaches have been pursued. The first approach has utilized reversible inhibitors that target specific regions in JAK3 with lipophilic or hydrogen bonding interactions to achieve enhanced selectivity toward JAK3.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> In this context, it is important to note that JAK3 has high affinity for ATP which makes it difficult to identify an inhibitor that is more than JAK3 biased. The second approach has targeted the JAK3 residue Cys909, a unique residue within the JAK family, with covalent inhibition. Several research groups have reported the identification of JAK3 covalent inhibitors that have commonly incorporated an <i>N</i>-aryl/heteroaryl acrylamide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <b>2</b>–<b>4</b>)<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> or an α-cyanoacrylamide (e.g., <b>5</b>) moiety as the electrophilic or cysteine reacting group (CRG).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Exquisite selectivity for JAK3 over other JAKs, as well as generally high kinome selectivity, has been achieved with these inhibitors. Furthermore, this approach has delivered useful tools for understanding the complex biology driven by JAK3. For example, <b>4</b> was recently utilized to identify new aspects of IL-2 signaling mediated by JAK3 catalytic activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of tofacitinib (<b>1</b>), PF-06651600 (<b>6</b>), a JAK3-specific inhibitor in clinical studies and recently reported JAK3 covalent inhibitors (<b>2</b>–<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our group has focused extensive research efforts toward the discovery of JAK3 selective inhibitors based on a covalent approach to identify potential candidates for human clinical studies. One of the important questions to address with such inhibitors is the relative JAK3 contribution to the overall efficacy observed with pan-JAK inhibitors. Our efforts recently culminated in the identification of <b>6</b>, a JAK3 specific inhibitor recently advanced into human clinical trials.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> The potency and selectivity of <b>6</b> were confirmed using both enzyme and cellular assays. Formation of a covalent bond with Cys909 was observed in the cocrystal structure of <b>6</b> with JAK3. A high degree of kinome selectivity was observed with <b>6</b> in a panel of 305 kinases. When evaluated in a panel of 11 kinases that possess a Cys residue at the same position as that found in JAK3, <b>6</b> exhibited generally good selectivity for JAK3 with measurable activity demonstrated mainly against kinases of the Tec family.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, <b>6</b> demonstrated low propensity for covalent binding to other proteins as determined by assessing the nonspecific chemical reactivity of <b>6</b> against the proteome using human serum albumin as a surrogate protein.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> One of the key features of <b>6</b> that distinguishes it from other reported covalent JAK3 inhibitors is its favorable pharmacokinetic profile that makes it suitable for oral dosing and for studies in both preclinical and clinical arenas. This includes human blood clearance that was predicted to be approximately 5.6 mL min<sup>–1</sup> kg<sup>–1</sup> and human half-life of approximately 2 h, values that were obtained from a thorough understanding of clearance mechanisms and in vitro to in vivo correlations.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> The favorable pharmacokinetic profile of <b>6</b> is critical because the half-life for JAK3 enzyme turnover determined in human primary CD4+ T cells was in the 3–4 h range,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> indicating that irreversible inhibition of JAK3 would not lead to a significantly prolonged effect.</div><div class="NLM_p last">As part of our ongoing efforts to discover novel JAK3 selective inhibitors based on a covalent approach, the replacement of an acrylamide with a structurally differentiated electrophile was pursued. Our interest in pursuing this work was to develop better understanding of the effect of different electrophiles on two key components of covalent JAK3 inhibitor design: (a) reactivity tuning to achieve optimal balance between <i>K</i><sub>i</sub> (reversible binding affinity) and <i>k</i><sub>inact</sub> and (b) pharmacokinetic properties. Our efforts targeted inhibitors based on cyanamide as the CRG for a number of reasons. For example, cyanamide derivatives have been described as covalent inhibitors of other active-site cysteine containing enzymes like cathepsins C, K and L and Bruton’s tyrosine kinase, in which they form a reversible isothiourea ester link to the active-site cysteine residue.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29−33)</a> In addition, the covalent-reversible mechanism reported with this electrophile was anticipated to provide differentiation versus our acrylamide-based inhibitors. The ability to tune cyanamide reactivity through structural modifications to achieve the proper balance between <i>K</i><sub>i</sub> and <i>k</i><sub>inact</sub> was an important consideration. As we have reported previously,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> since JAK3 has the highest affinity for ATP among the JAKs, the <i>K</i><sub>i</sub> component of target inhibition must not be the major driver for potency as this would only provide modest selectivity gains through covalent interaction with Cys909. Data reported from studies that evaluated the reactivity of diverse CRGs with either the biologically relevant nucleophile glutathione (GSH)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> or the model amine-based nucleophile <i>N</i>-α-acetyl-<span class="smallcaps smallerCapital">l</span>-lysine<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> have demonstrated that cyanamide reactivity can be modulated. For example, significant reactivity differences with <i>N</i>-α-acetyl-<span class="smallcaps smallerCapital">l</span>-lysine, using half-life values determined from pseudo-first-order rate constants, were observed among cyanamides derived from azetidine (<i>t</i><sub>1/2</sub> = 2.59 h), pyrrolidine (<i>t</i><sub>1/2</sub> = 7.7 h), or piperidine (<i>t</i><sub>1/2</sub> = 11.1 h). An intriguing aspect of cyanamide-based covalent inhibitors was their pharmacokinetic properties since published reports have not provided insight into the contribution from extrahepatic processes to the clearance of this type of covalent inhibitors.<a onclick="showRef(event, 'ref29 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref32">(29,32)</a> In this paper, the identification of a series of cyanamides based on an aminoindane scaffold leading to potent and selective JAK3 inhibitors is presented.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Screening Sequence</h3><div class="NLM_p last">The new compounds were evaluated in a panel that included JAK1, JAK2, JAK3, and TYK2 enzyme inhibition at 1 mM ATP. Our group has recently reported on the relevance of obtaining JAK1 and JAK3 enzyme inhibition at physiologically relevant ATP concentration to provide better insights into the cellular activity and selectivity of a compound.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Assays for JAK1 and JAK3 were also performed at the corresponding <i>K</i><sub>m</sub> for ATP for each kinase. These assays allowed for increased sensitivity and were used to quantify affinity of weaker inhibitors. Compounds were also assessed in a TR-FRET competition binding assay utilized to characterize inhibitor type (i.e., reversible vs irreversible). For irreversible covalent inhibitors, this assay was used to determine the second-order rate constant for enzyme inactivation (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>). The new compounds were also tested in a glutathione (GSH) reactivity assay utilized to understand impact of structural modifications on inherent cysteine reactivity. A limited number of selected compounds were further evaluated in cell-based assays measuring IL-15 induced STAT5 phosphorylation or IL-10 induced STAT3 phosphoryation in peripheral blood mononuclear cells (PBMCs) performed as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Identification of <i>N</i>-Aryl-Based Cyanamides</h3><div class="NLM_p">The lead molecules for the cyanamide-based JAK3 covalent inhibitors were acrylamides <b>7</b> and <b>8</b> obtained during the evaluation of several scaffolds that eventually led to the discovery of <b>6</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Acrylamide <b>7</b> was identified as a potent JAK3 inhibitor (IC<sub>50</sub> = 33 nM) with high selectivity (>300-fold) over other JAK isoforms (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, the potency and selectivity of this compound were attributed to high reactivity of the <i>N</i>-arylacrylamide scaffold. In fact, this compound showed a relatively short half-life in the GSH reactivity assay (<i>t</i><sub>1/2</sub> = 56 min). Furthermore, data obtained from whole blood stability assays in both rat and human showed <b>7</b> had a short half-life in both species (rat <i>t</i><sub>1/2</sub> = 29 min; human <i>t</i><sub>1/2</sub> = 148 min) suggesting high extrahepatic clearance primarily involving GSH conjugation mediated through glutathione <i>S</i>-transferases (GSTs).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These data were in agreement with the high in vivo clearance observed in a rat PK study with <b>7</b> (Cl = 455 mL min<sup>–1</sup> kg<sup>–1</sup>). In an attempt to modulate reactivity of <b>7</b> by introducing nonconjugated substituents on the nitrogen, the benzoxazine cyclic scaffold incorporated in acrylamide <b>8</b> was prepared. Although <b>8</b> showed high potency and selectivity for JAK3 (JAK3 IC<sub>50</sub> = 49 nM; >200-fold selectivity vs JAK1), it exhibited even higher reactivity with GSH (<i>t</i><sub>1/2</sub> = 3 min) and a much shorter half-life in blood stability assays (rat <i>t</i><sub>1/2</sub> = 4 min; human <i>t</i><sub>1/2</sub> = 5 min) than <b>7</b>. The high clearance of these compounds led us to consider alternative strategies to identify novel JAK3 covalent inhibitors with differentiated profiles. Among them was the replacement of an acrylamide with a structurally differentiated class of electrophile, in particular cyanamide.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Data for Compounds <b>6</b>–<b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0023.gif" alt="" id="gr24" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">ATP concentration for JAK3 is 4 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ATP concentration for JAK1 is 40 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value for <b>6</b> was taken from previous report.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">The benzoxazine scaffold utilized for <b>8</b> was chosen for providing reversible binding to JAK3 (<i>K</i><sub>i</sub>) and was selected to start investigation of a CRG replacement. Following this plan, cyanamide <b>9</b> was prepared, which to our surprise exhibited significant loss of JAK3 potency and selectivity (IC<sub>50</sub> = 1226 nM; ∼5-fold selectivity vs JAK1, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The significant potency difference between <b>8</b> and <b>9</b>, differing only by the CRG, may be derived from the intrinsic reactivity changes of the electrophile and/or suboptimal positioning to react with Cys909 in JAK3. Indeed, data from the GSH reactivity assay indicated a large reduction in reactivity with this CRG replacement (<b>9</b><i>t</i><sub>1/2</sub> > 190 min vs <b>8</b><i>t</i><sub>1/2</sub> = 3 min). Thus, modification of this scaffold was pursued to adjust reactivity. The effects of fluorine substitution on piperidine to modulate p<i>K</i><sub>a</sub> are well-known, with a 3,3-difluoro substitution leading to significant reduction in the p<i>K</i><sub>a</sub> value when compared to unsubstituted piperidine (Δp<i>K</i><sub>a</sub> exp = −3.7).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It was proposed that similar modification of <b>9</b> would lead to an adjustment of cyanamide reactivity, and thus <b>10</b> was prepared. This analog provided marked improvement in both potency and selectivity (IC<sub>50</sub> = 456 nM; >22-fold selectivity vs JAK1) when compared to <b>9</b>. Data from the GSH reactivity assay showed a modest increase in reactivity (<b>10</b>: <i>t</i><sub>1/2</sub> > 120 min) when compared to <b>9</b>. The interaction of <b>10</b> with JAK3 was evaluated in the competition assay (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 4.8 × 10<sup>4</sup> M<sup>–1</sup> s<sup>–1</sup>; <i>t</i><sub>1/2</sub> = 1.8 h) showing a profile that was not completely consistent with irreversible inhibition. The dissociation rate half-life of <b>10</b> was not in the range typically observed with irreversible inhibitors (<i>t</i><sub>1/2</sub> > 8 h) but was longer than values determined for reversible inhibitors (<i>t</i><sub>1/2</sub> ≤ 0.05 h). In an effort to better understand the interactions of this compound at a structural level, a crystal structure of <b>10</b> bound to JAK3 was solved at 2.9 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition to the hydrogen bonding interactions between the pyrrolopyrimidine of <b>10</b> and the hinge binding region of JAK3, the structure revealed highly interesting aspects of the binding. First, it showed the formation of a covalent bond between the nitrile moiety and Cys909 to give an isothiourea adduct, similar to the interaction reported with cyanamide-based cathepsin inhibitors.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30,32)</a> Second, it showed that the Cys909 side chain adopted a rotamer state different from that previously observed in other JAK3 crystal structures, including the structure of <b>1</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The Cys909 chi1 dihedral angle (N–C<sup>α</sup>-C<sup>β</sup>–S<sup>γ</sup>) in the structure of <b>10</b> is −65°, while the angle in the structure of <b>1</b> is 75°. Intrigued by this difference, a more extensive analysis of the Cys909 chi1 dihedral angle was carried out using over 160 proprietary and public JAK3 crystal structures. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, only six crystal structures were identified with dihedral angle within ±30° from the dihedral angle measured in the structure of <b>10</b>, confirming a rather uncommon rotamer state. The most common Cys909 rotamer in JAK3 structures has a Cys909 chi1 dihedral angle in the range of 65–85°. An intriguing question that emerged from this analysis was whether there was an energy difference associated with the Cys909 rotamer observed in the structure of <b>10</b>. To understand the preferred rotamer states of the Cys909 residue within the JAK3 binding site, an enhanced sampling method, metadynamics, was used to sample the free energy landscape of the chi1 dihedral angle of this residue. Metadynamics is an effective sampling technique in which the potential for one or more chosen variables called collective variables (CVs), i.e., dihedral angle in this case, are modified during the simulation by periodically adding a repulsive potential of Gaussian shape at the location given by particular values of the variable.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> In this way the system is discouraged from going back to its previous steps and forces the calculation to explore the full energy landscape. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows the free energy plot generated from a 50 ns metadynamics simulation of the Cys909 chi1 dihedral angle. The plot shows two nearly equienergetic minimas, one near −54°, which is similar to the observed rotamer state of Cys909 residue in the X-ray structure of <b>10</b> (−65°), and the other at 72° corresponding closely to the rotamer state observed in the structure of <b>1</b>. This calculation indicated that with a relative small free energy difference of ∼0.4 kcal/mol between the two rotamers along with a low energy barrier of ∼7.2 kcal/mol separating the two states, both rotamer states are accessible within the JAK3 binding site. Taken together, this analysis suggested either one of the Cys909 rotamer states could be targeted for covalent interaction without a significant energy penalty. However, the interaction of the nitrile in <b>10</b> with Cys909 was not considered optimal (e.g., kinetic data were not completely consistent with irreversible inhibition) and led us to pursue structural modifications that would better position the nitrile for reaction with the more common Cys909 rotamer.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>10</b> (gold) bound to JAK3 (ribbons in cyan, residues in gray) at 2.9 Å resolution. Formation of covalent bond with Cys909 was observed (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4">6DA4</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of Cys909 chi1 dihedral angle in JAK3 crystal structures (<i>n</i> = 168, includes both proprietary and public structures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative free energy surface (FES) generated from a 50 ns metadynamic simulation run of the Cys909 residue chi1 dihedral as the collective variable. The small relative energy difference and the low barrier between the two rotamers suggest both states would be accessible within the JAK3 binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Design of Indane-Based Cyanamides</h3><div class="NLM_p">Analysis of the crystal structure of <b>10</b> bound to JAK3 suggested that the nitrile may be better positioned for reaction with the more common Cys909 rotamer using a one atom extended linker between the aromatic ring and the CRG. Accordingly, analogs based on an indane (<b>11</b>–<b>15</b>) or chromane (<b>16</b>–<b>19</b>) scaffold were obtained (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The 2-methoxyethyl substituent at C5 of the pyrrolopyrimidine which was present in <b>7</b> and <b>8</b> was maintained in a number of initial analogs, as it had provided a boost in potency in the <i>N</i>-arylacrylamides series. The impact of substitution at the nitrogen bearing the CRG was investigated with analogs containing <i>N</i>-methyl substitution. Evaluation of indane-based <b>11</b> and chromane-based <b>16</b> showed both compounds possessed moderate JAK3 potency (<b>11</b>, IC<sub>50</sub> = 711 nM; <b>16</b>, IC<sub>50</sub> = 1211 nM) but no selectivity versus JAK1 (<b>11</b>, JAK1 IC<sub>50</sub> = 908 nM; <b>16</b>, JAK1 IC<sub>50</sub> = 1179 nM). Furthermore, <b>11</b> and <b>16</b> were evaluated in the TR-FRET competition assay to determine the kinetics of compound binding/dissociation to JAK3 and JAK3 inactivation (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>). Interestingly, both compounds exhibited long dissociation rate half-life values (<i>t</i><sub>1/2</sub> > 8 h) supporting irreversible inhibition of JAK3. With some encouragement from these data, separation of the enantiomers of <b>11</b> by chiral supercritical fluid chromatography (SFC) was pursued affording <b>12</b> and <b>13</b>. The absolute stereochemistry of these compounds was unambiguously assigned based on the single crystal structure obtained for <b>13</b>, and by inference the absolute stereochemistry of <b>12</b> was made (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>). Evaluation of this pair demonstrated the JAK3 activity resided primarily with <i>S</i>-enantiomer <b>12</b> (IC<sub>50</sub> = 256 nM), while the <i>R</i>-enantiomer <b>13</b> exhibited a significant potency drop (IC<sub>50</sub> > 5820 nM). Furthermore, these compounds exhibited significant differences in the competition binding assay (<b>12</b>, <i>t</i><sub>1/2</sub> > 8; <b>13</b>, <i>t</i><sub>1/2</sub> = 0.3 h). Following a similar procedure with the chromane scaffold, chiral separation of <b>15</b> using SFC provided <b>17</b> and <b>18</b>. The absolute stereochemistry of this pair was assigned based on biological data and the separation of activity observed with <b>12</b> and <b>13</b>. The <i>S</i>-enantiomer <b>17</b> was identified as the most potent enantiomer (<b>17</b> IC<sub>50</sub> = 781 nM vs <b>18</b> IC<sub>50</sub> = 6110 nM), with data from the competition assay supporting irreversible inhibition for this compound (<b>17</b>, <i>t</i><sub>1/2</sub> > 8; <b>18</b>, <i>t</i><sub>1/2</sub> = 6.5 h). The data for the <i>S</i>-enantiomers <b>12</b> (JAK1 IC<sub>50</sub> = 644 nM; JAK2 IC<sub>50</sub> = 1666 nM; TYK2 IC<sub>50</sub> = 1839 nM) and <b>17</b> (JAK1 IC<sub>50</sub> = 1215 nM; JAK2 IC<sub>50</sub> = 876 nM; TYK2 IC<sub>50</sub> = 2971 nM) against other JAK isoforms showed a modest improvement in JAK3 selectivity with <b>12</b>. There was also a small GSH reactivity difference observed between these scaffolds (<b>12</b>, <i>t</i><sub>1/2</sub> = 69 min; <b>17</b>, <i>t</i><sub>1/2</sub> = 41 min). Other modifications evaluated at this stage were found to be detrimental to JAK3 activity. Incorporation of the 2-methoxyethyl substituent in both of these scaffolds led to a potency loss as observed with <b>14</b> (JAK3 IC<sub>50</sub> = 1592 nM) and <b>19</b> (JAK3 IC<sub>50</sub> = 5828 nM). Incorporation of a methyl at the nitrogen containing the nitrile was detrimental to potency leading to complete loss of measurable activity as observed with <b>15</b> (JAK3 IC<sub>50</sub> > 10 000 nM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Data for Compounds <b>11</b>–<b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0024.gif" alt="" id="gr25" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">ATP concentration for JAK3 is 4 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ATP concentration for JAK1 is 40 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">In order to better understand the interactions of the indane-based cyanamides, a crystal structure of <b>12</b> in complex with JAK3 was obtained at 1.66 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The <i>S</i>-enantiomer <b>12</b> adopts a low-energy conformation, positioning the aminoindane NH to form a hydrogen bond with the backbone carbonyl of Arg953, with no obvious conformational or steric strain in the covalently bound conformation. As observed in the structure of <b>10</b>, the crystal structure of <b>12</b> showed the formation of a covalent isothiourea adduct between the cyanamide and the thiolate of Cys909, which was similar to the interaction reported with cyanamide-based cathepsin inhibitors.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30,32)</a> This structure also revealed that the nitrogen of the isothiourea is stabilized by hydrogen bonds to the side chain carboxyl of Asp912 and is within hydrogen bonding distance to the side chain guanidine group of Arg911. As described above, the aminoindane NH engages in hydrogen bonding with the backbone carbonyl of Arg953. This network of interactions suggested the potential for stabilization of the reactive conformation of the cyanamide through binding to these residues. A similar effect has been postulated in our series of aliphatic acrylamides in which the acrylamide is engaged in H-bonding to the NH of Cys909 and to a conserved water molecule, providing stabilization to the reactive conformation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>12</b> (purple) bound to JAK3 (ribbons in cyan, residues in gray) at 1.66 Å resolution. Formation of covalent bond with lower energy Cys909 rotamer was observed (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD">6DUD</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The crystal structures of JAK3 bound to compounds <b>10</b> and <b>12</b>, along with the data from the TR-FRET competition binding assay (<i>t</i><sub>1/2</sub> = 1.8 h and >8 h for <b>10</b> and <b>12</b>, respectively) indicate a reversible covalent interaction with <b>10</b> and an irreversible covalent interaction with <b>12</b>. The Cys909 chi1/chi2 (N–C<sup>α</sup>–C<sup>β</sup>–S<sup>γ</sup>/C<sup>α</sup>–C<sup>β</sup>–S<sup>γ</sup>–C<sup>δ</sup>) rotamer pairs for the JAK3/<b>10</b> and the JAK3/<b>12</b> structures are −54°/96.8° (gauche<sup>–</sup>/gauche<sup>+</sup>) and 81.7°/–128.8° (gauche<sup>+</sup>/trans), respectively. The gauche<sup>–</sup>/gauche<sup>+</sup> configuration for <b>10</b> is predicted to be less stable than the gauche<sup>+</sup>/trans configuration for <b>12</b>, as it results in a <i>syn</i>-pentane interaction between the backbone NH of Cys909 and the cyanamide moiety of the inhibitor. In contrast, the gauche<sup>+</sup>/trans configuration for <b>12</b> is a low energy conformer, with no steric clash between the inhibitor and protein backbone. These different rotamer values also place the Cys909 sulfhydryl in very different microenvironments, which may perturb its p<i>K</i><sub>a</sub> and thereby influence the nature of the covalent interaction with the nitrile group. The p<i>K</i><sub>a</sub> of Cys909 was therefore estimated using both a computational and an experimental approach. For the computational approach, the PROPKA method as implemented in MOE software (MOE 2015.10001)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was used to calculate the p<i>K</i><sub>a</sub> of Cys909 for the two observed rotamers. The PROPKA method is based upon empirical shifts in p<i>K</i><sub>a</sub> values associated with the different types of interactions that each ionizable group may make in the protein environment and can be computed rapidly as a simple pairwise scoring function. Briefly, the parameters used in this function consist of the p<i>K</i><sub>a</sub> of the group free in aqueous solution, the desolvation component measured as a function of the group burial, the sum of all potential hydrogen bonds made by the group, and a buried charge–charge interaction component. A benchmark study of PROPKA on cysteine residues for several Trx and ArsC proteins revealed a fair correlation (<i>R</i><sup>2</sup> = 0.74) with an average deviation from the experimental value of 0.88 p<i>K</i><sub>a</sub> units versus experimental p<i>K</i><sub>a</sub>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The calculated p<i>K</i><sub>a</sub> values are quite different for the two rotamers (p<i>K</i><sub>a</sub> = 4.5 for <b>12</b> versus p<i>K</i><sub>a</sub> = 9.0 for <b>10</b>). For the experimental approach, the rate of inactivation of JAK3, <i>k</i><sub>inact</sub>, was determined for a potent acrylamide-containing compound at various pH values (acrylamide <b>125</b>, see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). The thiol form of Cys909, which predominates when the pH is below the p<i>K</i><sub>a</sub>, is a poor nucleophile and would be less reactive toward the electrophilic acrylamide moiety, whereas the thiolate anion form, which predominates when the pH is above the p<i>K</i><sub>a</sub>, is a highly reactive nucleophile which should result in a measurably larger <i>k</i><sub>inact</sub>. When the <i>k</i><sub>inact</sub> is plotted against the pH, the midpoint of the curve yields an estimate of the thiolate p<i>K</i><sub>a</sub>. The p<i>K</i><sub>a</sub> measured by this method was determined to be 6.3 ± 0.2, significantly lower than that of a typical solvent exposed Cys residue (p<i>K</i><sub>a</sub> ≈ 8.3). A possible mechanism for the reduced p<i>K</i><sub>a</sub> value for Cys909 is a direct interaction with the helix dipole from helix 909–917. In the conformation of Cys909 observed with <b>10</b> (predicted p<i>K</i><sub>a</sub> 9), the Cys909 sulfhydryl is oriented well off the axis of helix 909–917, while in the conformation seen with <b>12</b> (predicted p<i>K</i><sub>a</sub> of 4.5, measured 6.2), it is oriented along the helix axis, positioned precisely at the N-terminal end where the positive helix dipole is directed. It is predicted that the positive helix dipole perturbs the p<i>K</i><sub>a</sub> of the Cys909 SH group, such that at physiological pH, the thiol will have a greater propensity to ionize to the thiolate anion, thereby facilitating nucleophilic attack. Because of these steric and p<i>K</i><sub>a</sub> effects, we hypothesize that the Cys909 conformation seen in <b>10</b> results in a less stable covalent interaction that leads to a reversible covalent interaction consistent with the TR-FRET results.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacokinetic Evaluation of Cyanamide <b>12</b></h3><div class="NLM_p">As outlined above, one of the objectives in pursuing cyanamide-based covalent JAK3 inhibitors was to develop a better understanding of the pharmacokinetic properties of this type of covalent inhibitor. On the basis of its profile consistent with that of an irreversible inhibitor of JAK3, including a long dissociation rate half-life value (<i>t</i><sub>1/2</sub> > 8 h) and crystallographic data showing formation of a covalent bond between the cyanamide and Cys909, cyanamide <b>12</b> was selected for profiling in blood stability assays and pharmacokinetic studies in rat. Evaluation of <b>12</b> in the blood stability assay showed longer half-life values in both rat and human (rat <i>t</i><sub>1/2</sub> = 150 min; human <i>t</i><sub>1/2</sub> > 360 min) than those observed for the acrylamides <b>7</b> and <b>8</b>, with the value in human reaching the upper limit of determination for the assay. These results suggested the potential for lower extrahepatic clearance derived from GST-mediated GSH conjugation for indane-based cyanamides when compared to <i>N</i>-arylacrylamides. The in vitro CYP450-mediated metabolism, assessed using liver microsomes, showed relatively high clearance for this compound in both rat and human (RLM CL<sub>int,app</sub> = 100 μL min<sup>–1</sup> mg<sup>–1</sup>; HLM CL<sub>int,app</sub> = 50 μL min<sup>–1</sup> mg<sup>–1</sup>). The pharmacokinetic properties of <b>12</b> were evaluated in rat (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In vivo clearance was about half hepatic blood flow (Cl = 36 mL min<sup>–1</sup> kg<sup>–1</sup>) with a low volume of distribution (<i>V</i><sub>ss</sub> = 0.35 L/kg) and short measured half-life (<i>t</i><sub>1/2</sub> = 0.27 h). In order to understand the contribution to clearance from non-CYP450 mediated pathways, the iv PK profile of <b>12</b> in the presence of the CYP450 inhibitor aminobenzotriazole (ABT) was also obtained. There was no significant difference in clearance values observed when the study was done in the presence of ABT (Cl = 34 mL min<sup>–1</sup> kg<sup>–1</sup>), suggesting that clearance of <b>12</b> is primarily GSH/GST-mediated. Notably, there was a significant difference in the rat <i>in vivo</i> clearance of <b>12</b> compared to that of acrylamide <b>7</b> (Cl = 455 mL min<sup>–1</sup> kg<sup>–1</sup>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Properties of <b>12</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">ABT (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub>(L/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">466</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">488</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">0.63</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Metabolism Studies of Cyanamide <b>12</b></h3><div class="NLM_p">To further expand on our understanding of the metabolic pathways of cyanamide-based covalent inhibitors, we pursued metabolism studies of <b>12</b>. Following incubation of <b>12</b> in the presence and absence of either NADPH, GSH alone or in human liver microsomes incubations, the major pathways of metabolism identified were glutathione conjugates (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Oxidative and hydrolytic metabolism of <b>12</b> was also identified but considered minor pathways.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. The major in vitro metabolic pathways of cyanamide <b>12</b> identified included three conjugates (<i>m</i>/<i>z</i> 583, 759, and 454) consistent with GSH addition.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Minor metabolic pathways included both hydrolytic and oxidative metabolism (<i>m</i>/<i>z</i> 294, 310, 292, and 296).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">LC–MS/MS analysis of NADPH-supplemented human liver microsomal incubations containing <b>12</b> and GSH led to the detection of three major peaks including conjugates with molecular ions (MH<sup>+</sup>) at <i>m</i>/<i>z</i> 583, 759, and 454 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). These conjugates were also observed when human liver microsomes and NADPH were omitted from the incubation mixtures, indicating intrinsic reactivity with GSH and that bioactivation was not a requirement for conjugation. The exact mass of the conjugates <b>M-583</b> (<i>m</i>/<i>z</i> 583.2083, C<sub>26</sub>H<sub>30</sub>N<sub>8</sub>O<sub>6</sub>S, −0.2 ppm) is consistent with the addition of one molecule of GSH to <b>12</b>, <b>M-759</b> (<i>m</i>/<i>z</i> 759.2333, C<sub>31</sub>H<sub>38</sub>N<sub>10</sub>O<sub>9</sub>S<sub>2</sub>, −0.5 ppm) a molecule of GSH and cysteine-glycine GSH fragment, and <b>M-454</b> (<i>m</i>/<i>z</i> 454.1655, C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub>S, −0.2 ppm) the addition of the cysteine-glycine fragment of GSH. The collision-induced dissociation (CID) spectrum of <b>M-583</b> and <b>M-759</b> displayed diagnostic loss of the pyroglutamate moiety (<i>m</i>/<i>z</i> 129), while <b>M-454</b> displayed diagnostic loss of the glycine moiety (<i>m</i>/<i>z</i> 74), all of which represent characteristic fragment ions derived from GSH type conjugates.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The conjugation of the thiol conjugates to the nitrile of <b>12</b> occurs through a Pinner reaction-like mechanism of nucleophilic addition. In all incubations fortified with GSH, based on UV profiles, <b>12</b> was entirely consumed over the duration of the incubation. These findings suggest that GSH conjugation to <b>12</b> was not reversible over this period under those conditions.</div><div class="NLM_p">Several minor hydrolytic and or oxidative peaks were detected in human liver microsomal incubations containing <b>12</b> with molecular ions (MH<sup>+</sup>) of <i>m</i>/<i>z</i> 294, 310, 292, and 296 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The hydrolysis peak <b>M-294</b> with molecular ion (MH<sup>+</sup>) at <i>m</i>/<i>z</i> 294 was detected in all incubations that included human liver microsomes regardless of the presence or absence of NADPH or GSH. The exact mass of <b>M-294</b> (<i>m</i>/<i>z</i> 294.1348, C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>O, −0.3 ppm) and CID fragmentation patterns are consistent with the addition of H<sub>2</sub>O to nitrile moiety of <b>12</b>. This reaction in the absence of cofactor in human liver microsomes suggests a role for any number of enzymatic hydrolases. Metabolite <b>M-294</b> was further oxidized to peak <b>M-310</b> detected with molecular ion (MH<sup>+</sup>) at <i>m</i>/<i>z</i> 310 and was detected in all incubations that included human liver microsomes and NADPH suggesting oxidation by cytochrome P450. The exact mass of <b>M-310</b> (<i>m</i>/<i>z</i> 310.1299, C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>O2, 0.0 ppm) and CID fragmentation patterns are consistent with the addition of oxygen to the urea moiety of <b>M-294</b>. The oxidative peak <b>M-292</b> with molecular ion (MH<sup>+</sup>) at <i>m</i>/<i>z</i> 292, was detected in all incubations that included human liver microsomes and NADPH suggesting oxidation by cytochrome P450. The exact mass of the conjugates <b>M-292</b> (<i>m</i>/<i>z</i> 292.1192, C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O, −0.3 ppm) and CID fragmentation patterns are consistent with the addition of oxygen to the cyclopentane ring of <b>12</b>. The oxidative peak <b>M-296</b> with molecular ion (MH<sup>+</sup>) at <i>m</i>/<i>z</i> 296 was detected in all incubations that included human liver microsomes and NADPH, suggesting oxidation by cytochrome P450. The exact mass of the metabolite <b>M-296</b> (<i>m</i>/<i>z</i> 296.1144, C<sub>15</sub>H<sub>13</sub>N<sub>5</sub>O<sub>2</sub>, 0.7 ppm) and CID fragmentation patterns are consistent with pyrrole ring epoxidation, rearrangement, and a Baeyer–Villiger reaction which results in the pyrrole ring opening, loss of carbon, and addition of two oxygens to <b>12</b>.</div><div class="NLM_p">The results obtained with <b>12</b> supported a focus on indane-based cyanamides. The moderate JAK3 potency and limited selectivity versus other JAK isoforms with this scaffold were attributed to a relatively high <i>K</i><sub>i</sub> contribution leading to significant reversible binding across the JAKs. More importantly, the inactivation rate (<i>k</i><sub>inact</sub>) was deemed suboptimal to achieve high selectivity. Further insight was gained by comparing <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values for <b>6</b> and <b>12</b>. The optimized acrylamide <b>6</b> demonstrated approximately 1 order of magnitude higher <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> than <b>12</b> (<b>6</b>, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 3.68 × 10<sup>5</sup> M<sup>–1</sup>·s<sup>–1</sup>; <b>12</b>, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 5.7 × 10<sup>4</sup> M<sup>–1</sup>·s<sup>–1</sup>) and exhibited high JAK3 selectivity, suggesting further opportunity to improve <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values for <b>12</b>. Therefore, efforts were directed at the identification of structural modifications that could improve JAK3 potency and selectivity over other JAK isoforms through optimization of the inactivation rate. Among the modifications that were considered, substitutions of the indane at the C1, C2, and C3 positions were particularly attractive. It was hypothesized that a substituent at one of these positions would modulate favorably cyanamide reactivity or would lead to improved positioning of the CRG. In addition, new interactions between such a substituent and protein residues through H-bonding, lipophilic contacts, or steric clash could lead to JAK3 potency and selectivity improvements. Analogs incorporating small substituents including methyl and hydroxyl were prepared (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Addition of a <i>cis</i> 2-methyl on cyanamide <b>12</b> led to <b>20</b>, which showed no improvement in potency or selectivity (JAK3 IC<sub>50</sub> = 603 nM), while the <i>trans</i> diastereomer <b>21</b> lost potency (JAK3 IC<sub>50</sub> = 1530 nM). Incorporation of a methyl to create a tertiary center gave <b>22</b> and led to a modest improvement in potency (JAK3 IC<sub>50</sub> = 92 nM). However, evaluation of <b>22</b> in the competition assay showed a profile consistent with reversible inhibition (<i>t</i><sub>1/2</sub> = 0.05 h). In addition, data from the GSH reactivity assay showed a decrease in reactivity with <b>22</b> (<i>t</i><sub>1/2</sub> > 120 min) when compared to <b>12</b> (<i>t</i><sub>1/2</sub> = 69 min). Intrigued by these results, <b>22</b> was separated into its enantiomers <b>23</b> and <b>24</b> using chiral SFC. The absolute stereochemistries were assigned based on crystallographic data with <b>23</b> assigned as the (<i>S</i>)-enantiomer (see below). Evaluation of <b>23</b> and <b>24</b> confirmed JAK3 activity was mainly retained by <b>23</b>, with approximately a 5-fold increase in potency (<b>23</b>, JAK3 IC<sub>50</sub> = 56 nM) when compared to <b>12</b> (IC<sub>50</sub> = 256 nM). However, a potency gain with <b>23</b> was also observed across the other JAKs (JAK1 IC<sub>50</sub> = 57 nM; JAK2 IC<sub>50</sub> = 71 nM; TYK2 IC<sub>50</sub> = 179 nM), thus leading to no improvement in selectivity. Profiling of <b>23</b> in the competition assay also showed a profile consistent with reversible inhibition (<i>t</i><sub>1/2</sub> ≤ 0.05 h). In keeping with the data observed with racemic <b>22</b>, <b>23</b> also exhibited longer half-life than <b>12</b> in the GSH reactivity assay (<i>t</i><sub>1/2</sub> > 120 min). Evaluation of <b>23</b> in blood stability assays showed half-life values in both rat and human greater than 360 min, which suggested a major reduction in extrahepatic clearance involving GSH conjugation mediated through GSTs. This was a key result because it demonstrated for the first time in our JAK3 covalent project that steric hindrance around the electrophile provided a productive approach to decrease glutathione <i>S</i>-transferase (GST)-mediated clearance. It is interesting to note that Laine and collaborators previously described their approach to improve plasma stability of cyanamide-based cathepsin inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Plasma instability was considered to be mediated by an esterase acting on the nitrile, and they pursued reduction of the rate of reaction with the esterase by decreasing the electrophilicity and steric accessibility of the nitrile head. Supported with our better understanding of the clearance pathways of covalent inhibitors, our findings go far beyond addressing esterase metabolism. Our findings demonstrate that steric hindrance around the electrophile can be used as a productive method to decrease one of the major clearance pathways of covalent inhibitors (GST-mediated clearance).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Data for Compounds <b>20</b>–<b>27</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0025.gif" alt="" id="gr26" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">ATP concentration for JAK3 is 4 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">ATP concentration for JAK1 is 40 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">The intriguing profile of <b>23</b> led us to seek a better understanding of the mode of interaction of this compound with JAK3. The initially proposed interactions with <b>23</b> and JAK3 were re-examined. On the basis of an initial docking model of <b>23</b>, its angular methyl group was predicted to be positioned near the backbone carbonyl of Leu828 from the JAK3 G-loop (CH<sub>3</sub>–C═O, ∼4.6 Å). The proximity of these groups was expected to limit the rotation around the indane–pyrrolopyrimidine bond, leading to stabilization of the reactive conformation for interaction of the nitrile with Cys909, thus improving potency with concomitant selectivity gain. Although potency was increased, the lack of selectivity improvement did not support this docking hypothesis. In order to further understand the mode of binding of <b>23</b>, a crystal structure of this compound bound to JAK3 was obtained at 1.97 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). To our surprise, rotation of approximately 110° around the indane–pyrrolopyrimidine bond relative to our docking pose took place. The cyanamide was now positioned away from Cys909 with no possibility for a covalent interaction and now directed toward the back pocket of the ATP binding site. The NH displaying the nitrile was located within H-bond distance to the catalytic Asp967 residue (3.1 Å). The angular methyl group partly filled the lipophilic pocket formed by Leu956 on the floor of the ATP binding site identified in the crystal structure of <b>1</b> and likely contributes to the potency across all JAKs for <b>23</b>. Thus, all data obtained with <b>23</b> supported its profile being that of a potent, reversible, but nonselective JAK3 inhibitor.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of <b>23</b> (orange) bound to JAK3 (ribbons in cyan, residues in gray) at 1.97 Å resolution. Rotation around the indane–pyrrolopyrimidine bond was observed leading to a completely different orientation and loss of covalent interaction with Cys909 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3">6DB3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast to the unsuccessful attempts to improve JAK3 selectivity by incorporation of a methyl at the indane C1 or C2 positions, addition of a hydroxyl group at C3 led to more promising results (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The incorporation of a <i>cis</i>-3-hydroxy in <b>25</b> led to a modest improvement in JAK3 potency (IC<sub>50</sub> = 163 nM), but more importantly, this modification led to marked selectivity gains (45-fold selectivity over JAK1 and >60-fold over JAK2 and TYK2). The stereochemistry and position of the hydroxyl group were important for both potency and selectivity. The <i>trans</i>-3-hydroxy compound <b>26</b> was approximately 8-fold less potent (JAK3 IC<sub>50</sub> = 1338 nM) than <b>25</b> and showed no selectivity over JAK1 (<b>26</b>, IC<sub>50</sub> = 1094 nM). On the other hand, moving the hydroxyl group to C2 to give <i>trans</i>-2-hydroxy compound <b>27</b> (JAK3 IC<sub>50</sub> = 280 nM) led to less than a 2-fold drop in potency as compared to <b>25</b> but only 5-fold selectivity over JAK1 (IC<sub>50</sub> = 1266 nM). The three cyanamides <b>25</b>–<b>27</b> exhibited irreversible binding to JAK3 in the competition binding assay. Assessment of <b>25</b>–<b>27</b> in the GSH assay showed reactivity increases compared to <b>12</b> (<b>25</b>, <i>t</i><sub>1/2</sub> = 28 min; <b>26</b>, <i>t</i><sub>1/2</sub> = 40 min; <b>27</b>, <i>t</i><sub>1/2</sub> = 47 min), with <b>25</b> exhibiting the highest reactivity. The increase in chemical reactivity of <b>25</b> may contribute to the observed potency and selectivity gain achieved with this compound. These results may be explained by the conformation of the <i>cis</i>-3-hydroxy group. In this regard, a theoretical conformational analysis of <i>cis</i>-3-aminoindan-1-ol was described recently.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This study showed that the predominant conformation of <i>cis</i>-3-aminoindan-1-ol has a puckered cyclopentenyl ring, where the C2 atom is located on the opposite side of the OH and NH<sub>2</sub> groups and is stabilized by a hydrogen bond between the NH and OH. However, the study also revealed that the <i>cis</i>-3-aminoindan-1-ol is a flexible system. A low energy barrier (3.5 kcal/mol) was calculated for interconversion to a second puckered conformation wherein the C2 atom is located on the same side as the OH and NH<sub>2</sub> groups and where no hydrogen bonding occurs. The <i>cis</i>-3-aminoindan-1-ol work suggested that the <i>cis</i>-3-hydroxy group in <b>25</b> might increase the reactivity of the cyanamide through H-bonding to the NH. Data from the GSH reactivity assay supported a higher reactivity increase going from <b>12</b> to the <i>cis</i>-3-hydroxy <b>25</b> versus the <i>trans</i>-3-hydroxy <b>26</b>. Data from blood stability assays also inferred the higher reactivity of <b>25</b> (rat <i>t</i><sub>1/2</sub> = 20 min; human <i>t</i><sub>1/2</sub> = 339 min) compared to <b>12</b>.</div><div class="NLM_p">The results obtained with <b>25</b> led us to consider that a hydrogen bond donor at C3 of the indane might be important to enhance potency and selectivity through modulation of cyanamide reactivity or CRG positioning. To explore this hypothesis, a set of analogs incorporating a <i>cis</i>-3-sulfonamide were prepared and selected examples <b>28</b>–<b>35</b> are presented in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. It was encouraging to observe that the methanesulfonamide <b>28</b> exhibited a 4-fold increase in JAK3 potency (IC<sub>50</sub> = 38 nM) when compared to <b>25</b> and that it retained similar selectivity vs JAK1 (51-fold). Evaluation of <b>28</b> in the blood stability assay showed a reduction in half-life values in both rat and human (rat <i>t</i><sub>1/2</sub> = 31 min; human <i>t</i><sub>1/2</sub> = 208 min) when compared to <b>12</b> and <b>25</b>. Further improvement in selectivity was obtained with sulfonamides possessing larger groups. Cyanamide <b>29</b>, incorporating a methoxyethylsulfonamide group, demonstrated good potency (JAK3 IC<sub>50</sub> = 111 nM) and high selectivity vs JAK1 (78-fold). The trend was also observed with heterocyclic sulfonamides like <b>30</b>, which possesses an <i>N</i>-methyl-5-pyrazolyl (IC<sub>50</sub> = 38 nM; 106-fold selectivity). Substituted arylsulfonamides also demonstrated a large improvement in selectivity, with the substituent on the phenyl ring having an important effect on potency and selectivity. The most selective compounds incorporated substitution at the <i>meta</i> and <i>para</i> positions. The 3-cyano analog <b>31</b> (JAK3 IC<sub>50</sub> = 14 nM) and 4-methoxy derivative <b>33</b> (JAK3 IC<sub>50</sub> = 16 nM) exhibited >100-fold selectivity vs other JAK isoforms, while the 3-fluorine analog <b>32</b> (JAK3 IC<sub>50</sub> = 11 nM) demonstrated the highest selectivity observed within this series of cyanamides (246-fold selectivity vs all JAKs). Cyanamides <b>28</b>–<b>33</b> showed irreversible binding in the competition assay consistent with covalent inhibition of JAK3. These cyanamides exhibited reactivity with GSH (<i>t</i><sub>1/2</sub> = 22–80 min) in a similar range, or slightly higher than that observed with <b>12</b>. The reasons for the large gain in selectivity with the 3-fluorophenylsulfonamide <b>32</b> are not well understood. Chemical reactivity may not have been a factor, as <b>32</b> exhibited comparable GSH reactivity when compared to <b>12</b> (<b>12</b>, <i>t</i><sub>1/2</sub> = 69 min; <b>32</b>, <i>t</i><sub>1/2</sub> = 80 min). It is possible that interactions of the 3-fluorophenylsulfonamide moiety with the JAK3 P-loop contribute to both potency and selectivity gains.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Data for Compounds <b>28</b>–<b>35</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0026.gif" alt="" id="gr27" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">ATP concentration for JAK3 is 4 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">ATP concentration for JAK1 is 40 μM at <i>K</i><sub>m</sub>.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Not determined.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Data obtained using racemic compound.</p></div></div><div></div></div><div class="NLM_p">One last tactic that was used to improve potency and selectivity in this series was the incorporation of aryl groups at C5 of the pyrrolopyrimidine. It was hypothesized that a C5 aryl or heteroaryl substituent would provide improvements in potency and selectivity in two ways. First, π–π stacking between the C5 aryl/heteroaryl substituent and the indane ring may influence the conformation around the indane–pyrrolopyrimidine bond leading to improved positioning of the CRG. Second, a properly positioned substituent on the C5 aryl or heteroaryl group could pick up specific interactions with JAK3 leading to improved potency and selectivity. Additionally, such a substituent could lead to steric clashes with other JAK isoforms leading to improved selectivity. Despite the limited number of analogs prepared from this effort, the results were encouraging and suggest further improvements may be possible following this tactic. The results obtained with <b>34</b> (C5 phenyl) and <b>35</b> (C5 3-hydroxymethylphenyl) are displayed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Both <b>34</b> (JAK3 IC<sub>50</sub> = 49 nM) and <b>35</b> (JAK3 IC<sub>50</sub> = 78 nM) demonstrated potency gains when compared to <b>12</b> (JAK3 IC<sub>50</sub> = 256 nM; JAK1 IC<sub>50</sub> = 644 nM). Selectivity vs JAK1 was also improved with <b>34</b> (JAK1 IC<sub>50</sub> = 3345 nM, 68-fold selectivity) and even more markedly with <b>35</b> (JAK1 IC<sub>50</sub> > 9604 nM, 123-fold selectivity). Both analogs <b>34</b> and <b>35</b> exhibited irreversible binding in the competition assay consistent with covalent inhibition of JAK3. Also, both compounds showed comparable or slightly reduced GSH reactivity (<b>34</b>, <i>t</i><sub>1/2</sub> = 94 min; <b>35</b>, <i>t</i><sub>1/2</sub> = 69 min) when compared to <b>12</b>. Evaluation of <b>34</b> and <b>35</b> in the blood stability assay showed an approximately 3- to 7-fold reduction in half-life values in both rat and human (<b>34</b>, rat <i>t</i><sub>1/2</sub> = 61 min; human <i>t</i><sub>1/2</sub> = 61 min; <b>35</b>, rat <i>t</i><sub>1/2</sub> = 59 min; human <i>t</i><sub>1/2</sub> = 48 min) when compared to <b>12</b>, suggesting higher affinities toward GSTs than those of C5-unsubstituted cyanamides like <b>12</b>. In order to confirm the mode of binding of this set of analogs, a crystal structure of <b>34</b> bound to JAK3 was obtained at 1.66 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). This structure showed the C5 phenyl ring resides over the lipophilic pocket on the floor of the active site and is at a 4.3 Å distance to the indane, measured from the center of each six-membered aromatic ring. These rings are nearly parallel to each other as determined from comparing torsion angles between pyrrolopyrimidine and phenyl (49°) vs between indane and pyrrolopyrimidine (39°). As observed in the crystal structure of <b>12</b> bound to JAK3, the nitrile of <b>34</b> forms a covalent isothiourea adduct with Cys909. The imino NH of the isothiourea moiety is stabilized by hydrogen bonds to the side chain carboxyl group of Asp912, which is further stabilized by interaction with Arg911. The nitrogen attached to the indane ring engages in hydrogen bonding with the backbone carbonyl of Arg953. The 5-fold increase in JAK3 potency and >20-fold improvement in selectivity vs JAK1 when <b>34</b> is compared to <b>12</b> may be explained by the interaction between the phenyl and indane rings leading to improved placement of the CRG. Strikingly, these improvements do not appear to be a consequence of increased reactivity, as <b>34</b> (<i>t</i><sub>1/2</sub> = 94 min) showed comparable half-life values in the GSH reactivity assay when compared to <b>12</b> (<i>t</i><sub>1/2</sub> = 69 min).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>34</b> (gold) bound to JAK3 (ribbons in cyan, residues in gray) at 1.66 Å resolution. Covalent interaction between the nitrile and Cys909 was observed. The indane and pyrrolopyrimidine rings are nearly parallel to each other as determined from comparing torsion angles between pyrrolopyrimidine and phenyl (49°) and between indane and pyrrolopyrimidine (39°) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4">6DB4</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Selected compounds were evaluated in cell-based assays using PBMCs with IL-15 stimulation, measuring STAT5 phosphorylation, or IL-10 stimulation measuring STAT3 phosphorylation (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Signaling by IL-15 is mediated through the JAK1/JAK3 heterodimer, while signaling by IL-10 is mediated through the JAK1/TYK2 heterodimer. Selected compounds were also tested in a human whole blood (HWB) IL-15-induced STAT5 phosphorylation assay. Demonstration of suitable potency in this assay has been used by our group as key criteria to advance compounds for further preclinical profiling.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The IL-15 and IL-10 PBMC and IL-15 HWB assays were performed as previously described.<a onclick="showRef(event, 'ref27 ref36'); return false;" href="javascript:void(0);" class="ref ref27 ref36">(27,36)</a> JAK3 and JAK1 IC<sub>50</sub> values at 1 mM ATP and JAK1 IC<sub>50</sub>/JAK3 IC<sub>50</sub> ratio (J1/J3) are included to facilitate data analysis. Passive permeability was obtained using Ralph Russ canine kidney (RRCK) cells, and results are included.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Data for acrylamides 6 and <b>7</b> are provided for comparison. In agreement with our previous reports,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> there was a strong correlation between potency for JAK1 and JAK3, selectivity (J1/J3), and permeability with the potency determined in the PBMC IL-15 assay. It is evident from examination of the permeability data presented in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> that several cyanamides exhibited low permeability values (RRCK <i>P</i><sub>app</sub>(AB) < 3 × 10<sup>–6</sup> cm/s), which in turn had a detrimental effect on cell potency. Among the cyanamides with good JAK3 selectivity (J1/J3 > 50) and good permeability (RRCK <i>P</i><sub>app</sub>(AB) ≥ 4 × 10<sup>–6</sup> cm/s), <b>10</b>, <b>31</b>, <b>32</b>, and <b>35</b> were of particular interest. Cyanamide <b>10</b> exhibited cell potency in the PBMC IL-15 assay (IC<sub>50</sub> = 162 nM) that was only about 3-fold lower than the potency observed with acrylamide <b>7</b> (IC<sub>50</sub> = 63 nM); also interestingly, no JAK1 activity was observed with this compound up to the top concentration of the JAK1 enzymatic assay (10 μM), suggesting that the activity observed in the IL-15-stimulated PBMC assay may be primarily driven by JAK3 inhibition. Indane-based cyanamides <b>31</b>, <b>32</b>, and <b>35</b> exhibited potency (IC<sub>50</sub> = 331 469 nM) in the IL-15 stimulated PMBCs assay that was within 5- to 7-fold of the potency observed with acrylamide <b>7</b>. In particular, among the compounds with greater than 100-fold JAK3 selectivity, <b>32</b> was identified as the most potent analog (IC<sub>50</sub> = 331 nM) in this assay and also displayed high JAK3 selectivity (246-fold) when compared to other JAK isoforms in enzymatic assays. The high JAK3 selectivity of <b>32</b> supports its potency in the IL-15 stimulated PBMC assay as being driven primarily through JAK3 inhibition. In order to gain further understanding of the selectivity of this set of compounds at a cellular level, evaluation in PBMCs stimulated with IL-10, measuring STAT3 phosphorylation, was carried out. As noted earlier, signaling by IL-10 is mediated through the JAK1/TYK2 heterodimer. Cyanamides <b>10</b>, <b>25</b>, <b>28</b>, and <b>31</b>–<b>34</b> exhibited no inhibition in this assay up to the top concentration tested (10 μM), further supporting that their effect in PBMCs stimulated with IL-15 is primarily driven through JAK3 inhibition. A set of cyanamides was further evaluated in a human whole blood IL-15-induced STAT5 phosphorylation assay that revealed a significant liability for this series. Despite the good potency exhibited by <b>12</b>, <b>32</b>, <b>34</b>, and <b>35</b> in the IL-15 PMBC assay (IC<sub>50</sub> = 331- 598 nM), these cyanamides demonstrated no inhibition in the human whole blood assay up to the top tested concentration (IC<sub>50</sub> > 10 μM). The less JAK3 selective cyanamide <b>10</b> (IL-15 PMBC IC<sub>50</sub> = 162 nM; IL-15 HWB IC<sub>50</sub> = 7252 nM) and the noncovalent analog <b>23</b> (IL-15 PMBC IC<sub>50</sub> = 56 nM; IL-15 HWB IC<sub>50</sub> = 5480 nM) also demonstrated poor correlation between assays. It is important to note that <b>6</b> demonstrated potent activity in this assay (IL-15 HWB IC<sub>50</sub> = 197 nM), indicating that JAK3 selective inhibitors can inhibit IL-15 in human whole blood, as previously reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The poor translation from a cell-based PBMC assay to one conducted in human whole blood has previously been observed by our group when comparing the poorly correlated arylaminoacrylamides versus the better correlated aliphatic aminoacrylamides.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The reasons for the poor correlation were not fully elucidated, but it was postulated that the enhanced reactivity of aryl aminoacrylamides was a major contributor to their poor correlation. It is unlikely that reactivity may explain the poor correlation observed with the cyanamides, as a number of these analogs exhibited low reactivity in the GSH assay (<b>10</b> and <b>23</b>, <i>t</i><sub>1/2</sub> > 120 min; <b>34</b>, <i>t</i><sub>1/2</sub> = 94 min). In addition, a number of these analogs also exhibited high stability in human blood stability assay (<b>12</b> and <b>23</b>, <i>t</i><sub>1/2</sub> > 120 min). Thus, the reasons for the poor correlation observed with the cyanamides are unclear.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Evaluation of Selected Cyanamides in Cell-Based Assays<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="​" /></col><col align="char" char="​" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">JAK3</th><th class="colsep0 rowsep0" align="center" char=".">JAK1</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">RRCK<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">IL-15 PBMC</th><th class="colsep0 rowsep0" align="center" char="​">IL-10 PBMC</th><th class="colsep0 rowsep0" align="center" char="​">IL-15 HWB</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">J1/J3</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub>(AB) (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="​">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="​">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>293</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char="​">>60000<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="​">197</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>323</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">953</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">456</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">162</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">7252</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">256</td><td class="colsep0 rowsep0" align="char" char=".">644</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">598</td><td class="colsep0 rowsep0" align="char" char="​">2815</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char="​">ND<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="​">5480</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">163</td><td class="colsep0 rowsep0" align="char" char=".">>7318</td><td class="colsep0 rowsep0" align="char" char=".">>45</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1728</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">1918</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">2240</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">1715</td><td class="colsep0 rowsep0" align="char" char=".">123</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">468</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">2703</td><td class="colsep0 rowsep0" align="char" char=".">246</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">331</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">>10000<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">1720</td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">947</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">3345</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">458</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">>9604</td><td class="colsep0 rowsep0" align="char" char=".">>123</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">498</td><td class="colsep0 rowsep0" align="char" char="​">>7843</td><td class="colsep0 rowsep0" align="char" char="​">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">ATP concentration for JAK3 and JAK1 assays is 1 mM.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Passive permeability was obtained using Ralph Russ canine kidney (RRCK) cells.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Data for <b>6</b> were reported previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Determined in total lymphocytes in human whole blood.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Not determined.</p></div><div class="footnote" id="t6fn6"><sup><sup>f</sup></sup><p class="last">Data obtained using racemic compound.</p></div></div></div><div class="NLM_p">Evaluation of the kinome selectivity of selected cyanamides <b>10</b>, <b>12</b>, <b>25</b>, <b>32</b>, and <b>35</b> was pursued in a panel of 40 kinases. The screen was run at a compound concentration of 1 μM and 1 mM ATP concentration for all kinases. Data showed that in general these cyanamides demonstrate high selectivity in this panel (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), with <b>10</b>, <b>25</b>, <b>32</b>, and <b>35</b> exhibiting >50% inhibition for only a single kinase in addition to JAK3. Kinases inhibited by these compounds include BTK (<b>10</b>, 75% inhibition), PRKCB2 (<b>35</b>, 52% inhibition), CHEK2 (<b>25</b>, 52% inhibition), and KDR (<b>32</b>, 58% inhibition). Cyanamide <b>12</b> inhibited 5/40 kinases with >50% inhibition. Cyanamides <b>12</b>, <b>32</b>, and <b>35</b> were selected for evaluation in a panel of kinases that contain a Cys residue at the equivalent position of Cys909 in JAK3. The IC<sub>50</sub> values were determined in the presence of 1 mM ATP (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The data showed that high selectivity for JAK3 versus this panel of kinases was achieved. BMX was the only kinase inhibited by all compounds and the one that exhibited the lowest margins of selectivity for <b>12</b> (IC<sub>50</sub> = 6310 nM, 24-fold selectivity) and <b>35</b> (IC<sub>50</sub> = 1900 nM, 24-fold selectivity). In contrast to these compounds, <b>32</b> exhibited high selectivity for JAK3 vs BMX (IC<sub>50</sub> = 3390 nM, 308-fold selectivity). <b>35</b> inhibited three other kinases (HER4, IC<sub>50</sub> = 3540 nM, 45-fold; TEC, IC<sub>50</sub> = 8960 nM 115-fold; TXK, IC<sub>50</sub> = 2990 nM 38-fold). Collectively, the data obtained for this selected set of cyanamide analogs demonstrated that high kinome selectivity can be obtained, even for kinases expected to be inhibited due to the presence of a Cys residue at the equivalent position of Cys909 in JAK3.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Heatmap of kinase activity profile (% inhibition at 1 mM ATP) of <b>10</b>, <b>12</b>, <b>25</b>, <b>32</b>, and <b>35</b> at 1 μM concentration: red, 100% inhibition; yellow, 50% inhibition; green, 0% inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Activity of <b>12</b>, <b>32</b>, and <b>35</b> against Kinases Containing a Cys Residue at the Same Position as Cys909 in JAK3</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char="."><b>12</b></th><th class="colsep0 rowsep0" align="center" char="."><b>32</b></th><th class="colsep0 rowsep0" align="center" char="."><b>35</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BLK</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMX</td><td class="colsep0 rowsep0" align="char" char=".">6310</td><td class="colsep0 rowsep0" align="char" char=".">3390</td><td class="colsep0 rowsep0" align="char" char=".">1900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTK</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HER2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HER4</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">3540</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ITK</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAP2K7</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TEC</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">8960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TXK</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">2990</td></tr></tbody></table></div></div><div class="NLM_p last">As discussed earlier, our interest in pursuing this work was to develop a better understanding of the effect of a cyanamide as the electrophile on key components of covalent JAK3 inhibitor design, including reactivity tuning to achieve an optimal balance between <i>K</i><sub>i</sub> and <i>k</i><sub>inact</sub>. The results obtained with the aminoindane based cyanamides showed that modulation of <i>K</i><sub>i</sub> and <i>k</i><sub>inact</sub> could be achieved through structural modifications to enhance potency and selectivity. This was observed in going from <b>12</b> (JAK3 IC<sub>50</sub> = 256 nM; 2-fold selectivity vs JAK1) to <b>32</b>, with the optimized <b>32</b> exhibiting potent JAK3 inhibition (IC<sub>50</sub> = 11 nM) and high selectivity for JAK3 vs other JAKs (246-fold). Despite the promising profile demonstrated with <b>32</b> and other analogs, the lack of potency of the indane-based cyanamides in the IL-15 human whole blood assay and lack of understanding of the factors that contribute to the poor translation between cell-based PBMC assays and the assay conducted in human whole blood led us to deprioritize this series for further progression.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of compound <b>7</b> is described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The synthesis starts with the selective bromination of 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>36</b>) with NBS at C-2 to give <b>37</b>, which after reaction with <i>n</i>BuLi to form the dianion was then reacted with 1-bromo-2-methoxyethane to give <b>38</b>. Intermediate <b>38</b> was subsequently coupled to (3-aminophenyl)boronic acid under Suzuki conditions to provide <b>39</b>,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> and this was followed by acylation with acryloyl chloride to give acrylamide <b>7</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acrylamide <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DCM, rt, 14 h, 51%; (b) Br(CH<sub>2</sub>)<sub>2</sub>OMe, <i>n</i>-BuLi, THF, −60 °C, 1 h, 15%; (c) <i>m</i>-NH<sub>2</sub>PhB(OH)<sub>2</sub>, dioxane/H<sub>2</sub>O (4:1), K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf), 90 °C, 3 h, 74%; (d) acryloyl chloride, <i>i</i>Pr<sub>2</sub>NEt, DMF, 0 °C, 4 h, 21%.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>8</b> and <b>9</b> is described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. 4-Chloro-5-(2-methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>38</b>) was reacted with boronate <b>40</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> under Suzuki cross-coupling conditions to give benzoxazinone <b>41</b>. Reduction of the carbonyl group of <b>41</b> with LAH in THF afforded amine <b>42</b>, which was acylated with acryloyl chloride to give <b>8</b>. The synthesis of the cyanamide derivative <b>9</b> was accomplished by reacting amine <b>42</b> with CNBr/K<sub>2</sub>CO<sub>3</sub> to provide the desired product.<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49−51)</a></div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acrylamide <b>8</b> and Cyanamide <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>40</b>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, 30 min, 38%; (b) LAH, THF, reflux, 18 h, 25%; (c) acryloyl chloride, THF, 0 °C, 18%; (d) BrCN, THF, K<sub>2</sub>CO<sub>3</sub>, 0 °C, 42%.</p></p></figure><div class="NLM_p">The synthesis of <b>10</b> is described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Thus, beginning with 2-amino-4-bromophenol (<b>43</b>) the hydroxyl group was selectively alkylated with CF<sub>2</sub>CHBr under basic conditions to provide the ether <b>44</b>, which was treated with potassium carbonate in DMF to give the morpholino derivative <b>45</b>. The bromide <b>45</b> was converted to its boronate ester <b>46</b> under standard conditions. With the boronate <b>46</b> in hand, this was then coupled to chloride <b>47</b> under Suzuki conditions to give <b>48</b>. The final compound was obtained in two steps: (1) cyanation of the amine in <b>48</b> with CNBr in the presence of sodium hydride at low temperature to give <b>49</b> and (2) SEM group removal to give <b>10</b>.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cyanamide <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CF<sub>2</sub>CHBr, KOH, CH<sub>3</sub>CN/H<sub>2</sub>O (7:1), 50 °C, 14 h, 98%; (b) K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 14 h, 99%; (c) (BPin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 100 °C, 95%; (d) <b>47</b>, PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, MeTHF/H<sub>2</sub>O (4:1), 70 °C, 14 h, 27%; (e) BrCN, NaH, DMF, 0 °C, 95%; (f) TFA, DCM, 2.5 h, then NH<sub>4</sub>OH, CH<sub>3</sub>CN, 42%.</p></p></figure><div class="NLM_p">The syntheses of cyanamides <b>12</b>–<b>15</b> are described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Commencing from pyrrolopyrimidine chloride <b>36</b>, Suzuki coupling with the known boronate <b>50</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> provided compound <b>51</b>. The Boc group was removed under acidic conditions to give amine <b>52</b>, which was then cyanated with cyanogen bromide and potassium carbonate to give racemic <b>11</b>. The racemate <b>11</b> was purified by chiral SFC chromatography to afford the single enantiomers <b>12</b> and <b>13</b>. The absolute stereochemistry of <b>13</b> was assigned as (<i>R</i>) based on a single X-ray structure (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>). By inference, the stereochemistry of <b>12</b> was assigned as (<i>S</i>). The synthesis of compounds <b>14</b> and <b>15</b> was carried out following a similar route to that described for <b>11</b> but starting from pyrrolopyrimidine chloride <b>38</b> and boronate <b>50</b> or <b>58</b>. The boronate <b>58</b> was readily prepared from 6-bromoindanone (<b>55</b>) by condensation with methylamine, followed by reduction to give amine <b>56</b>. The amine was then protected as the Boc carbamate to give <b>57</b>, and the bromide was subsequently converted to the boronate to give <b>58</b>.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyanamides <b>12</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>50</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (8:2), Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 16 h, 39%, (b) 2 N HCl/ether, 66–91%; (c) BrCN, K<sub>2</sub>CO<sub>3</sub>, THF, 40 °C, 16–26%; (d) chiral SFC (Chiralcel OD-3, CO<sub>2</sub>/MeOH + 0.05%TEA); (e) <b>50</b> or <b>58</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 1 h, microwave, 50–54%; (f) MeNH<sub>2</sub>, Ti(O-<i>i</i>Pr)<sub>4</sub> then NaBH<sub>4</sub>, MeOH, 75%; (g) Boc<sub>2</sub>O, TEA, DCM, 0 °C, 78%; (h) (BPin)<sub>2</sub>, KOAc, PdCl<sub>2</sub>(dppf), dioxane, 80 °C, 97%.</p></p></figure><div class="NLM_p">In order to establish the structure of the preferred tautomer (form A or B, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) of <b>12</b>, HSQC and COSY spectra (in DMSO-<i>d</i><sub>6</sub>) were taken (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>). The HSQC spectra clearly assigned all the key carbons and hydrogens. A COSY spectra showed a <sup>1</sup>H–<sup>1</sup>H correlation between H18 and H19 supporting the tautomeric form A. Moreover, the tautomeric form A is further supported by literature precedent on similar systems.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Possible tautomers of cyanamide <b>12</b>. Data from COSY experiment support tautomeric form A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of the chromane-based cyanamides <b>16</b>–<b>19</b> was carried out using a route similar to the one described above (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) but utilizing a different boronate coupling partner. Suzuki coupling of pyrrolopyrimidine chloride <b>36</b> and boronate <b>61</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> provided the Boc-protected amine <b>62</b>. The Boc group was removed under acidic conditions to give amine <b>63</b>, which was then cyanated with cyanogen bromide and potassium carbonate to give <b>16</b>. The racemate <b>16</b> was separated by chiral SFC to provide the enantiomers <b>17</b> and <b>18</b>. The absolute stereochemistry of <b>17</b> was assigned as (<i>S</i>) based on (a) the JAK3 activity of this compound that differentiates it from its opposite enantiomer and resembles the potency difference observed in the indane series and (b) a crystal structure of <b>17</b> bound to JAK3 determined at 1.99 Å resolution (data not shown). Finally, the racemic cyanamide <b>19</b> was prepared using a similar route but starting from pyrrolopyrimidine chloride <b>38</b>.</div><figure id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0015.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cyanamides <b>16</b>–<b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>61</b>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 16 h, 52%; (b) 2 N HCl/ether, 2 h, rt, 91–97%; (c) CNBr, K<sub>2</sub>CO<sub>3</sub>, THF, 40 °C, 25–27%; (d) chiral SFC (AD, MeOH/CO<sub>2</sub> + 0.1% NH<sub>4</sub>OH); (e) <b>38</b>, <b>61</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 1 h, microwave, 54%.</p></p></figure><div class="NLM_p">The preparation of compounds <b>20</b> and <b>21</b> is described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. For these compounds, the route begins with 6-bromo-2,3-dihydro-1<i>H</i>-inden-1-one (<b>55</b>), which was monoalkylated with methyl iodide in the presence of LDA to give <b>66</b>. The ketone group was then converted to an amine in two steps: (1) hydroxylamine formation to give <b>67</b> and (2) reduction with zinc under acidic conditions to give <b>68</b> as a mixture of <i>cis</i> and <i>trans</i> isomers. The amino group in <b>68</b> was protected to give carbamate <b>69</b>, and the bromide was converted to the boronate to give <b>70</b>. Suzuki coupling of pyrrolopyrimidine chloride <b>36</b> with boronate <b>70</b> under standard conditions gave <b>71</b> (rac-trans) and <b>73</b> (rac-cis) after chromatography. Both <b>71</b> and <b>73</b> were treated with acid to remove the Boc group and provide the amines <b>72</b> and <b>74</b>, respectively. The amines were then treated with cyanogen bromide in the presence of 4-methylmorpholine to afford <b>20</b> and <b>21</b>.</div><figure id="sch6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0016.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Cyanamides <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1 N LDA, THF, −78 °C, then MeI, 12%; (b) NH<sub>2</sub>OH·HCl, MeOH, reflux, 3 h, 100%; (c) Zn, 2 N HCl, THF, 3 h, 87%; (d) Boc<sub>2</sub>O, TEA, DCM, 24 h, 0 °C, 18%; (e) PdCl<sub>2</sub>(dppf), (BPin)<sub>2</sub>, KOAc, dioxane, 100 °C, 73%; (f) Pd(PPh<sub>3</sub>)<sub>4</sub>, <b>72</b>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, microwave, 30 min, 62%; (g) TFA, DCM, 0 °C, 100%; (h) CNBr, NMM, DMF, −20 °C, 2 h, 31%.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>22</b>–<b>24</b> is described in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. The synthesis of the boronate <b>79</b> starts from indenone <b>55</b>. Reaction of this ketone with methylmagnesium bromide provided cleanly the tertiary racemic alcohol <b>75</b>. The alcohol <b>75</b> was converted to the azide <b>76</b>, following a procedure similar to that described by Kumar et al.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> (warning: hydrazoic acid), which was then reduced using trimethylphosphine to give amine <b>77</b>. After protection of the amine as the Boc derivative to afford <b>78</b>, the bromide was converted to boronate <b>79</b>. Suzuki coupling of <b>36</b> with boronate <b>79</b> provided the Boc-protected amine <b>80</b>. Removal of the protecting group under acidic conditions gave amine <b>81</b>, which was readily converted to cyanamide <b>22</b>. The racemic Boc-protected amine <b>80</b> was separated by chiral SFC to give the enantiomeric pair <b>82</b> and <b>83</b>. Both <b>82</b> and <b>83</b> were separately treated with acid to provide the free amines, which were then cyanated to give <b>23</b> and <b>24</b>. The absolute stereochemistry of <b>23</b> was assigned as (<i>S</i>) based on the crystal structure of this compound bound to JAK3. By inference, the absolute stereochemistry of <b>24</b> was assigned as (<i>R</i>).</div><figure id="sch7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0017.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Cyanamides <b>22</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3 M MeMgBr, THF, 0 °C, 2 h, 71%; (b) NaN<sub>3</sub>, TFA, 0–30 °C, 3 h, 96%; (c) PMe<sub>3</sub>, THF/H<sub>2</sub>O (10:1), 30 °C, 24 h, 41%; (d) Boc<sub>2</sub>O, TEA, DCM, 24 h, 30 °C, 52%; (e) PdCl<sub>2</sub>(dppf), (BPin)<sub>2</sub>, KOAc, dioxane, 100 °C, 100%; (f) <b>36</b>, <b>79</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 100 °C, 14 h, 47%; (g) 4 N HCl, dioxane, 25 °C, 34%; (h) CNBr, NMM, DMF, −20 °C, 2 h, 16–37%; (i) chiral SFC (AD, CO<sub>2</sub>/EtOH + 0.1% NH<sub>4</sub>OH), 95%.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>25</b> and <b>26</b> is described in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. A key component of the synthesis of these analogs was the construction of ketone <b>92</b> with control of the absolute stereochemistry. This was accomplished using Ellman sulfinimine chemistry employing the chiral amine derivative <i>tert</i>-butanesulfinamide.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Thus, 3-bromobenzaldehyde (<b>84</b>) was condensed with (<i>R</i>)-2-methylpropane-2-sulfinamide to provide imine <b>85</b>. The imine <b>85</b> was then reacted with <i>tert</i>-butyl bromoacetate/SmI<sub>2</sub> to give <b>86</b>.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> Treatment of <b>86</b> under acidic conditions provided the amino acid <b>87</b>, which was protected as the trifluoroacetamide derivative <b>88</b>. The carboxylic acid <b>88</b> was converted to the acid chloride <b>89</b>, which was subjected to Friedel–Crafts acylation to give <b>90</b> and <b>91</b> (∼3:1 ratio of regioiosmers). The regiochemistry was confirmed by NMR (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>). The desired regioisomer bromide <b>90</b> was converted to boronate <b>92</b>, followed by Suzuki coupling with chloride <b>36</b> to provide ketone <b>93</b>. The ketone was then reduced with NaBH<sub>4</sub> to give <b>94</b> as a mixture of <i>cis</i> and <i>trans</i> alcohols, which were separated by RP-HPLC to afford <b>95</b> (<i>cis</i>) and <b>96</b> (<i>trans</i>). The stereochemistry of the compounds was confirmed by NOE. The trifluoroacetamide group in <b>95</b> was removed to give amine <b>97</b>, which in turn was cyanated to give <b>25</b>. Compound <b>96</b> was taken through a similar sequence as <b>95</b> to give cyanamide <b>26</b>.</div><figure id="sch8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0018.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Cyanamides <b>25</b> and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-2-methylpropane-2-sulfinamide, <i>p</i>-TsOH, MgSO<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h, 68%; (b) 0.1 M SmI<sub>2</sub>, <i>t</i>-BuO<sub>2</sub>CCH<sub>2</sub>Br, THF, −70 °C, 39%; (c) 4 N HCl/dioxane, 14 h, rt, 100%; (d) TFAA, 2 h, rt, 67%; (e) SOCl<sub>2</sub>, 1 h, reflux, 98%; (f) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 1 h, <b>90</b>, 58%, <b>91</b>, 19%; (g) PdCl<sub>2</sub>(dppf), KOAc, dioxane, 100 °C, 5 h, 100%; (h) <b>92</b>, PdCl<sub>2</sub>(dppf), KF, dioxane/H<sub>2</sub>O (4:1), 90 °C, 14 h, 53%; (i) NaBH<sub>4</sub>, MeOH, 0 °C, 2 h, 55%; %; (j) RP-HPLC CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% NH<sub>4</sub>OH; (k) Na<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (3:1), reflux, 14 h, 81%; (l) CNBr, NMM, CH<sub>2</sub>Cl<sub>2</sub>, −30 °C, 1.5 h, 36–47%.</p></p></figure><div class="NLM_p">The synthesis of compound <b>27</b> is described in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>. The amine of the known racemic <i>trans</i>-(1<i>R</i>,2<i>R</i>)-1-amino-6-bromo-2,3-dihydro-1<i>H</i>-inden-2-ol (<b>99</b>) was initially protected as the Boc-carbamate to give <b>100</b>, followed by replacement of the bromide to give boronate <b>101</b>. Suzuki coupling of <b>101</b> to pyrrolopyrimidine chloride <b>36</b> followed by chiral SFC provided the enantiomers <b>102</b> (peak 2, <i>R</i>,<i>R</i>) and <b>104</b> (peak 1, <i>S</i>,<i>S</i>). The absolute stereochemistry of <b>104</b> was determined by obtaining an X-ray crystal structure of the HCl salt of <b>105</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>), after Boc deprotection of <b>104</b>. This structure showed that <b>105</b> possessed 1<i>S</i>,2<i>S</i>-stereochemistry. By inference, the stereochemistry of <b>102</b> was assigned as 1<i>R</i>,2<i>R</i>. The Boc-amine <b>102</b> was converted to the amine <b>103</b> and then cyanated to give enantiomerically pure <b>27</b>.</div><figure id="sch9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0019.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Cyanamide <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, THF, 0 °C, 1 h, 38%; (b) PdCl<sub>2</sub>(dppf), KOAc, (BPin)<sub>2</sub>, dioxane, 3 h, 100 °C, 85%; (c) <b>36</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2.5 h, 100 °C, 48% then SFC, <b>102</b>, peak 2 carried forward; (d) 4 N HCl/dioxane, 1.5 h; (e) <b>103</b>, CNBr, NMM, DMF, 0 °C, 35% in two steps.</p></p></figure><div class="NLM_p">The synthesis of sulfonamides <b>28</b>–<b>33</b> is described in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>. The synthesis of these analogs starts from the chiral ketone <b>93</b> which was converted to hydroxylamine derivative <b>106</b>. Reduction with zinc under acidic conditions afforded the primary amines <b>107</b> and <b>108</b> after separation by chromatography (∼4:1 <i>cis</i>/<i>trans</i> ratio as determined by NMR). The <i>cis</i> isomer <b>107</b> was then taken forward through a three-step sequence in a parallel chemistry format: (1) sulfonamide formation with selected sulfonyl chlorides, (2) trifluoroacetamide removal, and finally (3) cyanation to give <b>28</b>–<b>33</b> as single enantiomers.</div><figure id="sch10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0020.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Sulfonamides <b>28</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, EtOH, 1 h, reflux, 100%; (b) Zn, 4 N HCl, THF, rt, 1 h. <b>107</b>: 23%. <b>108</b>: 5%. (c) RSO<sub>2</sub>Cl, DIPEA, DMF, 0 °C, 12 h, 14–75%; (d) K<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O (7:1), 100 °C, 8 h, 41–88%; (e) CNBr, NMM, DMF, −30 °C, 30 min, 19–38%.</p></p></figure><div class="NLM_p">The synthesis of cyanamide <b>34</b> is described in <a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>. The preparation begins from the known (<i>R</i>)-6-bromoindan-1-ol (<b>111</b>)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> to obtain optically active boronate <b>115</b> via four steps. It is important to note that compound <b>115</b> is the (<i>S</i>)-enantiomer of boronate <b>50</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Thus, alcohol <b>111</b> was reacted with DPPA and DBU to provide azide <b>112</b>, which was then reduced with tin chloride to give amine <b>113</b>. Protection of the amine afforded <b>114</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a> for single X-ray), which was then converted to the optically pure boronate <b>115</b>. Suzuki coupling of pyrrolopyrimidine chloride <b>116</b>, prepared as previously described,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> with boronate <b>115</b> gave <b>117</b>. Finally, the Boc group was removed under acidic conditions to give amine <b>118</b>, which was then cyanated to give cyanamide <b>34</b>.</div><figure id="sch11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0021.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Cyanamide <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DPPA, DBU, PhMe, 4 h, 0 °C, 70%; (b) SnCl<sub>2</sub>, MeOH, 0 °C, 5 h, 78%; (c) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 2 h, rt, 63%; (d) (BPin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 3 h, 80 °C, 90%; (e) <b>116</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 36%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 2 h, 0 °C, 78%; (g) CNBr, NMM, DMF, −30 °C, 1 h, 46%.</p></p></figure><div class="NLM_p">The synthesis of compound <b>35</b> is described in <a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>. The starting 4-chloro-5-iodo-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>119</b>) was prepared as previously described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Coupling of <b>119</b> with boronic acid <b>120</b> under Suzuki conditions gave <b>121</b>. The SEM protecting group was removed under acidic conditions to give <b>122</b>, which was coupled to boronate <b>115</b> to give <b>123</b>. Removal of the Boc-group with acid provided amine <b>124</b>, which was cyanated to give <b>35</b>.</div><figure id="sch12" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0022.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Cyanamide <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>119</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (5:1), 3 h, 100%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> then K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 89%; (c) <b>115</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane:H<sub>2</sub>O (5:1), 24 h, 80 °C, 43%; (d) 4 N HCl/EtOAc, 2 h, rt, 11%; (e) CNBr, NMM, DMF, 0.5 h, −20 °C, 41%.</p></p></figure><div class="NLM_p last">It is important to note that no atropoisomerism was observed for <b>34</b> and <b>35</b>. The <sup>1</sup>H NMR and HPLC of each of these compounds showed no doubling up of signals (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of selective JAK3 inhibitors has attracted attention from both academic and industrial research groups for several decades due to the key role that this kinase plays in the immune system. Recently, covalent inhibitors that target the JAK3 residue Cys909, a unique residue within the JAK family, have resulted in compounds with high JAK3 selectivity, including <b>6</b>, a JAK3-specific inhibitor currently in human clinical trials. Further interest in the discovery of selective JAK3 inhibitors led us to design novel covalent inhibitors that engage Cys909 through a cyanamide moiety, a structurally and mechanistically differentiated electrophile from the acrylamide moiety in <b>6</b>. Our results with aminoindane based cyanamides showed that modulation of two key parameters of covalent inhibitors, <i>K</i><sub>i</sub> and <i>k</i><sub>inact</sub>, could be achieved through structural modifications leading to enhanced potency and selectivity. This was demonstrated in the progression from the unoptimized cyanamide <b>12</b> (JAK3 IC<sub>50</sub> = 256 nM; 2-fold selectivity vs other JAKs) to the potent and highly JAK3 selective <b>32</b> (JAK3 IC<sub>50</sub> = 11 nM; 246-fold selectivity vs other JAKs). Cyanamide <b>32</b> also showed high kinome selectivity in a panel of 40 kinases (1/40 kinases, >50% inhibition) and in a panel of 10 kinases that contain a Cys residue at the equivalent position of Cys909 in JAK3 (>300-fold selectivity for JAK3 vs all kinases in panel). Furthermore, evaluation of <b>32</b> in IL-15-stimulated PBMC assays demonstrated that selective inhibition of JAK3 is sufficient to drive cellular activity in pathways signaled through the JAK1/JAK3 heterodimer (IL-15 PBMC IC<sub>50</sub> = 331 nM), a result in agreement with previous reports from this group. Even with the interesting profile demonstrated by <b>32</b> and other analogs, the weak potency observed with the indane-based cyanamides in the IL-15 human whole blood assay (e.g., <b>32</b>, IL-15 HWB IC<sub>50</sub> > 10 000 nM) and, more importantly, the lack of understanding of the factors that contribute to the poor translation between cell-based PBMC assays and the assay conducted in human whole blood were recognized as significant liabilities leading us to deprioritize this series for further progression.</div><div class="NLM_p">Gaining further understanding of the pharmacokinetic properties of cyanamide-based JAK3 covalent inhibitors was an important component of our work. To this end, the pharmacokinetic properties of <b>12</b> were evaluated in rat. An important finding was the significant contribution to the clearance of <b>12</b> from extrahepatic processes, including GSH/GST-mediated clearance. These data suggested cyanamide-based covalent inhibitors would likely face similar challenges as do other covalent JAK3 inhibitors based on different CRGs (e.g., acrylamides) to achieve favorable pharmacokinetic properties suitable for oral dosing in humans.</div><div class="NLM_p last">One of the more important results from this work was the identification of an approach to decrease GSH/GST-mediated clearance. It was demonstrated with <b>23</b> that steric hindrance around the electrophile significantly decreased GST-mediated clearance (GSH reactivity <i>t</i><sub>1/2</sub> > 120 min; human and rat blood stability <i>t</i><sub>1/2</sub> > 360 min). In the case of the aminoindane based cyanamide series, this modification led to loss of covalent interaction, but our group successfully applied this approach in the aliphatic acrylamide series leading to the identification of <b>6</b> as previously reported.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General</h3><div class="NLM_p last">All chemicals, reagents, and solvents were purchased from commercial sources when available and used without further purification. Anhydrous solvents (dioxane, dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>), toluene, acetonitrile) were purchased from Aldrich (SureSeal) and used in reactions without further purification. NADPH, GSH, and magnesium chloride utilized in metabolism studies were purchased from Sigma-Aldrich (St. Louis, MO). Reactions were magnetically stirred and monitored by thin layer chromatography (TLC) using precoated Whatman 250 μm silica gel plates and visualized by UV light and by GC/MS. Silica gel chromatography was performed utilizing ACS grade solvents and ISCO or Biotage purification systems and prepackaged columns. Yields refer to purified compounds. <sup>1</sup>H NMR spectra (400 MHz field strength) and <sup>13</sup>C NMR spectra (101 MHz field strength) were obtained on a Bruker AV III spectrometer equipped with a BBFO probe. Alternatively, <sup>1</sup>H NMR spectra (500 MHz field strength) and <sup>13</sup>C NMR spectra (125 MHz field strength) were obtained on a Bruker 500 Avance III HD using a 5 mm Prodigy BBO cryoprobe. Chemical shifts were referenced to the residual <sup>1</sup>H solvent signals (CDCl<sub>3</sub>, δ 7.27), (DMSO-<i>d</i><sub>6</sub>, δ 2.50) and solvent <sup>13</sup>C signals (CDCl<sub>3</sub>, δ 77.00) (DMSO-<i>d</i><sub>6</sub>, δ 39.51). Signals are listed as follows: chemical shift in ppm (multiplicity identified as s = singlet, br = broad, d = doublet, t = triplet, q = quartet, m = multiplet; coupling constants in Hz; integration). High resolution mass spectrometry (HRMS) was performed via atmospheric pressure chemical ionization (APCI) or electron scatter ionization (ESI) sources. Purity of final compounds was determined by HPLC or LCMS methods. All final compounds possess a purity of ≥95%, unless noted.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of <i>N</i>-(3-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)phenyl)acrylamide (<b>7</b>)</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 1: 5-Bromo-4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>36</b>)</h4><div class="NLM_p last">Prepared analogous to the procedure as described in WO201385802.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> To a suspension of 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine <b>36</b> (13.0 g, 84.65 mmol) in DCM (200 mL) was added NBS (18.08 g, 101.58 mmol). The reaction mixture was stirred at room temperature overnight. The suspension was filtered. The filter cake was suspended in saturated aqueous Na<sub>2</sub>SO<sub>3</sub> (200 mL) and stirred at room temperature for 30 min. The suspension was filtered again and the filter cake was washed with hot water (200 mL) and MTBE (200 mL), dried in vacuum to afford <b>37</b> (10.0 g, 51%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.9 (bs, 1H), 8.6 (s, 1H), 7.9 (s, 1H); LC/MS (M + H) expected, 231.93; observed, 231.9.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step 2: 4-Chloro-5-(2-methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>38</b>)</h4><div class="NLM_p last">Prepared analogous to the procedure as described in WO2015083028.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> To a suspension of <b>37</b> (4.0 g, 17.20 mmol) in THF (200 mL) at −60 °C under N<sub>2</sub> was added <i>n</i>BuLi (14.11 g, 35.27 mmol) dropwise over a period of 30 min. The reaction mixture was stirred at the same temperature for 30 min, then Br(CH<sub>2</sub>)<sub>2</sub>OMe (6.55 mL, 68.82 mmol) was added dropwise. The reaction was quenched with aqueous NH<sub>4</sub>Cl (50 mL), extracted with EtOAc (200 mL × 3). The organic phase was concentrated to dryness and the residue was purified by column chromatography (PE/EtOAc from 100:1 to 30:1) to afford compound <b>38</b> (400 mg, 15%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO- <i>d</i><sub>6</sub>) δ 12.3 (bs, 1H), 8.5 (s, 1H), 7.5 (s, 1H), 3.6 (t, 2H), 3.3 (s, 3H), 3.1 (t, 2H); LC/MS (M + H) expected, 212.06; observed, 212.18.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step 3: 3-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)aniline (<b>39</b>)</h4><div class="NLM_p last">To a solution of <b>38</b> (150 mg, 0.70 mmol) and (3-aminophenyl)boronic acid (107 mg, 0.77 mmol) in dioxane/water = 4:1 (20 mL) were added K<sub>3</sub>PO<sub>4</sub> (301 mg, 1.41 mmol) and PdCl<sub>2</sub>(dppf) (26 mg, 0.03 mmol). The reaction was stirred at 90 °C for 2.5 h. After the reaction was complete, the mixture was filtered and the filtrate was concentrated to dryness. The crude product was purified by column chromatography (DCM/MeOH from 10:1 to 20:1) to afford <b>39</b> (140 mg, 74%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.92 (br s, 1 H), 8.66 (s, 1 H), 7.33 (d, <i>J</i> = 1.95 Hz, 1 H), 7.11 (t, <i>J</i> = 7.71 Hz, 1 H), 6.57–6.79 (m, 3 H), 3.07 (t, <i>J</i> = 7.12 Hz, 2 H), 2.98 (s, 3 H), 2.69 (t, <i>J</i> = 7.22 Hz, 2 H); LC/MS (M + H) expected, 269.14; observed, 269.2</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 4: <i>N</i>-(3-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)phenyl)acrylamide (<b>7</b>)</h4><div class="NLM_p last">To a solution of <b>39</b> (130 mg, 0.48 mmol) in DMF (15 mL) were added acryloyl chloride (0.04 mL, 0.48 mmol) and DIPEA (0.43 mL, 2.42 mmol) at 0 °C. The reaction was stirred at 0 °C for 4 h. The reaction was quenched with CH<sub>3</sub>OH (15 mL) and evaporated to dryness. The residue was dissolved in water (15 mL) and then extracted with EtOAc (3 × 20 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by prep-HPLC to afford <b>7</b> (32.9 mg, 21.1%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (s, 1H), 10.33 (s, 1H), 8.76 (s, 1H), 8.03 (s, 1H), 7.77 (d, <i>J</i> = 8 Hz, 1H), 7.51–7.33 (m, 2H), 7.35 (d, <i>J</i> = 8 Hz, 1H), 6.44–6.41 (m, 1H), 6.29–6.24 (m, 1H), 5.78–5.76 (m, 1H), 3.09–3.05 (m, 2H), 2.97 (s, 3H), 2.74–2.71 (m, 2H); LC/MS (M + H) expected, 323.14; observed, 323.1. HRMS (ESI+) <i>m</i>/<i>z</i>: calculated for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1503; observed 323.1500.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthesis of 1-(6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazin-4-yl)prop-2-en-1-one (<b>8</b>) and 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>9</b>)</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Step 1: 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-3(4<i>H</i>)-one (<b>41</b>)</h4><div class="NLM_p last">To a solution of <b>38</b> (0.5 g, 2.36 mmol) in dioxane were added 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-3(4H)-one <b>40</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (0.78 g, 2.83 mmol), Cs<sub>2</sub>CO<sub>3</sub> (2.3 g, 7.08 mmol), and water (2 mL). The mixture was purged with nitrogen for 20 min, then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.14 g, 0.118 mmol) was added and the reaction again purged with nitrogen for 10 min. The reaction was heated to 100 °C in a microwave for 30 min. The reaction mixture was poured into ice–water and the aqueous mixture extracted with ethyl acetate. The organic extract was collected and washed with brine solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by washing with CH<sub>3</sub>CN, DCM, and pentane to give <b>41</b> as an off white solid (0.3 g, 38%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.1 (br s, 1H), 10.9 (s, 1H), 8.7 (s, 1H), 7.3–7.1 (m, 3 H), 4.7 (s, 2H), 3.2 (t, 2H), 3.1 (s, 3H), 2.7 (t, 2H); LC/MS (M + H) expected, 325.12; observed, 325.2;</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 2: 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine (<b>42</b>)</h4><div class="NLM_p last">To a suspension of LAH (0.05 g, 1.24 mmol) in THF (10 mL) was added <b>41</b> (0.1 g, 0.31 mmol) portionwise. After the addition was complete, the reaction was heated to reflux overnight. The reaction mixture was quenched with sat. Na<sub>2</sub>SO<sub>4</sub> solution and filtered through Celite. The solid was washed with EtOAc. The organic layer was washed with water, brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed and the crude material purified by column chromatography (silica, 10% MeOH/DCM) to give <b>42 (</b>0.024 g, 25%) as an off white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.9 (bs, 1H), 8.7 (s, 1H), 7.4 (s, 1H), 6.9 (s, 1H), 6.8–6.7 (m, 2H), 5.9 (s, 1H), 4.23–4.21 (m, 2H), 3.33–3.31 (m, 2H), 3.15 (t, 2H), 3.1 (s, 3H), 2.8 (t, 2H); LC/MS (M + H) expected, 311.14; observed, 311.2.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step 3: 1-(6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazin-4-yl)prop-2-en-1-one (<b>8</b>)</h4><div class="NLM_p last">To a solution of <b>42</b> (0.1 g, 0.32 mmol) in THF (10 mL) was added acryloyl chloride (0.03 g, 0.32 mmol) at 0 °C, and the mixture was stirred for 10 min. The reaction mixture was quenched with MeOH and NaHCO<sub>3</sub> solution. The volatiles were removed, and the crude mixture was extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude was purified by preparative TLC to provide <b>8</b> (0.04 g, 34%) as an off white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.1 (bs, 1H), 8.75 (s, 1H), 8.0–7.8 (bs, 1H), 7.42–7.35 (m, 2H), 7.15–7.13 (m, 1H), 6.91–6.79 (m, 1H), 6.31–6.21 (m, 1H), 5.84–5.76 (m, 1H), 4.41 (t, 2H), 4.05 (t, 2H), 3.12 (t, 2H), 3.09 (s, 3H), 2.78 (t, 2H); LC/MS (M + H) expected, 365.15; observed, 365.30. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 365.1608; observed, <i>m</i>/<i>z</i> 365.1607.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Step 4: 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>9</b>)</h4><div class="NLM_p last">To a mixture of <b>42</b> (50 mg, 0.16 mmol) in DMF (3 mL) at 0 °C was added BrCN (3 M in DCM, 0.16 mL). The reaction was stirred at 0 °C for 90 min and then quenched with NH<sub>4</sub>Cl (10% aqueous solution). The aqueous mixture was extracted (3 × EtOAc). The organic layer was washed with brine, dried and solvent removed to give crude product, which was purified by chromatography (silica, EtOAc/Hep) to give pure <b>9</b> (26 mg, 49%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.1 (bs, 1H), 8.74 (s, 1H), 7.45 (s, 1H), 7.33–7.30 (m, 2H), 7.11–7.08 (m, 1H), 4.37 (t, 2H), 3.99 (t, 2H), 3.18 (t, 2H), 3.07 (s, 3H), 2.77 (t, 2H); LC/MS (M + H) expected, 336.14; observed: 336.2.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Synthesis of 2,2-Difluoro-6-(5-(2-methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>10</b>)</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Step 1: 5-Bromo-2-(2-bromo-1,1-difluoroethoxy)aniline (<b>44</b>)</h4><div class="NLM_p last">To a solution of phenol <b>43</b> (180 mg, 0.95 mmol) in H<sub>2</sub>O/CH<sub>3</sub>CN (0.2 mL/1.5 mL) was added KOH (76 mg, 1.05 mmol, 1.2 equiv). The reaction was stirred at room temperature for 2 min and then a solution of 2-bromo-1,1-difluoroethene (1.5 mL in CH<sub>3</sub>CN, 1.05 mmol) was added. The reaction was warmed to 50 °C and stirred overnight. After completion, the reaction was filtered through Na<sub>2</sub>SO<sub>4</sub> and the desired product <b>44</b> isolated (300 mg, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.84–7.03 (m, 2 H), 6.64 (dd, <i>J</i> = 8.8, 2.2 Hz, 1 H), 5.49 (s, 2 H), 4.29 (t, <i>J</i> = 10.34 Hz, 2 H); <sup>19</sup>F NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −72.01 (s, 2 F); LC/MS (M + H) expected, 329.89; observed: 331.8.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step 2: 6-Bromo-2,2-difluoro-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine (<b>45</b>)</h4><div class="NLM_p last">To a solution of <b>44</b> (140 mg, 0.42 mmol) in DMF (3 mL) was added K<sub>2</sub>CO<sub>3</sub> (176 mg, 1.3 mmol). The reaction mixture was heated to 100 °C and stirred overnight. The solvent was removed and the residue dissolved in ethyl acetate. The mixture was washed with water, brine and dried (Na<sub>2</sub>SO<sub>4</sub>) to give after removal of solvent the crude product, which was purified by chromatography (silica, EtOAc/Hep) to give <b>45</b> (0.053 g, 67%). GC/MS observed: <i>m</i>/<i>z</i> 249, 251, expected 249, 251. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.89–7.00 (m, 2 H), 6.79–6.88 (m, 1 H), 3.97 (br s, 1 H), 3.57 (td, <i>J</i> = 6.16, 3.52 Hz, 2 H); <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>-<i>d</i>) δ −74.00 (s, 2 F).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 3: 2,2-Difluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine (<b>46</b>)</h4><div class="NLM_p last">To a round-bottom flask containing <b>45</b> (390 mg, 1.56 mmol) in dioxane (7 mL) were added (BPin)<sub>2</sub> (440 mg, 1.73 mmol), potassium acetate (459 mg, 4.68 mmol), and PdCl<sub>2</sub>(dppf) (60 mg, 0.078 mmol). The reaction mixture was heated to 100 °C overnight and then diluted with ethyl acetate. The mixture was washed with water, brine and dried (Na<sub>2</sub>SO<sub>4</sub>) to give the crude product, which was purified by chromatography (silica, EtOAc/Hep) to give product <b>46</b> (440 mg, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.10–7.38 (m, 1 H), 6.96 (d, <i>J</i> = 8.03 Hz, 1 H), 3.87 (br s, 1 H), 3.53 (br s, 2 H), 1.16–1.46 (m, 12 H); <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −73.55 (br s, 2 F); LC/MS (M + H) expected, 298; observed, 298.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step 4: 2,2-Difluoro-6-(5-(2-methoxyethyl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine (<b>48</b>)</h4><div class="NLM_p last">To a vial containing <b>46</b> (229 mg, 0.771 mmol) and <b>47</b> (264 mg, 0.771 mmol) in MeTHF/H<sub>2</sub>O (8 mL:2 mL) were added K<sub>3</sub>PO<sub>4</sub> (574 mg, 2.31 mmol) and PdCl<sub>2</sub>(dppf) (37.9 mg, 0.046 mmol). The mixture was purged with nitrogen and then heated to 70 °C overnight. The mixture was cooled to room temperature and diluted with water. The aqueous mixture was separated and the organic layer washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent removed to give crude material, which after chromatography (silica, EtOAc/Hep) provided <b>48</b> (100 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90 (s, 1 H), 7.29 (d, <i>J</i> = 6.16 Hz, 1 H), 7.02–7.19 (m, 3 H), 5.68 (s, 3 H), 4.15–4.24 (m, 1 H), 3.51–3.67 (m, 4 H), 3.33 (t, <i>J</i> = 6.82 Hz, 2 H), 3.23 (s, 3 H), 2.72–2.89 (m, 2 H), 0.89–1.02 (m, 2 H), −0.06 (s, 9 H); <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>-<i>d</i>) δ −73.67 (s, 2 F); LC/MS (M + H) expected, 477.2; observed, 477.1.</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Step 5: 2,2-Difluoro-6-(5-(2-methoxyethyl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>49</b>)</h4><div class="NLM_p last">To a solution of <b>48</b> (49 mg, 0.10 mmol) in DMF (3 mL) at 0 °C was added NaH. After 15 min, CNBr (3 M solution in DCM, 0.204 mmol) was added dropwise and the reaction stirred for 90 min. The reaction was quenched by the addition of NH<sub>4</sub>Cl (10% solution) and the subsequent aqueous mixture extracted with EtOAc (3 × 10 mL). The organic layers were combined, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give <b>49</b> (49 mg, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93 (s, 1 H), 7.63 (d, <i>J</i> = 1.5 Hz, 1 H), 7.49 (dd, <i>J</i> = 8.31, 1.5 Hz, 1 H), 7.14–7.38 (m, 2 H), 5.70 (s, 2 H), 3.89–4.23 (m, 2 H), 3.53–3.68 (m, 2 H), 3.37 (t, <i>J</i> = 6.85 Hz, 2 H), 3.25 (s, 3 H), 2.79 (t, <i>J</i> = 6.60 Hz, 2 H), 1.28 (t, <i>J</i> = 7.09 Hz, 2 H), 0.82–1.04 (m, 3 H), −0.06 (s, 9 H); <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>) δ −74.62 (s, 2 F); LC/MS (M + H) expected, 502.21; observed, 501.8.</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step 6: 2,2-Difluoro-6-(5-(2-methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>49</b> (49 mg, 0.098 mmol) in DCM (4 mL) at room temperature was added TFA (2 mL). The reaction was stirred for 2.5 h and then the solvent removed to give the crude product, which was then dissolved into CH<sub>3</sub>CN (3 mL), and NH<sub>4</sub>OH (2 mL) was added. The mixture was stirred for 50 min and the solvent removed to give the crude product. The residue was dissolved in dimethyl sulfoxide (1 mL) and purified by reversed-phase HPLC (column Waters Sunfire C18, 19 mm × 100 mm, 5 μm; mobile phase A, 0.05% TFA in water (v/v); mobile phase B, 0.05% TFA in acetonitrile (v/v); gradient 95.0% H<sub>2</sub>O/5.0% acetonitrile linear to 0% H<sub>2</sub>O/100% acetonitrile in 8.5 min, hold at 0% H<sub>2</sub>O/100% acetonitrile to 10.0 min. Flow: 25 mL/min) to give <b>10</b> (15 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.46 (br s, 1 H), 8.88 (s, 1 H), 7.38–7.63 (m, 4 H), 4.66 (t, <i>J</i> = 6.60 Hz, 2 H), 3.18 (t, <i>J</i> = 7.09 Hz, 2 H), 3.06 (s, 3 H), 2.71 (t, <i>J</i> = 7.09 Hz, 2 H); <sup>19</sup>F NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>) δ −73.72 (s, 1 F) −74.57 (s, 1 F); LC/MS (M + H) expected, 372.13; observed, 372.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>18</sub>H<sub>15</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 372.1267; observed 372.1262.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Synthesis of <i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>11</b>), (<i>S</i>)-<i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>12</b>), and (<i>R</i>)-<i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>13</b>)</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 1: <i>tert</i>-Butyl (6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>51</b>)</h4><div class="NLM_p last">To a solution of <b>36</b> (4 g, 26 mmol) in dioxane/water (8:2) (40 mL) were added <b>50</b> (1.69 g, 26 mmol prepared as previously described)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and K<sub>2</sub>CO<sub>3</sub> (4.48 g, 78 mmol) at room temperature. The mixture was degassed with nitrogen for 20 min, then Pd(PPh<sub>3</sub>)<sub>4</sub> (160 mg, 3.4 mmol) was added and nitrogen bubbling was continued for another 10 min. The reaction mixture was heated to 110 °C for 16 h. The reaction mixture was cooled to room temperature and diluted with water. The aqueous solution was extracted with ethyl acetate, washed with brine solution, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to provide crude product. The crude compound was purified by column chromatography (silica, EtOAc/Hep 10–80%) to give <b>51</b> (1.5 g, 39% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.2 (s, 1 H), 8.8 (s, 1H), 8.1–8.0 (m, 2 H), 7.8–7.3 (m, 3 H), 6.8 (s, 1 H), 5.2–5.0 (m, 1H), 3.1–2.8 (m, 2 H), 2.6–2.4 (m, 1 H), 1.8–2.0 (m, 1 H), 1.5 (s, 9 H); LC/MS (M + H) expected, 351.18; observed, 351.1.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step 2: 6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>52</b>)</h4><div class="NLM_p last">To a flask containing <b>51</b> (1.5 g, 4.28 mmol) was added 2 M HCl in diethyl ether (50 mL). After stirring at room temperature for 2 h, the solvent was decanted and the solid washed with diethyl ether (3×) to remove excess HCl. The solvent was evaporated under reduced pressure to give <b>52</b> as a gray solid (0.6 g as HCl salt, 66% crude yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.9 (bs, 1 H), 8.9 (s, 1H), 8.7 (bs, 3 H), 8.4 (s, 1 H), 8.2 (d, 1 H), 7.9 (s, 1 H), 7.6 (d, 1 H), 7.2 (s, 1 H), 4.8 (bs, 1 H), 3.3–2.8 (m, 2 H), 2.6–2.4 (m, 1 H), 2.2–2.0 (m, 1 H); LC/MS (M + H) expected, 251.12; observed, 251.1.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step 3: <i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>11</b>)</h4><div class="NLM_p last">To a solution of <b>52</b> (0.3 g, 1.19 mmol) in THF (10 mL) were added CNBr (0.13g, 1.19 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.24 g, 1.79 mmol). The mixture was heated to 40 °C for 1 h and then poured into ice–water, extracted with ethyl acetate, and washed with brine. The organic layer was collected, dried (Na<sub>2</sub>SO<sub>4</sub>) and solvent removed to give the crude compound, which was purified by column and preparative TLC to give <b>11</b> (0.055 g, 16%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.3 (bs, 1 H), 8.9 (s, 1 H), 8.2 (s, 1 H), 8.1 (d, 1 H), 7.8–7.6 (m, 1 H), 7.5–7.4 (m, 2 H), 6.85–6.90 (m, 1 H), 4.8–4.7 (m, 1 H), 3.1–3.0 (m, 1 H), 3.0–2.8 (m, 1 H), 2.6–2.5 (m, 1 H), 2.0–1.9 (m, 1 H); LC/MS (M + H) expected, 276.12; observed, 276.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub> [M + H]<sup>+</sup> 276.1244; observed 276.1243.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 4: (<i>S</i>)-<i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>12</b>) and (<i>R</i>)-<i>N</i>-(6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide(<b>13</b>)</h4><div class="NLM_p last"><b>9</b> (300 mg) was purified by chiral SFC (Chiralcel OD-3, CO<sub>2</sub>/MeOH + 0.05% TEA) to give two peaks, <b>12</b> (peak 1, 128 mg) and <b>13</b> (peak 2, 120 mg). Data for <b>12</b>: peak 1, <i>t</i><sub>R</sub> = 3.35 min; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.3 (bs, 1 H), 8.9 (s, 1 H), 8.2 (s, 1 H), 8.1 (d, 1 H), 7.8–7.6 (m, 1 H), 7.5–7.4 (m, 2 H), 6.85–6.90 (m, 1 H), 4.8–4.7 (m, 1 H), 3.1–3.0 (m, 1 H), 3.0–2.8 (m, 1 H), 2.6–2.5 (m, 1 H), 2.0–1.9 (m, 1 H); LC/MS (M + H) expected, 276.12; observed, 276.0. Data for <b>13</b>: peak 2, <i>t</i><sub>R</sub> = 3.47 min, <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.3 (bs, 1 H), 8.9 (s, 1 H), 8.2 (s, 1 H), 8.1 (d, 1 H), 7.8–7.6 (m, 1 H), 7.5–7.4 (m, 2 H), 6.85–6.90 (m, 1 H), 4.8–4.7 (m, 1 H), 3.1–3.0 (m, 1 H), 3.0–2.8 (m, 1 H), 2.6–2.5 (m, 1 H), 2.0–1.9 (m, 1 H); LC/MS (M + H) expected, 276.12; observed, 276.0. Absolute stereochemistry of <b>13</b> was determined as (<i>R</i>) by single crystal X-ray (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>). By inference, the stereochemistry of <b>12</b> was assigned as (<i>S</i>).</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Synthesis of 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>14</b>)</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Step 1: <i>tert</i>-Butyl (6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>53</b>)</h4><div class="NLM_p last">To a solution of <b>38</b> (1.0 g 2.78 mmol) in dioxane/water (4:1, 15 mL) were added <b>50</b> (588 mg, 2.78 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.15 g, 8.35 mmol). The mixture was degassed with nitrogen for 20 min, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (100 mg, 0.083 mmol) was added. The reaction mixture was heated to 110 °C for 16 h. The reaction mixture was cooled to room temperature and diluted with water. The aqueous mixture was extracted with ethyl acetate, and the organic extracts were combined, washed with brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed to provide the crude product, which after chromatography (silica, EtOAc/Hep 10–50%) provided <b>53</b> (400 mg, 35%) as a light yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.1 (bs, 1 H), 8.72 (s, 1H), 7.49 (m, 5H), 5.1 (d, 1H), 3.3 (t, 2H), 3.0 (s, 4H), 2.85 (m, 2H), 2.7 (m, 2H), 1.9 (m, 1H), 1.3 (s, 9H). LC/MS expected, <i>m</i>/<i>z</i> 409.22; observed, 409.3.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step 2: 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>54</b>)</h4><div class="NLM_p last">To a flask containing <b>53</b> (400 mg, 0.98 mmol) was added 2 M HCl in ether (10 mL). After 2 h, the reaction was concentrated to give <b>54</b> (274 mg, 91%). LC/MS (M + H) expected, 309.4; observed, 309.4.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step 3: <i>N</i>-(6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of <b>54</b> (373 mg, 0.98 mmol) in DMF (3 mL) at 0 °C were added NMM (0.44 mL, 3.91 mmol) and BrCN (3 M in DCM, 0.49 mL, 1.47 mmol). The reaction mixture was stirred for 2 h and then diluted with brine (25 mL) and ethyl acetate (25 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 200 mL). The combined extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent was removed to give the crude product, which after chromatography (silica, EtOAc/heptanes) gave the desired product <b>14</b> (140 mg, 43%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.02 (bs, 1 H), 8.87 (s, 1 H), 7.68 (s, 1 H), 7.61 (d, 1H), 7.40 (d, 1H), 7.18 (s, 1 H), 4.87–4.82 (m, 1 H), 3.26–3.20 (m, 1H), 3.16–3.08 (m, 3H), 3.10 (s, 3 H), 2.99–2.92 (m, 2 H), 2.85–2.28 (m, 2 H), 2.65–2.59 (m, 1 H); LC/MS (M + H) observed, 334.2; expected, 334.17.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Synthesis of 2,2-Difluoro-6-(5-(2-methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-4<i>H</i>-benzo[<i>b</i>][1,4]oxazine-4-carbonitrile (<b>15</b>)</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 1: 6-Bromo-<i>N</i>-methyl-2,3-dihydro-1<i>H</i>-inden-1-amine 6-bromo-<i>N</i>-methyl-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>59</b>)</h4><div class="NLM_p last">To a stirred solution of <b>55</b> (5.0 g, 23.7 mmol) in MeOH (150 mL) were added methylamine (2 M in THF, 35.5 mL, 71.09 mmol) and Ti(O-<i>i</i>Pr)<sub>4</sub> (16.8 mL, 59.22 mmol) at rt. After stirring at room temperature for 12 h the reaction was cooled to 0 °C and NaBH<sub>4</sub> (1.8 g, 47.38 mmol) was added in portions. The reaction was allowed to warm to rt and stirred for 10 h. The reaction mixture was quenched with water and extracted with ethyl acetate (2 × 25 mL). The organic extracts were collected and washed with brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>) and solvent was removed to provide crude <b>56</b> as a brownish liquid (4.0 g, 75% crude yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.58–7.46 (m, 1H), 7.38–7.29 (m, 1 H), 7.18–7.11 (m, 1H), 5.31–5.21 (m, 0.5H), 4.18–4.64 (m, 0.5H), 3.11–2.84 (m, 1H), 2.82–2.71 (m, 1H), 2.58–2.35 (m, 3H), 2.00–1.81 (m, 1H); LC/MS (M + H) expected, 226.02; observed, 226.12.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Step 2: <i>tert</i>-Butyl (6-Bromo-2,3-dihydro-1<i>H</i>-inden-1-yl)(methyl)carbamate (<b>57</b>)</h4><div class="NLM_p last">To a solution of <b>56</b> (4 g, 17.7 mmol) in DCM (500 mL) at 0 °C were added (Boc)<sub>2</sub>O (7.72 g, 35.39 mmol), TEA (3.58g, 35.39 mmol), and DMAP (50 mg). The reaction mixture was warmed to room temperature and stirred for 16 h. The reaction mixture was diluted with DCM (1 L) and washed with water twice. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to provide crude product. The crude <b>57</b> was purified by column chromatography (silica, EtOAc/heptanes, 0–10%) to give <b>57</b> as thick brown liquid (4.5 g, 78% yield). LC/MS (M + H) expected, 326.02; observed, 326.12.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Step 3: <i>tert</i>-Butyl Methyl(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>58</b>)</h4><div class="NLM_p last">To a solution of <b>57</b> (4.5 g, 13.8 mmol) in dioxane (150 mL) at room temperature were added bis(pinacolato)diboron (3.85 g, 15.18 mmol) and KOAc (4.06 g, 41.4 mmol). The reaction mixture was purged with nitrogen for 20 min. To the suspension was then added PdCl<sub>2</sub>(dppf) (430 mg, 0.69 mmol) in one portion. After heating to 80 °C for 16 h the reaction mixture was allowed to cool to room temperature and diluted with water (500 mL). The aqueous layer was extracted with ethyl acetate, washed with brine solution, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide <b>58</b> as a thick green liquid (5 g, 97% crude yield), which was taken onto the next step. LC/MS (M + H) expected, 374.25; observed, 374.2.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Step 4: <i>tert</i>-Butyl (6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)(methyl)carbamate (<b>59</b>)</h4><div class="NLM_p last">To a solution of <b>38</b> (5 g, 13.4 mmol) in dioxane/water (8:2) (150 mL) at room temperature were added <b>58</b> (2.25 g, 14.74 mmol) and K<sub>2</sub>CO<sub>3</sub> (5.55 g, 40.2 mmol). The mixture was then degassed with nitrogen for 20 min and then Pd(PPh<sub>3</sub>)<sub>4</sub> (774 mg, 0.67 mmol) was added and the reaction mixture heated to 110 °C for 16 h. The reaction mixture was cooled to room temperature and then diluted with water (250 mL). The aqueous mixture was extracted with ethyl acetate (2 × 500 mL). The organic extracts were washed with brine solution, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to provide crude <b>59</b>. The crude was purified by chromatography (silica, EtOAc/PE 10–80%) to give <b>59</b> (800 mg, 16% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.21 (bs, 1H), 8.81 (s, 1H), 8.15–8.07 (m, 1H), 7.82 (bs, 1H), 7.61 (s, 1H), 7.52–7.45 (m, 1H), 6.81 (s, 1H), 5.81–5.42 (m, 2H), 3.11–2.84 (m, 2H), 2.71–2.41 (m, 3H), 2.18–1.98 (m, 2H), 1.54–1.41 (m, 9H); LC/MS (M + H) expected, 365.19; observed, 365.2.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Step 5: <i>N</i>-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>60</b>)</h4><div class="NLM_p last">2 M HCl in ether (100 mL) was added to <b>59</b> (450 mg, 2.19 mmol). The reaction was stirred at room temperature for 2 h, and then the solvent was decanted and the solid washed with diethyl ether (3 × 100 mL) to remove excess HCl. The solid was dried under reduced pressure to give <b>60</b> as an off white solid (550 mg as HCl salt, 95% yield). <sup>1</sup>H NMR (300 MHz, DMSO) δ 12.58 (br s, 1H), 9.15–9.41 (m, 2H), 8.85 (s, 1H), 8.42 (s, 1H), 8.25–8.19 (m, 1H), 7.81 (s, 1H), 7.64–7.58 (m, 1 H), 7.15 (s, 1H), 4.91–4.81 (m, 1H), 3.25–2.85 (m, 2H), 2.72–2.21 (m, 5H); LC/MS (M + H) expected, 265.14; observed, 265.04.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Step 6: <i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-<i>N</i>-methylcyanamide (<b>15</b>)</h4><div class="NLM_p last">To a solution of <b>60</b> (450 mg, 1.70 mmol) in DMF (25 mL) were added CNBr (269 mg, 2.55 mmol) and K<sub>2</sub>CO<sub>3</sub> (470 mg, 3.4 mmol). After stirring at 40 °C for 2 h, the reaction mixture was diluted with ethyl acetate, washed with water, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give a pale green liquid. The material was purified by chromatography (silica, MeOH/DCM 0–2%) to give <b>15</b> as an off-white solid (135 mg, 26% yield). <sup>1</sup>H NMR (300 MHz, DMSO) δ 12.22 (br s, 1H), 8.82 (s, 1H), 8.18–8.11 (m, 2H), 7.71 (s, 1H), 7.58–7.51 (m, 1H), 6.95–6.88 (m, 1H), 4.84–4.78 (m, 1H), 3.18–3.09 (m, 1H), 2.98–2.90 (m, 4H), 2.61–2.43 (m, 1H), 2.18–2.04 (m, 1H); LC/MS (M + H) expected, 290.14; observed, 290.2.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Synthesis of <i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>16</b>)</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Step 1: <i>tert</i>-Butyl (6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)carbamate (<b>62</b>)</h4><div class="NLM_p last">To a solution of boronate <b>61</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (5 g, 13.33 mmol) in dioxane/water (8:2) (100 mL) at room temperature were added <b>36</b> (2 g, 13.07 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (8.64 g,26.66 mmol). The reaction mixture was degassed with nitrogen for 20 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (800 mg) was added, and the reaction mixture was heated to reflux for 16 h at 110 °C. The reaction mixture was cooled to room temperature and then diluted with water (250 mL). The aqueous mixture was extracted with ethyl acetate (2 × 500 mL). The organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to provide crude product. The crude was purified by chromatography (silica, EtOAc/PE 10–80%) to give <b>62</b> (2.5 g, 52% yield.). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.2 (bs, 1 H), 8.7 (s, 1 H), 8.1 (s, 1 H), 8.0 (d, 1 H), 7.65–7.60 (m, 1 H), 7.5 (d, 1 H), 6.9 (d, 1 H), 6.88–6.80 (m, 1 H), 4.9–4.8 (m, 1 H), 4.4–4.2 (m, 2 H), 2.2–1.9 (m, 2 H), 1.5 (s, 9 H); LC/MS (M + H) expected, 367.18; observed, 367.34.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Step 2: 6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-amine (<b>63</b>)</h4><div class="NLM_p last">A solution of 2 M HCl in ether (50 mL) was added to <b>62</b> (1 g, 2.73 mmol). After stirring at room temperature for 2 h, the solvent was decanted and solid washed with diethyl ether (3 × 100 mL) to remove excess HCl. The solvent was evaporated under reduced pressure to give <b>63</b> as an off-white solid (0.85 g, 97% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub><i>)</i> δ 13.1 (bs, 1 H), 9.1 (s, 1 H), 9.0–8.9 (bs, 3 H), 8.4 (s, 1 H), 8.1 (d, 1 H), 7.9 (s, 1 H), 7.4 (s, 1 H), 7.1 (d, 1 H), 4.8–4.7 (m, 1 H), 4.5–4.3 (m, 2 H), 2.4–2.2 (m, 2 H); LC/MS (M + H) expected, 267.12; observed, 267.24</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Step 3: <i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>16</b>)</h4><div class="NLM_p last">To a solution of <b>63</b> (120 mg, 0.45 mmol) in DMF (4 mL) at 0 °C was added K<sub>2</sub>CO<sub>3</sub> (125 mg, 0.90 mmol) followed by CNBr (52.5 mg, 0.49 mmol). The reaction mixture was stirred for 3 h and then poured into water/ethyl acetate. The layers were separated and the organic layer was dried over sodium sulfate and the solvent removed to give crude <b>16</b>, which was purified by RP-HPLC (column DuraShell, 150 mm × 25 mm, 5 μm; mobile phase A, 0.05% NH<sub>4</sub>OH in H<sub>2</sub>O; mobile phase B, 0.05% NH<sub>4</sub>OH in CH<sub>3</sub>CN; gradient 84:16 to 64:36 over 10 min; flow 30 mL/min) to give the desired product (55 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (br s, 1 H), 8.80 (s, 1 H), 8.21 (d, <i>J</i> = 1.76 Hz, 1 H), 8.09 (dd, <i>J</i> = 8.36, 2.20 Hz, 1 H), 7.46–7.74 (m, 2 H), 6.79–7.17 (m, 2 H), 4.58 (q, <i>J</i> = 4.84 Hz, 1 H), 4.09–4.41 (m, 2 H), 2.13–2.27 (m, 1 H), 1.94–2.13 (m, 1 H); LC/MS (M + H) expected, 292.11; observed, 292.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 292.1193; observed 292.1190.</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Step 4: (<i>S</i>)-<i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>17</b>) and (<i>R</i>)-<i>N</i>-(6-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>18</b>)</h4><div class="NLM_p last">The racemate <b>16</b> (120 mg) was purified by SFC (AD column, 250 mm × 30 mm, 5 μm; 0.1% NH<sub>4</sub>OH MeOH/CO<sub>2</sub>) to give two peaks: peak 1, <b>17</b>, 40 mg, 33%; peak 2, <b>18</b>, 40 mg. <b>17</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (br s, 1 H), 8.80 (s, 1 H), 8.21 (d, <i>J</i> = 1.76 Hz, 1 H), 8.09 (dd, <i>J</i> = 8.36, 2.20 Hz, 1 H), 7.46–7.74 (m, 2 H), 6.79–7.17 (m, 2 H), 4.58 (q, <i>J</i> = 4.84 Hz, 1 H), 4.09–4.41 (m, 2 H), 2.13–2.27 (m, 1 H), 1.94–2.13 (m, 1 H); LC/MS (M + H) expected, 292.11; observed, 292.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 292.1193; observed, <i>m</i>/<i>z</i> 292.1190. <b>18</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (br s, 1 H), 8.80 (s, 1 H), 8.21 (d, <i>J</i> = 1.76 Hz, 1 H), 8.09 (dd, <i>J</i> = 8.36, 2.20 Hz, 1 H), 7.46–7.74 (m, 2 H), 6.79–7.17 (m, 2 H), 4.58 (q, <i>J</i> = 4.84 Hz, 1 H), 4.09–4.41 (m, 2 H), 2.13–2.27 (m, 1 H), 1.94–2.13 (m, 1 H); LC/MS (M + H) expected, 292.11; observed, 292.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 292.1193; observed, <i>m</i>/<i>z</i> 292.1190. Absolute stereochemistry of <b>17</b> and <b>18</b> was assigned based on biological activity and protein–ligand crystal structure (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Synthesis of <i>N</i>-(6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>19</b>)</h3><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step 1: <i>tert</i>-Butyl (6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)carbamate (<b>64</b>)</h4><div class="NLM_p last">The boronate <b>61</b> (700 mg, 1.898 mmol) and <b>38</b> (321 mg, 1.599 mmol) were combined in a microwave vial, and dioxane/H<sub>2</sub>O (4:1; 10 mL) was added followed by K<sub>2</sub>CO<sub>3</sub> (785 mg, 5.694 mmol). The mixture was purged for 20 min with argon, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (64 mg, 0.056 mmol) was added. The vial was irradiated with microwave at 110 °C for 1 h. The reaction mixture was then poured into water (5 mL) and extracted with EtOAc (3 × 50 mL). The organic extracts were combined and washed with brine solution (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was removed to give crude material, which was purified by chromatography (silica, EtOAc/PE 90–100%) to give <b>64</b> (410 mg, 60%) as an off white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.01 (s, 1H), 8.71 (s, 1H), 7.39–7.55 (overlapping, 4H), 6.88 (d, 1H), 4.9–4.8 (m, 1H), 4.4–4.2 (m, 2H), 3.11–3.23 (m, 2H), 3.19 (s, 3H), 2.8–2.7 (m, 2H), 2.1–1.9 (m, 2H), 1.4 (s, 9 H); LCMS (M + H) expected, 425.21; observed, 425.3.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Step 2: 6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-amine (<b>65</b>)</h4><div class="NLM_p last">To a flask containing <b>64</b> (410 mg, 0.96 mmol) in dioxane (2 mL) at 0 °C was added 2 M HCl in diethyl ether (10 mL). After stirring at room temperature for 5 h, the ether/dioxane was decanted and the residual solid was washed with ether. The solid was dissolved in water and extracted with 10% MeOH in DCM (3 × 25 mL). The organic layer was dried over sodium sulfate and the solvent removed to give crude material, which was purified by chromatography (silica, MeOH/EtOAc, 0–10%) to provide <b>65</b> (110 mg) as an off white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.1 (s, 1H), 7.72 (s, 1H), 7.52–7.38 (m, 2H), 4.1–4.4 (m, 2 H), 6.84 (d, 1H), 4.41–4.23 (m, 1H), 4.28–4.19 (m, 1H), 4.08–3.39 (m, 1H); LCMS (M + H) expected, 325.16; observed, 325.2.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Step 3: <i>N</i>-(6-(5-(2-Methoxyethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)chroman-4-yl)cyanamide (<b>19</b>)</h4><div class="NLM_p last">To a flask containing <b>65</b> (105 mg, 0.32 mmol) in THF (5 mL) were added CNBr (40 mg, 0.387 mmol) and K<sub>2</sub>CO<sub>3</sub> (66 mg, 0.483 mmol). After heating the reaction at 40 °C for 5 h, the reaction mixture was poured into water (2 mL) and extracted with EtOAc (3 × 25 mL). The organic extracts were dried over sodium sulfate and the solvent was removed to give crude material, which was purified by preparative TLC (100% EtOAc) to give <b>19</b> (30 mg, 26%) as an off white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.02 (s, 1H), 8.75 (s, 1H), 7.63 (s, 1H), 7.42–7.58 (overlapping, 2H), 7.42 (s, 1H), 6.98 (d, 1H), 4.43–4.55 (m, 1H), 4.42–4.31 (m, 2H), 3.19 (t, 2H), 3.05 (s, 3H), 2.78 (t, 2H), 1.98–2.23 (m, 2H). LCMS (M + H) expected, 350.16; observed, 350.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>19</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 350.1612; observed 350.1609.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Synthesis of <i>N</i>-((1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>20</b>) and <i>N</i>-((1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>21</b>)</h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Step 1: 6-Bromo-2-methyl-2,3-dihydro-1<i>H</i>-inden-1-one (<b>66</b>)</h4><div class="NLM_p last">To a 1 N solution of LDA (120 mL, 0.24 mol) in anhydrous THF (300 mL) was added dropwise a solution of bromide <b>55</b> (50 g, 0.24 mol) in THF (300 mL) at −60 °C under N<sub>2</sub>. After addition was completed, the solution was stirred at −60 °C for 0.5 h and then MeI (33.78 g, 0.24 mol) was added. The reaction mixture was stirred at room temperature overnight. After the reaction was completed, aqueous NH<sub>4</sub>Cl (200 mL) was added to the reaction mixture. The organic layer was separated, and the aqueous layer was extracted with EtOAc (3 × 300 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed to give the crude material, which was purified by chromatography (silica, ethyl acetate/petroleum ether, 1–20%) to give <b>66</b> (6.5 g, 12.2%) as a yellow solid. Analytical data were consistent to previously reported data.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Step 2: (<i>Z</i>)-6-Bromo-2-methyl-2,3-dihydro-1<i>H</i>-inden-1-one Oxime (<b>67</b>)</h4><div class="NLM_p last">To a flask containing ketone <b>66</b> (5 g, 22 mmol) were added MeOH (80 mL) and NH<sub>2</sub>OH·HCl (6.12 g, 88 mmol). The reaction mixture was heated at reflux for 3 h, then was cooled to room temperature and diluted with ethyl acetate (80 mL). The pH was adjusted (∼8–9) with addition of aqueous NaHCO<sub>3</sub>. The organic layer was separated, and the aqueous phase was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford crude <b>67</b> (5.60 g, 105%) as a yellow solid, which was taken onto the next step. LC/MS (M + H) expected, 240.0; observed, 240.0.</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Step 3: 6-Bromo-2-methyl-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>68</b>)</h4><div class="NLM_p last">To a solution of hydroxylamine <b>67</b> (5.60 g, 23.4 mmol) in THF (200 mL) was added 2 N HCl (115 mL, 230 mmol), followed by Zn dust (14.93 g, 230 mmol). After the addition, the reaction mixture was heated at reflux for 3 h. The reaction mixture was cooled to room temperature and solvent removed. The crude material was then diluted with ethyl acetate (80 mL), and the pH was adjusted to ∼10 with addition of NH<sub>4</sub>OH. The organic layer was separated, and the aqueous phase was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed in vacuo to afford crude amine <b>68</b> (4.60 g, 87.3%) as a yellow oil. LC/MS (M + H) expected, 226.0; observed, 226.0.</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Step 4: <i>tert</i>-Butyl (6-Bromo-2-methyl-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>69</b>)</h4><div class="NLM_p last">To a solution of amine <b>68</b> (4.6 g, 20.4 mmol) and Et<sub>3</sub>N (5.7 mL, 40.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added dropwise a solution of (Boc)<sub>2</sub>O (8.87 g, 40.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) at 0 °C. After addition, the mixture was stirred at room temperature overnight. The solvent was removed in vacuo, and the residue was purified by chromatography (ethyl acetate/petroleum ether, 1–20%) to give <b>69</b> (1.2 g, 18%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28–7.52 (m, 2 H), 6.87–7.16 (m, 1 H), 5.11–5.08 (m, 0.5H), 4.53–4.85 (m, 1 H), 2.89–3.08 (m, 1 H), 2.70–2.84 (m, 0.5H), 2.38–2.62 (m, 1 H), 2.03–2.26 (m, 1 H), 1.50 (d, <i>J</i> = 7.03 Hz, 9H), 1.16–1.33 (m, 2 H), 0.95 (d, <i>J</i> = 7.03 Hz, 2 H); LC/MS (M + H) expected, 326.08 observed: 326.1.</div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Step 5: <i>tert</i>-Butyl (2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>70</b>)</h4><div class="NLM_p last">A mixture of bromide <b>69</b> (1.2 g, 3.68 mmol), bis(pinacolato)diborane (1.3 g, 5.12 mmol), KOAc (1.44 g, 14.7 mmol), and PdCl<sub>2</sub>(dppf) (300 mg, 0.37 mmol) in dioxane (30 mL) was degassed with nitrogen. The mixture was then stirred under nitrogen at 100 °C overnight. The solvent was removed in vacuo and the residue was purified by chromatography (EtOAc/petroleum ether, 1–20%) to give <b>70</b> (1 g, 73%) as a yellow solid. <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O) δ 7.72–7.62 (m, 2H), 7.21–7.14 (m, 1H), 5.12–5.06 (m, 1H), 4.71–4.68 (m, 1H), 3.05–2.91 (m, 1H), 2.79–2.71 (m, 1H), 2.52–2.48 (m, 1H), 1.54–1.50 (m, 9H), 1.24 (s, 12H), 1.15–1.10 (m, 3H); LC/MS (M + Na) expected, 396.2322; observed, 396.23.</div></div><div id="sec5_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Step 6: <i>tert</i>-Butyl ((1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>71</b>) and <i>tert</i>-Butyl ((1<i>R</i>,2<i>R</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>73</b>)</h4><div class="NLM_p last">To a solution of boronate <b>70</b> (400 mg, 1.07 mmol) and <b>36</b> (166.4 mg, 1.07 mmol) in dioxane (8 mL) was added Na<sub>2</sub>CO<sub>3</sub> (3.2 mL, 3.2 mmol). After degassing with nitrogen for 10 min, Pd(PPh<sub>3</sub>)<sub>4</sub> (140 mg, 0.12 mmol) was added in one portion. The reaction mixture was stirred at 120 °C under microwave irradiation for 30 min. The solvent was removed in vacuo and the residue was purified by chromatography (methanol/CH<sub>2</sub>Cl<sub>2</sub>, 1:50 to 1:30) to afford a mixture of <b>71</b> and <b>73</b> (480 mg, 61%, ∼1:1) as a yellow solid, which was further separated by chiral SFC (column AD, 250 mm × 30 mm, 5 μm; CO<sub>2</sub>/IPA(0.1% NH<sub>4</sub>OH), 73:27; flow 65 mL/min) to afford <b>71</b> and <b>73</b>. Data for <b>71</b>, rac-trans: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.19 (br s, 1 H), 8.76 (s, 1 H), 7.85–8.06 (m, 2 H), 7.61 (br s, 1 H), 7.20–7.45 (m, 2 H), 6.77 (br s, 1 H), 4.60 (t, <i>J</i> = 9.03 Hz, 1 H), 3.02 (dd, <i>J</i> = 15.56, 7.53 Hz, 1 H), 1.43 (s, 9 H), 1.17 (d, <i>J</i> = 6.53 Hz, 3 H), 1.00 (d, <i>J</i> = 6.02 Hz, 2 H); LC/MS (M + H) expected, 365.20; observed, 365.2. Data for <b>73</b>, rac-cis: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.29 (br s, 1 H), 8.87 (s, 1 H), 8.09 (d, <i>J</i> = 4.02 Hz, 2 H), 7.71 (br s, 1 H), 7.26–7.55 (m, 2 H), 6.95 (br s, 1 H), 5.13 (t, <i>J</i> = 7.78 Hz, 1 H), 2.96–3.16 (m, 1 H), 2.69–2.86 (m, 2 H), 1.50 (s, 9 H), 1.01 (d, <i>J</i> = 6.53 Hz, 3 H); LC/MS (M + H) expected, 365.20; observed, 365.2.</div></div><div id="sec5_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Step 7: (1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>72</b>)</h4><div class="NLM_p last">To a solution of <b>71</b> (0.12 g, 0.33 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise TFA (1.2 mL) at 0 °C. After addition, the mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo to give the crude product <b>72</b>, which was used in the next step without further purification. LC/MS (M + H) expected, 265.1; observed, 265.1.</div></div><div id="sec5_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Step 8: <i>N</i>-((1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>20</b>)</h4><div class="NLM_p last">To a solution of amine <b>72</b> (120 mg, 0.33 mmol) and NMM (100 mg, 0.99 mmol) in anhydrous DMF (6 mL) was added CNBr (70 mg, 0.66 mmol) at −20 °C. After addition, the reaction mixture was stirred at −20 °C for 2 h. The solvent was removed in vacuo and the residue was purified by preparative HPLC to afford <b>20</b> (40.3 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.24 (br s, 1H), 8.81 (s, 1H), 8.13–8.06 (m, 2H), 7.65–7.60 (m, 2H), 7.45–7.43 (m, 1H), 6.90–6.88 (m, 1H), 4.24–4.21 (m, 1H), 3.16–3.14 (m, 1H), 2.51–2.48 (m, 2H), 1.26 (d, 3H); LC/MS (M + Na) expected, 312.1; observed, 312.1.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Synthesis of <i>N</i>-((1<i>R</i>,2<i>R</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>21</b>)</h3><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Step 1: <i>tert</i>-Butyl ((1<i>R</i>,2<i>S</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>74</b>)</h4><div class="NLM_p last">To a solution of <b>73</b> (0.15 g, 0.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise TFA (1.5 mL) at 0 °C. After addition, the mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo to give the crude product, which was used in the next step without further purification. LC/MS (M + H) expected, 265.1; observed, 265.1.</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Step 2: <i>N</i>-((1<i>R</i>,2<i>R</i>)-2-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>21</b>)</h4><div class="NLM_p last">To a solution of <b>74</b> (150 mg, 0.41 mmol) and NMM (125 mg, 1.24 mmol) in anhydrous DMF (6 mL) was added CNBr (86 mg, 0.81 mmol) at −20 °C. After addition, the reaction mixture was stirred at −20 °C for 2 h. The solvent was removed in vacuo and the residue was purified by preparative HPLC to afford <b>21</b> (30 mg, 25.2%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.23 (br s, 1H), 8.81 (s, 1H), 8.16–8.08(m, 2H), 7.65 (s, 1H), 7.47–7.45 (m, 1H), 7.20–7.18 (m, 1H), 6.93 (s, 1H), 4.67–4.62 (m, 1H), 3.05–3.00 (m, 1H), 2.73–2.66 (m, 2H), 1.11 (d, <i>J</i> = 6.4 Hz, 3H); LC/MS (M + Na) expected 312.1; observed 312.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub> [M + H]<sup>+</sup> 290.1400; observed 290.1397.</div></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Synthesis of <i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>22</b>), (<i>R</i>)-<i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>23</b>), (<i>S</i>)-<i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>24</b>)</h3><div id="sec5_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Step 1: 6-Bromo-1-methyl-2,3-dihydro-1<i>H</i>-inden-1-ol (<b>75</b>)</h4><div class="NLM_p last">To a 3 M solution of methylmagnesium bromide in THF (63 mL, 0.19 mol) was added dropwise a solution of indanone <b>55</b> (10 g, 47.38 mmol) in THF (100 mL) at 0 °C. The solution was stirred at 25 °C for 2 h. The reaction solution was quenched with saturated aqueous NH<sub>4</sub>Cl (50 mL) and the pH adjusted to 6–7 with 1 N HCl. The aqueous mixture was extracted with EtOAc (3 × 200 mL). The combined organic layers were washed with brine (2 × 200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and solvent was removed. Purification by chromatography (silica, EtOAc/petroleum ether 30:1 to 20:1) gave <b>75</b> (7.65 g, 71%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41 (d, <i>J</i> = 1.51 Hz, 1 H), 7.34 (dd, <i>J</i> = 8.03, 1.51 Hz, 1 H), 7.15 (d, <i>J</i> = 8.03 Hz, 1 H), 5.13 (s, 1 H), 2.78–2.90 (m, 1 H), 2.62–2.74 (m, 1 H), 2.03 (t, <i>J</i> = 7.03 Hz, 2 H), 1.37 (s, 3 H); LC/MS (M + H) expected, 227.01; observed, 227.0</div></div><div id="sec5_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Step 2: 1-Azido-6-bromo-1-methyl-2,3-dihydro-1<i>H</i>-indene (<b>76</b>)</h4><div class="NLM_p last">To a solution of <b>75</b> (7.65 g, 33.68 mmol) in CHCl<sub>3</sub> (90 mL) were added NaN<sub>3</sub> (4.38 g, 67.37 mmol) and TFA (15 mL) at 0 °C. The reaction mixture was stirred at 30 °C for 3 h. To the reaction solution was added 10% NH<sub>4</sub>OH to adjust pH to be between 8 and 9, and then the aqueous mixture was extracted with CHCl<sub>3</sub> (2 × 100 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed to give <b>76</b> (8.2 g, 96% of yield) as a yellow oil, which was used for the next step directly.</div></div><div id="sec5_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Step 3: 6-Bromo-1-methyl-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>77</b>)</h4><div class="NLM_p last">To a solution of <b>76</b> (4.4 g, 17.45 mmol) in THF (200 mL) was added a 1 M solution of PMe<sub>3</sub> in THF (19.2 mL, 19.2 mmol) and water (20 mL). The solution was stirred at 30 °C overnight. The reaction mixture was diluted with EtOAc (200 mL) and then washed with saturated NaHCO<sub>3</sub> (3 × 100 mL) and brine (2 × 100 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give crude material, which was purified by chromatography (silica, DCM/MeOH 100:1 to 20:1) to give <b>77</b> (1.64 g, 41% of yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49 (d, <i>J</i> = 1.51 Hz, 1 H), 7.29 (dd, <i>J</i> = 7.78, 1.76 Hz, 1 H), 7.12 (d, <i>J</i> = 8.03 Hz, 1 H), 5.76 (s, 1 H), 2.64–2.85 (m, 3 H), 1.85–2.03 (m, 3 H), 1.23 (s, 3 H); LC/MS (M + H) expected, 226.02; observed, 226.0.</div></div><div id="sec5_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Step 4: <i>tert</i>-Butyl (6-Bromo-1-methyl-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>78</b>)</h4><div class="NLM_p last">To a solution of <b>77</b> (2.0 g, 8.84 mmol) in DCM (80 mL) was added Et<sub>3</sub>N (1.96 g, 19.45 mmol) followed by Boc<sub>2</sub>O (3.82 g, 17.69 mmol). The solution was stirred at 30 °C overnight. The solvent was removed in vacuo and the residue was purified by chromatography (silica, EtOAc/petroleum ether, 1–50%) to give <b>78</b> (1.5 g, 52%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (s, 1 H), 7.32 (d, <i>J</i> = 8.0 Hz, 1 H), 7.08 (d, <i>J</i> = 8.03 Hz, 1 H), 4.83 (br s, 1 H), 2.92 (dd, <i>J</i> = 8.78, 4.3 Hz, 1 H), 2.74–2.85 (m, 1 H), 2.62 (br s, 1 H), 2.13 (td, <i>J</i> = 8.41, 4.27 Hz, 1 H), 1.53 (br s, 3 H), 1.38 (br s, 9 H); LC/MS (M + H) expected, 326.08; observed, 326.1.</div></div><div id="sec5_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Step 5: <i>tert</i>-Butyl (1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>79</b>)</h4><div class="NLM_p last">To a degassed solution of bromide <b>78</b> (3.6 g, 11.0 mmol), bis(pinacolato)diborane (2.8 g, 11.0 mmol), and KOAc (3.23 g, 33.0 mmol) in dioxane (60 mL) was added PdCl<sub>2</sub>(dppf) (402 mg, 0.55 mmol). The mixture was stirred at 80 °C for 3 h. The reaction mixture was diluted with EtOAc (100 mL) and then washed with brine (3 × 50 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give crude material, which was purified by chromatography (silica, EtOAc/petroleum ether 1–50%) to give <b>79</b> (4.2 g, 100%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67 (d, 2H), 7.22 (d, 1H), 4.85 (br, 1H), 2.95 (m, 1H), 2.82 (m, 1H), 2.59 (m, 1H), 2.20 (m, 1H), 1.60 (s, 3H), 1.34 (m, 21H); LC/MS (M + Na) expected, 396.23; observed, 396.3.</div></div><div id="sec5_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Step 6: <i>tert</i>-Butyl (1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>80</b>)</h4><div class="NLM_p last">To a mixture of boronate <b>79</b> (1.72 g, 4.6 mmol), <b>36</b> (706 mg, 4.6 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.9 g, 13.8 mmol) in dioxane (50 mL) and water (10 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (690 mg, 0.6 mmol) under N<sub>2</sub>. The mixture was degassed and then stirred at 100 °C overnight. The solution was diluted with EtOAc (100 mL), then washed with brine (3 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography (petroleum ether/EtOAc = 10/1 to1/2) to give <b>80</b> (800 mg, 48%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.67 (br s, 1 H), 8.98 (s, 1 H), 7.97–8.13 (m, 2 H), 7.37–7.47 (m, 2 H), 6.88 (br s, 1 H), 2.87–3.20 (m, 2 H), 2.69 (d, <i>J</i> = 6.53 Hz, 1 H), 2.25 (ddd, <i>J</i> = 12.92, 8.16, 5.02 Hz, 1 H), 1.68 (br s, 3 H), 1.41 (br s, 9 H); LC/MS (M + H) expected, 365.20; observed, 365.2.</div></div><div id="sec5_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Step 7: 1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>81</b>)</h4><div class="NLM_p last">To a solution of <b>80</b> (450 mg, 1.23 mmol) in dioxane (20 mL) at 0 °C was added dropwise a solution of 4 N HCl in dioxane (6.2 mL). The mixtue was stirred at 25 °C for 2 h. Additional 4 N HCl in dioxane (10 mL) was added, and the mixture was stirred at 25 °C for 3 h. The reaction mixture was filtered. The wet cake was washed with EtOAc, dried in vacuo to give a green solid, which was recrystallized from 10:1 DCM/MeOH, (30 mL) to give <b>81</b> (110 mg, 34% of yield) as a green solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.90 (s, 1H), 8.97 (s, 1H), 8.73 (s, 3H), 8.35 (s, 1H), 8.11 (d, 1H), 7.88 (s, 1H), 7.58 (d, 1H), 7.19 (s, 1H), 3.15 (m, 1H), 3.02 (m, 1H), 2.26 (m, 2H), 1.68 (s, 3H); LC/MS (M + H) expected, 265.15; observed, 265.14.</div></div><div id="sec5_12_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Step 8: <i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>22</b>)</h4><div class="NLM_p last">To the solution of <b>81</b> (100 mg, 0.378 mmol) in DMF (6 mL) were added NMM (115 mg, 1.13 mmol) at 25 °C and then CNBr (80 mg, 0.756 mmol) in DCM (1 mL) at −20 °C. The reaction mixture was stirred below 0 °C for 2 h. The solvent was removed in vacuo and the residue was purified by chromatography (DCM/MeOH, 100/1 to 10/1) to give <b>22</b> (40 mg, 37%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.27 (s, 1H), 8.83 (s, 1H), 8.81–8.07 (m, 2H), 7.66 (d, 1H), 7.49–7.46 (m, 2H), 6.90 (d, 1H), 3.19–2.85 (m, 2H), 2.25–2.20 (m, 2H), 1.53 (s, 3H); LC/MS (M + H) expected, 290.14; observed, 290.2. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub> [M + H]<sup>+</sup> 290.1400; observed 290.1397.</div></div><div id="sec5_12_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Step 9: (<i>R</i>)-<i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>23</b>) and (<i>S</i>)-<i>N</i>-(1-Methyl-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>24</b>)</h4><div class="NLM_p last">400 mg of racemic <b>80</b> was separated by chiral SFC (column AD, 250 mm × 30 mm, 5 μm; mobile phase CO<sub>2</sub>/EtOH (0.1% NH<sub>4</sub>OH), 65:35; flow 60 mL/min) to give compound <b>82</b>, peak 1 (190 mg), and <b>83</b>, peak 2 (190 mg). <b>82</b> and <b>83</b> were converted to cyanamides <b>23</b> and <b>24</b> following the same steps as described for <b>22</b>. Data for <b>23</b> (peak 1): chiral SFC (column Chiralpak AS-H, 150 mm × 4.6 mm, 5 μm; mobile phase CO<sub>2</sub>/EtOH 5–40% (0.05% DIPEA), detection λ = 220 nm), <i>t</i><sub>R</sub> = 4.55 min; <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.27 (s, 1H), 8.83 (s, 1H), 8.81–8.07 (m, 2H), 7.66 (d, 1H), 7.49–7.46 (m, 2H), 6.90 (d, 1H), 3.19–2.85 (m, 2H), 2.25–2.20 (m, 2H), 1.53 (s, 3H); LC/MS (M + H) expected, 290.14; observed, 290.2. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub> [M + H]<sup>+</sup> 290.1400; observed 290.1397. Data for <b>24</b> (peak 2): chiral SFC, <i>t</i><sub>R</sub> = 4.85 min; <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.27 (s, 1H), 8.83 (s, 1H), 8.81–8.07 (m, 2H), 7.66 (d, 1H), 7.49–7.46 (m, 2H), 6.90 (d, 1H), 3.19–2.85 (m, 2H), 2.25–2.20 (m, 2H), 1.53 (s, 3H); LC/MS (M + H) expected, 290.14; observed, 290.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub> [M + H]<sup>+</sup> 290.1400; observed 290.1397. The absolute stereochemistry of <b>23</b> was assigned as (<i>S</i>) based on protein–ligand cocrystal. By inference, absolute stereochemistry of <b>24</b> was assigned as (<i>R</i>).</div></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Synthesis of <i>N</i>-((1<i>S</i>,3<i>S</i>)-3-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>25</b>) and <i>N</i>-((1<i>S</i>,3<i>R</i>)-3-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>26</b>)</h3><div id="sec5_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Step 1: (<i>R</i>,<i>Z</i>)-<i>N</i>-(3-Bromobenzylidene)-2-methylpropane-2-sulfinamide (<b>85</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-2-methylpropane-2-sulfinamide (32.67 g, 0.27 mol) in DCM (500 mL) were added <i>p</i>-TsOH (27.8 g, 0.108 mol), MgSO<sub>4</sub> (162 g, 1.35 mol), and then 3-bromobenzaldehyde <b>84</b> (50 g, 0.27 mol). The mixture was stirred at room temperature overnight and then filtered. The filtrate was concentrated and the residue was purified via column chromatography (petroleum ether/EtOAc, 100/1 to 20/1) to give compound <b>85</b> (53.5 g, 68% of yield) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1 H), 8.03 (s, 1 H), 7.74 (d, <i>J</i> = 7.53 Hz, 1 H), 7.64 (d, <i>J</i> = 8.03 Hz, 1 H), 7.36 (t, <i>J</i> = 7.78 Hz, 1 H), 1.28 (s, 9 H); LC/MS (M + H) expected, 288.01; observed, 288.0.</div></div><div id="sec5_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Step 2: <i>tert</i>-Butyl (<i>S</i>)-3-(3-Bromophenyl)-3-(((<i>R</i>)-<i>tert</i>-butylsulfinyl)amino)propanoate (<b>86</b>)</h4><div class="NLM_p last">To a 0.1 M solution of SmI<sub>2</sub> in THF (800 mL,) at −70 °C under N<sub>2</sub> was added a solution of <b>85</b> (5.75 g, 19.95 mmol) in THF (10 mL) followed by dropwise addition of a solution of <i>tert</i>-butyl 2-bromoacetate (11.67 g, 59.84 mmol) in THF (100 mL) of at −70 °C. The reaction mixture was stirred for 3 h at −70 °C and then allowed to warm to 0 °C. After 1 h, the mixture was quenched with saturated NH<sub>4</sub>Cl (200 mL) at 0 °C. The aqueous mixture was extracted with EtOAc (2 × 300 mL), and the combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was then removed and the residue was purified by chromatography (EtOAc/petroleum ether, 1:50 to 1:5) to give compound <b>86</b> (3.2 g, 39%) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49 (s, 1 H), 7.42 (d, <i>J</i> = 8.0 Hz, 1 H), 7.16–7.31 (m, 2 H), 4.60–4.77 (m, 2 H), 2.71–2.79 (m, 2 H), 1.40 (s, 9 H), 1.24 (s, 9 H); LC/MS (M + H) expected, 404.08; observed, 403.7.</div></div><div id="sec5_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Step 3: (<i>S</i>)-3-Amino-3-(3-bromophenyl)propanoic Acid (<b>87</b>)</h4><div class="NLM_p last">To a flask containing <b>86</b> (5 g, 12.38 mmol) was added 4 N HCl in dioxane (200 mL), and the mixture was stirred overnight at room temperature. The solvent was evaporated in vacuo to afford <b>87</b> (3.2 g, >100%) which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (br s, 3H), 7.71–7.92 (m, 1 H), 7.47–7.64 (m, 2 H), 7.25–7.46 (m, 1 H), 4.60 (br s, 1 H), 2.84–3.13 (m, 2 H).</div></div><div id="sec5_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Step 4: (<i>S</i>)-3-(3-Bromophenyl)-3-(2,2,2-trifluoroacetamido)propanoic Acid (<b>88</b>)</h4><div class="NLM_p last">To a flask containing <b>87</b> (3.2 g, 12.38 mmol) was added TFAA (20 mL). After 2 h at room temperature, the solvent was removed in vacuo and the residue was purified by chromatography (EtOAc/petroleum ether, 1:20 to 1:1) to give <b>88</b> (2.8 g, 67%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41–7.59 (m, 2 H), 7.22–7.32 (m, 1 H), 7.12–7.21 (m, 1 H), 5.35–5.46 (m, 1 H), 2.94–3.14 (m, 2 H); <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −75.83 (s, 3 F); LC/MS (M + H) expected, 339.98; observed, 340.0.</div></div><div id="sec5_13_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Step 5: (<i>S</i>)-3-(3-Bromophenyl)-3-(2,2,2-trifluoroacetamido)propanoyl Chloride (<b>89</b>)</h4><div class="NLM_p last">To a flask containing <b>88</b> (2.8 g, 8.23 mmol) was added SOCl<sub>2</sub> (35 mL). The mixture was heated to reflux for 1 h and then concentrated in vacuo to give the crude product. The crude was azeotroped with dry DCM to give <b>89</b> (2.9 g, 98%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (d, <i>J</i> = 7.53 Hz, 1 H), 7.43–7.48 (m, 1 H), 7.22–7.35 (m, 3 H), 6.85 (br s, 1 H), 5.40 (q, <i>J</i> = 6.53 Hz, 1 H) 3.45–3.71 (m, 2 H); <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −75.68 (s, 3 F).</div></div><div id="sec5_13_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Step 6: (<i>S</i>)-<i>N</i>-(4-Bromo-3-oxo-2,3-dihydro-1<i>H</i>-inden-1-yl)-2,2,2-trifluoroacetamide (<b>90</b>) and (<i>S</i>)-<i>N</i>-(6-Bromo-3-oxo-2,3-dihydro-1<i>H</i>-inden-1-yl)-2,2,2-trifluoroacetamide (<b>91</b>)</h4><div class="NLM_p last">To a solution of <b>89</b> (2.9 g, 8.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (35 mL) at room temperature was added AlCl<sub>3</sub> (2.1 g, 15.4 mmol). The mixture was heated to reflux for 1 h and then allowed to cool to room temperature. The mixture was poured into 1 N HCl (20 mL), and the aqueous mixture was extracted with ethyl acetate (80 mL). The organic layer was washed with saturated aqueous NH<sub>4</sub>Cl (50 mL), then brine and dried over sodium sulfate. The solvent was removed to give the crude product, which was purified by preparative HPLC to afford <b>90</b> (1.5 g, 58%) and <b>91</b> (0.5 g, 19%) as white solids. Data for <b>90</b>: <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.0 (d, 1H), 7.84 (s, 1H), 7.78–7.76 (m, 1H), 7.64–7.62 (m, 1H), 5.62–5.57 (m, 1H), 3.17–3.11 (m, 1H), 2.68–2.64 (m, 1H); LC/MS (M + H) expected, 321.9691; observed, 321.9; chiral SFC (column AD-3, 150 mm × 4.6 mm; mobile phase IPA + 0.05% DEA; flow = 2.5 mL/min, 5–40% CO<sub>2</sub>/IPA), <i>t</i><sub>R</sub> = 3.4 min; [α]<sup>20</sup><sub>D</sub> −46.8 (<i>c</i> 2.8 mg/mL, EtOH). Data for <b>91</b>: <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.99 (s, 1H), 7.76 (m, 1H), 7.64 (m, 2H), 5.58 (m, 1H), 3.17 (m, 1H), 2.67 (m, 1H); LC/MS (M + H) expected 321.9691, observed 322.0; chiral SFC (column OJ-H, 150 mm × 4.6 mm; MeOH + 0.05% DEA, flow = 2.5 mL/min, 5–40% CO<sub>2</sub>/MeOH), <i>t</i><sub>R</sub> = 4.6 min; [α]<sup>20</sup><sub>D</sub> −84.72 (<i>c</i> 3.6 mg/mL, EtOH).</div></div><div id="sec5_13_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Step 7: (<i>S</i>)-2,2,2-Trifluoro-<i>N</i>-(3-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>92</b>)</h4><div class="NLM_p last">To a solution of <b>90</b> (2.5 g, 7.76 mmol), bis(pinacolato)diboron (2.08 g, 8.15 mmol), and KOAc (2.28 g, 2.3 mmol) in dioxane (60 mL) was added PdCl<sub>2</sub>(dppf) (316 mg, 0.38 mmol) under nitrogen. The mixture was degassed with nitrogen and stirred at 100 °C for 5 h. The reaction mixture was diluted water and the aqueous mixture extracted with EtOAc (3 × 50 mL), washed with brine (3 × 30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (EtOAc/petroleum ether) to give <b>92</b> (2.9 g, 100%) as a red solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (s, 1 H), 7.98 (d, <i>J</i> = 7.53 Hz, 1 H), 7.79 (d, <i>J</i> = 7.53 Hz, 1 H), 6.69 (d, <i>J</i> = 7.53 Hz, 1 H), 5.68 (td, <i>J</i> = 7.78, 3.01 Hz, 1 H), 3.31 (dd, <i>J</i> = 19.07, 7.53 Hz, 1 H), 2.58 (dd, <i>J</i> = 19.07, 3.51 Hz, 1 H), 1.37 (bs, 12 H); LC/MS (M + H) expected, 370.0; observed, 370.0.</div></div><div id="sec5_13_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Step 8: (<i>S</i>)-2,2,2-Trifluoro-<i>N</i>-(3-oxo-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>93</b>)</h4><div class="NLM_p last">To a solution of <b>92</b> (2.7 g, 7.31 mmol), <b>36</b> (1.21 g, 7.85 mmol), and KF (0.85 g, 14.6 mmol) in dioxane/water (64 mL/16 mL) was added PdCl<sub>2</sub>(dppf) (268 mg, 0.37 mmol) under nitrogen. The solution was degassed with nitrogen and then heated to 90 °C overnight. The reaction mixture was diluted with water, and the aqueous mixture was extracted with EtOAc (3 × 50 mL), washed with brine (3 × 30 mL), dried over sodium sulfate, filtered and solvent removed in vacuo. The residue was purified by column chromatography (EtOAc/petroleum ether) to give <b>93</b> (2.0 g, 76%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.42 (br s, 1 H), 10.12 (d, <i>J</i> = 7.82 Hz, 1 H), 8.92 (s, 1 H), 8.19–8.50 (m, 2 H), 7.63–7.98 (m, 2 H), 6.86 (d, <i>J</i> = 1.96 Hz, 1 H), 5.61–5.93 (m, 1 H), 3.09–3.27 (m, 1 H), 2.61–2.82 (m, 1 H); LC/MS (M + H) expected, 360.08; observed, 360.1.</div></div><div id="sec5_13_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Step 9: 2,2,2-Trifluoro-<i>N</i>-((1<i>S</i>)-3-hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>94</b>), 2,2,2-Trifluoro-<i>N</i>-((1<i>S</i>,3<i>R</i>)-3-hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>95</b>), and 2,2,2-Trifluoro-<i>N</i>-((1<i>S</i>,3<i>S</i>)-3-hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>96</b>)</h4><div class="NLM_p last">To a solution of ketone <b>93</b> (2.0 g, 5.56 mmol) in MeOH (150 mL) at 0 °C was added NaBH<sub>4</sub> (0.7 g, 16.67 mmol). After 2 h at room temperature, the reaction mixture was quenched with water (10 mL) and the mixture was extracted with EtOAc (3 × 50 mL), washed with brine (3 × 30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and the solvent removed to provide crude product <b>94</b> (1.1 g, 55%), as a mixture of <i>cis</i>/<i>trans</i> isomers. The crude was purified by preparative HPLC (column DuraShell, 150 mm × 25 mm, 5 μm; mobile phase CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% NH4OH) to give two peaks. Data for <b>94</b>, <i>cis</i>/<i>trans</i> mixture: <sup>1</sup>H NMR (400 MHz, DMSO- <i>d</i><sub>6</sub>) δ 12.30 (s, 1H), 10.03–9.91 (m, 1H), 8.83 (s, 1H), 8.16–7.92 (m, 2H), 7.68–7.60 (m, 2H), 6.80 (m, 1H), 5.82–5.61 (m, 1H), 5.50–5.11 (m, 2H), 2.87–2.84 (m, 0.7H), 2.35 (m, 0.5H), 1.97–1.95 (m, 0.8H); LC/MS (M + H) expected, 363.10; observed, 363.10. Data for <b>96</b>: peak 1, <i>trans</i>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.29 (br s, 1 H), 9.91 (d, <i>J</i> = 8.03 Hz, 1 H), 8.84 (s, 1 H), 8.16 (d, <i>J</i> = 8.03 Hz, 1 H), 8.04 (s, 1 H), 7.45–7.75 (m, 2 H), 6.82 (d, <i>J</i> = 3.01 Hz, 1 H), 5.62 (q, <i>J</i> = 7.03 Hz, 1 H), 5.48 (d, <i>J</i> = 6.02 Hz, 1 H), 5.22–5.38 (m, 1 H), 2.26–2.43 (m, 2 H); LC/MS (M + H) expected, 363.10; observed, 363.10. Data for <b>95</b>, peak 2, <i>cis</i>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.28 (br s, 1 H), 10.01 (d, <i>J</i> = 8.03 Hz, 1 H), 8.84 (s, 1 H), 8.16 (d, <i>J</i> = 8.03 Hz, 1 H), 7.92 (s, 1 H), 7.48–7.78 (m, 2 H) 6.81 (d, <i>J</i> = 2.51 Hz, 1 H), 5.80 (d, <i>J</i> = 5.52 Hz, 1 H), 5.33 (d, <i>J</i> = 8.53 Hz, 1 H), 5.12 (d, <i>J</i> = 6.53 Hz, 1 H), 2.87 (d, <i>J</i> = 12.05 Hz, 1 H), 1.96 (d, <i>J</i> = 11.54 Hz, 1 H); LC/MS (M + H) expected, 363.10; observed, 363.10.</div></div><div id="sec5_13_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Step 10: (1<i>R</i>,3<i>S</i>)-3-Amino-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-ol (<b>97</b>)</h4><div class="NLM_p last">To a solution of <b>95</b> (73.0 mg, 0.20 mmol) in MeOH (5 mL) was added a 2 M solution of NH<sub>3</sub> in MeOH (10 mL). The mixture was stirred at 50 °C for 16 h and then concentrated in vacuo and the material carried onto the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (br s, 1 H), 8.67–8.95 (m, 1 H), 8.50 (br s, 1 H), 7.99–8.27 (m, 2 H), 7.66 (d, <i>J</i> = 3.51 Hz, 1 H), 7.52 (d, <i>J</i> = 7.53 Hz, 1 H), 6.92 (d, <i>J</i> = 3.51 Hz, 1 H), 5.76 (s, 1 H) 5.52 (br s, 1 H), 4.97 (br s, 1 H), 2.70–2.88 (m, 1 H), 1.91–2.13 (m, 1 H), 1.51–1.68 (m, 1 H); LC/MS (M + H) expected, 267.1; observed, 266.9.</div></div><div id="sec5_13_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Step 11: (<i>N</i>-((1<i>S</i>,3<i>R</i>)-3-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>25</b>)</h4><div class="NLM_p last">To a solution of <b>97</b> (53.7 mg, 0.20 mmol) in DMF (2 mL) at −30 °C were added NMM (40.8 mg, 0.40 mmol) and then BrCN (29.9 mg in 1 mL of DMF). After 1.5 h the reaction mixture was concentrated to give the crude product, which was purified by preparative HPLC (column Durashell 150 mm × 25 mm, 5 μm; mobile phase CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% NH<sub>4</sub>OH) and lyophilized to give <b>25</b> (27.6 mg, 47%) as a white solid. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>OH-<i>d</i><sub>4</sub>) δ 8.79 (s, 1 H), 8.01–8.15 (m, 2 H), 7.65 (d, <i>J</i> = 7.81 Hz, 1 H), 7.54 (d, <i>J</i> = 3.51 Hz, 1 H), 6.90 (d, <i>J</i> = 3.51 Hz, 1 H), 5.15 (t, <i>J</i> = 7.42 Hz, 1 H), 4.61 (t, <i>J</i> = 8.00 Hz, 1 H), 3.04 (dt, <i>J</i> = 12.54, 7.00 Hz, 1 H), 1.93 (dt, <i>J</i> = 12.54, 8.46 Hz, 1 H); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.28 (br s, 1 H), 8.66–8.98 (m, 1 H), 8.02–8.28 (m, 2 H), 7.47–7.81 (m, 3 H), 6.92 (d, <i>J</i> = 3.51 Hz, 1 H), 5.75 (d, <i>J</i> = 6.53 Hz, 1 H), 5.03 (q, <i>J</i> = 7.03 Hz, 1 H), 4.55 (q, <i>J</i> = 7.36 Hz, 1 H), 2.89 (dt, <i>J</i> = 12.17, 6.96 Hz, 1 H), 1.79 (dt, <i>J</i> = 11.92, 8.85 Hz, 1 H); LC/MS (M + H) expected, 292.1; observed, 292.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 292.1193; observed 292.1191.</div></div><div id="sec5_13_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Step 12: (1<i>S</i>,3<i>S</i>)-3-Amino-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-ol (<b>98</b>)</h4><div class="NLM_p last">To a solution of <b>96</b> (36.4 mg, 0.10 mmol) in MeOH (2.5 mL) was added a 2 M solution of NH<sub>3</sub> in MeOH (5 mL). The reaction was heated to 50 °C for 16 h and then the solvent removed in vacuo to give a colorless oil, which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.23 (br s, 1 H), 8.83 (s, 1 H), 7.97–8.24 (m, 2 H), 7.66 (d, <i>J</i> = 3.51 Hz, 1 H), 7.51 (d, <i>J</i> = 7.53 Hz, 1 H), 6.93 (d, <i>J</i> = 3.51 Hz, 1 H), 5.66–5.92 (m, 1 H), 5.18 (s, 2 H), 3.00 (d, <i>J</i> = 5.02 Hz, 1 H), 2.21 (d, <i>J</i> = 6.53 Hz, 1 H), 1.83–2.07 (m, 3 H); LC/MS (M + H) expected, 267.1; observed, 266.9.</div></div><div id="sec5_13_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Step 13: <i>N</i>-((1<i>S</i>,3<i>S</i>)-3-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>26</b>)</h4><div class="NLM_p last">To a solution of <b>98</b> (26.7 mg, 0.1 mmol) in DMF (1 mL) at −30 °C was added NMM (20.3 mg, 0.20 mmol). After 10 min, BrCN (14.9 mg in 1 mL DMF) was added dropwise and the reaction stirred for 1.5 h. The solvent was removed in vacuo and the crude product was purified by preparative HPLC (column Durashell, 150 mm × 25 mm, 5 μm; mobile phase CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% NH<sub>4</sub>OH) to give <b>26</b> (10.48 mg, 36%) as a white solid after lyophilization. <sup>1</sup>H NMR (400 MHz, CH<sub>3</sub>OH-<i>d</i><sub>4</sub>) δ 8.79 (s, 1 H), 8.04–8.19 (m, 2 H), 7.66 (d, <i>J</i> = 7.81 Hz, 1 H), 7.55 (d, <i>J</i> = 3.51 Hz, 1 H), 6.92 (d, <i>J</i> = 3.71 Hz, 1 H), 5.41 (t, <i>J</i> = 5.27 Hz, 1 H), 4.96 (t, <i>J</i> = 6.05 Hz, 1 H), 2.45 (t, <i>J</i> = 5.76 Hz, 2 H); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.28 (br s, 1 H), 8.85 (s, 1 H), 8.07–8.28 (m, 2 H), 7.54–7.76 (m, 2 H), 7.44 (d, <i>J</i> = 5.38 Hz, 1 H), 6.95 (d, <i>J</i> = 1.96 Hz, 1 H), 5.49 (d, <i>J</i> = 5.87 Hz, 1 H), 5.29 (q, <i>J</i> = 5.38 Hz, 1 H), 4.89 (q, <i>J</i> = 5.87 Hz, 1 H), 2.14–2.39 (m, 2 H); LC/MS (M + H) expected, 292.1; observed, 292.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 292.1193; observed 292.1191.</div></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Synthesis of <i>N</i>-((1<i>R</i>,2<i>R</i>)-2-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>27</b>)</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Step 1: Rac <i>tert</i>-Butyl ((1<i>R</i>,2<i>R</i>)-6-Bromo-2-hydroxy-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>100</b>)</h4><div class="NLM_p last">To a solution of rac-trans amine <b>99</b> (2.0 g, 8.7 mmol) in THF (10 mL) at 0 °C were added TEA (1.48 mL, 10.5 mmol) and Boc<sub>2</sub>O (1.93 g, 8.77 mmol). The reaction was stirred for 1 h and then the solvent was removed to give a residue, which was triturated with heptane and filtered to give desired product <b>100</b> (1.1 g, 38%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.42 (m, 2 H), 7.10 (d, <i>J</i> = 8.00 Hz, 1 H), 4.81–5.05 (m, 2 H), 4.33–4.47 (m, 1 H), 3.25 (dd, <i>J</i> = 16.00, 7.71 Hz, 1 H), 2.85 (dd, <i>J</i> = 15.91, 8.20 Hz, 1 H), 1.51 (s, 9 H); LC/MS (M + Na) expected, 350.368; observed, 350.10.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Step 2: Rac <i>tert</i>-Butyl ((1<i>R</i>,2<i>R</i>)-2-Hydroxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>101</b>)</h4><div class="NLM_p last">To a solution of bromide <b>100</b> (590 mg, 1.80 mmol) in dioxane (10 mL) were added (BPin)<sub>2</sub> (548 mg, 2.16 mmol), KOAc (535 mg, 5.39 mmol), and PdCl<sub>2</sub>(dppf) (65.9 mg, 0.09 mmol). The reaction mixture was heated to 100 °C for 3 h and then allowed to cool to room temperature. The reaction mixture was diluted with ethyl acetate and filtered through Celite. The filtrate was concentrated to afford a brown oil, which after chromatography (silica, EtOAc/heptane) gave the desired product <b>101</b> as a white solid (570 mg, 84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 7.42 Hz, 1 H), 7.62 (s, 1 H), 7.23 (d, <i>J</i> = 7.61 Hz, 1 H), 5.15 (d, <i>J</i> = 3.32 Hz, 1 H), 4.88 (t, <i>J</i> = 5.66 Hz, 1 H), 4.35–4.47 (m, 1 H), 3.30 (dd, <i>J</i> = 16.20, 7.81 Hz, 1 H), 2.92 (dd, <i>J</i> = 16.10, 8.49 Hz, 1 H), 1.50 (s, 9 H), 1.35 (d, <i>J</i> = 3.30 Hz, 12 H).</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Step 3: <i>tert</i>-Butyl ((1<i>R</i>,2<i>R</i>)-2-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>102</b>) and <i>tert</i>-Butyl ((1<i>S</i>,2<i>S</i>)-2-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>104</b>)</h4><div class="NLM_p last">To a solution of boronate <b>101</b> (530 mg, 1.41 mmol) in dioxane/water (47 mL:12 mL) at room temperature were added pyrrolopyrimidine chloride <b>36</b> (238 mg, 1.55 mmol), K<sub>2</sub>CO<sub>3</sub> (644 mg, 4.66 mmol), and PdCl<sub>2</sub>dppf (106 mg, 0.127 mmoL). After heating to 100 °C for 2.5 h, the reaction was diluted with ethyl acetate and washed with 10% NH<sub>4</sub>Cl and water. The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give the crude product, which after purification by chromatography (EtOAc/heptanes) gave racemic product (250 mg, 48%), as a mixture of racemic <i>trans</i> isomers. The racemate was separated by chiral SFC (column ChiralPak AY-H, 30 mm × 250 mm; mobile phase 65:35 CO<sub>2</sub>/MeOH; flow 10 mL/min; detection λ = 210 nm) to give two peaks. <b>102</b>: peak 2, <i>t</i><sub>R</sub> = 4.34; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.21 (br s, 1 H), 8.78 (s, 1 H), 8.00 (d, <i>J</i> = 7.80 Hz, 1 H), 7.92 (s, 1 H), 7.62 (d, <i>J</i> = 3.12 Hz, 1 H), 7.35 (d, <i>J</i> = 7.81 Hz, 1 H), 6.77 (d, <i>J</i> = 3.32 Hz, 1 H), 5.32 (d, <i>J</i> = 5.66 Hz, 1 H), 4.78 (t, <i>J</i> = 7.61 Hz, 1 H), 4.19–4.30 (m, 1 H), 3.09–3.22 (m, 2 H), 2.73 (dd, <i>J</i> = 15.90, 7.51 Hz, 1 H), 1.44 (s, 9 H); LC/MS (M + H) expected, 367.1770; observed, 367.2. Data for <b>104</b>: peak 1, <i>t</i><sub>R</sub> = 3.60 min; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.21 (br s, 1 H), 8.78 (s, 1 H), 8.00 (d, <i>J</i> = 8.00 Hz, 1 H), 7.92 (s, 1 H), 7.62 (d, <i>J</i> = 3.12 Hz, 1 H), 7.35 (d, <i>J</i> = 7.61 Hz, 2 H), 6.77 (d, <i>J</i> = 3.51 Hz, 1 H), 5.32 (d, <i>J</i> = 5.85 Hz, 1 H), 4.78 (t, <i>J</i> = 7.61 Hz, 1 H), 4.18–4.39 (m, 1 H), 3.04–3.21 (m, 2 H), 2.73 (dd, <i>J</i> = 15.81, 7.61 Hz, 1 H), 1.44 (s, 9 H); LC/MS (M + H) expected, 367.1770; observed, 367.2. Absolute stereochemistry of <b>102</b> and <b>104</b> was assigned based on single X-ray of <b>105</b> (see below).</div></div><div id="sec5_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Step 4a: (1<i>R</i>,2<i>R</i>)-1-Amino-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-2-ol (<b>103</b>)</h4><div class="NLM_p last">To a solution of <b>102</b> (111 mg, 0.30 mmol) in dioxane (4 mL) was added a 4 N solution of HCl in dioxane (4 mL). The reaction mixture was stirred at room temperature for 1.5 h and then the solvent removed in vacuo to give a residue, which was triturated with ether to give a solid. The solid was filtered and dried to give the desired product as the HCl salt <b>103</b> (94 mg, 103%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.01 (br s, 1 H), 9.00–8.87 (m, 2 H), 8.40 (s, 1 H), 8.12 (dd, <i>J</i> = 7.90, 1.07 Hz, 1 H), 7.90 (br s, 1 H), 7.57 (d, <i>J</i> = 7.81 Hz, 1 H), 7.24 (d, <i>J</i> = 1.95 Hz, 1 H), 4.51 (br s, 2 H), 3.59–3.73 (m, 2 H), 3.31–3.51 (m, 2 H), 2.90 (dd, <i>J</i> = 16.49, 5.17 Hz, 1 H); LC/MS (M + H) expected, 267.1246; observed, 267.1.</div></div><div id="sec5_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Step 4b: (1<i>S</i>,2<i>S</i>)-1-Amino-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-2-ol (<b>105</b>)</h4><div class="NLM_p last">To a solution of <b>104</b> (55 mg, 0.30 mmol) in dioxane (2 mL) was added a 4 N solution of HCl in dioxane (2 mL). The reaction mixture was stirred at room temperature for 1.5 h and then the solvent removed in vacuo to give a residue, which was triturated with ether to give a solid. The solid was filtered and dried to give the desired product as the HCl salt <b>105</b> (47 mg, 103%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.01 (br s, 1 H), 9.00–8.87 (m, 2 H), 8.40 (s, 1 H), 8.12 (dd, <i>J</i> = 7.90, 1.1 Hz, 1 H), 7.90 (br s, 1 H), 7.57 (d, <i>J</i> = 7.81 Hz, 1 H), 7.24 (d, <i>J</i> = 1.95 Hz, 1 H), 4.51 (br s, 2 H), 3.59–3.73 (m, 2 H), 3.31–3.51 (m, 2 H), 2.90 (dd, <i>J</i> = 16.49, 5.17 Hz, 1 H); LC/MS (M + H) expected, 267.1246; observed, 267.1. The absolute stereochemistry of <b>105</b> was determined by single X-ray crystallography to be (<i>S</i>,<i>S</i>) (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information</a>); by inference <b>103</b> was assigned as (<i>R</i>,<i>R</i>).</div></div><div id="sec5_14_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Step 5: <i>N</i>-((1<i>R</i>,2<i>R</i>)-2-Hydroxy-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>27</b>)</h4><div class="NLM_p last">To a solution of <b>103</b> (105 mg, 0.394 mmol) in DMF (4 mL) at 0 °C was added NMM (121 mg, 1.18 mmol) followed by CNBr (2 M solution in DCM, 1.1 equiv). After 20 min, the reaction was diluted with brine and ethyl acetate. The layers were separated, and the aqueous layer extracted twice with ethyl acetate. The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed to give the crude product, which was diluted with methanol and triturated with diethyl ether to provide desired product <b>27</b> (40 mg, 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.23 (br s, 1 H), 8.81 (s, 1 H), 7.95–8.14 (m, 2 H), 7.56–7.69 (m, 2 H), 7.42 (d, <i>J</i> = 8.39 Hz, 1 H), 6.89 (d, <i>J</i> = 2.15 Hz, 1 H), 5.64 (d, <i>J</i> = 5.46 Hz, 1 H), 4.15–4.41 (m, 2 H), 3.21 (dd, <i>J</i> = 16.10, 6.93 Hz, 1 H), 2.69–2.83 (m, 1 H); LC/MS (M + H) expected, 292.1198; observed, 292.0.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> Synthesis of <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)methanesulfonamide (<b>28</b>), <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-2-methoxyethane-1-sulfonamide (<b>29</b>), <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-1-methyl-1<i>H</i>-pyrazole-5-sulfonamide (<b>30</b>), <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-3-fluorobenzenesulfonamide (<b>31</b>), <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-3-cyanobenzenesulfonamide (<b>32</b>), and <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-4-methoxybenzenesulfonamide (<b>33</b>)</h3><div id="sec5_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Step 1: (<i>S</i>)-2,2,2-Trifluoro-<i>N</i>-(3-(hydroxyimino)-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>106</b>)</h4><div class="NLM_p last">To a flask containing ketone <b>93</b> (13.0 g, 36 mmol) in ethanol (300 mL) was added NH<sub>2</sub>OH·HCl (6.2 g, 90 mmol). After heating the reaction mixture at reflux for 1 h, the mixture was concentrated in vacuo to give crude <b>106</b> (17 g, 100%) as a white solid, which was used in the next step without further purification.</div></div><div id="sec5_15_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Step 2: <i>N</i>-((1<i>S</i>,3<i>R</i>)-3-Amino-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-2,2,2-trifluoroacetamide (<b>107</b>) and <i>N</i>-((1<i>S</i>,3<i>S</i>)-3-Amino-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-2,2,2-trifluoroacetamide (<b>108</b>)</h4><div class="NLM_p last">To a solution of hydroxylamine <b>106</b> (2.1 g, 5.54 mmol) in aqueous HCl (14.0 mL, 55.4 mmol) and THF (73 mL) was added zinc powder (3.63 g, 55.4 mmol). After stirring at 60 °C for 1.5 h, the reaction mixture was neutralized with NH<sub>4</sub>OH at 5 °C. The solution was extracted with 2:1 THF/EtOAc (6 × 300 mL) and water (200 mL). The organic layer was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed to give the crude product, which was purified by preparative HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O + 0.22% formic acid) to give the <i>trans</i> derivative <b>108</b> (310 mg, 12%) as a brown solid formate salt and cis derivative <b>107</b> (858 mg, 34% yield) as a brown solid formate salt. Data for <b>107</b>: <i>cis</i> (major) <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.72 (br s, 1 H), 10.19 (d, <i>J</i> = 7.82 Hz, 1 H), 8.96 (s, 1 H), 8.88 (br s, 3 H), 8.22 (d, <i>J</i> = 8.31 Hz, 1 H), 8.01 (s, 1 H), 7.94 (d, <i>J</i> = 7.82 Hz, 1 H), 7.84 (br s, 1 H), 6.91 (d, <i>J</i> = 1.96 Hz, 1 H), 5.51 (q, <i>J</i> = 7.83 Hz, 1 H), 4.83 (d, <i>J</i> = 5.38 Hz, 1 H), 3.02 (dt, <i>J</i> = 12.84, 7.76 Hz, 1 H), 2.17 (dt, <i>J</i> = 12.96, 7.70 Hz, 1 H); LC/MS (M + H) expected, 362.12; observed, 362.1. Data for <b>108</b>: <i>trans</i> (minor) <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (br s, 1 H), 10.08 (d, <i>J</i> = 7.82 Hz, 1 H), 8.98 (s, 1 H), 8.75 (br s, 3 H), 8.22 (d, <i>J</i> = 7.82 Hz, 1 H), 8.07 (s, 1 H), 7.95 (d, <i>J</i> = 8.31 Hz, 1 H), 7.86 (br s, 1 H), 6.91 (d, <i>J</i> = 1.47 Hz, 1 H), 5.79 (q, <i>J</i> = 7.34 Hz, 1 H), 5.03 (br s, 1 H), 2.55–2.63 (m, 2 H); LC/MS (M + H) expected, 362.12; observed, 362.1.</div></div><div id="sec5_15_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Step 3: 2,2,2-Trifluoro-<i>N</i>-((1<i>S</i>,3<i>R</i>)-3-(methylsulfonamido)-6-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)acetamide (<b>109a</b>)</h4><div class="NLM_p last">To a solution of amine <b>107</b> (150 mg, 0.38 mmol) in pyridine (10 mL) at 0 °C was added methylsulfonyl chloride (65.1 mg, 0.57 mmol in 0.5 mL of pyridine). After stirring at room temperature overnight, the reaction mixture was quenched by the addition of H<sub>2</sub>O (10 mL) and the mixture extracted with EtOAc (2 × 30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed in vacuo to give a residue which was purified via column chromatography on (MeOH/DCM, 2–20%) to give <b>109a</b> (100 mg, 60.3%) as a white solid.</div></div><div id="sec5_15_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Step 4: <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Amino-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)methanesulfonamide (<b>110a</b>)</h4><div class="NLM_p last">To a solution of <b>109a</b> (100 mg, 0.23 mmol) in ethanol/water (10 mL:1.5 mL) was added K<sub>2</sub>CO<sub>3</sub> (94.09 mg, 0.68 mmol). After heating at reflux for 8 h, the solvent was removed in vacuo and the residue was treated with silica gel directly and purified via column chromatography (MeOH/DCM, 2–20%) to give <b>110a</b> (60 mg, 77.06%) as a white solid.</div></div><div id="sec5_15_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Step 5: <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)methanesulfonamide (<b>28</b>)</h4><div class="NLM_p">To a solution of <b>110a</b> (60 mg, 0.175 mmol) in DMF (2 mL) was added NMM (35 mg, 0.35 mmol) at room temperature. The mixture was cooled to −30 °C, and a solution of BrCN (22.3 mg, 0.21 mmol in 0.5 mL of DMF) was added dropwise. After 30 min at −30 °C, the reaction mixture was diluted with water and extracted with EtOAc (2 × 30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated and purified via column chromatography (MeOH/DCM, gradient of 2–10%) to afford <b>28</b> (12 mg, 18.75%) as an off-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.32 (s, 1H), 8.85 (s, 1H), 8.20–8.15 (m, 2H), 7.88 (m, 1H), 7.74–7.69 (m, 2H), 7.61 (m, 1H), 6.92 (m, 1H), 4.83 (m, 1H), 4.62 (m, 1H), 3.10 (s, 3H), 3.01 (m, 1H), 1.92–1.89 (m, 1H).; LC/MS (M + H) expected 369.11, observed 391.2. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 369.1128; observed 369.1127.</div><div class="NLM_p last">Compounds <b>29</b>–<b>33</b> were prepared via a similar sequence as that described for <b>28</b> but done in parallel. The data for final compounds <b>29</b>–<b>33</b> are below.</div></div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-2-methoxyethane-1-sulfonamide (<b>29</b>)</h3><div class="NLM_p last"><b>29</b> (25 mg, 20%) was obtained as white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.31 (s, 1H), 8.86 (s, 1H), 8.22–8.190 (d, 1H), 8.17 (s, 1H), 7.95–7.93(m, 1H), 7.74–7.70 (m, 2H), 7.63–7.61 (d, 1H), 6.93–6.92 (d, 1H), 4.83–4.81 (m, 1H), 4.62 (s, 1H), 3.78–3.74 (m, 2H), 3.49–3.45 (m, 2H), 3.32 (s, 3H), 2.98–2.95 (m1 1H), 1.94–1.91 (m, 1H). LC/MS (M + H) expected, 412.13; observed, 413.2. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 413.1390; observed 413.1388.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-1-methyl-1<i>H</i>-pyrazole-5-sulfonamide (<b>30</b>)</h3><div class="NLM_p last">The residue was lyophilized to give <b>30</b> (35 mg, 34.7%) as an off-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.31 (s, 1H), 9.07–9.05 (s, 1H), 8.84 (s, 1H), 8.17–8.13(m, 2H), 7.71–7.68 (m, 2H), 7.62 (m, 1H), 7.35–7.33 (m, 1H), 6.90–6.85 (m, 2H), 4.63–4.61 (m, 1H), 4.57–4.52 (m, 1H), 4.08 (m, 1H), 2.52–2.49 (m, 1H), 1.73 (m, 1H); LC/MS (M + H) expected, 435.14; observed, 435.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>20</sub>H<sub>18</sub>N<sub>8</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 435.1346; observed 435.1346.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-3-fluorobenzenesulfonamide (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.30 (br s, 1 H), 8.85 (s, 1 H), 8.64 (d, <i>J</i> = 6.02 Hz, 1 H), 8.04–8.30 (m, 2 H), 7.53–7.88 (m, 7 H), 7.40 (d, <i>J</i> = 7.53 Hz, 1 H), 6.90 (d, <i>J</i> = 3.01 Hz, 1 H), 4.80 (d, <i>J</i> = 6.02 Hz, 1 H), 4.54 (br s, 1 H), 2.39–2.48 (m, 1 H), 1.55–1.81 (m, 1 H); LC/MS (M + H) expected 456.12, observed 456.1. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>23</sub>H<sub>17</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 456.1237; observed 456.1238.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-3-cyanobenzenesulfonamide (<b>32</b>)</h3><div class="NLM_p last">Purified via column chromatography (CH<sub>3</sub>OH/DCM, gradient 2–10%) to afford <b>32</b> (30 mg, 35%) as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.81 (s, 1H), 8.38 (s, 1 H), 8.32–8.29 (m, 1 H), 8.11–8.06 (m, 3H), 7.88–7.84 (m, 1H), 7.58–7.56 (m, 1 H), 7.46–7.44 (m, 1 H), 6.91–6.90 (m, 1H), 4.96–4.91 (m, 1 H), 4.63–4.60 (m, 1 H), 2.75–2.72 (m, 1 H), 1.78–1.75 (m, 1 H); LC/MS (M + Na) expected, 478.11; observed, 478.0. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>22</sub>H<sub>17</sub>FN<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 449.1190; observed 449.1188.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> <i>N</i>-((1<i>R</i>,3<i>S</i>)-3-Cyanamido-5-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)-4-methoxybenzenesulfonamide (<b>33</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.31 (br s, 1 H), 8.85 (s, 1 H), 8.33 (d, <i>J</i> = 9.03 Hz, 1 H), 8.05–8.22 (m, 2 H), 7.87 (d, <i>J</i> = 8.53 Hz, 2 H), 7.59–7.74 (m, 2 H), 7.42 (d, <i>J</i> = 8.03 Hz, 1 H), 7.19 (d, <i>J</i> = 8.53 Hz, 2 H), 6.90 (d, <i>J</i> = 2.51 Hz, 1 H), 4.69 (d, <i>J</i> = 7.53 Hz, 1 H), 4.52 (d, <i>J</i> = 8.53 Hz, 1 H), 3.79–3.92 (m, 3 H), 2.37–2.45 (m, 1 H), 1.53–1.79 (m, 1 H); LC/MS (M + H) expected, 461.14; observed, 461.1.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> Synthesis of (<i>S</i>)-<i>N</i>-(6-(5-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>34</b>)</h3><div id="sec5_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> Step 1: (<i>S</i>)-1-Azido-6-bromo-2,3-dihydro-1<i>H</i>-indene (<b>111</b>)</h4><div class="NLM_p last">To a solution of enantiomerically pure alcohol <b>110</b><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> (8.1 g, 38 mmol) in PhMe (230 mL) was added DPPA (13.6 g, 49 mmol) at 0 °C, followed by DBU (8.08 g, 53 mmol). After 4 h at room temperature, the reaction was quenched with H<sub>2</sub>O (150 mL) at 0–10 °C and ethyl acetate (150 mL) was added. The organic layer was separated, collected, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed and the crude product was purified by column chromatography (petroleum ether) to give <b>112</b> (6.3 g, 70%) as an oil. LC/MS (M + H<sup>+</sup>) expected, 238.00; observed, 238.0.</div></div><div id="sec5_21_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Step 2: (<i>S</i>)-6-Bromo-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>113</b>)</h4><div class="NLM_p last">To a solution of azide <b>112</b> (2 g, 8.4 mmol) in MeOH (60 mL) was added SnCl<sub>2</sub> (2.8 g, 12.6 mmol) at 0 °C. After 5 h at room temperature, the reaction mixture was concentrated to dryness and aqueous 1 M NaOH (20 mL) added. The aqueous mixture was extracted with ethyl acetate (2 × 100 mL). Aqueous 1 M HCl (100 mL) was added to the combined organic layer and stirred for 5 min, and then the aqueous layer was separated and basified to pH = 9–10 with 1 M NaOH. The solution was extracted with ethyl acetate (3 × 100 mL), and organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed to give <b>113</b> (1.5 g, 78%) as oil. LC/MS (M + H<sup>+</sup>) expected, 212.01; observed, 212.0.</div></div><div id="sec5_21_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Step 3: <i>tert</i>-Butyl (<i>S</i>)-(6-Bromo-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>113</b>)</h4><div class="NLM_p last">To a solution of amine <b>113</b>, (1.5 g, 7 mmol) in DCM (60 mL) at 0 °C was added Et<sub>3</sub>N (2.9 mL, 21 mmol) followed by Boc<sub>2</sub>O (1.98 g, 9.19 mmol). After 2 h at room temperature, the reaction mixture was quenched with H<sub>2</sub>O (20 mL) and the organic layer separated, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give crude product. The crude product was purified by column chromatography (EtOAc/petroleum ether, 2–5%) to give <b>114</b> (1.4 g, 63%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.27–7.42 (m, 3 H), 7.20 (d, <i>J</i> = 8.20 Hz, 1 H), 4.99 (d, <i>J</i> = 7.81 Hz, 1 H), 2.81–2.92 (m, 1 H), 2.72 (dt, <i>J</i> = 16.10, 8.15 Hz, 1 H), 2.29–2.42 (m, 1 H), 1.76–1.91 (m, 1 H), 1.45 (s, 9 H); LC/MS (M + H<sup>+</sup>) expected, 312.06; observed, 312.0; [α]<sup>24</sup><sub>D</sub> −56.5 (<i>c</i> 25 mg/mL, MeOH).</div></div><div id="sec5_21_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> Step 4: <i>tert</i>-Butyl (<i>S</i>)-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>115</b>)</h4><div class="NLM_p last">To a solution of bromide <b>114</b> (1.5 g, 4.8 mmol) in dioxane (80 mL) at room temperature were added bis(pinacolato)diborane (1.71 g, 6.76 mmol) and KOAc (1.88 g, 19.2 mmol). Pd(dppf)Cl<sub>2</sub> (0.27 g, 0.336 mmol) was added under N<sub>2</sub>. After heating the reaction mixture at 80 °C for 3 h, it was concentrated to dryness. The reaction mixture was partitioned between ethyl acetate (100 mL) and H<sub>2</sub>O (15 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed in vacuo to give a residue, which was purified via chromatography (EtOAc/petroleum ether, 2–5%) to afford <b>115</b> (1.54 g, 90%) as yellow oil. LC/MS (M + H<sup>+</sup>) expected, 233.14; observed, 233.1.</div></div><div id="sec5_21_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> Step 5: <i>tert</i>-Butyl (<i>S</i>)-(6-(5-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>117</b>)</h4><div class="NLM_p last">To a solution of boronate <b>115</b> (1.1 g, 3.06 mmol) in dioxane (80 mL) and H<sub>2</sub>O (20 mL) at room temperature were added chloride <b>116</b> (0.7 g, 3.06 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.2 g, 9.2 mmol). Pd(dppf)Cl<sub>2</sub> (0.12 g, 0.15 mmol) was added under N<sub>2</sub>. After heating the reaction mixture at 90 °C for 9 h, it was concentrated to dryness and diluted with ethyl acetate (60 mL) and H<sub>2</sub>O (10 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give a residue, which was purified by chromatography (EtOAc/petroleum ether, 10–50%) to afford <b>117</b> (480 mg, 36%) as a yellow solid. LC/MS (M + H<sup>+</sup>) expected, 427.21; observed, 427.2.</div></div><div id="sec5_21_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Step 6: (<i>S</i>)-6-(5-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>118</b>)</h4><div class="NLM_p last">To a solution of <b>117</b> (80 mg, 0.18 mmol) in DCM (6 mL) at 0 °C was added TFA (1 mL). After 2 h, the solvent was removed in vacuo and the residue was diluted with ethyl acetate (15 mL) and H<sub>2</sub>O (20 mL). The organic layer was separated and discarded. The pH of the aqueous layer was adjusted to 9–10 with aqueous K<sub>2</sub>CO<sub>3</sub> and then extracted with (6:1 CHCl<sub>3</sub>/CH<sub>3</sub>OH, 3 × 30 mL). The combined organic extracts were washed with brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed to give amine <b>118</b> (48 mg, 78%) as white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (s, 1H), 7.72 (s, 1H), 7.36–7.34 (m, 1H), 7.34–7.05 (m, 5H), 6.95–6.93 (m, 2H), 3.85–3.81 (m, 1H), 2.83–2.76 (m, 1H), 2.68–2.60 (m, 1H), 2.26–2.21 (m, 1H), 1.46–1.44 (m, 1H); chiral SFC (column Chiralpak AS-H, 150 mm × 4.6 mm; mobile phase MeOH (0.05% DEA)/CO<sub>2</sub> 55–40%), <i>t</i><sub>R</sub> = 4.974 min; LC/MS (M + H) expected, 327.16; observed, 326.9.</div></div><div id="sec5_21_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> Step 7: (<i>S</i>)-<i>N</i>-(6-(5-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>34</b>)</h4><div class="NLM_p last">To a solution of amine <b>118</b> (60 mg, 0.184 mmol) in DMF (8 mL) at 0 °C was added NMM (0.06 mL, 0.55 mmol). The reaction was then cooled to −25 °C, and BrCN (29 mg, 0.27 mmol) was added under N<sub>2</sub>. After 1 h at 0 °C, the reaction was quenched with H<sub>2</sub>O (8 mL) and diluted with DCM (20 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed to give the crude product, which was purified by column chromatography (EtOAc/DCM 5–35%) to give <b>34</b> (30 mg, 46%) as white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.46 (s, 1H), 8.86 (s, 1H), 7.73 (s, 1H), 7.32 (s, 1H), 7.24–6.94 (m, 9H), 4.24–4.22 (m, 1H), 2.93–2.88 (m, 1H), 2.78–2.73 (m, 1H), 2.34–2.32 (m, 1H), 1.87–1.83 (m, 1H); chiral SFC (column Chiralpak AS-H, 150 mm × 4.6 mm; mobile phase MeOH (0.05% DEA)/CO<sub>2</sub> 55–40%): <i>t</i><sub>R</sub> = 5.559 min.; LC/MS (M + H) expected, 352.16; observed, 352.2.</div></div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> Synthesis of (<i>S</i>)-<i>N</i>-(6-(5-(3-(Hydroxymethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>35</b>)</h3><div id="sec5_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> Step 1: (3-(4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)phenyl)methanol (<b>121</b>)</h4><div class="NLM_p last">To a mixture of iodide <b>119</b> (13.3 g, 32.5 mmol), boronate <b>120</b> (5.43 g, 35.7 mmol), K<sub>2</sub>CO<sub>3</sub> (8.97 g, 65 mmol) in dioxane/H<sub>2</sub>O (150:30 mL) at room temperature was added Pd(dppf)Cl<sub>2</sub> (1.19 g, 1.63 mmol). After heating the reaction mixture at reflux for 3 h, the mixture was diluted with ethyl acetate (1.5 L), washed with brine (500 mL), dried over sodium sulfate and the solvent removed. The crude product was purified by chromatography (EtOAc/petroleum ether, 10–50%) to afford <b>121</b> (13 g, 100%) as a yellow solid. LC/MS (M + H) expected, 389.1326; observed, 389.15.</div></div><div id="sec5_22_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> Step 2: (3-(4-Chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)phenyl)methanol (<b>122</b>)</h4><div class="NLM_p last">To a solution of <b>121</b> (13.0 g, 32.5 mmol) in DCM (66 mL) at room temperature was added dropwise TFA (33 mL). After 4 h at room temperature, the reaction solution was concentrated to afford a brown oil. The solution of crude <b>122</b> in methanol (150 mL) was adjusted to pH = 10 with addition of solid K<sub>2</sub>CO<sub>3</sub>. After 2.5 h at room temperature, the solvent was removed and the residue was partitioned between water (500 mL) and ethyl acetate (1 L). The layers were separated, and the aqueous phase was extracted with ethyl acetate (2 × 500 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed to give <b>122</b> (7.5 g, 89%) as a yellow solid, which was used for the next step without purification. LC/MS (M + H) expected, 260.0591; observed, 260.0.</div></div><div id="sec5_22_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> Step 3: <i>tert</i>-Butyl (<i>S</i>)-(6-(5-(3-(Hydroxymethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)carbamate (<b>123</b>)</h4><div class="NLM_p last">To a mixture of chloride <b>122</b> (1.6 g, 5.64 mmol), chiral boronate <b>115</b> (2.02 g, 5.64 mmol), K<sub>2</sub>CO<sub>3</sub> (1.6 g, 11.2 mmol) in dioxane/water (30:6 mL) at room temperature was added Pd(dppf)Cl<sub>2</sub> (410 mg, 0.56 mmol). After heating the reaction mixture at 80 °C for 24 h, the mixture was cooled to room temperature and then diluted with water (50 mL). The aqueous mixture was extracted with ethyl acetate (3 × 200 mL) and the organic layers were collected, dried over Na<sub>2</sub>SO<sub>4</sub> and solvent was removed. The crude product was purified by column chromatography (EtOAc/petroleum ether, 10–100%) to afford <b>123</b> (1.1 g, 42.8%). LC/MS (M + H) expected, 457.22; observed, 457.2.</div></div><div id="sec5_22_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> Step 4: (<i>S</i>)-(3-(4-(3-Amino-2,3-dihydro-1<i>H</i>-inden-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)phenyl)methanol (<b>124</b>)</h4><div class="NLM_p last">To a solution of <b>123</b>, (350 mg, 0.77 mmol) in EtOAc (5 mL) at 0 °C was added a 4 M solution of HCl in ethyl acetate (5 mL). After the addition was completed, the reaction mixture was stirred at room temperature for 2 h and then concentrated to give 360 mg of crude product, 260 mg of which was purified by preparative HPLC to afford amine <b>124</b> (30.5 mg, 11%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.85 (s, 1H), 7.73 (s, 1H), 7.30 (d, 1H), 7.17 (s, 1H), 7.10 (m, 3H), 6.99 (d, 1H), 6.67 (s, 1H), 4.18 (s, 2H), 3.95 (m, 1H), 2.89 (m, 1H), 2.73 (m, 1H), 2.29 (m, 1H), 1.57 (m, 1H); LC/MS (M + H) expected, 357.17; observed, 357.4.</div></div><div id="sec5_22_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> Step 5: (<i>S</i>)-<i>N</i>-(6-(5-(3-(Hydroxymethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-2,3-dihydro-1<i>H</i>-inden-1-yl)cyanamide (<b>35</b>)</h4><div class="NLM_p">To a solution of amine <b>124</b> (100 mg, 0.26 mmol) as HCl salt and NMM (78 mg, 0.78 mmol) in DMF (5 mL) at −20 °C was added BrCN (55 mg, 0.52 mmol). After stirring the reaction mixture at −20 °C for 30 min, it was diluted with brine (20 mL). The aqueous mixture was extracted with ethyl acetate (3 × 20 mL), and the organic extracts were combined, washed with brine (2 × 10 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed to give a residue, which was purified by column chromatography (NH<sub>4</sub>OH/MeOH/DCM, 0/1/50 to 1/10/100) to afford <b>35</b> (41 mg, 41%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.45 (br, 1H), 8.85 (s, 1H), 7.72 (s, 1H), 7.23 (m, 2H), 7.14 (m, 4H), 6.89 (d, 1H), 6.69 (s, 1H), 5.00 (m, 1H), 4.23 (m, 3H), 2.93 (m, 1H), 2.77 (m, 1H), 2.39 (m, 1H), 1.88 (m, 1H); LC/MS (M + H) expected, 404.1487; observed, 404.4. HRMS (ESI) <i>m</i>/<i>z</i>: calculated for C<sub>23</sub>H<sub>19</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 382.1662; observed 382.1661.</div><div class="NLM_p last">The JAK enzyme data and the PBMC data were obtained as previously described.<a onclick="showRef(event, 'ref36 ref27'); return false;" href="javascript:void(0);" class="ref ref36 ref27">(36,27)</a></div></div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> Determination of Compound Binding and JAK3 Inactivation Kinetics</h3><div class="NLM_p">The kinetics of compound binding/dissociation to JAK3 and JAK3 inactivation (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>) was measured using a time-resolved Förster resonance energy transfer (TR-FRET) competition binding assay based on the LanthaScreen Eu kinase binding assay (Invitrogen/Life Technologies). The assay utilizes a fluorescently labeled kinase active site probe and a JAK3 construct labeled with a Eu<sup>3+</sup>-conjugated antibody. Active site occupancy by the probe elicits a TR-FRET signal between the Eu<sup>3+</sup>-labeled kinase and probe, and thus compound binding or dissociation is detected by the concomitant change in TR-FRET signal upon exchange with the probe.</div><div class="NLM_p">Experimental conditions (final assay concentrations) were the following: 4 nM JAK3-GST (human protein, GST-tagged, amino acids 781–1124; Invitrogen no. PR7507B) and 2 nM Eu<sup>3+</sup>-labeled anti-GST antibody (Invitrogen no. PV5594). Assay buffer conditions were 20 mM HEPES, pH 7.5, 10 mM MgCl<sub>2</sub>, 0.0005% Tween 20, 0.01% BSA, 1 mM DTT. Compounds were prepared at 100× concentration in DMSO. A 1:3 dilution series was prepared for a total number of five compound concentrations in addition to a “no compound” control. Immediately prior to assay, 4× compound were prepared by dilution of the 100× DMSO solutions into buffer containing no DTT. Experiments were performed in a low volume NBS, black 384-well plate (Corning no. 3676).</div><div class="NLM_p">Two assays types were performed for each compound. To measure compound dissociation (20 μL total volume), 15 μL solutions containing a 1.33× final concentration of JAK3, compound, and Eu<sup>3+</sup>-labeled anti-GST antibody were incubated at room temperature for 2 h, and the assay was initiated by adding 5 μL of 4× of final concentration of kinase tracer-236 (Invitrogen no. PV5592) (prepared in 4% DMSO, final 150 nM). To measure compound binding (20 μL total volume), 15 μL solutions containing a 1.33× final concentration of JAK3, Eu<sup>3+</sup>-labeled anti-GST antibody, and kinase tracer-178 (Invitrogen no. PV5593, 150 nM final) were incubated at room temperature for 2 h, and the assay was initiated by adding 5 μL of 4× compound. Each assay was mixed thoroughly and then read on an EnVision plate reader (excitation wavelength, 340 nm; TR-FRET was calculated by dividing the signal from the emission peak of the probe (665 nm) by that of the europium (615 nm). Data were recorded every 60 s for 75 cycles.</div><div class="NLM_p last">Data were analyzed by global fit of the TR-FRET data to the integrated rate equation using the DynaFit fitting program (BioKin Ltd.). For reversible inhibitors, the data were analyzed according to a simple one-step binding mechanism described by an on-rate (<i>k</i><sub>on</sub>) and off-rate (<i>k</i><sub>off</sub>). JAK3 inactivation by a covalent inhibitor is described by the following two-step mechanism:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_m001.gif" alt="" id="_i143" /></img></span><span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_m002.gif" alt="" id="_i144" /></img></span>Steps 1 and 2 are described by <i>K</i><sub><i>i</i></sub> (equal to <i>k</i><sub>off</sub><i>/k</i><sub>on</sub>) and <i>k</i><sub>inact</sub>, respectively, and the ratio (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>) is the apparent second order rate constant for kinase inactivation. For most compounds tested, the data could not be fit to a unique solution for a two-step mechanism and were thus analyzed according to a single step inactivation mechanism, where the observed rate constant is equal to (<i>k</i><sub>inact</sub><i>/K</i><sub><i>i</i></sub>). The <i>t</i><sub>1/2</sub> was calculated from the off-rate (ln 2/<i>k</i><sub>off</sub>).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> JAK3 Kinase Kinetics</h3><div class="NLM_p last">ATP, phosphoenolpyruvate (PEP), NADH, pyruvate kinase (PK), lactate dehydrogenase (LDH), and the buffer HEPES were purchased from Sigma Chemical Co. (St. Louis, MO). The JAK1 peptide substrate (KAIETDKEYYTVKD-NH2) was from AnaSpec (San Jose, CA). The enzymatic activity of JAK3 (JH1 domain was determined at 25 °C using the coupled PK/LDH assay at 340 nm on a Tecan plate reader in a base assay buffer of 25 mM HEPES (pH 7.5), 10 mM MgCl<sub>2</sub>, 25 mM KCl, 0.005% Brij-35, and 1 mM DTT. The continuous assay solution contained an additional 20 units of pyruvate kinase (PK), 30 units of lactate dehydrogenase (LDH), 0.25 mM NADH, and 2 mM PEP.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> Determination of JAK3 Cys909 p<i>K</i><sub>a</sub> by the Kinetics of <b>125</b> Irreversible Inhibition across a Range of pH Values</h3><div class="NLM_p">JAK3 (2.5 μM final concentration) was incubated with 5 μM 1-((4aR,8aS)-4-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)hexahydro-2<i>H</i>-pyrido[4,3-<i>b</i>][1,4]oxazin-6(5H)-yl)prop-2-en-1-one (<b>125</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> in buffer of varying pH between 5.1 and 9.7 using the multicomponent system of 50 mM MES, 25 mM Tris, 25 mM CAPS, and 50 mM NaCl (MTCN buffer) containing 10 mM MgCl<sub>2</sub>, 1 mM DTT, and 0.005% Brij-35. After various incubation times, 2 μL aliquots were removed and diluted 1:100 into continuous assay buffer containing 1 mM ATP and 0.2 mM JAK1 peptide substrate. JAK3 incubated with buffer served as control to determine the percent of activity remaining in each kinase-inhibitor aliquot. The percent remaining activity was plotted against time and fit to a single exponential to determine the <i>k</i><sub>inact</sub>. The <i>k</i><sub>inact</sub> at each pH was then plotted against pH, and the p<i>K</i><sub>a</sub> was determined by a direct fit to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>,<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_m003.gif" alt="" id="_i147" /></img><span class="labelSpan">(1)</span></span>where <i>y</i><sub>min</sub> is the lower plateau at low pH, and <i>y</i><sub>max</sub> is the upper plateau at high pH. The data were analyzed using GraphPad Prism version 6.03 for Windows (GraphPad Software, La Jolla, CA).</div><figure id="fig11" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0030.jpeg" id="GRAPHIC-d7e12002-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of acrylamide <b>125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i148" class="anchor-spacer"></div><h3 class="article-section__title" id="_i148"> Determination of Reactivity of Compounds with Glutathione</h3><div class="NLM_p last">A solution of <span class="smallcaps smallerCapital">l</span>-glutathione reduced was prepared by dissolving <span class="smallcaps smallerCapital">l</span>-glutathione reduced (Sigma G-4251) in 100 mM phosphate buffer (pH = 7.4). The concentration of this solution was 5.5 mM. A 20 μM stock solution of test compound was prepared in DMSO. In a microtube kept at 37 °C in a heat-block, 450 μL of 5.5 mM <span class="smallcaps smallerCapital">l</span>-glutathione reduced solution or 100 mM phosphate buffer was added and warmed for approximately 5 min. 50 μL of 20 μM test compound solution was added into above matrixes to start reaction. The mixture was incubated at 37 °C. The reaction was quenched by removing 10 μL of sample and placed into 200 μL of acetonitrile containing internal standard at the required time points. Sample was analyzed by LC–MS/MS. The area ratio was used for calculation.<span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_m004.gif" alt="" id="_i149" /></img></span></div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i150" class="anchor-spacer"></div><h3 class="article-section__title" id="_i150"> Pharmacokinetics Studies</h3><div class="NLM_p last">Plasma concentrations of cyanamide <b>12</b> were determined in male rats (<i>n</i> = 2) after a single 1 mg/kg intravenous (iv) dose with pretreatment of 100 mg/kg oral (po) ABT, which was conducted at comparative medicine (Pfizer), and 1 mg/kg intravenous (iv) dose without pretreatment of 100 mg/kg oral (po) ABT, which was conducted at BioDuro (Beijing, China) according to standard protocols, respectively. Briefly, test compound and ABT were formulated in standard solubilizing vehicles: (iv dose (test compound)) 10% DMSO/50% PEG400/40% water; (po dose (ABT)) 0.5% methycellulose in water. Serial blood samples were collected at various times from 5 min to 24 h. Plasma was harvested from blood samples following centrifugation. Plasma samples (50 μL) and standards were prepared by protein precipitation with acetonitrile (1:1 v:v) containing an internal standard, propranolol or terfenadine. Samples were vortexed and centrifuged to obtain supernatant, which was analyzed using general LC–MS/MS methodology as described above (Sciex API 4000; <a href="http://sciex.com" class="ext-link">sciex.com</a>). Pharmacokinetic parameters were determined from individual animal data using noncompartmental analysis in Watson LIMS 7.4.1 (<a href="http://thermoscientific.com" class="ext-link">thermoscientific.com</a>).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i151" class="anchor-spacer"></div><h3 class="article-section__title" id="_i151"> Metabolism Studies</h3><div class="NLM_p">Stock solutions of cyanamide <b>12</b> were prepared in dimethyl sulfoxide/acetonitrile [25%:75%, (v/v)]. The final concentration of organic solvent in the incubation medium was 0.1% (v/v). Incubations were carried out at 37 °C for 45 min in a shaking water bath. The incubation volume was 3 mL and consisted of the following: 0.1 M potassium phosphate buffer (pH 7.4) containing MgCl<sub>2</sub> (5 mM), human liver microsomes (purchased from BD Gentest, Woburn, MA; P450 concentration 25 pmol), NADPH (1.3 mM), substrate (10 μM), and GSH (5 mM). Incubations that lacked either NADPH or GSH served as negative controls. Aliquots (1 mL) were removed after at 10 and 45 min, and reactions were terminated by the addition of ice-cold acetonitrile (4 mL). The samples were combined and centrifuged (3000<i>g</i>, 15 min), and the supernatants were dried under a steady nitrogen stream. The residue was reconstituted with mobile phase, vortexed, centrifuged (15 000<i>g</i>, 3 min) and analyzed for metabolite formation by liquid chromatography tandem mass spectrometry (LC–MS/MS).</div><div class="NLM_p last">Qualitative assessment of the metabolism of cyanamide <b>12</b> was conducted using a Thermo Finnegan Surveyor photodiode array plus detector, Thermo Acela pump, and a Thermo Acela autosampler (Thermo Scientific, West Palm Beach, FL). The monitoring wavelength (λ) was 280 nm. Chromatography was performed on a Phenomenex Aqua C18 (2.0 mm × 150 mm, 5 μm) column. The mobile phase composed of 0.1% HCOOH (solvent A) and acetonitrile (solvent B) at a flow rate of 0.7 mL/min. The binary gradient was as follows: solvent A to solvent B ratio was held at 95:5 (v/v) for 5 min and then adjusted to 30:70 (v/v) from 5 to 40 min, 30:70 (v/v) from 40 to 43 min, and 5:95 (v/v) from 44 to 60 min. Identification of the metabolites was performed on a Thermo Orbitrap mass spectrometer operating in positive ion electrospray mode. The spray potential was 3 kV and heated capillary was at 275 °C. Xcalibur software version 2.0 was used to control the HPLC–MS system. MS2 and MS3 product ion spectra were acquired at a normalized collision energy of 20 and 40 eV, with an isolation width of 2 amu. LC–MS spectra were acquired over a mass range of 150–900 <i>m</i>/<i>z</i>. Data dependent scanning was used to trigger MS2 and MS3 analysis of molecular ions and product ions. The two most intense ion from MS and MS2 scans were selected for MS2 and MS3 scans, respectively. Searching of LC-MSn data for molecular ions representing possible metabolites of <b>12</b> was performed manually. A reference list of all possible metabolites of <b>12</b> and their expected molecular ions was used during this process. LC–MS peaks identified to be possible metabolites, based on the molecular ions, were compared against blank samples. In cases where the signal strength was of sufficient intensity to trigger MSn scanning, the subsequent MS2 and MS3 spectra were examined to further confirm the identity and structure of possible metabolites. In addition, LC–MS chromatograms were compared directly against the appropriate blank chromatogram to identify additional metabolite peaks.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i152" class="anchor-spacer"></div><h3 class="article-section__title" id="_i152"> X-ray Crystallography</h3><div class="NLM_p last">Crystal structures of JAK3 bound to <b>10</b>, <b>12</b>, <b>23</b>, and <b>34</b> were determined as reported previously.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> To generate the desired complexes, JAK3/CMP-6 crystals were soaked for ∼24 h in the reservoir solution supplemented with 3 mM compound, resulting in full exchange of the bound CMP-6 for the compound of interest. Data for Jak3/<b>10</b> were collected at 100 K on a Rigaku FRE X-ray generator outfitted with a Saturn 944 CCD detector and processed with HKL2000.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Data for JAK3/<b>12</b>, JAK3/<b>23</b>, and JAK3/<b>34</b> were collected at 100 K at the Industrial Macromolecular Crystallography Association (IMCA) Collaborative Access Team Beamline 17-ID (Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA) and processed using XDS (Kabsch 2010) and AUTOPROC.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> All other data manipulations utilized the CCP4 suite of programs.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> For all data sets, a common test set of reflections corresponding to ∼5% of the total were used throughout refinement. All structures were solved by rigid body refinement in REFMAC using a reference structure of JAK3 with all ligands and waters removed.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Iterative rounds of refinement using AUTOBUSTER<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> were interspersed with manual model building in COOT.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Crystallographic data statistics and refinement results are detailed in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">Supporting Information Table 1</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i153"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01308" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01308" class="ext-link">10.1021/acs.jmedchem.8b01308</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystallographic data collection and structure refinement statistics for structures of JAK3 bound to <b>10</b>, <b>12</b>, <b>23</b>, or <b>34</b>; single molecule X-ray crystallography for <b>13</b>, <b>105</b>, and <b>114</b>; <sup>1</sup>H NMR data for <b>90</b> and <b>91</b>; electron density of <b>10</b>, <b>12</b>, <b>23</b>, and <b>34</b> in complex with JAK3; determination of preferred tautomer form of <b>12</b> using 2D NMR; <sup>1</sup>H NMR and HPLC data for <b>34</b> and <b>35</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf">jm8b01308_si_001.pdf (1.96 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_002.csv">jm8b01308_si_002.csv (2.58 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factor amplitudes for JAK3 complexes with compounds <b>10</b>, <b>12</b>, <b>23</b>, and <b>34</b> have been deposited with the Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">http://www.rcsb.org</a>) with the following accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4">6DA4</a> (<b>10</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD">6DUD</a> (<b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3">6DB3</a> (<b>23</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4">6DB4</a> (<b>34</b>). The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01308" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agustin Casimiro-Garcia</span> - <span class="hlFld-Affiliation affiliation">Medicine Design and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9618-2547" title="Orcid link">http://orcid.org/0000-0001-9618-2547</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#28494f5d5b5c4146064b495b4145415a47054f495a4b414968584e41524d5a064b4745"><span class="__cf_email__" data-cfemail="5534322026213c3b7b3634263c383c273a78323427363c341525333c2f30277b363a38">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John I. Trujillo</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Vajdos</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Juba</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Immunology Research Unit and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ellen Banker</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Aulabaugh</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Balbo</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Immunology Research Unit and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Bauman</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jill Chrencik</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jotham W. Coe</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Czerwinski</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Immunology Research Unit and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Dowty</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 1 Burtt Road, Andover, Massachusetts 01810, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Knafels</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soojin Kwon</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis Leung</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sidney Liang</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph P. Robinson</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4066-5299" title="Orcid link">http://orcid.org/0000-0002-4066-5299</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Baptiste Telliez</span> - <span class="hlFld-Affiliation affiliation">Inflammation and Immunology Research Unit and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ray Unwalla</span> - <span class="hlFld-Affiliation affiliation">Medicine Design and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5789-7336" title="Orcid link">http://orcid.org/0000-0002-5789-7336</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Yang</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Inc., 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atli Thorarensen</span> - <span class="hlFld-Affiliation affiliation">Medicine Design and , Pfizer Inc., 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): This work was funded by Pfizer. All authors were employed by Pfizer Inc. at the time this work was done.<br /></br><p class="inlineNote">All activities involving laboratory animals were carried out in accordance with federal, state, local, and institutional guidelines governing the use of laboratory animals in research and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Pfizer animal care facilities that supported this work are fully accredited by AAALAC International.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i156">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Tsung Lin, Jason Jussif, and Nancy Wood for PBMC and human whole blood assay data, Shihua Yao for JAK3 inactivation kinetics data, and Cuiman Cai, Gaurav Arora, Arindrajit Basak, Mihir D. Parikh, and Steven E. Heasley for chemistry contributions. We also thank Kathleen A.  Farley for NMR studies and Ivan J. Samardjiev for single X-ray crystallography contributions. This research used resources at the Industrial Macromolecular Crystallography Association Collaborative Access Team (IMCA-CAT) beamline 17-ID, supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ABT</td><td class="NLM_def"><p class="first last">aminobenzotriazole</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BLK</td><td class="NLM_def"><p class="first last">B lymphocyte kinase</p></td></tr><tr><td class="NLM_term">BMX</td><td class="NLM_def"><p class="first last">cytoplasmic tyrosine-protein kinase BMX</p></td></tr><tr><td class="NLM_term">BTK</td><td class="NLM_def"><p class="first last">Bruton’s tyrosine kinase</p></td></tr><tr><td class="NLM_term">CID</td><td class="NLM_def"><p class="first last">collision-induced dissociation</p></td></tr><tr><td class="NLM_term">COSY</td><td class="NLM_def"><p class="first last">homonuclear correlation spectroscopy</p></td></tr><tr><td class="NLM_term">CRG</td><td class="NLM_def"><p class="first last">cysteine reacting group</p></td></tr><tr><td class="NLM_term">Cys</td><td class="NLM_def"><p class="first last">cysteine</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">HER-2</td><td class="NLM_def"><p class="first last">receptor tyrosine-protein kinase erbB-2</p></td></tr><tr><td class="NLM_term">HER-4</td><td class="NLM_def"><p class="first last">receptor tyrosine-protein kinase erbB-4</p></td></tr><tr><td class="NLM_term">HSQC</td><td class="NLM_def"><p class="first last">heteronuclear single quantum coherence spectroscopy</p></td></tr><tr><td class="NLM_term">ITK</td><td class="NLM_def"><p class="first last">interleukin-2-inducible T-cell kinase</p></td></tr><tr><td class="NLM_term">JAK1</td><td class="NLM_def"><p class="first last">Janus kinase 1</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">JAK3</td><td class="NLM_def"><p class="first last">Janus kinase 3</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription protein</p></td></tr><tr><td class="NLM_term">TEC</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase TEC</p></td></tr><tr><td class="NLM_term">TYK2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">TXK</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase TXK</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i158">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, J. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, G. R.</span></span> <span> </span><span class="NLM_article-title">JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1126/science.8197455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.8197455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8197455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK2cXktlalsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=1415-1421&author=J.+E.+Darnellauthor=I.+M.+Kerrauthor=G.+R.+Stark&title=JAK-STAT+pathways+and+transcriptional+activation+in+response+to+IFNs+and+other+extracellular+signaling+proteins&doi=10.1126%2Fscience.8197455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins</span></div><div class="casAuthors">Darnell, James E., Jr.; Kerr, Ian M.; Stark, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">5164</span>),
    <span class="NLM_cas:pages">1415-21</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 97 refs.  Through the study of transcriptional activation in response to interferon α (IFN-α) and interferon γ (IFN-γ), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription).  The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription.  Recognition of the mols. involved in the IFN-α and IFN-γ pathway has led to discoveries that a no. of STAT family members exist and that other polypeptide ligands also use the Jak-STAT mols. in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo64rvN_qWlmLVg90H21EOLACvtfcHk0liTkwPsK44peQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktlalsL4%253D&md5=f63d2c7bb3c1aeca6f36fef38aff713c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.8197455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8197455%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26aulast%3DKerr%26aufirst%3DI.%2BM.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DJAK-STAT%2520pathways%2520and%2520transcriptional%2520activation%2520in%2520response%2520to%2520IFNs%2520and%2520other%2520extracellular%2520signaling%2520proteins%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D1415%26epage%3D1421%26doi%3D10.1126%2Fscience.8197455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedy, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1002/jlb.60.4.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fjlb.60.4.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8864127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK28XmsVSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1996&pages=441-452&author=J.+A.+Johnstonauthor=C.+M.+Baconauthor=M.+C.+Riedyauthor=J.+J.+O%E2%80%99Shea&title=Signaling+by+IL-2+and+related+cytokines%3A+JAKs%2C+STATs%2C+and+relationship+to+immunodeficiency&doi=10.1002%2Fjlb.60.4.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency</span></div><div class="casAuthors">Johnston, James A.; Bacon, Chris M.; Riedy, M. C.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 153 refs.  Cytokines that bind to the interleukin-2 (IL-2) receptor common gamma chain (γc), including IL-2, IL-4, IL-7, IL-9, and IL-15, are important for the growth and differentiation of T and B lymphocytes, natural killer cells, macrophages, and monocytes.  These cytokines have overlapping biol. effects that in part result from the use of the shared receptor subunit γc.  Recently it has become clear that these cytokines activate a no. of important intracellular signaling mols., including the Janus kinases JAK1 and JAK3 and members of the transcription factor family of signal transducers and activators of transcription (STATs).  The discovery of these signaling pathways has led to important new insights into their role of lymphocyte maturation, as it has emerged that mutations in the genes encoding both γc and JAK3 result in similar forms of severe combined immunodeficiency (SCID).  In this review we examine the structure and function of cytokine receptors and the signaling pathways involved in their regulation of gene expression.  Furthermore, we discuss recent advances that have led to a better understanding of how cytokines elicit intracellular responses, as well as their role in normal lymphoid development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxBS-4Fw4Io7Vg90H21EOLACvtfcHk0liTkwPsK44peQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVSls78%253D&md5=6ccea65ed0126878728f639506a565ac</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fjlb.60.4.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.60.4.441%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DBacon%26aufirst%3DC.%2BM.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSignaling%2520by%2520IL-2%2520and%2520related%2520cytokines%253A%2520JAKs%252C%2520STATs%252C%2520and%2520relationship%2520to%2520immunodeficiency%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1996%26volume%3D60%26spage%3D441%26epage%3D452%26doi%3D10.1002%2Fjlb.60.4.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKS and STATS: Biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATS%3A+Biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0liccQK3hIMvqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATS%253A%2520Biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0liccQK3hIMvqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenge, R.</span></span> <span> </span><span class="NLM_article-title">JAK and STAT signaling molecules in immunoregulation and immune-mediated disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.immuni.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22520847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+signaling+molecules+in+immunoregulation+and+immune-mediated+disease&doi=10.1016%2Fj.immuni.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span></div><div class="casAuthors">O'Shea, John J.; Plenge, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-550</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway, a landmark in cell biol., provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins.  As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technol. that permits genome-wide views.  As we celebrate the 20th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease.  Not only have genome-wide assocn. studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6dj5Zf9fdLVg90H21EOLACvtfcHk0liccQK3hIMvqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D&md5=de187a0555549f9f00f5a41052c05352</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520signaling%2520molecules%2520in%2520immunoregulation%2520and%2520immune-mediated%2520disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550%26doi%3D10.1016%2Fj.immuni.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwillich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00644.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases&doi=10.1111%2Fj.1600-065X.2008.00644.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0lifltz0GpTv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142%26doi%3D10.1111%2Fj.1600-065X.2008.00644.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontzias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.coph.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22819198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=464-470&author=A.+Kontziasauthor=A.+Kotlyarauthor=A.+Laurenceauthor=P.+Changelianauthor=J.+J.+O%E2%80%99Shea&title=Jakinibs%3A+a+new+class+of+kinase+inhibitors+in+cancer+and+autoimmune+disease&doi=10.1016%2Fj.coph.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease</span></div><div class="casAuthors">Kontzias, Apostolos; Kotlyar, Alexander; Laurence, Arian; Changelian, Paul; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">464-470</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines are crit. for normal cell growth and immunoregulation but also contribute to growth of malignant cells and drive immune-mediated disease.  A large subset of immunoregulatory cytokines uses the type I and type II cytokine receptors and pharmacol. targeting of these cytokines/cytokines receptors has proven to be efficacious in treating immune and inflammatory diseases.  These receptors rely on Janus family of kinases (Jaks) for signal transduction.  Recently the first Jak inhibitor (jakinib) has been approved by the FDA and a second has been recommended for approval.  Many other Jakinibs are likely to follow and in this brief review, we will discuss the state-of-the art of this new class of pharmacol. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmJV4I6HPAx7Vg90H21EOLACvtfcHk0lifltz0GpTv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbE&md5=22bcfa4414642f3d72214c4d4be84e2c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DKontzias%26aufirst%3DA.%26aulast%3DKotlyar%26aufirst%3DA.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DChangelian%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJakinibs%253A%2520a%2520new%2520class%2520of%2520kinase%2520inhibitors%2520in%2520cancer%2520and%2520autoimmune%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2012%26volume%3D12%26spage%3D464%26epage%3D470%26doi%3D10.1016%2Fj.coph.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-051113-024537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1146%2Fannurev-med-051113-024537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25587654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=311-328&author=J.+J.+O%E2%80%99Sheaauthor=D.+M.+Schwartzauthor=A.+V.+Villarinoauthor=M.+Gadinaauthor=I.+B.+McInnesauthor=A.+Laurence&title=The+JAK-STAT+pathway%3A+impact+on+human+disease+and+therapeutic+intervention&doi=10.1146%2Fannurev-med-051113-024537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span></div><div class="casAuthors">O'Shea, John J.; Schwartz, Daniella M.; Villarino, Alejandro V.; Gadina, Massimo; McInnes, Iain B.; Laurence, Arian</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-328</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)-signal transducer of activators of transcription (STAT) pathway is now recognized as an evolutionarily conserved signaling pathway employed by diverse cytokines, interferons, growth factors, and related mols.  This pathway provides an elegant and remarkably straightforward mechanism whereby extracellular factors control gene expression.  It thus serves as a fundamental paradigm for how cells sense environmental cues and interpret these signals to regulate cell growth and differentiation.  Genetic mutations and polymorphisms are functionally relevant to a variety of human diseases, esp. cancer and immune-related conditions.  The clin. relevance of the pathway has been confirmed by the emergence of a new class of therapeutics that targets JAKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxvQCRiTbL7Vg90H21EOLACvtfcHk0lifltz0GpTv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D&md5=19182154f1a046df039eb4a37b66bf78</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-051113-024537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-051113-024537%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLaurence%26aufirst%3DA.%26atitle%3DThe%2520JAK-STAT%2520pathway%253A%2520impact%2520on%2520human%2520disease%2520and%2520therapeutic%2520intervention%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2015%26volume%3D66%26spage%3D311%26epage%3D328%26doi%3D10.1146%2Fannurev-med-051113-024537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spolski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">New insights into the regulation of T cells by γc family cytokines</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nri2580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines&doi=10.1038%2Fnri2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by γc family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor γ-chain (γc) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional αβ T cells, γδ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0lg1hv13bJfqeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D480%26epage%3D490%26doi%3D10.1038%2Fnri2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortaldo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McVicar, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation and activation of the JAK-3 Janus kinase in response to interleukin-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1038/370151a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2F370151a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1994&pages=151-153&author=J.%0AA.+Johnstonauthor=M.+Kawamuraauthor=R.+A.+Kirkenauthor=Y.-Q.+Chenauthor=T.+B.+Blakeauthor=K.+Shibuyaauthor=J.+R.+Ortaldoauthor=D.+W.+McVicarauthor=J.+J.+O%E2%80%99Shea&title=Phosphorylation+and+activation+of+the+JAK-3+Janus+kinase+in+response+to+interleukin-2&doi=10.1038%2F370151a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F370151a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F370151a0%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DKirken%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DY.-Q.%26aulast%3DBlake%26aufirst%3DT.%2BB.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DOrtaldo%26aufirst%3DJ.%2BR.%26aulast%3DMcVicar%26aufirst%3DD.%2BW.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DPhosphorylation%2520and%2520activation%2520of%2520the%2520JAK-3%2520Janus%2520kinase%2520in%2520response%2520to%2520interleukin-2%26jtitle%3DNature%26date%3D1994%26volume%3D370%26spage%3D151%26epage%3D153%26doi%3D10.1038%2F370151a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuti, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklyn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koslov, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milici, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckius, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodworth, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beals, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagouras, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magna, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltarelli, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelms, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Etages, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finco-Kent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paniagua, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span> <span> </span><span class="NLM_article-title">Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1126/science.1087061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.1087061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=14593182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=875-878&author=P.+S.+Changelianauthor=M.+E.+Flanaganauthor=D.+J.+Ballauthor=C.+R.+Kentauthor=K.+S.+Magnusonauthor=W.+H.+Martinauthor=B.+J.+Rizzutiauthor=P.+S.+Sawyerauthor=B.+D.+Perryauthor=W.+H.+Brissetteauthor=S.+P.+McCurdyauthor=E.+M.+Kudlaczauthor=M.+J.+Conklynauthor=E.+A.+Elliottauthor=E.+R.+Koslovauthor=M.+B.+Fisherauthor=T.+J.+Strelevitzauthor=K.+Yoonauthor=D.+A.+Whippleauthor=J.+Sunauthor=M.+J.+Munchhofauthor=J.+L.+Dotyauthor=J.+M.+Casavantauthor=T.+A.+Blumenkopfauthor=M.+Hinesauthor=M.+F.+Brownauthor=B.+M.+Lillieauthor=C.+Subramanyamauthor=S.-P.+Changauthor=A.+J.+Miliciauthor=G.+E.+Beckiusauthor=J.+D.+Moyerauthor=C.+Suauthor=T.+G.+Woodworthauthor=A.+S.+Gawecoauthor=C.+R.+Bealsauthor=B.+H.+Littmanauthor=D.+A.+Fisherauthor=J.+F.+Smithauthor=P.+Zagourasauthor=H.+A.+Magnaauthor=M.+J.+Saltarelliauthor=K.+S.+Johnsonauthor=L.+F.+Nelmsauthor=S.+G.+Des+Etagesauthor=L.+S.+Hayesauthor=T.+T.+Kawabataauthor=D.+Finco-Kentauthor=D.+L.+Bakerauthor=M.+Larsonauthor=M.-S.+Siauthor=R.+Paniaguaauthor=J.+Higginsauthor=B.+Holmauthor=B.+Reitzauthor=Y.-J.+Zhouauthor=R.+E.+Morrisauthor=J.+J.+O%E2%80%99Sheaauthor=D.+C.+Borie&title=Prevention+of+organ+allograft+rejection+by+a+specific+Janus+kinase+3+inhibitor&doi=10.1126%2Fscience.1087061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span></div><div class="casAuthors">Changelian, Paul S.; Flanagan, Mark E.; Ball, Douglas J.; Kent, Craig R.; Magnuson, Kelly S.; Martin, William H.; Rizzuti, Bonnie J.; Sawyer, Perry S.; Perry, Bret D.; Brissette, William H.; McCurdy, Sandra P.; Kudlacz, Elizabeth M.; Conklyn, Maryrose J.; Elliott, Eileen A.; Koslov, Erika R.; Fisher, Michael B.; Strelevitz, Timothy J.; Yoon, Kwansik; Whipple, David A.; Sun, Jianmin; Munchhof, Michael J.; Doty, John L.; Casavant, Jeffrey M.; Blumenkopf, Todd A.; Hines, Michael; Brown, Matthew F.; Lillie, Brett M.; Subramanyam, Chakrapani; Chang, Shang-Poa; Milici, Anthony J.; Beckius, Gretchen E.; Moyer, James D.; Su, Chunyan; Woodworth, Thasia G.; Gaweco, Anderson S.; Beals, Chan R.; Littman, Bruce H.; Fisher, Douglas A.; Smith, James F.; Zagouras, Panayiotis; Magna, Holly A.; Saltarelli, Mary J.; Johnson, Kimberly S.; Nelms, Linda F.; Des Etages, Shelley G.; Hayes, Lisa S.; Kawabata, Thomas T.; Finco-Kent, Deborah; Baker, Deanna L.; Larson, Michael; Si, Ming-Sing; Paniagua, Ricardo; Higgins, John; Holm, Bari; Reitz, Bruce; Zhou, Yong-Jie; Morris, Randall E.; O'Shea, John J.; Borie, Dominic C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clin. immunosuppression.  The authors report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants.  CP-690,550 treatment was not assocd. with hypertension, hyperlipidemia, or lymphoproliferative disease.  On the basis of these preclin. results, the authors believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoo8qryWWkbVg90H21EOLACvtfcHk0lg1hv13bJfqeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D&md5=85b6ea64a6711f95fc28408d42ce9c49</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087061%26sid%3Dliteratum%253Aachs%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DD.%2BJ.%26aulast%3DKent%26aufirst%3DC.%2BR.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DRizzuti%26aufirst%3DB.%2BJ.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DConklyn%26aufirst%3DM.%2BJ.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DKoslov%26aufirst%3DE.%2BR.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DBeckius%26aufirst%3DG.%2BE.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWoodworth%26aufirst%3DT.%2BG.%26aulast%3DGaweco%26aufirst%3DA.%2BS.%26aulast%3DBeals%26aufirst%3DC.%2BR.%26aulast%3DLittman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DZagouras%26aufirst%3DP.%26aulast%3DMagna%26aufirst%3DH.%2BA.%26aulast%3DSaltarelli%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BS.%26aulast%3DNelms%26aufirst%3DL.%2BF.%26aulast%3DDes%2BEtages%26aufirst%3DS.%2BG.%26aulast%3DHayes%26aufirst%3DL.%2BS.%26aulast%3DKawabata%26aufirst%3DT.%2BT.%26aulast%3DFinco-Kent%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLarson%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DM.-S.%26aulast%3DPaniagua%26aufirst%3DR.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DHolm%26aufirst%3DB.%26aulast%3DReitz%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.-J.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26atitle%3DPrevention%2520of%2520organ%2520allograft%2520rejection%2520by%2520a%2520specific%2520Janus%2520kinase%25203%2520inhibitor%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D875%26epage%3D878%26doi%3D10.1126%2Fscience.1087061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witthuhn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cwik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, J. N.</span></span> <span> </span><span class="NLM_article-title">Involvement of the JAK-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1038/370153a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2F370153a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1994&pages=153-157&author=B.+A.+Witthuhnauthor=O.+Silvennoinenauthor=O.+Miuraauthor=K.+S.+Laiauthor=C.+Cwikauthor=E.+T.+Liuauthor=J.+N.+Ihle&title=Involvement+of+the+JAK-3+Janus+kinase+in+signalling+by+interleukins+2+and+4+in+lymphoid+and+myeloid+cells&doi=10.1038%2F370153a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F370153a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F370153a0%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DLai%26aufirst%3DK.%2BS.%26aulast%3DCwik%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DInvolvement%2520of%2520the%2520JAK-3%2520Janus%2520kinase%2520in%2520signalling%2520by%2520interleukins%25202%2520and%25204%2520in%2520lymphoid%2520and%2520myeloid%2520cells%26jtitle%3DNature%26date%3D1994%26volume%3D370%26spage%3D153%26epage%3D157%26doi%3D10.1038%2F370153a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblatt, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovich, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adelstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(93)90167-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2F0092-8674%2893%2990167-O" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=147-157&author=M.+Noguchiauthor=H.+Yiauthor=H.+M.+Rosenblattauthor=A.+H.+Filipovichauthor=S.+Adelsteinauthor=W.+S.+Modiauthor=O.+W.+McBrideauthor=W.+J.+Leonard&title=Interleukin-2+receptor+%CE%B3+chain+mutation+results+in+X-linked+severe+combined+immunodeficiency+in+humans&doi=10.1016%2F0092-8674%2893%2990167-O"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990167-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990167-O%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DRosenblatt%26aufirst%3DH.%2BM.%26aulast%3DFilipovich%26aufirst%3DA.%2BH.%26aulast%3DAdelstein%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DW.%2BS.%26aulast%3DMcBride%26aufirst%3DO.%2BW.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DInterleukin-2%2520receptor%2520%25CE%25B3%2520chain%2520mutation%2520results%2520in%2520X-linked%2520severe%2520combined%2520immunodeficiency%2520in%2520humans%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D147%26epage%3D157%26doi%3D10.1016%2F0092-8674%2893%2990167-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of CP-690,550: A potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8484</span>, <span class="refDoi"> DOI: 10.1021/jm1004286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=S.-P.+Changauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+A+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection&doi=10.1021%2Fjm1004286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0li6KtQo5wfIFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520A%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484%26doi%3D10.1021%2Fjm1004286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+Janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lh53PRJwlCHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuninger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1021/jm101157q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family&doi=10.1021%2Fjm101157q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D284%26epage%3D288%26doi%3D10.1021%2Fjm101157q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVicente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span> <span> </span><span class="NLM_article-title">Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2800</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmcl.2013.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2793-2800&author=S.+M.+Lynchauthor=J.+DeVicenteauthor=J.+C.+Hermannauthor=S.+Jaime-Figueroaauthor=S.+Jinauthor=A.+Kuglstatterauthor=H.+Liauthor=A.+Loveyauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=D.+Royauthor=M.+Sothauthor=S.+Steinerauthor=P.+Tivitmahaisoonauthor=M.+D.+Vuauthor=C.+Yee&title=Strategic+use+of+conformational+bias+and+structure+based+design+to+identify+potent+JAK3+inhibitors+with+improved+selectivity+against+the+JAK+family+and+the+kinome&doi=10.1016%2Fj.bmcl.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DDeVicente%26aufirst%3DJ.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DYee%26aufirst%3DC.%26atitle%3DStrategic%2520use%2520of%2520conformational%2520bias%2520and%2520structure%2520based%2520design%2520to%2520identify%2520potent%2520JAK3%2520inhibitors%2520with%2520improved%2520selectivity%2520against%2520the%2520JAK%2520family%2520and%2520the%2520kinome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2793%26epage%3D2800%26doi%3D10.1016%2Fj.bmcl.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4722</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmc.2016.08.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4711-4722&author=Y.+Nakajimaauthor=N.+Aoyamaauthor=F.+Takahashiauthor=H.+Sasakiauthor=K.+Hatanakaauthor=A.+Moritomoauthor=M.+Inamiauthor=M.+Itoauthor=K.+Nakamuraauthor=F.+Nakamoriauthor=T.+Inoueauthor=S.+Shirakami&title=Design%2C+synthesis%2C+and+evaluation+of+4%2C6-diaminonicotinamide+derivatives+as+novel+and+potent+immunomodulators+targeting+JAK3&doi=10.1016%2Fj.bmc.2016.08.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DK.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DNakamori%26aufirst%3DF.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25204%252C6-diaminonicotinamide%2520derivatives%2520as%2520novel%2520and%2520potent%2520immunomodulators%2520targeting%2520JAK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4711%26epage%3D4722%26doi%3D10.1016%2Fj.bmc.2016.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson-Nutter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimble, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrocklage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewet, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krykbaev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Togias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidl, K. J.</span></span> <span> </span><span class="NLM_article-title">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2293</span>, <span class="refDoi"> DOI: 10.1002/art.27536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fart.27536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20506481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2283-2293&author=T.+H.+Linauthor=M.+Hegenauthor=E.+Quadrosauthor=C.+L.+Nickerson-Nutterauthor=K.+C.+Appellauthor=A.+G.+Coleauthor=Y.+Shaoauthor=S.+Tamauthor=M.+Ohlmeyerauthor=B.+Wangauthor=D.+G.+Goodwinauthor=E.+F.+Kimbleauthor=J.+Quinteroauthor=M.+Gaoauthor=P.+Symanowiczauthor=C.+Wrocklageauthor=J.+Lussierauthor=S.+H.+Schellingauthor=A.+G.+Hewetauthor=D.+Xuanauthor=R.+Krykbaevauthor=J.+Togiasauthor=X.+Xuauthor=R.+Harrisonauthor=T.+Mansourauthor=M.+Collinsauthor=J.+D.+Clarkauthor=M.+L.+Webbauthor=K.+J.+Seidl&title=Selective+functional+inhibition+of+JAK-3+is+sufficient+for+efficacy+in+collagen-induced+arthritis+in+mice&doi=10.1002%2Fart.27536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span></div><div class="casAuthors">Lin, Tsung H.; Hegen, Martin; Quadros, Elizabeth; Nickerson-Nutter, Cheryl L.; Appell, Kenneth C.; Cole, Andrew G.; Shao, Yuefei; Tam, Steve; Ohlmeyer, Michael; Wang, Bojing; Goodwin, Debra G.; Kimble, Earl F.; Quintero, Jorge; Gao, Min; Symanowicz, Peter; Wrocklage, Christopher; Lussier, Jennifer; Schelling, Scott H.; Hewet, Amha G.; Xuan, Dejun; Krykbaev, Rustem; Togias, Jenny; Xu, Xin; Harrison, Richard; Mansour, Tarek; Collins, Mary; Clark, James D.; Webb, Maria L.; Seidi, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2283-2293</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. All γ-chain cytokines signal through JAK-3 and JAK-1 acting in tandem.  We undertook this study to det. whether the JAK-3 selective inhibitor WYE-151650 would be sufficient to disrupt cytokine signaling and to ameliorate autoimmune disease pathol. without inhibiting other pathways mediated by JAK-1, JAK-2, and Tyk-2.  Methods. JAK-3 kinase selective compds. were characterized by kinase assay and JAK-3-dependent (interleukin-2 [IL-2]) and -independent (IL-6, granulocyte-macrophage colony-stimulating factor [GM-CSF]) cell-based assays measuring proliferation or STAT phosphorylation.  In vivo, off-target signaling was measured by IL-22- and erythropoietin (EPO)-mediated models, while on-target signaling was measured by IL-2-mediated signaling.  Efficacy of JAK-3 inhibitors was detd. using delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.  Results. In vitro, WYE-151650 potently suppressed IL-2-induced STAT-5 phosphorylation and cell proliferation, while exhibiting 10-29-fold less activity against JAK-3-independent IL-6- or GM-CSF-induced STAT phosphorylation.  Ex vivo, WYE-151650 suppressed IL-2-induced STAT phosphorylation, but not IL-6-induced STAT phosphorylation, as measured in whole blood.  In vivo, WYE-151650 inhibited JAK-3-mediated IL-2-induced interferon-γ prodn. and decreased the natural killer cell population in mice, while not affecting IL-22-induced serum amyloid A prodn. or EPO-induced reticulocytosis.  WYE-151650 was efficacious in mouse DTH and CIA models.  Conclusion. In vitro, ex vivo, and in vivo assays demonstrate that WYE-151650 is efficacious in mouse CIA despite JAK-3 selectivity.  These data question the need to broadly inhibit JAK-1-, JAK-2-, or Tyk-2-dependent cytokine pathways for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogcss6tt3iw7Vg90H21EOLACvtfcHk0lh1MdxpXF5sCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP&md5=7fd4f4dae47df1d1a33d3fc0edf5e13d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fart.27536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27536%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGoodwin%26aufirst%3DD.%2BG.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DQuintero%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DSchelling%26aufirst%3DS.%2BH.%26aulast%3DHewet%26aufirst%3DA.%2BG.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DKrykbaev%26aufirst%3DR.%26aulast%3DTogias%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DSeidl%26aufirst%3DK.%2BJ.%26atitle%3DSelective%2520functional%2520inhibition%2520of%2520JAK-3%2520is%2520sufficient%2520for%2520efficacy%2520in%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2283%26epage%3D2293%26doi%3D10.1002%2Fart.27536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fcmdc.201300520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=277-281&author=M.+Gehringerauthor=E.+Pfaffenrotauthor=S.+Bauerauthor=S.+A.+Laufer&title=Design+and+synthesis+of+tricyclic+JAK3+inhibitors+with+picomolar+affinities+as+novel+molecular+probes&doi=10.1002%2Fcmdc.201300520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tricyclic%2520JAK3%2520inhibitors%2520with%2520picomolar%2520affinities%2520as%2520novel%2520molecular%2520probes%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D277%26epage%3D281%26doi%3D10.1002%2Fcmdc.201300520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banach, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. W.</span></span> <span> </span><span class="NLM_article-title">Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.595181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1074%2Fjbc.M114.595181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25552479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=4573-4589&author=E.+R.+Goedkenauthor=M.+A.+Argiriadiauthor=D.+L.+Banachauthor=B.+A.+Fiamengoauthor=S.+E.+Foleyauthor=K.+E.+Frankauthor=J.+S.+Georgeauthor=C.+M.+Harrisauthor=A.+D.+Hobsonauthor=D.+C.+Ihleauthor=D.+Marcotteauthor=P.+J.+Mertaauthor=M.+E.+Michalakauthor=S.+E.+Murdockauthor=M.+J.+Tomlinsonauthor=J.+W.+Voss&title=Tricyclic+covalent+inhibitors+selectively+target+Jak3+through+an+active+site+thiol&doi=10.1074%2Fjbc.M114.595181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol</span></div><div class="casAuthors">Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4573-4589</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The action of Janus kinases (JAKs) is required for multiple cytokine signaling pathways, and as such, JAK inhibitors hold promise for treatment of autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis.  However, due to high similarity in the active sites of the four members (Jak1, Jak2, Jak3, and Tyk2), developing selective inhibitors within this family is challenging.  We have designed and characterized substituted, tricyclic Jak3 inhibitors that selectively avoid inhibition of the other JAKs.  This is accomplished through a covalent interaction between an inhibitor contg. a terminal electrophile and an active site cysteine (Cys-909).  We found that these ATP competitive compds. are irreversible inhibitors of Jak3 enzyme activity in vitro.  They possess high selectivity against other kinases and can potently (IC50 < 100 nm) inhibit Jak3 activity in cell-based assays.  These results suggest irreversible inhibitors of this class may be useful selective agents, both as tools to probe Jak3 biol. and potentially as therapies for autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjt9jFjpWGbVg90H21EOLACvtfcHk0lh1MdxpXF5sCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2lsLY%253D&md5=4d99cf5b13fd05df5c4abc197c1fe284</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595181%26sid%3Dliteratum%253Aachs%26aulast%3DGoedken%26aufirst%3DE.%2BR.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DFiamengo%26aufirst%3DB.%2BA.%26aulast%3DFoley%26aufirst%3DS.%2BE.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHobson%26aufirst%3DA.%2BD.%26aulast%3DIhle%26aufirst%3DD.%2BC.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DMichalak%26aufirst%3DM.%2BE.%26aulast%3DMurdock%26aufirst%3DS.%2BE.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DVoss%26aufirst%3DJ.%2BW.%26atitle%3DTricyclic%2520covalent%2520inhibitors%2520selectively%2520target%2520Jak3%2520through%2520an%2520active%2520site%2520thiol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D4573%26epage%3D4589%26doi%3D10.1074%2Fjbc.M114.595181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyskens, K. M. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herter-Sprie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of selective covalent Janus kinase 3 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6589</span>– <span class="NLM_lpage">6606</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00710</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00710" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6589-6606&author=L.+Tanauthor=K.+Akahaneauthor=R.+McNallyauthor=K.+M.+S.+E.+Reyskensauthor=S.+B.+Ficarroauthor=S.+Liuauthor=G.+S.+Herter-Sprieauthor=S.+Koyamaauthor=M.+J.+Pattisonauthor=K.+Labellaauthor=L.+Johannessenauthor=E.+A.+Akbayauthor=K.-K.+Wongauthor=D.+A.+Frankauthor=J.+A.+Martoauthor=T.+A.+Lookauthor=J.+S.+C.+Arthurauthor=M.+J.+Eckauthor=N.+S.+Gray&title=Development+of+selective+covalent+Janus+kinase+3+inhibitors&doi=10.1021%2Facs.jmedchem.5b00710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective Covalent Janus Kinase 3 Inhibitors</span></div><div class="casAuthors">Tan, Li; Akahane, Koshi; McNally, Randall; Reyskens, Kathleen M. S. E.; Ficarro, Scott B.; Liu, Suhu; Herter-Sprie, Grit S.; Koyama, Shohei; Pattison, Michael J.; Labella, Katherine; Johannessen, Liv; Akbay, Esra A.; Wong, Kwok-Kin; Frank, David A.; Marto, Jarrod A.; Look, Thomas A.; Arthur, J. Simon C.; Eck, Michael J.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6589-6606</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) and their downstream effectors, signal transducer and activator of transcription proteins (STATs), form a crit. immune cell signaling circuit, which is of fundamental importance in innate immunity, inflammation, and hematopoiesis, and dysregulation is frequently obsd. in immune disease and cancer.  The high degree of structural conservation of the JAK ATP binding pockets has posed a considerable challenge to medicinal chemists seeking to develop highly selective inhibitors as pharmacol. probes and as clin. drugs.  Here we report the discovery and optimization of 2,4-substituted pyrimidines as covalent JAK3 inhibitors that exploit a unique cysteine (Cys909) residue in JAK3.  Investigation of structure-activity relationship (SAR) utilizing biochem. and transformed Ba/F3 cellular assays resulted in identification of potent and selective inhibitors such as compds. 9 and 45.  A 2.9 Å cocrystal structure of JAK3 in complex with 9 confirms the covalent interaction.  Compd. 9 exhibited decent pharmacokinetic properties and is suitable for use in vivo.  These inhibitors provide a set of useful tools to pharmacol. interrogate JAK3-dependent biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqKncS0tb27Vg90H21EOLACvtfcHk0lhuqXsU-cx3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ksLjM&md5=af334f0cdd1d4f58462182f138619099</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00710%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DR.%26aulast%3DReyskens%26aufirst%3DK.%2BM.%2BS.%2BE.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHerter-Sprie%26aufirst%3DG.%2BS.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DLabella%26aufirst%3DK.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DLook%26aufirst%3DT.%2BA.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520selective%2520covalent%2520Janus%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6589%26epage%3D6606%26doi%3D10.1021%2Facs.jmedchem.5b00710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnchembio.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27018889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=373-379&author=G.+A.+Smithauthor=K.+Uchidaauthor=A.+Weissauthor=J.+Taunton&title=Essential+biphasic+role+for+JAK3+catalytic+activity+in+IL-2+receptor+signaling&doi=10.1038%2Fnchembio.2056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span></div><div class="casAuthors">Smith, Geoffrey A.; Uchida, Kenji; Weiss, Arthur; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To drive lymphocyte proliferation and differentiation, common γ-chain (γc) cytokine receptors require hours to days of sustained stimulation.  JAK1 and JAK3 kinases are found together in all γc-receptor complexes, but how their resp. catalytic activities contribute to signaling over time is not known.  Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i).  By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4+ T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave.  Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase.  An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice.  Our chem. genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of γc-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfXNNV1cRJbVg90H21EOLACvtfcHk0lhuqXsU-cx3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D&md5=573d99767ce37cf58a8f71e9e01102b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2056%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DEssential%2520biphasic%2520role%2520for%2520JAK3%2520catalytic%2520activity%2520in%2520IL-2%2520receptor%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnchembio.2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimermancic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimermancicauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC β-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0lhuqXsU-cx3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimermancic%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.chembiol.2016.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27840070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1335-1340&author=M.+Forsterauthor=A.+Chaikuadauthor=S.+M.+Bauerauthor=J.+Holsteinauthor=M.+B.+Robersauthor=C.+R.+Coronaauthor=M.+Gehringerauthor=E.+Pfaffenrotauthor=K.+Ghoreschiauthor=S.+Knappauthor=S.+A.+Laufer&title=Selective+JAK3+inhibitors+with+a+covalent+reversible+binding+mode+targeting+a+new+induced+fit+binding+pocket&doi=10.1016%2Fj.chembiol.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket</span></div><div class="casAuthors">Forster, Michael; Chaikuad, Apirat; Bauer, Silke M.; Holstein, Julia; Robers, Matthew B.; Corona, Cesear R.; Gehringer, Matthias; Pfaffenrot, Ellen; Ghoreschi, Kamran; Knapp, Stefan; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1335-1340</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are a family of cytoplasmatic tyrosine kinases that are attractive targets for the development of anti-inflammatory drugs given their roles in cytokine signaling.  One question regarding JAKs and their inhibitors that remains under intensive debate is whether JAK inhibitors should be isoform selective.  Since JAK3 functions are restricted to immune cells, an isoform-selective inhibitor for JAK3 could be esp. valuable to achieve clin. more useful and precise effects.  However, the high degree of structural conservation makes isoform-selective targeting a challenging task.  Here, we present picomolar inhibitors with unprecedented kinome-wide selectivity for JAK3.  Selectivity was achieved by concurrent covalent reversible targeting of a JAK3-specific cysteine residue and a ligand-induced binding pocket.  We confirmed that in vitro activity and selectivity translate well into the cellular environment and suggest that our inhibitors are powerful tools to elucidate JAK3-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMAP9hFX_TrVg90H21EOLACvtfcHk0lhuqXsU-cx3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsLrJ&md5=348c5b5fbfa91fd02fa21d984620ea16</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520JAK3%2520inhibitors%2520with%2520a%2520covalent%2520reversible%2520binding%2520mode%2520targeting%2520a%2520new%2520induced%2520fit%2520binding%2520pocket%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D1335%26epage%3D1340%26doi%3D10.1016%2Fj.chembiol.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a JAK3-selective inhibitor: Functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3442</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGku7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3442-3451&author=J.-B.+Telliezauthor=M.+E.+Dowtyauthor=L.+Wangauthor=J.+Jussifauthor=T.+Linauthor=L.+Liauthor=E.+Moyauthor=P.+Balboauthor=W.+Liauthor=Y.+Zhaoauthor=K.+Crouseauthor=C.+Dickinsonauthor=P.+Symanowiczauthor=M.+Hegenauthor=M.+E.+Bankerauthor=F.+Vincentauthor=R.+Unwallaauthor=S.+Liangauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=X.+Yangauthor=J.+Baumanauthor=J.+I.+Trujilloauthor=A.+Casimiro-Garciaauthor=F.+F.+Vajdosauthor=L.+Leungauthor=K.+F.+Geogheganauthor=A.+Quaziauthor=D.+Xuanauthor=L.+Jonesauthor=E.+Hettauthor=K.+Wrightauthor=J.+D.+Clarkauthor=A.+Thorarensen&title=Discovery+of+a+JAK3-selective+inhibitor%3A+Functional+differentiation+of+JAK3-selective+inhibition+over+pan-JAK+or+JAK1-selective+inhibition&doi=10.1021%2Facschembio.6b00677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition</span></div><div class="casAuthors">Telliez, Jean-Baptiste; Dowty, Martin E.; Wang, Lu; Jussif, Jason; Lin, Tsung; Li, Li; Moy, Erick; Balbo, Paul; Li, Wei; Zhao, Yajuan; Crouse, Kimberly; Dickinson, Caitlyn; Symanowicz, Peter; Hegen, Martin; Banker, Mary Ellen; Vincent, Fabien; Unwalla, Ray; Liang, Sidney; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Yang, Xin; Bauman, Jonathan; Trujillo, John I.; Casimiro-Garcia, Agustin; Vajdos, Felix F.; Leung, Louis; Geoghegan, Kieran F.; Quazi, Amira; Xuan, Dejun; Jones, Lyn; Hett, Erik; Wright, Katherine; Clark, James D.; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3442-3451</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PF-06651600, a newly discovered potent JAK3-selective inhibitor is highly efficacious at inhibiting γc cytokine signaling which is dependent on both JAK1 and JAK3.  PF-06651600 allowed the comparison of JAK3-selective inhibition to pan-JAK or JAK1-selective inhibition, in relevant immune cells to a level that couldn't be achieved previously without such potency and selectivity.  In vitro, PF-06651600 inhibits Th1 and Th17 cell differentiation and function, and in vivo it reduces disease pathol. in the rat adjuvant-induced arthritis as well as in the mouse exptl. autoimmune encephalomyelitis models.  Importantly, by sparing JAK1 function, PF-06651600 selectively targets γc cytokine pathways while preserving JAK1-dependent anti-inflammatory signaling such as the IL-10 suppressive functions following LPS treatment in macrophages and the suppression of TNFα and IL-1β prodn. in IL-27-primed macrophages.  Thus, JAK3-selective inhibition differentiates from pan-JAK or JAK1 inhibition in various immune cellular responses which could potentially translate to advantageous clin. outcomes in inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNLk0mtStNSrVg90H21EOLACvtfcHk0lhj9GeASHEkgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGku7nK&md5=dd83978cf9ac22947f4a3f07c5eed8ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00677%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMoy%26aufirst%3DE.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCrouse%26aufirst%3DK.%26aulast%3DDickinson%26aufirst%3DC.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQuazi%26aufirst%3DA.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DHett%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520JAK3-selective%2520inhibitor%253A%2520Functional%2520differentiation%2520of%2520JAK3-selective%2520inhibition%2520over%2520pan-JAK%2520or%2520JAK1-selective%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3442%26epage%3D3451%26doi%3D10.1021%2Facschembio.6b00677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a Janus kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+Janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0lhj9GeASHEkgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520Janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span> <span> </span><span class="NLM_article-title">Clearance prediction of targeted covalent inhibitors by in vitro-in vivo extrapolation of hepatic and extrahepatic clearance mechanisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.072983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1124%2Fdmd.116.072983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27784718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlSksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1-7&author=L.+Leungauthor=X.+Yangauthor=T.+J.+Strelevitzauthor=J.+Montgomeryauthor=M.+F.+Brownauthor=C.+Banfieldauthor=A.+M.+Gilbertauthor=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+A.+Zientek&title=Clearance+prediction+of+targeted+covalent+inhibitors+by+in+vitro-in+vivo+extrapolation+of+hepatic+and+extrahepatic+clearance+mechanisms&doi=10.1124%2Fdmd.116.072983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance prediction of targeted covalent inhibitors by in vitro-in vivo extrapolation of hepatic and extrahepatic clearance mechanisms</span></div><div class="casAuthors">Leung, Louis; Yang, Xin; Strelevitz, Timothy J.; Montgomery, Justin; Brown, Matthew F.; Zientek, Michael A.; Banfield, Christopher; Gilbert, Adam M.; Thorarensen, Atli; Dowty, Martin E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concept of target-specific covalent enzyme inhibitors appears attractive from both an efficacy and a selectivity viewpoint considering the potential for enhanced biochem. efficiency assocd. with an irreversible mechanism.  Aside from potential safety concerns, clearance prediction of covalent inhibitors represents a unique challenge due to the inclusion of nontraditional metabolic pathways of direct conjugation with glutathione (GSH) or via GSH S-transferase-mediated processes.  In this article, a novel pharmacokinetic algorithm was developed using a series of Pfizer kinase selective acrylamide covalent inhibitors based on their in vitro-in vivo extrapolation of systemic clearance in rats.  The algorithmencompasses the use of hepatocytes as an in vitro model for hepatic clearance due to oxidative metab. and GSH conjugation, and the use of whole blood as an in vitro surrogate for GSH conjugation in extrahepatic tissues.  Initial evaluations with clin. covalent inhibitors suggested that the scaling algorithm developed from rats may also be useful for human clearance prediction when species-specific parameters, such as hepatocyte and blood stability and blood binding, were considered.  With careful consideration of clearance mechanisms, the described in vitro-in vivo extrapolation approach may be useful to facilitate candidate optimization, selection, and prediction of human pharmacokinetic clearance during the discovery and development of targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIMBCrCxzNLVg90H21EOLACvtfcHk0liCBLQMrzGK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlSksL4%253D&md5=8c8b918b087278b2025e0ae56a7abe37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.072983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.072983%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DBanfield%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DZientek%26aufirst%3DM.%2BA.%26atitle%3DClearance%2520prediction%2520of%2520targeted%2520covalent%2520inhibitors%2520by%2520in%2520vitro-in%2520vivo%2520extrapolation%2520of%2520hepatic%2520and%2520extrahepatic%2520clearance%2520mechanisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26spage%3D1%26epage%3D7%26doi%3D10.1124%2Fdmd.116.072983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.-P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0liCBLQMrzGK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span> <span> </span><span class="NLM_article-title">Novel and potent cyclic cyanamide-based cathepsin K inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1815</span>– <span class="NLM_lpage">1819</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmcl.2005.02.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1815-1819&author=D.+N.+Deatonauthor=A.+M.+Hassellauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=L.+M.+Shewchukauthor=F.+X.+Tavaresauthor=D.+H.+Willardauthor=L.+L.+Wright&title=Novel+and+potent+cyclic+cyanamide-based+cathepsin+K+inhibitors&doi=10.1016%2Fj.bmcl.2005.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWillard%26aufirst%3DD.%2BH.%26aulast%3DWright%26aufirst%3DL.%2BL.%26atitle%3DNovel%2520and%2520potent%2520cyclic%2520cyanamide-based%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1815%26epage%3D1819%26doi%3D10.1016%2Fj.bmcl.2005.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span> <span> </span><span class="NLM_article-title">Design of cathepsin K inhibitors for osteoporosis</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.2174/156802605775009676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.2174%2F156802605775009676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=16375747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1639-1675&author=D.+N.+Deatonauthor=F.+X.+Tavares&title=Design+of+cathepsin+K+inhibitors+for+osteoporosis&doi=10.2174%2F156802605775009676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design of cathepsin K inhibitors for osteoporosis</span></div><div class="casAuthors">Deaton, David N.; Tavares, Francis X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1639-1675</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is a progressive, debilitating bone disease resulting in increased cost and morbidity to the elderly.  This review summarizes the therapeutic approaches taken in the treatment of osteoporosis with particular emphasis on cathepsin K inhibitors.  Cathepsin K, a cysteine protease predominantly expressed in osteoclasts, is a key player involved in bone matrix degrdn.  Both genetic ablation and small mol. inhibitor strategies vs. cathepsin K have validated the importance of this enzyme in bone resorption.  Starting from aldehyde-based leads, this review synopsizes the design of improved small mol. inhibitors by GlaxoWellcome researchers.  These efforts involved the evaluation of various warheads, including cyanamides, ketoheterocycles, and ketoamides.  Initial structure/activity relationships of aldehyde-based inhibitors proved useful in the design of ketoamide-based cathepsin K inhibitors.  Further exploration of S3, S2, S1, and S1· subsites with P3, P2, P1, and P1· probes have resulted in the identification of potent, selective, orally bioavailable ketoamide-based inhibitors of cathepsin K with demonstrated in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp4CDcrFAqIbVg90H21EOLACvtfcHk0lhMvRGWs2Mmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsLY%253D&md5=0db953d6235ce75579ec1c8191e773b1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802605775009676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009676%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26atitle%3DDesign%2520of%2520cathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1639%26epage%3D1675%26doi%3D10.2174%2F156802605775009676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitjean, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel cyanamide-based inhibitors of cathepsin C</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1021/ml100212k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100212k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=142-147&author=D.+Laineauthor=M.+Palovichauthor=B.+McClelandauthor=E.+Petitjeanauthor=I.+Delhomauthor=H.+Xieauthor=J.+Dengauthor=G.+Linauthor=R.+Davisauthor=A.+Jolitauthor=N.+Nevinsauthor=B.+Zhaoauthor=J.+Villaauthor=J.+Schneckauthor=P.+McDevittauthor=R.+Midgettauthor=C.+Kmettauthor=S.+Umbrechtauthor=B.+Peckauthor=A.+B.+Davisauthor=D.+Bettoun&title=Discovery+of+novel+cyanamide-based+inhibitors+of+cathepsin+C&doi=10.1021%2Fml100212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel cyanamide-based inhibitors of cathepsin C</span></div><div class="casAuthors">Laine, Dramane; Palovich, Michael; McCleland, Brent; Petitjean, Emilie; Delhom, Isabelle; Xie, Haibo; Deng, Jianghe; Lin, Guoliang; Davis, Roderick; Jolit, Anais; Nevins, Neysa; Zhao, Baoguang; Villa, Jim; Schneck, Jessica; McDevitt, Patrick; Midgett, Robert; Kmett, Casey; Umbrecht, Sandra; Peck, Brian; Davis, Alicia Bacon; Bettoun, David</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of potent and selective cyanamide-based inhibitors of the cysteine protease cathepsin C is detailed.  Optimization of the template with regard to plasma stability led to the identification of (2S,4R)-1-cyano-2-methyl-4-(2,5-dibromophenylsulfonylamino)pyrrolidine (I), a potent cathepsin C inhibitor with excellent selectivity over other cathepsins and potent in vivo activity in a cigarette smoke mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnAQabB_znSrVg90H21EOLACvtfcHk0lhMvRGWs2Mmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK&md5=5b8478f6abc28e4d273eb9aa7c93aeb1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fml100212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100212k%26sid%3Dliteratum%253Aachs%26aulast%3DLaine%26aufirst%3DD.%26aulast%3DPalovich%26aufirst%3DM.%26aulast%3DMcCleland%26aufirst%3DB.%26aulast%3DPetitjean%26aufirst%3DE.%26aulast%3DDelhom%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DJolit%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVilla%26aufirst%3DJ.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DMidgett%26aufirst%3DR.%26aulast%3DKmett%26aufirst%3DC.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DA.%2BB.%26aulast%3DBettoun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520novel%2520cyanamide-based%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D142%26epage%3D147%26doi%3D10.1021%2Fml100212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyeva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashiro, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunussi-Joannopoulos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson-Nutter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douhan, J.,  III.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4550</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1301553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.4049%2Fjimmunol.1301553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=24068666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1eqs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=4540-4550&author=A.+L.+Rankinauthor=N.+Sethauthor=S.+Keeganauthor=T.+Andreyevaauthor=T.+A.+Cookauthor=J.+Edmondsauthor=N.+Mathialaganauthor=M.+J.+Bensonauthor=J.+Syedauthor=Y.+Zhanauthor=S.+E.+Benoitauthor=J.+S.+Miyashiroauthor=N.+Woodauthor=S.+Mohanauthor=E.+Peevaauthor=S.+K.+Ramaiahauthor=D.+Messingauthor=B.+L.+Homerauthor=K.+Dunussi-Joannopoulosauthor=C.+L.+Nickerson-Nutterauthor=M.+E.+Schnuteauthor=J.+Douhan&title=Selective+inhibition+of+BTK+prevents+murine+lupus+and+antibody-mediated+glomerulonephritis&doi=10.4049%2Fjimmunol.1301553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis</span></div><div class="casAuthors">Rankin, Andrew L.; Seth, Nilufer; Keegan, Sean; Andreyeva, Tatyana; Cook, Tim A.; Edmonds, Jason; Mathialagan, Nagappan; Benson, Micah J.; Syed, Jameel; Zhan, Yutian; Benoit, Stephen E.; Miyashiro, Joy S.; Wood, Nancy; Mohan, Shashi; Peeva, Elena; Ramaiah, Shashi K.; Messing, Dean; Homer, Bruce L.; Dunussi-Joannopoulos, Kyri; Nickerson-Nutter, Cheryl L.; Schnute, Mark E.; Douhan, John, III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4540-4550</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Autoantibody prodn. and immune complex deposition within the kidney promote renal disease in patients with lupus nephritis.  Thus, therapeutics that inhibit these pathways may be efficacious in the treatment of systemic lupus erythematosus.  Bruton's tyrosine kinase (BTK) is a crit. signaling component of both BCR and FcR signaling.  We sought to assess the efficacy of inhibiting BTK in the development of lupus-like disease, and in this article describe (R)-5-amino-1-(1-cyanopiperidin-3-yl)-3-(4-[2,4-difluorophenoxy]phenyl)-1H-pyrazole-4-carboxamide (PF-06250112), a novel highly selective and potent BTK inhibitor.  We demonstrate in vitro that PF-06250112 inhibits both BCR-mediated signaling and proliferation, as well as FcR-mediated activation.  To assess the therapeutic impact of BTK inhibition, we treated aged NZBxWF1 mice with PF-06250112 and demonstrate that PF-06250112 significantly limits the spontaneous accumulation of splenic germinal center B cells and plasma cells.  Correspondingly, anti-dsDNA and autoantibody levels were reduced in a dose-dependent manner.  Moreover, administration of PF-06250112 prevented the development of proteinuria and improved glomerular pathol. scores in all treatment groups.  Strikingly, this therapeutic effect could occur with only a modest redn. obsd. in anti-dsDNA titers, implying a crit. role for BTK signaling in disease pathogenesis beyond inhibition of autoantibody prodn.  We subsequently demonstrate that PF-06250112 prevents proteinuria in an FcR-dependent, Ab-mediated model of glomerulonephritis.  Importantly, these results highlight that BTK inhibition potently limits the development of glomerulonephritis by impacting both cell- and effector mol.-mediated pathways.  These data provide support for evaluating the efficacy of BTK inhibition in systemic lupus erythematosus patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBldekay4INLVg90H21EOLACvtfcHk0lhMvRGWs2Mmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1eqs7zE&md5=7abfb074bf422aa3fb63aa0bc3d8cf58</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301553%26sid%3Dliteratum%253Aachs%26aulast%3DRankin%26aufirst%3DA.%2BL.%26aulast%3DSeth%26aufirst%3DN.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DAndreyeva%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DT.%2BA.%26aulast%3DEdmonds%26aufirst%3DJ.%26aulast%3DMathialagan%26aufirst%3DN.%26aulast%3DBenson%26aufirst%3DM.%2BJ.%26aulast%3DSyed%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DBenoit%26aufirst%3DS.%2BE.%26aulast%3DMiyashiro%26aufirst%3DJ.%2BS.%26aulast%3DWood%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DPeeva%26aufirst%3DE.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DHomer%26aufirst%3DB.%2BL.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DDouhan%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520BTK%2520prevents%2520murine%2520lupus%2520and%2520antibody-mediated%2520glomerulonephritis%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D4540%26epage%3D4550%26doi%3D10.4049%2Fjimmunol.1301553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span> <span> </span><span class="NLM_article-title">Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10072</span>– <span class="NLM_lpage">10079</span>, <span class="refDoi"> DOI: 10.1021/jm501412a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501412a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10072-10079&author=M.+E.+Flanaganauthor=J.+A.+Abramiteauthor=D.+P.+Andersonauthor=A.+Aulabaughauthor=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=C.+Liauthor=J.+Montgomeryauthor=S.+R.+Oppenheimerauthor=T.+Ryderauthor=B.+P.+Schuffauthor=D.+P.+Uccelloauthor=G.+S.+Walkerauthor=Y.+Wuauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=M.+M.+Haywardauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=L.+Philippeauthor=V.+Shanmugasundaramauthor=M.+J.+Shapiroauthor=J.+Starrauthor=J.+Strohauthor=Y.+Che&title=Chemical+and+computational+methods+for+the+characterization+of+covalent+reactive+groups+for+the+prospective+design+of+irreversible+inhibitors&doi=10.1021%2Fjm501412a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors</span></div><div class="casAuthors">Flanagan, Mark E.; Abramite, Joseph A.; Anderson, Dennis P.; Aulabaugh, Ann; Dahal, Upendra P.; Gilbert, Adam M.; Li, Chao; Montgomery, Justin; Oppenheimer, Stacey R.; Ryder, Tim; Schuff, Brandon P.; Uccello, Daniel P.; Walker, Gregory S.; Wu, Yan; Brown, Matthew F.; Chen, Jinshan M.; Hayward, Matthew M.; Noe, Mark C.; Obach, R. Scott; Philippe, Laurence; Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Starr, Jeremy; Stroh, Justin; Che, Ye</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10072-10079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interest in drugs that covalently modify their target is driven by the desire for enhanced efficacy that can result from the silencing of enzymic activity until protein resynthesis can occur, along with the potential for increased selectivity by targeting uniquely positioned nucleophilic residues in the protein.  However, covalent approaches carry addnl. risk for toxicities or hypersensitivity reactions that can result from covalent modification of unintended targets.  Here we describe methods for measuring the reactivity of covalent reactive groups (CRGs) with a biol. relevant nucleophile, glutathione (GSH), along with kinetic data for a broad array of electrophiles.  We also describe a computational method for predicting electrophilic reactivity, which taken together can be applied to the prospective design of thiol-reactive covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzTSCv_Nj6bVg90H21EOLACvtfcHk0lgYgTQUW80ITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM&md5=3ccf59ab7a494655185e5eb5becf8c48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm501412a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501412a%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DOppenheimer%26aufirst%3DS.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DSchuff%26aufirst%3DB.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26atitle%3DChemical%2520and%2520computational%2520methods%2520for%2520the%2520characterization%2520of%2520covalent%2520reactive%2520groups%2520for%2520the%2520prospective%2520design%2520of%2520irreversible%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10072%26epage%3D10079%26doi%3D10.1021%2Fjm501412a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Irizarry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. A.</span></span> <span> </span><span class="NLM_article-title">Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1039/C6MD00017G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1039%2FC6MD00017G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFyjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=864-872&author=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=R.+S.+Obachauthor=M.+E.+Flanaganauthor=J.+M.+Chenauthor=C.+Garcia-Irizarryauthor=J.+T.+Starrauthor=B.+Schuffauthor=D.+P.+Uccelloauthor=J.+A.+Young&title=Intrinsic+reactivity+profile+of+electrophilic+moieties+to+guide+covalent+drug+design%3A+N-%CE%B1-acetyl-L-lysine+as+an+amine+nucleophile&doi=10.1039%2FC6MD00017G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile</span></div><div class="casAuthors">Dahal, Upendra P.; Gilbert, Adam M.; Obach, R. Scott; Flanagan, Mark E.; Chen, Jinshan M.; Garcia-Irizarry, Carmen; Starr, Jeremy T.; Schuff, Brandon; Uccello, Daniel P.; Young, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">864-872</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covalent drugs contain a reactive electrophilic moiety or covalent reactive group (CRG), which forms an irreversible bond between the drug and a biol. target.  Consequently, the intrinsic reactivity of the CRG is an important consideration in the design of irreversible inhibitors.  Although reactivity assessments of CRGs with sulfur nucleophiles, such as glutathione and cysteine have been reported, reactivity of these moieties with amine-contg. nucleophiles is not well described.  In this study, intrinsic reactivities were detd. for a series of electrophiles (acrylamides, nitriles, cyanamides, sulfones, and sulfonamides) using N-α-acetyl-L-lysine as a model amine-based nucleophile and compared with results using glutathione (GSH).  Since the ε-amine of N-α-acetyl-L-lysine is protonated at neutral pH, reactions were carried out at pH 10.2.  In addn. to reporting rate data for reactions of CRGs with N-α-acetyl-L-lysine, elements of selectivity relative to thiol-contg. nucleophiles are also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofuy3ICddAE7Vg90H21EOLACvtfcHk0lgYgTQUW80ITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFyjtrk%253D&md5=08e681ea8dfb353f89d8cdedba685694</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC6MD00017G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00017G%26sid%3Dliteratum%253Aachs%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DGarcia-Irizarry%26aufirst%3DC.%26aulast%3DStarr%26aufirst%3DJ.%2BT.%26aulast%3DSchuff%26aufirst%3DB.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%26atitle%3DIntrinsic%2520reactivity%2520profile%2520of%2520electrophilic%2520moieties%2520to%2520guide%2520covalent%2520drug%2520design%253A%2520N-%25CE%25B1-acetyl-L-lysine%2520as%2520an%2520amine%2520nucleophile%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D864%26epage%3D872%26doi%3D10.1039%2FC6MD00017G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span> <span> </span><span class="NLM_article-title">ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK kinase isoforms to cellular signaling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1558</span>, <span class="refDoi"> DOI: 10.1021/cb5002125</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5002125" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslart7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1552-1558&author=A.+Thorarensenauthor=M.+E.+Bankerauthor=A.+Fensomeauthor=J.-B.+Telliezauthor=B.+Jubaauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garcia&title=ATP-mediated+kinome+selectivity%3A+the+missing+link+in+understanding+the+contribution+of+individual+JAK+kinase+isoforms+to+cellular+signaling&doi=10.1021%2Fcb5002125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling</span></div><div class="casAuthors">Thorarensen, Atli; Banker, Mary Ellen; Fensome, Andrew; Telliez, Jean-Baptiste; Juba, Brian; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1552-1558</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinases constitute an important class of therapeutic targets being explored both by academia and the pharmaceutical industry.  The major focus of this effort was directed toward the identification of ATP competitive inhibitors.  Although it has long been recognized that the intracellular concn. of ATP is very different from the concns. utilized in biochem. enzyme assays, little thought has been devoted to incorporating this discrepancy into our understanding of translation from enzyme inhibition to cellular function.  Significant work has been dedicated to the discovery of JAK kinase inhibitors; however, a disconnect between enzyme and cellular function is prominently displayed in the literature for this class of inhibitors.  Herein, we demonstrate utilizing the four JAK family members (JAK1, JAK2, JAK3, and TYK2) that the difference in the ATP Km of each individual kinase has a significant impact on the enzyme to cell inhibition translation.  We evaluated a large no. of JAK inhibitors in enzymic assays utilizing either 1 mM ATP or Km ATP for the four isoforms as well as in primary cell assays.  This data set provided the opportunity to examine individual kinase contributions to the heterodimeric kinase complexes mediating cellular signaling.  In contrast to a recent study, we demonstrate that for IL-15 cytokine signaling it is sufficient to inhibit either JAK1 or JAK3 to fully inhibit downstream STAT5 phosphorylation.  This addnl. data thus provides a crit. piece of information explaining why JAK1 has incorrectly been thought to have a dominant role over JAK3.  Beyond enabling a deeper understanding of JAK signaling, conducting similar analyses for other kinases by taking into account potency at high ATP rather than Km ATP may provide crucial insights into a compd.'s activity and selectivity in cellular contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYiMVl7OpPFLVg90H21EOLACvtfcHk0lgYgTQUW80ITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslart7s%253D&md5=c87874cb1748e13eef2aa241ecef3e79</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5002125%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DATP-mediated%2520kinome%2520selectivity%253A%2520the%2520missing%2520link%2520in%2520understanding%2520the%2520contribution%2520of%2520individual%2520JAK%2520kinase%2520isoforms%2520to%2520cellular%2520signaling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1552%26epage%3D1558%26doi%3D10.1021%2Fcb5002125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhX2tJcnUrhbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lhGDme5qSD80Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindorff-Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bank, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jumper, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wriggers, W.</span></span> <span> </span><span class="NLM_article-title">Atomic-level characterization of the structural dynamics of proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1126/science.1187409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.1187409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20947758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OisL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=341-346&author=D.+E.+Shawauthor=P.+Maragakisauthor=K.+Lindorff-Larsenauthor=S.+Pianaauthor=R.+O.+Drorauthor=M.+P.+Eastwoodauthor=J.+A.+Bankauthor=J.+M.+Jumperauthor=J.+K.+Salmonauthor=Y.+Shanauthor=W.+Wriggers&title=Atomic-level+characterization+of+the+structural+dynamics+of+proteins&doi=10.1126%2Fscience.1187409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic-Level Characterization of the Structural Dynamics of Proteins</span></div><div class="casAuthors">Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6002</span>),
    <span class="NLM_cas:pages">341-346</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) simulations are widely used to study protein motions at an at. level of detail, but they have been limited to time scales shorter than those of many biol. crit. conformational changes.  We examd. two fundamental processes in protein dynamics-protein folding and conformational change within the folded state-by means of extremely long all-atom MD simulations conducted on a special-purpose machine.  Equil. simulations of a WW protein domain captured multiple folding and unfolding events that consistently follow a well-defined folding pathway; sep. simulations of the protein's constituent substructures shed light on possible determinants of this pathway.  A 1-ms simulation of the folded protein BPTI reveals a small no. of structurally distinct conformational states whose reversible interconversion is slower than local relaxations within those states by a factor of more than 1000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnwCEGvUFVELVg90H21EOLACvtfcHk0lhGDme5qSD80Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OisL%252FN&md5=85c9d897881e8684fc39d69b2b6b2fad</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1126%2Fscience.1187409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1187409%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DMaragakis%26aufirst%3DP.%26aulast%3DLindorff-Larsen%26aufirst%3DK.%26aulast%3DPiana%26aufirst%3DS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DBank%26aufirst%3DJ.%2BA.%26aulast%3DJumper%26aufirst%3DJ.%2BM.%26aulast%3DSalmon%26aufirst%3DJ.%2BK.%26aulast%3DShan%26aufirst%3DY.%26aulast%3DWriggers%26aufirst%3DW.%26atitle%3DAtomic-level%2520characterization%2520of%2520the%2520structural%2520dynamics%2520of%2520proteins%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D341%26epage%3D346%26doi%3D10.1126%2Fscience.1187409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barducci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrinello, M.</span></span> <span> </span><span class="NLM_article-title">Linking well-tempered metadynamics simulations with experiments</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">L44</span>– <span class="NLM_lpage">L46</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2010.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bpj.2010.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20441734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2010&pages=L44-L46&author=A.+Barducciauthor=M.+Bonomiauthor=M.+Parrinello&title=Linking+well-tempered+metadynamics+simulations+with+experiments&doi=10.1016%2Fj.bpj.2010.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Linking well-tempered metadynamics simulations with experiments</span></div><div class="casAuthors">Barducci, Alessandro; Bonomi, Massimiliano; Parrinello, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">L44-L46</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Linking expts. with the atomistic resoln. provided by mol. dynamics simulations can shed light on the structure and dynamics of protein-disordered states.  The sampling limitations of classical mol. dynamics can be overcome using metadynamics, which is based on the introduction of a history-dependent bias on a small no. of suitably chosen collective variables.  Even if such bias distorts the probability distribution of the other degrees of freedom, the equil. Boltzmann distribution can be reconstructed using a recently developed reweighting algorithm.  Quant. comparison with exptl. data is thus possible.  Here we show the potential of this combined approach by characterizing the conformational ensemble explored by a 13-residue helix-forming peptide by means of a well-tempered metadynamics/parallel tempering approach and comparing the reconstructed NMR scalar couplings with exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjowMWWV2H7Vg90H21EOLACvtfcHk0lhGDme5qSD80Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVansb8%253D&md5=16bc83b663df3e1e2185938102bb8b12</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2010.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2010.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DBarducci%26aufirst%3DA.%26aulast%3DBonomi%26aufirst%3DM.%26aulast%3DParrinello%26aufirst%3DM.%26atitle%3DLinking%2520well-tempered%2520metadynamics%2520simulations%2520with%2520experiments%26jtitle%3DBiophys.%2520J.%26date%3D2010%26volume%3D98%26spage%3DL44%26epage%3DL46%26doi%3D10.1016%2Fj.bpj.2010.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span> <i>Molecular Operating
Environment (MOE)</i>, version <span class="NLM_edition">2015.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
QC, Canada</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%2C+version+2015.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C%0AQC%2C+Canada%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladyshev, V. N.</span></span> <span> </span><span class="NLM_article-title">Analysis and functional prediction of reactive cysteine residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4425</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.275578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1074%2Fjbc.R111.275578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22157013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFahur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4419-4425&author=S.+M.+Marinoauthor=V.+N.+Gladyshev&title=Analysis+and+functional+prediction+of+reactive+cysteine+residues&doi=10.1074%2Fjbc.R111.275578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis and Functional Prediction of Reactive Cysteine Residues</span></div><div class="casAuthors">Marino, Stefano M.; Gladyshev, Vadim N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4419-4425</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Cys is much different from other common amino acids in proteins.  Being 1 of the least abundant residues, Cys is often obsd. in functional sites in proteins.  This residue is reactive, polarizable, and redox-active; has high affinity for metals; and is particularly responsive to the local environment.  A better understanding of the basic properties of Cys is essential for interpretation of high-throughput data sets and for prediction and classification of functional Cys residues.  We provide an overview of approaches used to study Cys residues, from methods for investigation of their basic properties, such as exposure and pKa, to algorithms for functional prediction of different types of Cys in proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4WM1o3L2LTrVg90H21EOLACvtfcHk0lhrVA43TvM9hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFahur0%253D&md5=87691c160b33b4896e06ece905bccbc8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.275578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.275578%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DS.%2BM.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26atitle%3DAnalysis%2520and%2520functional%2520prediction%2520of%2520reactive%2520cysteine%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4419%26epage%3D4425%26doi%3D10.1074%2Fjbc.R111.275578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. R.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometry in the analysis of glutathione conjugates</span>. <i>Biol. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1002/bms.1200220602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fbms.1200220602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8329460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK3sXltFams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=319-25&author=T.+A.+Baillieauthor=M.+R.+Davis&title=Mass+spectrometry+in+the+analysis+of+glutathione+conjugates&doi=10.1002%2Fbms.1200220602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometry in the analysis of glutathione conjugates</span></div><div class="casAuthors">Baillie, Thomas A.; Davis, Margaret R.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Mass Spectrometry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">319-25</span>CODEN:
                <span class="NLM_cas:coden">BIMSEH</span>;
        ISSN:<span class="NLM_cas:issn">1052-9306</span>.
    </div><div class="casAbstract">A review with 42 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jRrl5L795bVg90H21EOLACvtfcHk0lhrVA43TvM9hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFams7k%253D&md5=2e946c5aebae5c3907e09be1b4359bf5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fbms.1200220602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbms.1200220602%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DDavis%26aufirst%3DM.%2BR.%26atitle%3DMass%2520spectrometry%2520in%2520the%2520analysis%2520of%2520glutathione%2520conjugates%26jtitle%3DBiol.%2520Mass%2520Spectrom.%26date%3D1993%26volume%3D22%26spage%3D319%26epage%3D25%26doi%3D10.1002%2Fbms.1200220602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kheffache, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guemmour, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benaboura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouamerali, O.</span></span> <span> </span><span class="NLM_article-title">Conformational analysis and intramolecular hydrogen bonding of cis-3-aminoindan-1-ol: a quantum chemical study</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1007/s00894-013-1989-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1007%2Fs00894-013-1989-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=24026578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOktLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4837-4847&author=D.+Kheffacheauthor=H.+Guemmourauthor=A.+Dekhiraauthor=A.+Benabouraauthor=O.+Ouamerali&title=Conformational+analysis+and+intramolecular+hydrogen+bonding+of+cis-3-aminoindan-1-ol%3A+a+quantum+chemical+study&doi=10.1007%2Fs00894-013-1989-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational analysis and intramolecular hydrogen bonding of cis-3-aminoindan-1-ol: a quantum chemical study</span></div><div class="casAuthors">Kheffache, Djaffar; Guemmour, Hind; Dekhira, Azzedine; Benaboura, Ahmed; Ouamerali, Ourida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4837-4847</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the present work, we carried out a conformational anal. of cis-3-aminoindan-1-ol and evaluated the role of the intramol. hydrogen bond in the stabilization of various conformers using quantum mech. DFT (B3LYP) and MP2 methods.  On the basis of relative energies, we have found nine conformational min., which can interchange through the ring-puckering and the internal rotation of the OH and NH2 groups on the five-membered ring.  The intramol. hydrogen bonds such as OH····π, NH····π, NH····OH and HN····HO are expected to be of crit. importance for the conformational stabilities.  The intramol. interactions of the min. have been analyzed by calcn. of electron d. (ρ) and Laplacian at the bond crit. points (BCPs) using atoms-in-mol. (AIM) theory.  The existence or absence of OH····π and NH····π in cis-3-aminoindan-1-ol remains unclear since the geometrical investigation has not been confirmed by topol. criteria.  The results of theor. calcns. demonstrate that this compd. exists predominantly in one ring-puckering form stabilized by strong hydrogen bond HN····HO interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGta-4ZOzs7Vg90H21EOLACvtfcHk0lhrVA43TvM9hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOktLfO&md5=11cea9aa3db017cf4cddbca409b85e67</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs00894-013-1989-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-013-1989-3%26sid%3Dliteratum%253Aachs%26aulast%3DKheffache%26aufirst%3DD.%26aulast%3DGuemmour%26aufirst%3DH.%26aulast%3DDekhira%26aufirst%3DA.%26aulast%3DBenaboura%26aufirst%3DA.%26aulast%3DOuamerali%26aufirst%3DO.%26atitle%3DConformational%2520analysis%2520and%2520intramolecular%2520hydrogen%2520bonding%2520of%2520cis-3-aminoindan-1-ol%253A%2520a%2520quantum%2520chemical%2520study%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D4837%26epage%3D4847%26doi%3D10.1007%2Fs00894-013-1989-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lhrVA43TvM9hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995–1998</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>576</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1016/S0022-328X(98)01055-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+advances+in+the+cross-coupling+reactions+of+organoboron+derivatives+with+organic+electrophiles%2C+1995%E2%80%931998&doi=10.1016%2FS0022-328X%2898%2901055-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0lhmd_gcOHF4QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520cross-coupling%2520reactions%2520of%2520organoboron%2520derivatives%2520with%2520organic%2520electrophiles%252C%25201995%25E2%2580%25931998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168%26doi%3D10.1016%2FS0022-328X%2898%2901055-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span>; <span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Salituro, F.</span>; <span class="NLM_string-name">Duffy, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tricyclicheteroaryl Derivatives for Use as Janus Kinase Inhibitors</span>. <span class="NLM_patent">WO2008079521A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Bennani&author=T.+Wang&author=F.+Salituro&author=J.+Duffy&title=Preparation+of+Tricyclicheteroaryl+Derivatives+for+Use+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennani%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Tricyclicheteroaryl%2520Derivatives%2520for%2520Use%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span>; <span class="NLM_string-name">Matsunaga, N.</span>; <span class="NLM_string-name">Ohra, T.</span>; <span class="NLM_string-name">Ohyabu, N.</span>; <span class="NLM_string-name">Hasui, T.</span>; <span class="NLM_string-name">Motoyaji, T.</span>; <span class="NLM_string-name">Siedem, C. S.</span>; <span class="NLM_string-name">Tang, T. P.</span>; <span class="NLM_string-name">Demeese, L. A.</span>; <span class="NLM_string-name">Gauthier, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Heterocycles as Mineralocorticoid Receptor Antagonists</span>. <span class="NLM_patent">WO2007077961A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Fukumoto&author=N.+Matsunaga&author=T.+Ohra&author=N.+Ohyabu&author=T.+Hasui&author=T.+Motoyaji&author=C.+S.+Siedem&author=T.+P.+Tang&author=L.+A.+Demeese&author=C.+Gauthier&title=Preparation+of+Fused+Heterocycles+as+Mineralocorticoid+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Fused%2520Heterocycles%2520as%2520Mineralocorticoid%2520Receptor%2520Antagonists%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrig, S.</span>; <span class="NLM_string-name">Pohlmann, J.</span>; <span class="NLM_string-name">Arndt, S.</span>; <span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Perzborn, E.</span>; <span class="NLM_string-name">Gerdes, C.</span>; <span class="NLM_string-name">Schlemmer, K.-H.</span>; <span class="NLM_string-name">Tuch, A.</span>; <span class="NLM_string-name">Lobell, M.</span>; <span class="NLM_string-name">Nell, P.</span>; <span class="NLM_string-name">Burkhardt, N.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Imino-3-phenyloxazolidines and Related Compounds for the Treatment of Thromboembolic Diseases</span>. <span class="NLM_patent">WO2006058630A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+Roehrig&author=J.+Pohlmann&author=S.+Arndt&author=M.+Jeske&author=M.+Akbaba&author=E.+Perzborn&author=C.+Gerdes&author=K.-H.+Schlemmer&author=A.+Tuch&author=M.+Lobell&author=P.+Nell&author=N.+Burkhardt&title=Preparation+of+2-Imino-3-phenyloxazolidines+and+Related+Compounds+for+the+Treatment+of+Thromboembolic+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrig%26aufirst%3DS.%26atitle%3DPreparation%2520of%25202-Imino-3-phenyloxazolidines%2520and%2520Related%2520Compounds%2520for%2520the%2520Treatment%2520of%2520Thromboembolic%2520Diseases%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">A simple method for the electrophilic cyanation of secondary amines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1021/ol403245r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403245r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=247-249&author=C.+Zhuauthor=J.-B.+Xiaauthor=C.+Chen&title=A+simple+method+for+the+electrophilic+cyanation+of+secondary+amines&doi=10.1021%2Fol403245r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fol403245r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403245r%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DJ.-B.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520electrophilic%2520cyanation%2520of%2520secondary%2520amines%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D247%26epage%3D249%26doi%3D10.1021%2Fol403245r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maulik, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S.</span></span> <span> </span><span class="NLM_article-title">Sodium hydride mediated cascade reaction towards the synthesis of 1,5-disubstituted uracil from cyanamides derived from Baylis-Hillman adducts</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">917</span>, <span class="refDoi"> DOI: 10.1055/s-2007-965931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-2007-965931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=911-917&author=S.+Nagauthor=G.+P.+Yadavauthor=P.+R.+Maulikauthor=S.+Batra&title=Sodium+hydride+mediated+cascade+reaction+towards+the+synthesis+of+1%2C5-disubstituted+uracil+from+cyanamides+derived+from+Baylis-Hillman+adducts&doi=10.1055%2Fs-2007-965931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-965931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-965931%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DG.%2BP.%26aulast%3DMaulik%26aufirst%3DP.%2BR.%26aulast%3DBatra%26aufirst%3DS.%26atitle%3DSodium%2520hydride%2520mediated%2520cascade%2520reaction%2520towards%2520the%2520synthesis%2520of%25201%252C5-disubstituted%2520uracil%2520from%2520cyanamides%2520derived%2520from%2520Baylis-Hillman%2520adducts%26jtitle%3DSynthesis%26date%3D2007%26volume%3D2007%26spage%3D911%26epage%3D917%26doi%3D10.1055%2Fs-2007-965931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Burns, D. M.</span>; <span class="NLM_string-name">Feng, H.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Mei, S.</span>; <span class="NLM_string-name">Pan, J.</span>; <span class="NLM_string-name">Vechorkin, O.</span>; <span class="NLM_string-name">Ye, H. F.</span>; <span class="NLM_string-name">Zhu, W.</span>; <span class="NLM_string-name">Rafalski, M.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Xue, C.-B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Furo- and Thieno-Pyridine Carboxamide Compounds Useful as Pim Kinase Inhibitors</span>. <span class="NLM_patent">WO2015027124A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.-L.+Li&author=D.+M.+Burns&author=H.+Feng&author=T.+Huang&author=S.+Mei&author=J.+Pan&author=O.+Vechorkin&author=H.+F.+Ye&author=W.+Zhu&author=M.+Rafalski&author=A.+Wang&author=C.-B.+Xue&title=Preparation+of+Furo-+and+Thieno-Pyridine+Carboxamide+Compounds+Useful+as+Pim+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3DPreparation%2520of%2520Furo-%2520and%2520Thieno-Pyridine%2520Carboxamide%2520Compounds%2520Useful%2520as%2520Pim%2520Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larraufie, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maestri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ollivier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensterbank, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacote, E.</span></span> <span> </span><span class="NLM_article-title">The cyanamide moiety, synthesis and reactivity</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1289749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-0031-1289749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1CjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1279-1292&author=M.-H.+Larraufieauthor=G.+Maestriauthor=M.+Malacriaauthor=C.+Ollivierauthor=L.+Fensterbankauthor=E.+Lacote&title=The+cyanamide+moiety%2C+synthesis+and+reactivity&doi=10.1055%2Fs-0031-1289749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The cyanamide moiety, synthesis and reactivity</span></div><div class="casAuthors">Larraufie, Marie-Helene; Maestri, Giovanni; Malacria, Max; Ollivier, Cyril; Fensterbank, Louis; Lacote, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1279-1292</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  The cyanamide moiety provides many opportunities as a building block for the synthesis of nitrogen-contg. heterocycles.  This review discusses the reported methods for the prepn. of alkyl- and N-acylcyanamides and illustrates their reactivity vis-a-vis nucleophilic addns., cycloaddns., radical chem. and coordination chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopc4w-uJKc-rVg90H21EOLACvtfcHk0ljEsHhPYdMItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1CjsL8%253D&md5=7d10094d0e3a1be29c48f8018b932a09</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1289749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1289749%26sid%3Dliteratum%253Aachs%26aulast%3DLarraufie%26aufirst%3DM.-H.%26aulast%3DMaestri%26aufirst%3DG.%26aulast%3DMalacria%26aufirst%3DM.%26aulast%3DOllivier%26aufirst%3DC.%26aulast%3DFensterbank%26aufirst%3DL.%26aulast%3DLacote%26aufirst%3DE.%26atitle%3DThe%2520cyanamide%2520moiety%252C%2520synthesis%2520and%2520reactivity%26jtitle%3DSynthesis%26date%3D2012%26volume%3D44%26spage%3D1279%26epage%3D1292%26doi%3D10.1055%2Fs-0031-1289749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span>; <span class="NLM_string-name">Baldwin, E. T.</span>; <span class="NLM_string-name">Beck, J. T.</span>; <span class="NLM_string-name">Hughes, R.</span>; <span class="NLM_string-name">John, V.</span>; <span class="NLM_string-name">Pulley, S. R.</span>; <span class="NLM_string-name">Tenbrink, R.</span></span> <span> </span><span class="NLM_article-title">Preparation of Ring-containing N-Acetyl 2-hydroxy-1,3-diaminoalkanes as β-Secretase Inhibitors for Treating Alzheimer’s Disease and Other Diseases Characterized by Deposition of Aβ-Peptide</span>. <span class="NLM_patent">WO2004024081A2</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Maillard&author=E.+T.+Baldwin&author=J.+T.+Beck&author=R.+Hughes&author=V.+John&author=S.+R.+Pulley&author=R.+Tenbrink&title=Preparation+of+Ring-containing+N-Acetyl+2-hydroxy-1%2C3-diaminoalkanes+as+%CE%B2-Secretase+Inhibitors+for+Treating+Alzheimer%E2%80%99s+Disease+and+Other+Diseases+Characterized+by+Deposition+of+A%CE%B2-Peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaillard%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Ring-containing%2520N-Acetyl%25202-hydroxy-1%252C3-diaminoalkanes%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%2520for%2520Treating%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Other%2520Diseases%2520Characterized%2520by%2520Deposition%2520of%2520A%25CE%25B2-Peptide%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, H. M.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjaneyulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J. S.</span></span> <span> </span><span class="NLM_article-title">An expedient and highly selective conversion of alcohols to azides using a NaN<sub>3</sub>/BF<sub>3</sub>.Et<sub>2</sub>O system</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">7385</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)01602-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0040-4039%2898%2901602-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=7385-7388&author=H.+M.%0AS.+Kumarauthor=B.+V.+S.+Reddyauthor=S.+Anjaneyuluauthor=J.+S.+Yadav&title=An+expedient+and+highly+selective+conversion+of+alcohols+to+azides+using+a+NaN3%2FBF3.Et2O+system&doi=10.1016%2FS0040-4039%2898%2901602-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901602-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901602-5%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DH.%2BM.%2BS.%26aulast%3DReddy%26aufirst%3DB.%2BV.%2BS.%26aulast%3DAnjaneyulu%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520expedient%2520and%2520highly%2520selective%2520conversion%2520of%2520alcohols%2520to%2520azides%2520using%2520a%2520NaN3%252FBF3.Et2O%2520system%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D7385%26epage%3D7388%26doi%3D10.1016%2FS0040-4039%2898%2901602-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of tert-butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+applications+of+tert-butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0ljEsHhPYdMItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520tert-butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.-H.</span></span> <span> </span><span class="NLM_article-title">SmI2-promoted imino-Reformatsky reaction for facile synthesis of enantioenriched β-amino acid esters</span>. <i>Sci. China: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s11426-010-4180-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1007%2Fs11426-010-4180-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Giuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=61-65&author=L.+Wangauthor=C.+Shenauthor=M.-H.+Xu&title=SmI2-promoted+imino-Reformatsky+reaction+for+facile+synthesis+of+enantioenriched+%CE%B2-amino+acid+esters&doi=10.1007%2Fs11426-010-4180-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">SmI2-promoted imino-Reformatsky reaction for facile synthesis of enantioenriched β-amino acid esters</span></div><div class="casAuthors">Wang, Li; Shen, Chun; Xu, Ming-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">SCCCCS</span>;
        ISSN:<span class="NLM_cas:issn">1869-1870</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">A facile and efficient method for the stereoselective synthesis of β-amino acid esters via SmI2-promoted imino-Reformatsky reaction is described.  Asym. addn. of tert-Bu bromoacetate to N-tert-butanesulfinyl aldimines afforded β-amino acid esters in moderate to high yields with excellent diastereoselectivities.  The synthetic utilities of the tert-Bu β-amino acid esters were expanded by the prepn. of β-lactams and 3-aminoindan-1-ones derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO7HjntKVVWbVg90H21EOLACvtfcHk0ljEsHhPYdMItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Giuw%253D%253D&md5=9f7e69095b65332e4e94981e644baad6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs11426-010-4180-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-010-4180-z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DM.-H.%26atitle%3DSmI2-promoted%2520imino-Reformatsky%2520reaction%2520for%2520facile%2520synthesis%2520of%2520enantioenriched%2520%25CE%25B2-amino%2520acid%2520esters%26jtitle%3DSci.%2520China%253A%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D61%26epage%3D65%26doi%3D10.1007%2Fs11426-010-4180-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doughan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, D. J.</span></span> <span> </span><span class="NLM_article-title">Scalable synthesis of β-amino esters via Reformatsky reaction with N-tert-butanesulfinyl imines</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1087964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-0028-1087964" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=991-993&author=K.+Brinnerauthor=B.+Doughanauthor=D.+J.+Poon&title=Scalable+synthesis+of+%CE%B2-amino+esters+via+Reformatsky+reaction+with+N-tert-butanesulfinyl+imines&doi=10.1055%2Fs-0028-1087964"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1087964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1087964%26sid%3Dliteratum%253Aachs%26aulast%3DBrinner%26aufirst%3DK.%26aulast%3DDoughan%26aufirst%3DB.%26aulast%3DPoon%26aufirst%3DD.%2BJ.%26atitle%3DScalable%2520synthesis%2520of%2520%25CE%25B2-amino%2520esters%2520via%2520Reformatsky%2520reaction%2520with%2520N-tert-butanesulfinyl%2520imines%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D991%26epage%3D993%26doi%3D10.1055%2Fs-0028-1087964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span>; <span class="NLM_string-name">Fliri, H.
G.</span>; <span class="NLM_string-name">Keats, A.
J.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Sanvoisin, J.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Watt, G. M.</span></span> <span> </span><span class="NLM_article-title">Preparation of Macrocyclic Peptides as Inhibitors of Flaviviridae Viruses for Treating particularly Hepatitis C Infections</span>. <span class="NLM_patent">WO2012078915A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Appleby&author=H.%0AG.+Fliri&author=A.%0AJ.+Keats&author=L.+Lazarides&author=R.+L.+Mackman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=J.+Sanvoisin&author=V.+A.+Steadman&author=G.+M.+Watt&title=Preparation+of+Macrocyclic+Peptides+as+Inhibitors+of+Flaviviridae+Viruses+for+Treating+particularly+Hepatitis+C+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAppleby%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Macrocyclic%2520Peptides%2520as%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%2520for%2520Treating%2520particularly%2520Hepatitis%2520C%2520Infections%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, L. D.</span>; <span class="NLM_string-name">Moyer, M. P.</span>; <span class="NLM_string-name">Sobolov-Jaynes, S. B.</span></span> <span> </span><span class="NLM_article-title">Fused Bicyclic Pyrimidine Derivatives Useful as Antihyperproliferative Agents</span>. <span class="NLM_patent">WO9823613A1</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=L.+D.+Arnold&author=M.+P.+Moyer&author=S.+B.+Sobolov-Jaynes&title=Fused+Bicyclic+Pyrimidine+Derivatives+Useful+as+Antihyperproliferative+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DFused%2520Bicyclic%2520Pyrimidine%2520Derivatives%2520Useful%2520as%2520Antihyperproliferative%2520Agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span>; <span class="NLM_string-name">Janne, P.</span>; <span class="NLM_string-name">Eck, M.
J.</span></span> <span> </span><span class="NLM_article-title">Substituted Heteroaryl Derivatives as EGFR and HER Kinase Modulators and Their Preparation and Use for the Treatment of Diseases</span>. <span class="NLM_patent">WO2010129053A2</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=N.+S.+Gray&author=P.+Janne&author=M.%0AJ.+Eck&title=Substituted+Heteroaryl+Derivatives+as+EGFR+and+HER+Kinase+Modulators+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSubstituted%2520Heteroaryl%2520Derivatives%2520as%2520EGFR%2520and%2520HER%2520Kinase%2520Modulators%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahearn, S. P.</span>; <span class="NLM_string-name">Christopher, M.</span>; <span class="NLM_string-name">Jung, J.</span>; <span class="NLM_string-name">Pu, Q.</span>; <span class="NLM_string-name">Rivkin, A.</span>; <span class="NLM_string-name">Scott, M. E.</span>; <span class="NLM_string-name">Witter, D. J.</span>; <span class="NLM_string-name">Woo, H. C.</span>; <span class="NLM_string-name">Cash, B.</span>; <span class="NLM_string-name">Dinsmore, C.</span>; <span class="NLM_string-name">Guerin, D.</span></span> <span> </span><span class="NLM_article-title">Preparation of Pyrrolopyrimidines as Janus Kinase Inhibitors</span>. <span class="NLM_patent">WO2013085802A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+P.+Ahearn&author=M.+Christopher&author=J.+Jung&author=Q.+Pu&author=A.+Rivkin&author=M.+E.+Scott&author=D.+J.+Witter&author=H.+C.+Woo&author=B.+Cash&author=C.+Dinsmore&author=D.+Guerin&title=Preparation+of+Pyrrolopyrimidines+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhearn%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Pyrrolopyrimidines%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span>; <span class="NLM_string-name">Casimiro-Garcia, A.</span>; <span class="NLM_string-name">Che, Y.</span>; <span class="NLM_string-name">Coe, J.
W.</span>; <span class="NLM_string-name">Flanagan, M. E.</span>; <span class="NLM_string-name">Gilbert, A. M.</span>; <span class="NLM_string-name">Hayward, M. M.</span>; <span class="NLM_string-name">Langille, J. D.</span>; <span class="NLM_string-name">Montgomery, J. I.</span>; <span class="NLM_string-name">Telliez, J.-B.</span>; <span class="NLM_string-name">Thorarensen, A.</span>; <span class="NLM_string-name">Unwalla, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyrrolo[2,3-d]pyrimidinyl-, Pyrrolo[2,3-b]pyrazinyl- and Pyrrolo[2,3-d]pyridinylacrylamides as JAK Inhibitor and Their Preparation</span>. <span class="NLM_patent">WO2015083028A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+F.+Brown&author=A.+Casimiro-Garcia&author=Y.+Che&author=J.%0AW.+Coe&author=M.+E.+Flanagan&author=A.+M.+Gilbert&author=M.+M.+Hayward&author=J.+D.+Langille&author=J.+I.+Montgomery&author=J.-B.+Telliez&author=A.+Thorarensen&author=R.+J.+Unwalla&title=Pyrrolo%5B2%2C3-d%5Dpyrimidinyl-%2C+Pyrrolo%5B2%2C3-b%5Dpyrazinyl-+and+Pyrrolo%5B2%2C3-d%5Dpyridinylacrylamides+as+JAK+Inhibitor+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BF.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidinyl-%252C%2520Pyrrolo%255B2%252C3-b%255Dpyrazinyl-%2520and%2520Pyrrolo%255B2%252C3-d%255Dpyridinylacrylamides%2520as%2520JAK%2520Inhibitor%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segmuller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ybarra, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of acrylophenones and 2-alkyl indanones utilizing hexamethylenetetramine as an inexpensive Mannich reagent</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1775</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1080/00397919608002617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1080%2F00397919608002617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK28XitlWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1775-1784&author=A.+Bhattacharyaauthor=B.+Segmullerauthor=A.+Ybarra&title=Preparation+of+acrylophenones+and+2-alkyl+indanones+utilizing+hexamethylenetetramine+as+an+inexpensive+Mannich+reagent&doi=10.1080%2F00397919608002617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of acrylophenones and 2-alkyl indanones utilizing hexamethylenetetramine as an inexpensive Mannich reagent</span></div><div class="casAuthors">Bhattacharya, Apurba; Segmuller, Brigitte; Ybarra, Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1775-84</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">Hexamethylenetetramine/acetic anhydride-promoted α-methylenation of aryl alkyl ketones I (R1 = Me, Et, n-Bu, n-octyl, n-Pr, Ph, R1 = H, Cl, R3 = H, Br, Cl, R4 = H, OMe) followed by acid-catalyzed cyclization of the resulting acrylophenones produce 2-alkylindanones II in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjNjGDuWPILVg90H21EOLACvtfcHk0lgX8whIteMrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlWhsLk%253D&md5=5d2899ba26931b6c21068311f14ccf5c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F00397919608002617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919608002617%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DSegmuller%26aufirst%3DB.%26aulast%3DYbarra%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520acrylophenones%2520and%25202-alkyl%2520indanones%2520utilizing%2520hexamethylenetetramine%2520as%2520an%2520inexpensive%2520Mannich%2520reagent%26jtitle%3DSynth.%2520Commun.%26date%3D1996%26volume%3D26%26spage%3D1775%26epage%3D1784%26doi%3D10.1080%2F00397919608002617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>. In  <i>Macromolecular Crystallography, Part A</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr.</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; Methods in Enzymology, Vol. 276; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lj2mlpvSNdjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lj2mlpvSNdjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>D53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhMBRLv1uObKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version <span class="NLM_edition">2.8.0</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>D66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhMBRLv1uObKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qichao Bao, Liangying Zhang, Nan Wang, Brian Gabet, Weikang Yang, Xingyang Gao, Qidong You, <span class="NLM_string-name hlFld-ContribAuthor">Zhengyu Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Peroxide Inducible JAK3 Covalent Inhibitor: Prodrug for the Treatment of RA with Enhanced Safety Profile. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2182-2189. <a href="https://doi.org/10.1021/acsmedchemlett.0c00323" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00323%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHydrogen%252BPeroxide%252BInducible%252BJAK3%252BCovalent%252BInhibitor%25253A%252BProdrug%252Bfor%252Bthe%252BTreatment%252Bof%252BRA%252Bwith%252BEnhanced%252BSafety%252BProfile%26aulast%3DBao%26aufirst%3DQichao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11062020%26date%3D01102020%26date%3D05102020%26volume%3D11%26issue%3D11%26spage%3D2182%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Edouard Duchamp, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanide-Free Synthesis of Air Stable N-Substituted Li and K Cyanamide Salts from Tetrazoles. Applications toward the Synthesis of Primary and Secondary Cyanamides as Precursors to Amidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8487-8491. <a href="https://doi.org/10.1021/acs.orglett.0c03085" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03085%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCyanide-Free%252BSynthesis%252Bof%252BAir%252BStable%252BN-Substituted%252BLi%252Band%252BK%252BCyanamide%252BSalts%252Bfrom%252BTetrazoles.%252BApplications%252Btoward%252Bthe%252BSynthesis%252Bof%252BPrimary%252Band%252BSecondary%252BCyanamides%252Bas%252BPrecursors%252Bto%252BAmidines%26aulast%3DDuchamp%26aufirst%3DEdouard%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14092020%26date%3D22102020%26volume%3D22%26issue%3D21%26spage%3D8487%26epage%3D8491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuefeng Cong, Gu Zhan, Zhenbo Mo, Masayoshi Nishiura, <span class="NLM_string-name hlFld-ContribAuthor">Zhaomin Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereodivergent [3 + 2] Annulation of Aromatic Aldimines with Alkenes via C–H Activation by Half-Sandwich Rare-Earth Catalysts. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (12)
                                     , 5531-5537. <a href="https://doi.org/10.1021/jacs.0c01171" title="DOI URL">https://doi.org/10.1021/jacs.0c01171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c01171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c01171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDiastereodivergent%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulation%252Bof%252BAromatic%252BAldimines%252Bwith%252BAlkenes%252Bvia%252BC%2525E2%252580%252593H%252BActivation%252Bby%252BHalf-Sandwich%252BRare-Earth%252BCatalysts%26aulast%3DCong%26aufirst%3DXuefeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30012020%26date%3D12032020%26date%3D08032020%26volume%3D142%26issue%3D12%26spage%3D5531%26epage%3D5537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Minjian Yang, Bingzhong Tao, Chengjuan Chen, Wenqiang Jia, Shaolei Sun, Tiantai Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojian Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5002-5012. <a href="https://doi.org/10.1021/acs.jcim.9b00798" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMachine%252BLearning%252BModels%252BBased%252Bon%252BMolecular%252BFingerprints%252Band%252Ban%252BExtreme%252BGradient%252BBoosting%252BMethod%252BLead%252Bto%252Bthe%252BDiscovery%252Bof%252BJAK2%252BInhibitors%26aulast%3DYang%26aufirst%3DMinjian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15092019%26date%3D04122019%26date%3D20112019%26volume%3D59%26issue%3D12%26spage%3D5002%26epage%3D5012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven H. Spergel, Michael E. Mertzman, James Kempson, Junqing Guo, Sylwia Stachura, Lauren Haque, Jonathan S. Lippy, Rosemary F. Zhang, Michael Galella, Sidney Pitt, Guoxiang Shen, Aberra Fura, Kathleen Gillooly, Kim W. McIntyre, Vicky Tang, John Tokarski, John S. Sack, Javed Khan, Percy H. Carter, Joel C. Barrish, Steven G. Nadler, Luisa M. Salter-Cid, Gary L. Schieven, Stephen T. Wrobleski, <span class="NLM_string-name hlFld-ContribAuthor">William J. Pitts</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 306-311. <a href="https://doi.org/10.1021/acsmedchemlett.8b00508" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00508%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BJAK1%25252F3%252BInhibitor%252Band%252BUse%252Bof%252Ba%252BProdrug%252BTo%252BDemonstrate%252BEfficacy%252Bin%252Ba%252BModel%252Bof%252BRheumatoid%252BArthritis%26aulast%3DSpergel%26aufirst%3DSteven%2BH.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D26102018%26date%3D07022019%26date%3D13022019%26volume%3D10%26issue%3D3%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivy  Guan</span>, <span class="hlFld-ContribAuthor ">Kayla  Williams</span>, <span class="hlFld-ContribAuthor ">Jolyn  Pan</span>, <span class="hlFld-ContribAuthor ">Xuyu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">New Cysteine Covalent Modification Strategies Enable Advancement of Proteome‐wide Selectivity of Kinase Modulators. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 949-963. <a href="https://doi.org/10.1002/ajoc.202100036" title="DOI URL">https://doi.org/10.1002/ajoc.202100036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100036%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNew%252BCysteine%252BCovalent%252BModification%252BStrategies%252BEnable%252BAdvancement%252Bof%252BProteome%2525E2%252580%252590wide%252BSelectivity%252Bof%252BKinase%252BModulators%26aulast%3DGuan%26aufirst%3DIvy%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D949%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Visekhonuo  Kuotsu</span>, <span class="hlFld-ContribAuthor ">Vevosa  Nakro</span>, <span class="hlFld-ContribAuthor ">Imkong  Yanger</span>, <span class="hlFld-ContribAuthor ">Tsenbeni N.  Lotha</span>, <span class="hlFld-ContribAuthor ">Ketiyala  Tzudir</span>, <span class="hlFld-ContribAuthor ">Upasana Bora  Sinha</span>, <span class="hlFld-ContribAuthor ">Latonglila  Jamir</span>. </span><span class="cited-content_cbyCitation_article-title">An environmentally benign synthesis of Tetrabutylphosphonium tribromide (TBPTB) – a versatile and efficient phase transfer reagent for organic transformations. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry Letters and Reviews</span><span> <strong>2021,</strong> <em>14 </em>
                                    (2)
                                     , 425-434. <a href="https://doi.org/10.1080/17518253.2021.1929511" title="DOI URL">https://doi.org/10.1080/17518253.2021.1929511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17518253.2021.1929511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17518253.2021.1929511%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%2520Letters%2520and%2520Reviews%26atitle%3DAn%252Benvironmentally%252Bbenign%252Bsynthesis%252Bof%252BTetrabutylphosphonium%252Btribromide%252B%252528TBPTB%252529%252B%2525E2%252580%252593%252Ba%252Bversatile%252Band%252Befficient%252Bphase%252Btransfer%252Breagent%252Bfor%252Borganic%252Btransformations%26aulast%3DKuotsu%26aufirst%3DVisekhonuo%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D2%26spage%3D425%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atli  Thorarensen</span>, <span class="hlFld-ContribAuthor ">Paul  Balbo</span>, <span class="hlFld-ContribAuthor ">Mary E.  Banker</span>, <span class="hlFld-ContribAuthor ">Robert M.  Czerwinski</span>, <span class="hlFld-ContribAuthor ">Max  Kuhn</span>, <span class="hlFld-ContribAuthor ">Tristan S.  Maurer</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Arthur J.  Wittwer</span>. </span><span class="cited-content_cbyCitation_article-title">The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115865. <a href="https://doi.org/10.1016/j.bmc.2020.115865" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115865%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Badvantages%252Bof%252Bdescribing%252Bcovalent%252Binhibitor%252Bin%252Bvitro%252Bpotencies%252Bby%252BIC50%252Bat%252Ba%252Bfixed%252Btime%252Bpoint.%252BIC50%252Bdetermination%252Bof%252Bcovalent%252Binhibitors%252Bprovides%252Bmeaningful%252Bdata%252Bto%252Bmedicinal%252Bchemistry%252Bfor%252BSAR%252Boptimization%26aulast%3DThorarensen%26aufirst%3DAtli%26date%3D2021%26volume%3D29%26spage%3D115865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena De  Vita</span>. </span><span class="cited-content_cbyCitation_article-title">10 years into the resurgence of covalent drugs. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 193-210. <a href="https://doi.org/10.4155/fmc-2020-0236" title="DOI URL">https://doi.org/10.4155/fmc-2020-0236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0236%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D10%252Byears%252Binto%252Bthe%252Bresurgence%252Bof%252Bcovalent%252Bdrugs%26aulast%3DVita%26aufirst%3DElena%2BDe%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D193%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>, <span class="hlFld-ContribAuthor ">Suniti  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131662. <a href="https://doi.org/10.1016/j.tet.2020.131662" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131662%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bsulfonamide%252Band%252Btheir%252Bsynthetic%252Band%252Btherapeutic%252Bapplications%25253A%252BRecent%252Badvances%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel E.  Dalton</span>, <span class="hlFld-ContribAuthor ">Sebastien  Campos</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Small Molecules as Enabling Platforms for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (8)
                                     , 1080-1100. <a href="https://doi.org/10.1002/cbic.201900674" title="DOI URL">https://doi.org/10.1002/cbic.201900674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900674%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DCovalent%252BSmall%252BMolecules%252Bas%252BEnabling%252BPlatforms%252Bfor%252BDrug%252BDiscovery%26aulast%3DDalton%26aufirst%3DSamuel%2BE.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D8%26spage%3D1080%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 43-94. <a href="https://doi.org/10.1007/7355_2020_103" title="DOI URL">https://doi.org/10.1007/7355_2020_103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_103%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%25253A%252BAn%252BOverview%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D43%26epage%3D94%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Dai</span>, <span class="hlFld-ContribAuthor ">LiXi  Yang</span>, <span class="hlFld-ContribAuthor ">Glynn  Addison</span>. </span><span class="cited-content_cbyCitation_article-title">Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (18)
                                     , 1531-1543. <a href="https://doi.org/10.2174/1389557519666190617152011" title="DOI URL">https://doi.org/10.2174/1389557519666190617152011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190617152011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190617152011%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252BStatus%252Bin%252Bthe%252BDiscovery%252Bof%252BCovalent%252BJanus%252BKinase%252B3%252B%252528JAK3%252529%252BInhibitors%26aulast%3DDai%26aufirst%3DJun%26date%3D2019%26volume%3D19%26issue%3D18%26spage%3D1531%26epage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henry  van den Bedem</span>, <span class="hlFld-ContribAuthor ">Mark A  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Shining light on cysteine modification: connecting protein conformational dynamics to catalysis and regulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synchrotron Radiation</span><span> <strong>2019,</strong> <em>26 </em>
                                    (4)
                                     , 958-966. <a href="https://doi.org/10.1107/S160057751900568X" title="DOI URL">https://doi.org/10.1107/S160057751900568X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S160057751900568X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS160057751900568X%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synchrotron%2520Radiation%26atitle%3DShining%252Blight%252Bon%252Bcysteine%252Bmodification%25253A%252Bconnecting%252Bprotein%252Bconformational%252Bdynamics%252Bto%252Bcatalysis%252Band%252Bregulation%26aulast%3Dvan%2Bden%2BBedem%26aufirst%3DHenry%26date%3D2019%26date%3D2019%26volume%3D26%26issue%3D4%26spage%3D958%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Warren J.  Leonard</span>, <span class="hlFld-ContribAuthor ">Jian-Xin  Lin</span>, <span class="hlFld-ContribAuthor ">John J.  O'Shea</span>. </span><span class="cited-content_cbyCitation_article-title">The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications. </span><span class="cited-content_cbyCitation_journal-name">Immunity</span><span> <strong>2019,</strong> <em>50 </em>
                                    (4)
                                     , 832-850. <a href="https://doi.org/10.1016/j.immuni.2019.03.028" title="DOI URL">https://doi.org/10.1016/j.immuni.2019.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.immuni.2019.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.immuni.2019.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunity%26atitle%3DThe%252B%2525CE%2525B3c%252BFamily%252Bof%252BCytokines%25253A%252BBasic%252BBiology%252Bto%252BTherapeutic%252BRamifications%26aulast%3DLeonard%26aufirst%3DWarren%2BJ.%26date%3D2019%26volume%3D50%26issue%3D4%26spage%3D832%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of tofacitinib (<b>1</b>), PF-06651600 (<b>6</b>), a JAK3-specific inhibitor in clinical studies and recently reported JAK3 covalent inhibitors (<b>2</b>–<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>10</b> (gold) bound to JAK3 (ribbons in cyan, residues in gray) at 2.9 Å resolution. Formation of covalent bond with Cys909 was observed (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4">6DA4</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Distribution of Cys909 chi1 dihedral angle in JAK3 crystal structures (<i>n</i> = 168, includes both proprietary and public structures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative free energy surface (FES) generated from a 50 ns metadynamic simulation run of the Cys909 residue chi1 dihedral as the collective variable. The small relative energy difference and the low barrier between the two rotamers suggest both states would be accessible within the JAK3 binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>12</b> (purple) bound to JAK3 (ribbons in cyan, residues in gray) at 1.66 Å resolution. Formation of covalent bond with lower energy Cys909 rotamer was observed (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD">6DUD</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. The major in vitro metabolic pathways of cyanamide <b>12</b> identified included three conjugates (<i>m</i>/<i>z</i> 583, 759, and 454) consistent with GSH addition.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Minor metabolic pathways included both hydrolytic and oxidative metabolism (<i>m</i>/<i>z</i> 294, 310, 292, and 296).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of <b>23</b> (orange) bound to JAK3 (ribbons in cyan, residues in gray) at 1.97 Å resolution. Rotation around the indane–pyrrolopyrimidine bond was observed leading to a completely different orientation and loss of covalent interaction with Cys909 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3">6DB3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Crystal structure of <b>34</b> (gold) bound to JAK3 (ribbons in cyan, residues in gray) at 1.66 Å resolution. Covalent interaction between the nitrile and Cys909 was observed. The indane and pyrrolopyrimidine rings are nearly parallel to each other as determined from comparing torsion angles between pyrrolopyrimidine and phenyl (49°) and between indane and pyrrolopyrimidine (39°) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4">6DB4</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Heatmap of kinase activity profile (% inhibition at 1 mM ATP) of <b>10</b>, <b>12</b>, <b>25</b>, <b>32</b>, and <b>35</b> at 1 μM concentration: red, 100% inhibition; yellow, 50% inhibition; green, 0% inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acrylamide <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DCM, rt, 14 h, 51%; (b) Br(CH<sub>2</sub>)<sub>2</sub>OMe, <i>n</i>-BuLi, THF, −60 °C, 1 h, 15%; (c) <i>m</i>-NH<sub>2</sub>PhB(OH)<sub>2</sub>, dioxane/H<sub>2</sub>O (4:1), K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf), 90 °C, 3 h, 74%; (d) acryloyl chloride, <i>i</i>Pr<sub>2</sub>NEt, DMF, 0 °C, 4 h, 21%.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acrylamide <b>8</b> and Cyanamide <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>40</b>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (10:1), Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, 30 min, 38%; (b) LAH, THF, reflux, 18 h, 25%; (c) acryloyl chloride, THF, 0 °C, 18%; (d) BrCN, THF, K<sub>2</sub>CO<sub>3</sub>, 0 °C, 42%.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cyanamide <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CF<sub>2</sub>CHBr, KOH, CH<sub>3</sub>CN/H<sub>2</sub>O (7:1), 50 °C, 14 h, 98%; (b) K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 14 h, 99%; (c) (BPin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 100 °C, 95%; (d) <b>47</b>, PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, MeTHF/H<sub>2</sub>O (4:1), 70 °C, 14 h, 27%; (e) BrCN, NaH, DMF, 0 °C, 95%; (f) TFA, DCM, 2.5 h, then NH<sub>4</sub>OH, CH<sub>3</sub>CN, 42%.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyanamides <b>12</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>50</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (8:2), Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 16 h, 39%, (b) 2 N HCl/ether, 66–91%; (c) BrCN, K<sub>2</sub>CO<sub>3</sub>, THF, 40 °C, 16–26%; (d) chiral SFC (Chiralcel OD-3, CO<sub>2</sub>/MeOH + 0.05%TEA); (e) <b>50</b> or <b>58</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 1 h, microwave, 50–54%; (f) MeNH<sub>2</sub>, Ti(O-<i>i</i>Pr)<sub>4</sub> then NaBH<sub>4</sub>, MeOH, 75%; (g) Boc<sub>2</sub>O, TEA, DCM, 0 °C, 78%; (h) (BPin)<sub>2</sub>, KOAc, PdCl<sub>2</sub>(dppf), dioxane, 80 °C, 97%.</p></p></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Possible tautomers of cyanamide <b>12</b>. Data from COSY experiment support tautomeric form A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0015.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cyanamides <b>16</b>–<b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>61</b>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 16 h, 52%; (b) 2 N HCl/ether, 2 h, rt, 91–97%; (c) CNBr, K<sub>2</sub>CO<sub>3</sub>, THF, 40 °C, 25–27%; (d) chiral SFC (AD, MeOH/CO<sub>2</sub> + 0.1% NH<sub>4</sub>OH); (e) <b>38</b>, <b>61</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>4</sub>, 110 °C, 1 h, microwave, 54%.</p></p></figure><figure data-id="sch6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0016.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Cyanamides <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1 N LDA, THF, −78 °C, then MeI, 12%; (b) NH<sub>2</sub>OH·HCl, MeOH, reflux, 3 h, 100%; (c) Zn, 2 N HCl, THF, 3 h, 87%; (d) Boc<sub>2</sub>O, TEA, DCM, 24 h, 0 °C, 18%; (e) PdCl<sub>2</sub>(dppf), (BPin)<sub>2</sub>, KOAc, dioxane, 100 °C, 73%; (f) Pd(PPh<sub>3</sub>)<sub>4</sub>, <b>72</b>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, microwave, 30 min, 62%; (g) TFA, DCM, 0 °C, 100%; (h) CNBr, NMM, DMF, −20 °C, 2 h, 31%.</p></p></figure><figure data-id="sch7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0017.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Cyanamides <b>22</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3 M MeMgBr, THF, 0 °C, 2 h, 71%; (b) NaN<sub>3</sub>, TFA, 0–30 °C, 3 h, 96%; (c) PMe<sub>3</sub>, THF/H<sub>2</sub>O (10:1), 30 °C, 24 h, 41%; (d) Boc<sub>2</sub>O, TEA, DCM, 24 h, 30 °C, 52%; (e) PdCl<sub>2</sub>(dppf), (BPin)<sub>2</sub>, KOAc, dioxane, 100 °C, 100%; (f) <b>36</b>, <b>79</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 100 °C, 14 h, 47%; (g) 4 N HCl, dioxane, 25 °C, 34%; (h) CNBr, NMM, DMF, −20 °C, 2 h, 16–37%; (i) chiral SFC (AD, CO<sub>2</sub>/EtOH + 0.1% NH<sub>4</sub>OH), 95%.</p></p></figure><figure data-id="sch8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0018.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Cyanamides <b>25</b> and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>R</i>)-2-methylpropane-2-sulfinamide, <i>p</i>-TsOH, MgSO<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h, 68%; (b) 0.1 M SmI<sub>2</sub>, <i>t</i>-BuO<sub>2</sub>CCH<sub>2</sub>Br, THF, −70 °C, 39%; (c) 4 N HCl/dioxane, 14 h, rt, 100%; (d) TFAA, 2 h, rt, 67%; (e) SOCl<sub>2</sub>, 1 h, reflux, 98%; (f) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 1 h, <b>90</b>, 58%, <b>91</b>, 19%; (g) PdCl<sub>2</sub>(dppf), KOAc, dioxane, 100 °C, 5 h, 100%; (h) <b>92</b>, PdCl<sub>2</sub>(dppf), KF, dioxane/H<sub>2</sub>O (4:1), 90 °C, 14 h, 53%; (i) NaBH<sub>4</sub>, MeOH, 0 °C, 2 h, 55%; %; (j) RP-HPLC CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% NH<sub>4</sub>OH; (k) Na<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (3:1), reflux, 14 h, 81%; (l) CNBr, NMM, CH<sub>2</sub>Cl<sub>2</sub>, −30 °C, 1.5 h, 36–47%.</p></p></figure><figure data-id="sch9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0019.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Cyanamide <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, THF, 0 °C, 1 h, 38%; (b) PdCl<sub>2</sub>(dppf), KOAc, (BPin)<sub>2</sub>, dioxane, 3 h, 100 °C, 85%; (c) <b>36</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2.5 h, 100 °C, 48% then SFC, <b>102</b>, peak 2 carried forward; (d) 4 N HCl/dioxane, 1.5 h; (e) <b>103</b>, CNBr, NMM, DMF, 0 °C, 35% in two steps.</p></p></figure><figure data-id="sch10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0020.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Sulfonamides <b>28</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, EtOH, 1 h, reflux, 100%; (b) Zn, 4 N HCl, THF, rt, 1 h. <b>107</b>: 23%. <b>108</b>: 5%. (c) RSO<sub>2</sub>Cl, DIPEA, DMF, 0 °C, 12 h, 14–75%; (d) K<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O (7:1), 100 °C, 8 h, 41–88%; (e) CNBr, NMM, DMF, −30 °C, 30 min, 19–38%.</p></p></figure><figure data-id="sch11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0021.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Cyanamide <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DPPA, DBU, PhMe, 4 h, 0 °C, 70%; (b) SnCl<sub>2</sub>, MeOH, 0 °C, 5 h, 78%; (c) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 2 h, rt, 63%; (d) (BPin)<sub>2</sub>, PdCl<sub>2</sub>(dppf), KOAc, dioxane, 3 h, 80 °C, 90%; (e) <b>116</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 36%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 2 h, 0 °C, 78%; (g) CNBr, NMM, DMF, −30 °C, 1 h, 46%.</p></p></figure><figure data-id="sch12" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0022.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Cyanamide <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>119</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (5:1), 3 h, 100%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> then K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 89%; (c) <b>115</b>, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane:H<sub>2</sub>O (5:1), 24 h, 80 °C, 43%; (d) 4 N HCl/EtOAc, 2 h, rt, 11%; (e) CNBr, NMM, DMF, 0.5 h, −20 °C, 41%.</p></p></figure><figure data-id="fig11" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/medium/jm-2018-01308j_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0030.jpeg" id="rightTab-GRAPHIC-d7e12002-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of acrylamide <b>125</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b01308/20181207/images/large/jm-2018-01308j_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01308&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i158">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darnell, J. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, G. R.</span></span> <span> </span><span class="NLM_article-title">JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1126/science.8197455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.8197455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8197455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK2cXktlalsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=1415-1421&author=J.+E.+Darnellauthor=I.+M.+Kerrauthor=G.+R.+Stark&title=JAK-STAT+pathways+and+transcriptional+activation+in+response+to+IFNs+and+other+extracellular+signaling+proteins&doi=10.1126%2Fscience.8197455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins</span></div><div class="casAuthors">Darnell, James E., Jr.; Kerr, Ian M.; Stark, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">5164</span>),
    <span class="NLM_cas:pages">1415-21</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 97 refs.  Through the study of transcriptional activation in response to interferon α (IFN-α) and interferon γ (IFN-γ), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription).  The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription.  Recognition of the mols. involved in the IFN-α and IFN-γ pathway has led to discoveries that a no. of STAT family members exist and that other polypeptide ligands also use the Jak-STAT mols. in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo64rvN_qWlmLVg90H21EOLACvtfcHk0liVzbwhVr8IDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktlalsL4%253D&md5=f63d2c7bb3c1aeca6f36fef38aff713c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.8197455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8197455%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26aulast%3DKerr%26aufirst%3DI.%2BM.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DJAK-STAT%2520pathways%2520and%2520transcriptional%2520activation%2520in%2520response%2520to%2520IFNs%2520and%2520other%2520extracellular%2520signaling%2520proteins%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D1415%26epage%3D1421%26doi%3D10.1126%2Fscience.8197455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedy, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1002/jlb.60.4.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fjlb.60.4.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8864127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK28XmsVSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1996&pages=441-452&author=J.+A.+Johnstonauthor=C.+M.+Baconauthor=M.+C.+Riedyauthor=J.+J.+O%E2%80%99Shea&title=Signaling+by+IL-2+and+related+cytokines%3A+JAKs%2C+STATs%2C+and+relationship+to+immunodeficiency&doi=10.1002%2Fjlb.60.4.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency</span></div><div class="casAuthors">Johnston, James A.; Bacon, Chris M.; Riedy, M. C.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 153 refs.  Cytokines that bind to the interleukin-2 (IL-2) receptor common gamma chain (γc), including IL-2, IL-4, IL-7, IL-9, and IL-15, are important for the growth and differentiation of T and B lymphocytes, natural killer cells, macrophages, and monocytes.  These cytokines have overlapping biol. effects that in part result from the use of the shared receptor subunit γc.  Recently it has become clear that these cytokines activate a no. of important intracellular signaling mols., including the Janus kinases JAK1 and JAK3 and members of the transcription factor family of signal transducers and activators of transcription (STATs).  The discovery of these signaling pathways has led to important new insights into their role of lymphocyte maturation, as it has emerged that mutations in the genes encoding both γc and JAK3 result in similar forms of severe combined immunodeficiency (SCID).  In this review we examine the structure and function of cytokine receptors and the signaling pathways involved in their regulation of gene expression.  Furthermore, we discuss recent advances that have led to a better understanding of how cytokines elicit intracellular responses, as well as their role in normal lymphoid development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxBS-4Fw4Io7Vg90H21EOLACvtfcHk0ljn2MxmwD_DEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVSls78%253D&md5=6ccea65ed0126878728f639506a565ac</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fjlb.60.4.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.60.4.441%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DBacon%26aufirst%3DC.%2BM.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSignaling%2520by%2520IL-2%2520and%2520related%2520cytokines%253A%2520JAKs%252C%2520STATs%252C%2520and%2520relationship%2520to%2520immunodeficiency%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1996%26volume%3D60%26spage%3D441%26epage%3D452%26doi%3D10.1002%2Fjlb.60.4.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKS and STATS: Biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATS%3A+Biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0ljn2MxmwD_DEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATS%253A%2520Biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0ljn2MxmwD_DEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenge, R.</span></span> <span> </span><span class="NLM_article-title">JAK and STAT signaling molecules in immunoregulation and immune-mediated disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.immuni.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22520847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+signaling+molecules+in+immunoregulation+and+immune-mediated+disease&doi=10.1016%2Fj.immuni.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span></div><div class="casAuthors">O'Shea, John J.; Plenge, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-550</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway, a landmark in cell biol., provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins.  As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technol. that permits genome-wide views.  As we celebrate the 20th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease.  Not only have genome-wide assocn. studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6dj5Zf9fdLVg90H21EOLACvtfcHk0lj5oNSL24fsJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D&md5=de187a0555549f9f00f5a41052c05352</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520signaling%2520molecules%2520in%2520immunoregulation%2520and%2520immune-mediated%2520disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550%26doi%3D10.1016%2Fj.immuni.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwillich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00644.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases&doi=10.1111%2Fj.1600-065X.2008.00644.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0lj5oNSL24fsJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142%26doi%3D10.1111%2Fj.1600-065X.2008.00644.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontzias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.coph.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22819198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=464-470&author=A.+Kontziasauthor=A.+Kotlyarauthor=A.+Laurenceauthor=P.+Changelianauthor=J.+J.+O%E2%80%99Shea&title=Jakinibs%3A+a+new+class+of+kinase+inhibitors+in+cancer+and+autoimmune+disease&doi=10.1016%2Fj.coph.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease</span></div><div class="casAuthors">Kontzias, Apostolos; Kotlyar, Alexander; Laurence, Arian; Changelian, Paul; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">464-470</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines are crit. for normal cell growth and immunoregulation but also contribute to growth of malignant cells and drive immune-mediated disease.  A large subset of immunoregulatory cytokines uses the type I and type II cytokine receptors and pharmacol. targeting of these cytokines/cytokines receptors has proven to be efficacious in treating immune and inflammatory diseases.  These receptors rely on Janus family of kinases (Jaks) for signal transduction.  Recently the first Jak inhibitor (jakinib) has been approved by the FDA and a second has been recommended for approval.  Many other Jakinibs are likely to follow and in this brief review, we will discuss the state-of-the art of this new class of pharmacol. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmJV4I6HPAx7Vg90H21EOLACvtfcHk0lj5oNSL24fsJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbE&md5=22bcfa4414642f3d72214c4d4be84e2c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DKontzias%26aufirst%3DA.%26aulast%3DKotlyar%26aufirst%3DA.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DChangelian%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJakinibs%253A%2520a%2520new%2520class%2520of%2520kinase%2520inhibitors%2520in%2520cancer%2520and%2520autoimmune%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2012%26volume%3D12%26spage%3D464%26epage%3D470%26doi%3D10.1016%2Fj.coph.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-051113-024537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1146%2Fannurev-med-051113-024537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25587654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=311-328&author=J.+J.+O%E2%80%99Sheaauthor=D.+M.+Schwartzauthor=A.+V.+Villarinoauthor=M.+Gadinaauthor=I.+B.+McInnesauthor=A.+Laurence&title=The+JAK-STAT+pathway%3A+impact+on+human+disease+and+therapeutic+intervention&doi=10.1146%2Fannurev-med-051113-024537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span></div><div class="casAuthors">O'Shea, John J.; Schwartz, Daniella M.; Villarino, Alejandro V.; Gadina, Massimo; McInnes, Iain B.; Laurence, Arian</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-328</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)-signal transducer of activators of transcription (STAT) pathway is now recognized as an evolutionarily conserved signaling pathway employed by diverse cytokines, interferons, growth factors, and related mols.  This pathway provides an elegant and remarkably straightforward mechanism whereby extracellular factors control gene expression.  It thus serves as a fundamental paradigm for how cells sense environmental cues and interpret these signals to regulate cell growth and differentiation.  Genetic mutations and polymorphisms are functionally relevant to a variety of human diseases, esp. cancer and immune-related conditions.  The clin. relevance of the pathway has been confirmed by the emergence of a new class of therapeutics that targets JAKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxvQCRiTbL7Vg90H21EOLACvtfcHk0lj5oNSL24fsJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D&md5=19182154f1a046df039eb4a37b66bf78</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-051113-024537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-051113-024537%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLaurence%26aufirst%3DA.%26atitle%3DThe%2520JAK-STAT%2520pathway%253A%2520impact%2520on%2520human%2520disease%2520and%2520therapeutic%2520intervention%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2015%26volume%3D66%26spage%3D311%26epage%3D328%26doi%3D10.1146%2Fannurev-med-051113-024537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spolski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">New insights into the regulation of T cells by γc family cytokines</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nri2580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines&doi=10.1038%2Fnri2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by γc family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor γ-chain (γc) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional αβ T cells, γδ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0liDhm-hhHUN_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D480%26epage%3D490%26doi%3D10.1038%2Fnri2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortaldo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McVicar, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation and activation of the JAK-3 Janus kinase in response to interleukin-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1038/370151a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2F370151a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1994&pages=151-153&author=J.%0AA.+Johnstonauthor=M.+Kawamuraauthor=R.+A.+Kirkenauthor=Y.-Q.+Chenauthor=T.+B.+Blakeauthor=K.+Shibuyaauthor=J.+R.+Ortaldoauthor=D.+W.+McVicarauthor=J.+J.+O%E2%80%99Shea&title=Phosphorylation+and+activation+of+the+JAK-3+Janus+kinase+in+response+to+interleukin-2&doi=10.1038%2F370151a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F370151a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F370151a0%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DKirken%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DY.-Q.%26aulast%3DBlake%26aufirst%3DT.%2BB.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DOrtaldo%26aufirst%3DJ.%2BR.%26aulast%3DMcVicar%26aufirst%3DD.%2BW.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DPhosphorylation%2520and%2520activation%2520of%2520the%2520JAK-3%2520Janus%2520kinase%2520in%2520response%2520to%2520interleukin-2%26jtitle%3DNature%26date%3D1994%26volume%3D370%26spage%3D151%26epage%3D153%26doi%3D10.1038%2F370151a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuti, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklyn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koslov, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milici, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckius, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodworth, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beals, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagouras, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magna, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltarelli, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelms, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Etages, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finco-Kent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paniagua, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span> <span> </span><span class="NLM_article-title">Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1126/science.1087061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.1087061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=14593182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=875-878&author=P.+S.+Changelianauthor=M.+E.+Flanaganauthor=D.+J.+Ballauthor=C.+R.+Kentauthor=K.+S.+Magnusonauthor=W.+H.+Martinauthor=B.+J.+Rizzutiauthor=P.+S.+Sawyerauthor=B.+D.+Perryauthor=W.+H.+Brissetteauthor=S.+P.+McCurdyauthor=E.+M.+Kudlaczauthor=M.+J.+Conklynauthor=E.+A.+Elliottauthor=E.+R.+Koslovauthor=M.+B.+Fisherauthor=T.+J.+Strelevitzauthor=K.+Yoonauthor=D.+A.+Whippleauthor=J.+Sunauthor=M.+J.+Munchhofauthor=J.+L.+Dotyauthor=J.+M.+Casavantauthor=T.+A.+Blumenkopfauthor=M.+Hinesauthor=M.+F.+Brownauthor=B.+M.+Lillieauthor=C.+Subramanyamauthor=S.-P.+Changauthor=A.+J.+Miliciauthor=G.+E.+Beckiusauthor=J.+D.+Moyerauthor=C.+Suauthor=T.+G.+Woodworthauthor=A.+S.+Gawecoauthor=C.+R.+Bealsauthor=B.+H.+Littmanauthor=D.+A.+Fisherauthor=J.+F.+Smithauthor=P.+Zagourasauthor=H.+A.+Magnaauthor=M.+J.+Saltarelliauthor=K.+S.+Johnsonauthor=L.+F.+Nelmsauthor=S.+G.+Des+Etagesauthor=L.+S.+Hayesauthor=T.+T.+Kawabataauthor=D.+Finco-Kentauthor=D.+L.+Bakerauthor=M.+Larsonauthor=M.-S.+Siauthor=R.+Paniaguaauthor=J.+Higginsauthor=B.+Holmauthor=B.+Reitzauthor=Y.-J.+Zhouauthor=R.+E.+Morrisauthor=J.+J.+O%E2%80%99Sheaauthor=D.+C.+Borie&title=Prevention+of+organ+allograft+rejection+by+a+specific+Janus+kinase+3+inhibitor&doi=10.1126%2Fscience.1087061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span></div><div class="casAuthors">Changelian, Paul S.; Flanagan, Mark E.; Ball, Douglas J.; Kent, Craig R.; Magnuson, Kelly S.; Martin, William H.; Rizzuti, Bonnie J.; Sawyer, Perry S.; Perry, Bret D.; Brissette, William H.; McCurdy, Sandra P.; Kudlacz, Elizabeth M.; Conklyn, Maryrose J.; Elliott, Eileen A.; Koslov, Erika R.; Fisher, Michael B.; Strelevitz, Timothy J.; Yoon, Kwansik; Whipple, David A.; Sun, Jianmin; Munchhof, Michael J.; Doty, John L.; Casavant, Jeffrey M.; Blumenkopf, Todd A.; Hines, Michael; Brown, Matthew F.; Lillie, Brett M.; Subramanyam, Chakrapani; Chang, Shang-Poa; Milici, Anthony J.; Beckius, Gretchen E.; Moyer, James D.; Su, Chunyan; Woodworth, Thasia G.; Gaweco, Anderson S.; Beals, Chan R.; Littman, Bruce H.; Fisher, Douglas A.; Smith, James F.; Zagouras, Panayiotis; Magna, Holly A.; Saltarelli, Mary J.; Johnson, Kimberly S.; Nelms, Linda F.; Des Etages, Shelley G.; Hayes, Lisa S.; Kawabata, Thomas T.; Finco-Kent, Deborah; Baker, Deanna L.; Larson, Michael; Si, Ming-Sing; Paniagua, Ricardo; Higgins, John; Holm, Bari; Reitz, Bruce; Zhou, Yong-Jie; Morris, Randall E.; O'Shea, John J.; Borie, Dominic C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clin. immunosuppression.  The authors report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants.  CP-690,550 treatment was not assocd. with hypertension, hyperlipidemia, or lymphoproliferative disease.  On the basis of these preclin. results, the authors believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoo8qryWWkbVg90H21EOLACvtfcHk0liDhm-hhHUN_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D&md5=85b6ea64a6711f95fc28408d42ce9c49</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087061%26sid%3Dliteratum%253Aachs%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DD.%2BJ.%26aulast%3DKent%26aufirst%3DC.%2BR.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DRizzuti%26aufirst%3DB.%2BJ.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DConklyn%26aufirst%3DM.%2BJ.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DKoslov%26aufirst%3DE.%2BR.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DBeckius%26aufirst%3DG.%2BE.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWoodworth%26aufirst%3DT.%2BG.%26aulast%3DGaweco%26aufirst%3DA.%2BS.%26aulast%3DBeals%26aufirst%3DC.%2BR.%26aulast%3DLittman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DZagouras%26aufirst%3DP.%26aulast%3DMagna%26aufirst%3DH.%2BA.%26aulast%3DSaltarelli%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BS.%26aulast%3DNelms%26aufirst%3DL.%2BF.%26aulast%3DDes%2BEtages%26aufirst%3DS.%2BG.%26aulast%3DHayes%26aufirst%3DL.%2BS.%26aulast%3DKawabata%26aufirst%3DT.%2BT.%26aulast%3DFinco-Kent%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLarson%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DM.-S.%26aulast%3DPaniagua%26aufirst%3DR.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DHolm%26aufirst%3DB.%26aulast%3DReitz%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.-J.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26atitle%3DPrevention%2520of%2520organ%2520allograft%2520rejection%2520by%2520a%2520specific%2520Janus%2520kinase%25203%2520inhibitor%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D875%26epage%3D878%26doi%3D10.1126%2Fscience.1087061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witthuhn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cwik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, J. N.</span></span> <span> </span><span class="NLM_article-title">Involvement of the JAK-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1038/370153a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2F370153a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=1994&pages=153-157&author=B.+A.+Witthuhnauthor=O.+Silvennoinenauthor=O.+Miuraauthor=K.+S.+Laiauthor=C.+Cwikauthor=E.+T.+Liuauthor=J.+N.+Ihle&title=Involvement+of+the+JAK-3+Janus+kinase+in+signalling+by+interleukins+2+and+4+in+lymphoid+and+myeloid+cells&doi=10.1038%2F370153a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F370153a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F370153a0%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DLai%26aufirst%3DK.%2BS.%26aulast%3DCwik%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DInvolvement%2520of%2520the%2520JAK-3%2520Janus%2520kinase%2520in%2520signalling%2520by%2520interleukins%25202%2520and%25204%2520in%2520lymphoid%2520and%2520myeloid%2520cells%26jtitle%3DNature%26date%3D1994%26volume%3D370%26spage%3D153%26epage%3D157%26doi%3D10.1038%2F370153a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblatt, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovich, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adelstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(93)90167-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2F0092-8674%2893%2990167-O" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=147-157&author=M.+Noguchiauthor=H.+Yiauthor=H.+M.+Rosenblattauthor=A.+H.+Filipovichauthor=S.+Adelsteinauthor=W.+S.+Modiauthor=O.+W.+McBrideauthor=W.+J.+Leonard&title=Interleukin-2+receptor+%CE%B3+chain+mutation+results+in+X-linked+severe+combined+immunodeficiency+in+humans&doi=10.1016%2F0092-8674%2893%2990167-O"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990167-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990167-O%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DRosenblatt%26aufirst%3DH.%2BM.%26aulast%3DFilipovich%26aufirst%3DA.%2BH.%26aulast%3DAdelstein%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DW.%2BS.%26aulast%3DMcBride%26aufirst%3DO.%2BW.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DInterleukin-2%2520receptor%2520%25CE%25B3%2520chain%2520mutation%2520results%2520in%2520X-linked%2520severe%2520combined%2520immunodeficiency%2520in%2520humans%26jtitle%3DCell%26date%3D1993%26volume%3D73%26spage%3D147%26epage%3D157%26doi%3D10.1016%2F0092-8674%2893%2990167-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of CP-690,550: A potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8484</span>, <span class="refDoi"> DOI: 10.1021/jm1004286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=S.-P.+Changauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+A+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection&doi=10.1021%2Fjm1004286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lhNSaOkOBuO-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520A%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484%26doi%3D10.1021%2Fjm1004286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+Janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lg9m_amhh9AXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuninger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1021/jm101157q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family&doi=10.1021%2Fjm101157q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D284%26epage%3D288%26doi%3D10.1021%2Fjm101157q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVicente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span> <span> </span><span class="NLM_article-title">Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2800</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmcl.2013.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2793-2800&author=S.+M.+Lynchauthor=J.+DeVicenteauthor=J.+C.+Hermannauthor=S.+Jaime-Figueroaauthor=S.+Jinauthor=A.+Kuglstatterauthor=H.+Liauthor=A.+Loveyauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=D.+Royauthor=M.+Sothauthor=S.+Steinerauthor=P.+Tivitmahaisoonauthor=M.+D.+Vuauthor=C.+Yee&title=Strategic+use+of+conformational+bias+and+structure+based+design+to+identify+potent+JAK3+inhibitors+with+improved+selectivity+against+the+JAK+family+and+the+kinome&doi=10.1016%2Fj.bmcl.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DDeVicente%26aufirst%3DJ.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DYee%26aufirst%3DC.%26atitle%3DStrategic%2520use%2520of%2520conformational%2520bias%2520and%2520structure%2520based%2520design%2520to%2520identify%2520potent%2520JAK3%2520inhibitors%2520with%2520improved%2520selectivity%2520against%2520the%2520JAK%2520family%2520and%2520the%2520kinome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2793%26epage%3D2800%26doi%3D10.1016%2Fj.bmcl.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4722</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmc.2016.08.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4711-4722&author=Y.+Nakajimaauthor=N.+Aoyamaauthor=F.+Takahashiauthor=H.+Sasakiauthor=K.+Hatanakaauthor=A.+Moritomoauthor=M.+Inamiauthor=M.+Itoauthor=K.+Nakamuraauthor=F.+Nakamoriauthor=T.+Inoueauthor=S.+Shirakami&title=Design%2C+synthesis%2C+and+evaluation+of+4%2C6-diaminonicotinamide+derivatives+as+novel+and+potent+immunomodulators+targeting+JAK3&doi=10.1016%2Fj.bmc.2016.08.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DK.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DNakamori%26aufirst%3DF.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%25204%252C6-diaminonicotinamide%2520derivatives%2520as%2520novel%2520and%2520potent%2520immunomodulators%2520targeting%2520JAK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4711%26epage%3D4722%26doi%3D10.1016%2Fj.bmc.2016.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson-Nutter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimble, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrocklage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewet, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krykbaev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Togias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidl, K. J.</span></span> <span> </span><span class="NLM_article-title">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2293</span>, <span class="refDoi"> DOI: 10.1002/art.27536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fart.27536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20506481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2283-2293&author=T.+H.+Linauthor=M.+Hegenauthor=E.+Quadrosauthor=C.+L.+Nickerson-Nutterauthor=K.+C.+Appellauthor=A.+G.+Coleauthor=Y.+Shaoauthor=S.+Tamauthor=M.+Ohlmeyerauthor=B.+Wangauthor=D.+G.+Goodwinauthor=E.+F.+Kimbleauthor=J.+Quinteroauthor=M.+Gaoauthor=P.+Symanowiczauthor=C.+Wrocklageauthor=J.+Lussierauthor=S.+H.+Schellingauthor=A.+G.+Hewetauthor=D.+Xuanauthor=R.+Krykbaevauthor=J.+Togiasauthor=X.+Xuauthor=R.+Harrisonauthor=T.+Mansourauthor=M.+Collinsauthor=J.+D.+Clarkauthor=M.+L.+Webbauthor=K.+J.+Seidl&title=Selective+functional+inhibition+of+JAK-3+is+sufficient+for+efficacy+in+collagen-induced+arthritis+in+mice&doi=10.1002%2Fart.27536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span></div><div class="casAuthors">Lin, Tsung H.; Hegen, Martin; Quadros, Elizabeth; Nickerson-Nutter, Cheryl L.; Appell, Kenneth C.; Cole, Andrew G.; Shao, Yuefei; Tam, Steve; Ohlmeyer, Michael; Wang, Bojing; Goodwin, Debra G.; Kimble, Earl F.; Quintero, Jorge; Gao, Min; Symanowicz, Peter; Wrocklage, Christopher; Lussier, Jennifer; Schelling, Scott H.; Hewet, Amha G.; Xuan, Dejun; Krykbaev, Rustem; Togias, Jenny; Xu, Xin; Harrison, Richard; Mansour, Tarek; Collins, Mary; Clark, James D.; Webb, Maria L.; Seidi, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2283-2293</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. All γ-chain cytokines signal through JAK-3 and JAK-1 acting in tandem.  We undertook this study to det. whether the JAK-3 selective inhibitor WYE-151650 would be sufficient to disrupt cytokine signaling and to ameliorate autoimmune disease pathol. without inhibiting other pathways mediated by JAK-1, JAK-2, and Tyk-2.  Methods. JAK-3 kinase selective compds. were characterized by kinase assay and JAK-3-dependent (interleukin-2 [IL-2]) and -independent (IL-6, granulocyte-macrophage colony-stimulating factor [GM-CSF]) cell-based assays measuring proliferation or STAT phosphorylation.  In vivo, off-target signaling was measured by IL-22- and erythropoietin (EPO)-mediated models, while on-target signaling was measured by IL-2-mediated signaling.  Efficacy of JAK-3 inhibitors was detd. using delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.  Results. In vitro, WYE-151650 potently suppressed IL-2-induced STAT-5 phosphorylation and cell proliferation, while exhibiting 10-29-fold less activity against JAK-3-independent IL-6- or GM-CSF-induced STAT phosphorylation.  Ex vivo, WYE-151650 suppressed IL-2-induced STAT phosphorylation, but not IL-6-induced STAT phosphorylation, as measured in whole blood.  In vivo, WYE-151650 inhibited JAK-3-mediated IL-2-induced interferon-γ prodn. and decreased the natural killer cell population in mice, while not affecting IL-22-induced serum amyloid A prodn. or EPO-induced reticulocytosis.  WYE-151650 was efficacious in mouse DTH and CIA models.  Conclusion. In vitro, ex vivo, and in vivo assays demonstrate that WYE-151650 is efficacious in mouse CIA despite JAK-3 selectivity.  These data question the need to broadly inhibit JAK-1-, JAK-2-, or Tyk-2-dependent cytokine pathways for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogcss6tt3iw7Vg90H21EOLACvtfcHk0liOI77S41M3Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP&md5=7fd4f4dae47df1d1a33d3fc0edf5e13d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fart.27536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27536%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGoodwin%26aufirst%3DD.%2BG.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DQuintero%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DSchelling%26aufirst%3DS.%2BH.%26aulast%3DHewet%26aufirst%3DA.%2BG.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DKrykbaev%26aufirst%3DR.%26aulast%3DTogias%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DSeidl%26aufirst%3DK.%2BJ.%26atitle%3DSelective%2520functional%2520inhibition%2520of%2520JAK-3%2520is%2520sufficient%2520for%2520efficacy%2520in%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2283%26epage%3D2293%26doi%3D10.1002%2Fart.27536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fcmdc.201300520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=277-281&author=M.+Gehringerauthor=E.+Pfaffenrotauthor=S.+Bauerauthor=S.+A.+Laufer&title=Design+and+synthesis+of+tricyclic+JAK3+inhibitors+with+picomolar+affinities+as+novel+molecular+probes&doi=10.1002%2Fcmdc.201300520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tricyclic%2520JAK3%2520inhibitors%2520with%2520picomolar%2520affinities%2520as%2520novel%2520molecular%2520probes%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D277%26epage%3D281%26doi%3D10.1002%2Fcmdc.201300520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banach, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. W.</span></span> <span> </span><span class="NLM_article-title">Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.595181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1074%2Fjbc.M114.595181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25552479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=4573-4589&author=E.+R.+Goedkenauthor=M.+A.+Argiriadiauthor=D.+L.+Banachauthor=B.+A.+Fiamengoauthor=S.+E.+Foleyauthor=K.+E.+Frankauthor=J.+S.+Georgeauthor=C.+M.+Harrisauthor=A.+D.+Hobsonauthor=D.+C.+Ihleauthor=D.+Marcotteauthor=P.+J.+Mertaauthor=M.+E.+Michalakauthor=S.+E.+Murdockauthor=M.+J.+Tomlinsonauthor=J.+W.+Voss&title=Tricyclic+covalent+inhibitors+selectively+target+Jak3+through+an+active+site+thiol&doi=10.1074%2Fjbc.M114.595181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol</span></div><div class="casAuthors">Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4573-4589</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The action of Janus kinases (JAKs) is required for multiple cytokine signaling pathways, and as such, JAK inhibitors hold promise for treatment of autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis.  However, due to high similarity in the active sites of the four members (Jak1, Jak2, Jak3, and Tyk2), developing selective inhibitors within this family is challenging.  We have designed and characterized substituted, tricyclic Jak3 inhibitors that selectively avoid inhibition of the other JAKs.  This is accomplished through a covalent interaction between an inhibitor contg. a terminal electrophile and an active site cysteine (Cys-909).  We found that these ATP competitive compds. are irreversible inhibitors of Jak3 enzyme activity in vitro.  They possess high selectivity against other kinases and can potently (IC50 < 100 nm) inhibit Jak3 activity in cell-based assays.  These results suggest irreversible inhibitors of this class may be useful selective agents, both as tools to probe Jak3 biol. and potentially as therapies for autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjt9jFjpWGbVg90H21EOLACvtfcHk0liOI77S41M3Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2lsLY%253D&md5=4d99cf5b13fd05df5c4abc197c1fe284</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595181%26sid%3Dliteratum%253Aachs%26aulast%3DGoedken%26aufirst%3DE.%2BR.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DFiamengo%26aufirst%3DB.%2BA.%26aulast%3DFoley%26aufirst%3DS.%2BE.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHobson%26aufirst%3DA.%2BD.%26aulast%3DIhle%26aufirst%3DD.%2BC.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DMichalak%26aufirst%3DM.%2BE.%26aulast%3DMurdock%26aufirst%3DS.%2BE.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DVoss%26aufirst%3DJ.%2BW.%26atitle%3DTricyclic%2520covalent%2520inhibitors%2520selectively%2520target%2520Jak3%2520through%2520an%2520active%2520site%2520thiol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D4573%26epage%3D4589%26doi%3D10.1074%2Fjbc.M114.595181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyskens, K. M. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herter-Sprie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of selective covalent Janus kinase 3 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6589</span>– <span class="NLM_lpage">6606</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00710</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00710" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6589-6606&author=L.+Tanauthor=K.+Akahaneauthor=R.+McNallyauthor=K.+M.+S.+E.+Reyskensauthor=S.+B.+Ficarroauthor=S.+Liuauthor=G.+S.+Herter-Sprieauthor=S.+Koyamaauthor=M.+J.+Pattisonauthor=K.+Labellaauthor=L.+Johannessenauthor=E.+A.+Akbayauthor=K.-K.+Wongauthor=D.+A.+Frankauthor=J.+A.+Martoauthor=T.+A.+Lookauthor=J.+S.+C.+Arthurauthor=M.+J.+Eckauthor=N.+S.+Gray&title=Development+of+selective+covalent+Janus+kinase+3+inhibitors&doi=10.1021%2Facs.jmedchem.5b00710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective Covalent Janus Kinase 3 Inhibitors</span></div><div class="casAuthors">Tan, Li; Akahane, Koshi; McNally, Randall; Reyskens, Kathleen M. S. E.; Ficarro, Scott B.; Liu, Suhu; Herter-Sprie, Grit S.; Koyama, Shohei; Pattison, Michael J.; Labella, Katherine; Johannessen, Liv; Akbay, Esra A.; Wong, Kwok-Kin; Frank, David A.; Marto, Jarrod A.; Look, Thomas A.; Arthur, J. Simon C.; Eck, Michael J.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6589-6606</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) and their downstream effectors, signal transducer and activator of transcription proteins (STATs), form a crit. immune cell signaling circuit, which is of fundamental importance in innate immunity, inflammation, and hematopoiesis, and dysregulation is frequently obsd. in immune disease and cancer.  The high degree of structural conservation of the JAK ATP binding pockets has posed a considerable challenge to medicinal chemists seeking to develop highly selective inhibitors as pharmacol. probes and as clin. drugs.  Here we report the discovery and optimization of 2,4-substituted pyrimidines as covalent JAK3 inhibitors that exploit a unique cysteine (Cys909) residue in JAK3.  Investigation of structure-activity relationship (SAR) utilizing biochem. and transformed Ba/F3 cellular assays resulted in identification of potent and selective inhibitors such as compds. 9 and 45.  A 2.9 Å cocrystal structure of JAK3 in complex with 9 confirms the covalent interaction.  Compd. 9 exhibited decent pharmacokinetic properties and is suitable for use in vivo.  These inhibitors provide a set of useful tools to pharmacol. interrogate JAK3-dependent biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqKncS0tb27Vg90H21EOLACvtfcHk0liOI77S41M3Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ksLjM&md5=af334f0cdd1d4f58462182f138619099</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00710%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DR.%26aulast%3DReyskens%26aufirst%3DK.%2BM.%2BS.%2BE.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHerter-Sprie%26aufirst%3DG.%2BS.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DLabella%26aufirst%3DK.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DLook%26aufirst%3DT.%2BA.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520selective%2520covalent%2520Janus%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6589%26epage%3D6606%26doi%3D10.1021%2Facs.jmedchem.5b00710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnchembio.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27018889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=373-379&author=G.+A.+Smithauthor=K.+Uchidaauthor=A.+Weissauthor=J.+Taunton&title=Essential+biphasic+role+for+JAK3+catalytic+activity+in+IL-2+receptor+signaling&doi=10.1038%2Fnchembio.2056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span></div><div class="casAuthors">Smith, Geoffrey A.; Uchida, Kenji; Weiss, Arthur; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To drive lymphocyte proliferation and differentiation, common γ-chain (γc) cytokine receptors require hours to days of sustained stimulation.  JAK1 and JAK3 kinases are found together in all γc-receptor complexes, but how their resp. catalytic activities contribute to signaling over time is not known.  Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i).  By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4+ T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave.  Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase.  An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice.  Our chem. genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of γc-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfXNNV1cRJbVg90H21EOLACvtfcHk0liyPFnKWTN9QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D&md5=573d99767ce37cf58a8f71e9e01102b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2056%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DEssential%2520biphasic%2520role%2520for%2520JAK3%2520catalytic%2520activity%2520in%2520IL-2%2520receptor%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnchembio.2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimermancic, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimermancicauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC β-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0liyPFnKWTN9QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimermancic%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.chembiol.2016.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27840070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1335-1340&author=M.+Forsterauthor=A.+Chaikuadauthor=S.+M.+Bauerauthor=J.+Holsteinauthor=M.+B.+Robersauthor=C.+R.+Coronaauthor=M.+Gehringerauthor=E.+Pfaffenrotauthor=K.+Ghoreschiauthor=S.+Knappauthor=S.+A.+Laufer&title=Selective+JAK3+inhibitors+with+a+covalent+reversible+binding+mode+targeting+a+new+induced+fit+binding+pocket&doi=10.1016%2Fj.chembiol.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket</span></div><div class="casAuthors">Forster, Michael; Chaikuad, Apirat; Bauer, Silke M.; Holstein, Julia; Robers, Matthew B.; Corona, Cesear R.; Gehringer, Matthias; Pfaffenrot, Ellen; Ghoreschi, Kamran; Knapp, Stefan; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1335-1340</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are a family of cytoplasmatic tyrosine kinases that are attractive targets for the development of anti-inflammatory drugs given their roles in cytokine signaling.  One question regarding JAKs and their inhibitors that remains under intensive debate is whether JAK inhibitors should be isoform selective.  Since JAK3 functions are restricted to immune cells, an isoform-selective inhibitor for JAK3 could be esp. valuable to achieve clin. more useful and precise effects.  However, the high degree of structural conservation makes isoform-selective targeting a challenging task.  Here, we present picomolar inhibitors with unprecedented kinome-wide selectivity for JAK3.  Selectivity was achieved by concurrent covalent reversible targeting of a JAK3-specific cysteine residue and a ligand-induced binding pocket.  We confirmed that in vitro activity and selectivity translate well into the cellular environment and suggest that our inhibitors are powerful tools to elucidate JAK3-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMAP9hFX_TrVg90H21EOLACvtfcHk0lhUGRGYar358A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsLrJ&md5=348c5b5fbfa91fd02fa21d984620ea16</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520JAK3%2520inhibitors%2520with%2520a%2520covalent%2520reversible%2520binding%2520mode%2520targeting%2520a%2520new%2520induced%2520fit%2520binding%2520pocket%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D1335%26epage%3D1340%26doi%3D10.1016%2Fj.chembiol.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a JAK3-selective inhibitor: Functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3442</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGku7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3442-3451&author=J.-B.+Telliezauthor=M.+E.+Dowtyauthor=L.+Wangauthor=J.+Jussifauthor=T.+Linauthor=L.+Liauthor=E.+Moyauthor=P.+Balboauthor=W.+Liauthor=Y.+Zhaoauthor=K.+Crouseauthor=C.+Dickinsonauthor=P.+Symanowiczauthor=M.+Hegenauthor=M.+E.+Bankerauthor=F.+Vincentauthor=R.+Unwallaauthor=S.+Liangauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=X.+Yangauthor=J.+Baumanauthor=J.+I.+Trujilloauthor=A.+Casimiro-Garciaauthor=F.+F.+Vajdosauthor=L.+Leungauthor=K.+F.+Geogheganauthor=A.+Quaziauthor=D.+Xuanauthor=L.+Jonesauthor=E.+Hettauthor=K.+Wrightauthor=J.+D.+Clarkauthor=A.+Thorarensen&title=Discovery+of+a+JAK3-selective+inhibitor%3A+Functional+differentiation+of+JAK3-selective+inhibition+over+pan-JAK+or+JAK1-selective+inhibition&doi=10.1021%2Facschembio.6b00677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition</span></div><div class="casAuthors">Telliez, Jean-Baptiste; Dowty, Martin E.; Wang, Lu; Jussif, Jason; Lin, Tsung; Li, Li; Moy, Erick; Balbo, Paul; Li, Wei; Zhao, Yajuan; Crouse, Kimberly; Dickinson, Caitlyn; Symanowicz, Peter; Hegen, Martin; Banker, Mary Ellen; Vincent, Fabien; Unwalla, Ray; Liang, Sidney; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Yang, Xin; Bauman, Jonathan; Trujillo, John I.; Casimiro-Garcia, Agustin; Vajdos, Felix F.; Leung, Louis; Geoghegan, Kieran F.; Quazi, Amira; Xuan, Dejun; Jones, Lyn; Hett, Erik; Wright, Katherine; Clark, James D.; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3442-3451</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PF-06651600, a newly discovered potent JAK3-selective inhibitor is highly efficacious at inhibiting γc cytokine signaling which is dependent on both JAK1 and JAK3.  PF-06651600 allowed the comparison of JAK3-selective inhibition to pan-JAK or JAK1-selective inhibition, in relevant immune cells to a level that couldn't be achieved previously without such potency and selectivity.  In vitro, PF-06651600 inhibits Th1 and Th17 cell differentiation and function, and in vivo it reduces disease pathol. in the rat adjuvant-induced arthritis as well as in the mouse exptl. autoimmune encephalomyelitis models.  Importantly, by sparing JAK1 function, PF-06651600 selectively targets γc cytokine pathways while preserving JAK1-dependent anti-inflammatory signaling such as the IL-10 suppressive functions following LPS treatment in macrophages and the suppression of TNFα and IL-1β prodn. in IL-27-primed macrophages.  Thus, JAK3-selective inhibition differentiates from pan-JAK or JAK1 inhibition in various immune cellular responses which could potentially translate to advantageous clin. outcomes in inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNLk0mtStNSrVg90H21EOLACvtfcHk0lhUGRGYar358A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGku7nK&md5=dd83978cf9ac22947f4a3f07c5eed8ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00677%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMoy%26aufirst%3DE.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCrouse%26aufirst%3DK.%26aulast%3DDickinson%26aufirst%3DC.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQuazi%26aufirst%3DA.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DHett%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520JAK3-selective%2520inhibitor%253A%2520Functional%2520differentiation%2520of%2520JAK3-selective%2520inhibition%2520over%2520pan-JAK%2520or%2520JAK1-selective%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3442%26epage%3D3451%26doi%3D10.1021%2Facschembio.6b00677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a Janus kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+Janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0lhd5N7EM09dIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520Janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M. A.</span></span> <span> </span><span class="NLM_article-title">Clearance prediction of targeted covalent inhibitors by in vitro-in vivo extrapolation of hepatic and extrahepatic clearance mechanisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.072983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1124%2Fdmd.116.072983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=27784718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlSksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1-7&author=L.+Leungauthor=X.+Yangauthor=T.+J.+Strelevitzauthor=J.+Montgomeryauthor=M.+F.+Brownauthor=C.+Banfieldauthor=A.+M.+Gilbertauthor=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+A.+Zientek&title=Clearance+prediction+of+targeted+covalent+inhibitors+by+in+vitro-in+vivo+extrapolation+of+hepatic+and+extrahepatic+clearance+mechanisms&doi=10.1124%2Fdmd.116.072983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Clearance prediction of targeted covalent inhibitors by in vitro-in vivo extrapolation of hepatic and extrahepatic clearance mechanisms</span></div><div class="casAuthors">Leung, Louis; Yang, Xin; Strelevitz, Timothy J.; Montgomery, Justin; Brown, Matthew F.; Zientek, Michael A.; Banfield, Christopher; Gilbert, Adam M.; Thorarensen, Atli; Dowty, Martin E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concept of target-specific covalent enzyme inhibitors appears attractive from both an efficacy and a selectivity viewpoint considering the potential for enhanced biochem. efficiency assocd. with an irreversible mechanism.  Aside from potential safety concerns, clearance prediction of covalent inhibitors represents a unique challenge due to the inclusion of nontraditional metabolic pathways of direct conjugation with glutathione (GSH) or via GSH S-transferase-mediated processes.  In this article, a novel pharmacokinetic algorithm was developed using a series of Pfizer kinase selective acrylamide covalent inhibitors based on their in vitro-in vivo extrapolation of systemic clearance in rats.  The algorithmencompasses the use of hepatocytes as an in vitro model for hepatic clearance due to oxidative metab. and GSH conjugation, and the use of whole blood as an in vitro surrogate for GSH conjugation in extrahepatic tissues.  Initial evaluations with clin. covalent inhibitors suggested that the scaling algorithm developed from rats may also be useful for human clearance prediction when species-specific parameters, such as hepatocyte and blood stability and blood binding, were considered.  With careful consideration of clearance mechanisms, the described in vitro-in vivo extrapolation approach may be useful to facilitate candidate optimization, selection, and prediction of human pharmacokinetic clearance during the discovery and development of targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIMBCrCxzNLVg90H21EOLACvtfcHk0lhd5N7EM09dIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlSksL4%253D&md5=8c8b918b087278b2025e0ae56a7abe37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.072983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.072983%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DBanfield%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DZientek%26aufirst%3DM.%2BA.%26atitle%3DClearance%2520prediction%2520of%2520targeted%2520covalent%2520inhibitors%2520by%2520in%2520vitro-in%2520vivo%2520extrapolation%2520of%2520hepatic%2520and%2520extrahepatic%2520clearance%2520mechanisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2017%26volume%3D45%26spage%3D1%26epage%3D7%26doi%3D10.1124%2Fdmd.116.072983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.-P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0lhd5N7EM09dIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L. L.</span></span> <span> </span><span class="NLM_article-title">Novel and potent cyclic cyanamide-based cathepsin K inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1815</span>– <span class="NLM_lpage">1819</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bmcl.2005.02.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1815-1819&author=D.+N.+Deatonauthor=A.+M.+Hassellauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=L.+M.+Shewchukauthor=F.+X.+Tavaresauthor=D.+H.+Willardauthor=L.+L.+Wright&title=Novel+and+potent+cyclic+cyanamide-based+cathepsin+K+inhibitors&doi=10.1016%2Fj.bmcl.2005.02.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWillard%26aufirst%3DD.%2BH.%26aulast%3DWright%26aufirst%3DL.%2BL.%26atitle%3DNovel%2520and%2520potent%2520cyclic%2520cyanamide-based%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1815%26epage%3D1819%26doi%3D10.1016%2Fj.bmcl.2005.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span> <span> </span><span class="NLM_article-title">Design of cathepsin K inhibitors for osteoporosis</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.2174/156802605775009676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.2174%2F156802605775009676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=16375747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1639-1675&author=D.+N.+Deatonauthor=F.+X.+Tavares&title=Design+of+cathepsin+K+inhibitors+for+osteoporosis&doi=10.2174%2F156802605775009676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design of cathepsin K inhibitors for osteoporosis</span></div><div class="casAuthors">Deaton, David N.; Tavares, Francis X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1639-1675</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is a progressive, debilitating bone disease resulting in increased cost and morbidity to the elderly.  This review summarizes the therapeutic approaches taken in the treatment of osteoporosis with particular emphasis on cathepsin K inhibitors.  Cathepsin K, a cysteine protease predominantly expressed in osteoclasts, is a key player involved in bone matrix degrdn.  Both genetic ablation and small mol. inhibitor strategies vs. cathepsin K have validated the importance of this enzyme in bone resorption.  Starting from aldehyde-based leads, this review synopsizes the design of improved small mol. inhibitors by GlaxoWellcome researchers.  These efforts involved the evaluation of various warheads, including cyanamides, ketoheterocycles, and ketoamides.  Initial structure/activity relationships of aldehyde-based inhibitors proved useful in the design of ketoamide-based cathepsin K inhibitors.  Further exploration of S3, S2, S1, and S1· subsites with P3, P2, P1, and P1· probes have resulted in the identification of potent, selective, orally bioavailable ketoamide-based inhibitors of cathepsin K with demonstrated in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp4CDcrFAqIbVg90H21EOLACvtfcHk0liyGXk73YXGlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsLY%253D&md5=0db953d6235ce75579ec1c8191e773b1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802605775009676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009676%26sid%3Dliteratum%253Aachs%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26atitle%3DDesign%2520of%2520cathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1639%26epage%3D1675%26doi%3D10.2174%2F156802605775009676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitjean, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel cyanamide-based inhibitors of cathepsin C</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1021/ml100212k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100212k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=142-147&author=D.+Laineauthor=M.+Palovichauthor=B.+McClelandauthor=E.+Petitjeanauthor=I.+Delhomauthor=H.+Xieauthor=J.+Dengauthor=G.+Linauthor=R.+Davisauthor=A.+Jolitauthor=N.+Nevinsauthor=B.+Zhaoauthor=J.+Villaauthor=J.+Schneckauthor=P.+McDevittauthor=R.+Midgettauthor=C.+Kmettauthor=S.+Umbrechtauthor=B.+Peckauthor=A.+B.+Davisauthor=D.+Bettoun&title=Discovery+of+novel+cyanamide-based+inhibitors+of+cathepsin+C&doi=10.1021%2Fml100212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel cyanamide-based inhibitors of cathepsin C</span></div><div class="casAuthors">Laine, Dramane; Palovich, Michael; McCleland, Brent; Petitjean, Emilie; Delhom, Isabelle; Xie, Haibo; Deng, Jianghe; Lin, Guoliang; Davis, Roderick; Jolit, Anais; Nevins, Neysa; Zhao, Baoguang; Villa, Jim; Schneck, Jessica; McDevitt, Patrick; Midgett, Robert; Kmett, Casey; Umbrecht, Sandra; Peck, Brian; Davis, Alicia Bacon; Bettoun, David</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of potent and selective cyanamide-based inhibitors of the cysteine protease cathepsin C is detailed.  Optimization of the template with regard to plasma stability led to the identification of (2S,4R)-1-cyano-2-methyl-4-(2,5-dibromophenylsulfonylamino)pyrrolidine (I), a potent cathepsin C inhibitor with excellent selectivity over other cathepsins and potent in vivo activity in a cigarette smoke mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnAQabB_znSrVg90H21EOLACvtfcHk0liyGXk73YXGlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK&md5=5b8478f6abc28e4d273eb9aa7c93aeb1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fml100212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100212k%26sid%3Dliteratum%253Aachs%26aulast%3DLaine%26aufirst%3DD.%26aulast%3DPalovich%26aufirst%3DM.%26aulast%3DMcCleland%26aufirst%3DB.%26aulast%3DPetitjean%26aufirst%3DE.%26aulast%3DDelhom%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DJolit%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVilla%26aufirst%3DJ.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DMidgett%26aufirst%3DR.%26aulast%3DKmett%26aufirst%3DC.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DA.%2BB.%26aulast%3DBettoun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520novel%2520cyanamide-based%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D142%26epage%3D147%26doi%3D10.1021%2Fml100212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyeva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashiro, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunussi-Joannopoulos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson-Nutter, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douhan, J.,  III.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4550</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1301553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.4049%2Fjimmunol.1301553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=24068666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1eqs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2013&pages=4540-4550&author=A.+L.+Rankinauthor=N.+Sethauthor=S.+Keeganauthor=T.+Andreyevaauthor=T.+A.+Cookauthor=J.+Edmondsauthor=N.+Mathialaganauthor=M.+J.+Bensonauthor=J.+Syedauthor=Y.+Zhanauthor=S.+E.+Benoitauthor=J.+S.+Miyashiroauthor=N.+Woodauthor=S.+Mohanauthor=E.+Peevaauthor=S.+K.+Ramaiahauthor=D.+Messingauthor=B.+L.+Homerauthor=K.+Dunussi-Joannopoulosauthor=C.+L.+Nickerson-Nutterauthor=M.+E.+Schnuteauthor=J.+Douhan&title=Selective+inhibition+of+BTK+prevents+murine+lupus+and+antibody-mediated+glomerulonephritis&doi=10.4049%2Fjimmunol.1301553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis</span></div><div class="casAuthors">Rankin, Andrew L.; Seth, Nilufer; Keegan, Sean; Andreyeva, Tatyana; Cook, Tim A.; Edmonds, Jason; Mathialagan, Nagappan; Benson, Micah J.; Syed, Jameel; Zhan, Yutian; Benoit, Stephen E.; Miyashiro, Joy S.; Wood, Nancy; Mohan, Shashi; Peeva, Elena; Ramaiah, Shashi K.; Messing, Dean; Homer, Bruce L.; Dunussi-Joannopoulos, Kyri; Nickerson-Nutter, Cheryl L.; Schnute, Mark E.; Douhan, John, III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4540-4550</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Autoantibody prodn. and immune complex deposition within the kidney promote renal disease in patients with lupus nephritis.  Thus, therapeutics that inhibit these pathways may be efficacious in the treatment of systemic lupus erythematosus.  Bruton's tyrosine kinase (BTK) is a crit. signaling component of both BCR and FcR signaling.  We sought to assess the efficacy of inhibiting BTK in the development of lupus-like disease, and in this article describe (R)-5-amino-1-(1-cyanopiperidin-3-yl)-3-(4-[2,4-difluorophenoxy]phenyl)-1H-pyrazole-4-carboxamide (PF-06250112), a novel highly selective and potent BTK inhibitor.  We demonstrate in vitro that PF-06250112 inhibits both BCR-mediated signaling and proliferation, as well as FcR-mediated activation.  To assess the therapeutic impact of BTK inhibition, we treated aged NZBxWF1 mice with PF-06250112 and demonstrate that PF-06250112 significantly limits the spontaneous accumulation of splenic germinal center B cells and plasma cells.  Correspondingly, anti-dsDNA and autoantibody levels were reduced in a dose-dependent manner.  Moreover, administration of PF-06250112 prevented the development of proteinuria and improved glomerular pathol. scores in all treatment groups.  Strikingly, this therapeutic effect could occur with only a modest redn. obsd. in anti-dsDNA titers, implying a crit. role for BTK signaling in disease pathogenesis beyond inhibition of autoantibody prodn.  We subsequently demonstrate that PF-06250112 prevents proteinuria in an FcR-dependent, Ab-mediated model of glomerulonephritis.  Importantly, these results highlight that BTK inhibition potently limits the development of glomerulonephritis by impacting both cell- and effector mol.-mediated pathways.  These data provide support for evaluating the efficacy of BTK inhibition in systemic lupus erythematosus patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBldekay4INLVg90H21EOLACvtfcHk0liyGXk73YXGlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1eqs7zE&md5=7abfb074bf422aa3fb63aa0bc3d8cf58</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1301553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1301553%26sid%3Dliteratum%253Aachs%26aulast%3DRankin%26aufirst%3DA.%2BL.%26aulast%3DSeth%26aufirst%3DN.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DAndreyeva%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DT.%2BA.%26aulast%3DEdmonds%26aufirst%3DJ.%26aulast%3DMathialagan%26aufirst%3DN.%26aulast%3DBenson%26aufirst%3DM.%2BJ.%26aulast%3DSyed%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DBenoit%26aufirst%3DS.%2BE.%26aulast%3DMiyashiro%26aufirst%3DJ.%2BS.%26aulast%3DWood%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DPeeva%26aufirst%3DE.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DHomer%26aufirst%3DB.%2BL.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DDouhan%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520BTK%2520prevents%2520murine%2520lupus%2520and%2520antibody-mediated%2520glomerulonephritis%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D191%26spage%3D4540%26epage%3D4550%26doi%3D10.4049%2Fjimmunol.1301553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramite, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppenheimer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span> <span> </span><span class="NLM_article-title">Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10072</span>– <span class="NLM_lpage">10079</span>, <span class="refDoi"> DOI: 10.1021/jm501412a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501412a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10072-10079&author=M.+E.+Flanaganauthor=J.+A.+Abramiteauthor=D.+P.+Andersonauthor=A.+Aulabaughauthor=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=C.+Liauthor=J.+Montgomeryauthor=S.+R.+Oppenheimerauthor=T.+Ryderauthor=B.+P.+Schuffauthor=D.+P.+Uccelloauthor=G.+S.+Walkerauthor=Y.+Wuauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=M.+M.+Haywardauthor=M.+C.+Noeauthor=R.+S.+Obachauthor=L.+Philippeauthor=V.+Shanmugasundaramauthor=M.+J.+Shapiroauthor=J.+Starrauthor=J.+Strohauthor=Y.+Che&title=Chemical+and+computational+methods+for+the+characterization+of+covalent+reactive+groups+for+the+prospective+design+of+irreversible+inhibitors&doi=10.1021%2Fjm501412a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors</span></div><div class="casAuthors">Flanagan, Mark E.; Abramite, Joseph A.; Anderson, Dennis P.; Aulabaugh, Ann; Dahal, Upendra P.; Gilbert, Adam M.; Li, Chao; Montgomery, Justin; Oppenheimer, Stacey R.; Ryder, Tim; Schuff, Brandon P.; Uccello, Daniel P.; Walker, Gregory S.; Wu, Yan; Brown, Matthew F.; Chen, Jinshan M.; Hayward, Matthew M.; Noe, Mark C.; Obach, R. Scott; Philippe, Laurence; Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Starr, Jeremy; Stroh, Justin; Che, Ye</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10072-10079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interest in drugs that covalently modify their target is driven by the desire for enhanced efficacy that can result from the silencing of enzymic activity until protein resynthesis can occur, along with the potential for increased selectivity by targeting uniquely positioned nucleophilic residues in the protein.  However, covalent approaches carry addnl. risk for toxicities or hypersensitivity reactions that can result from covalent modification of unintended targets.  Here we describe methods for measuring the reactivity of covalent reactive groups (CRGs) with a biol. relevant nucleophile, glutathione (GSH), along with kinetic data for a broad array of electrophiles.  We also describe a computational method for predicting electrophilic reactivity, which taken together can be applied to the prospective design of thiol-reactive covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzTSCv_Nj6bVg90H21EOLACvtfcHk0ljGQ4Uvx3NrXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyjtLbM&md5=3ccf59ab7a494655185e5eb5becf8c48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm501412a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501412a%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DOppenheimer%26aufirst%3DS.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DSchuff%26aufirst%3DB.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DShapiro%26aufirst%3DM.%2BJ.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26atitle%3DChemical%2520and%2520computational%2520methods%2520for%2520the%2520characterization%2520of%2520covalent%2520reactive%2520groups%2520for%2520the%2520prospective%2520design%2520of%2520irreversible%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10072%26epage%3D10079%26doi%3D10.1021%2Fjm501412a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahal, U. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Irizarry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. A.</span></span> <span> </span><span class="NLM_article-title">Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1039/C6MD00017G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1039%2FC6MD00017G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFyjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=864-872&author=U.+P.+Dahalauthor=A.+M.+Gilbertauthor=R.+S.+Obachauthor=M.+E.+Flanaganauthor=J.+M.+Chenauthor=C.+Garcia-Irizarryauthor=J.+T.+Starrauthor=B.+Schuffauthor=D.+P.+Uccelloauthor=J.+A.+Young&title=Intrinsic+reactivity+profile+of+electrophilic+moieties+to+guide+covalent+drug+design%3A+N-%CE%B1-acetyl-L-lysine+as+an+amine+nucleophile&doi=10.1039%2FC6MD00017G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile</span></div><div class="casAuthors">Dahal, Upendra P.; Gilbert, Adam M.; Obach, R. Scott; Flanagan, Mark E.; Chen, Jinshan M.; Garcia-Irizarry, Carmen; Starr, Jeremy T.; Schuff, Brandon; Uccello, Daniel P.; Young, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">864-872</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covalent drugs contain a reactive electrophilic moiety or covalent reactive group (CRG), which forms an irreversible bond between the drug and a biol. target.  Consequently, the intrinsic reactivity of the CRG is an important consideration in the design of irreversible inhibitors.  Although reactivity assessments of CRGs with sulfur nucleophiles, such as glutathione and cysteine have been reported, reactivity of these moieties with amine-contg. nucleophiles is not well described.  In this study, intrinsic reactivities were detd. for a series of electrophiles (acrylamides, nitriles, cyanamides, sulfones, and sulfonamides) using N-α-acetyl-L-lysine as a model amine-based nucleophile and compared with results using glutathione (GSH).  Since the ε-amine of N-α-acetyl-L-lysine is protonated at neutral pH, reactions were carried out at pH 10.2.  In addn. to reporting rate data for reactions of CRGs with N-α-acetyl-L-lysine, elements of selectivity relative to thiol-contg. nucleophiles are also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofuy3ICddAE7Vg90H21EOLACvtfcHk0ljGQ4Uvx3NrXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFyjtrk%253D&md5=08e681ea8dfb353f89d8cdedba685694</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC6MD00017G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00017G%26sid%3Dliteratum%253Aachs%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DGarcia-Irizarry%26aufirst%3DC.%26aulast%3DStarr%26aufirst%3DJ.%2BT.%26aulast%3DSchuff%26aufirst%3DB.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%26atitle%3DIntrinsic%2520reactivity%2520profile%2520of%2520electrophilic%2520moieties%2520to%2520guide%2520covalent%2520drug%2520design%253A%2520N-%25CE%25B1-acetyl-L-lysine%2520as%2520an%2520amine%2520nucleophile%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D864%26epage%3D872%26doi%3D10.1039%2FC6MD00017G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span> <span> </span><span class="NLM_article-title">ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK kinase isoforms to cellular signaling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1558</span>, <span class="refDoi"> DOI: 10.1021/cb5002125</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5002125" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslart7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1552-1558&author=A.+Thorarensenauthor=M.+E.+Bankerauthor=A.+Fensomeauthor=J.-B.+Telliezauthor=B.+Jubaauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garcia&title=ATP-mediated+kinome+selectivity%3A+the+missing+link+in+understanding+the+contribution+of+individual+JAK+kinase+isoforms+to+cellular+signaling&doi=10.1021%2Fcb5002125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling</span></div><div class="casAuthors">Thorarensen, Atli; Banker, Mary Ellen; Fensome, Andrew; Telliez, Jean-Baptiste; Juba, Brian; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1552-1558</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinases constitute an important class of therapeutic targets being explored both by academia and the pharmaceutical industry.  The major focus of this effort was directed toward the identification of ATP competitive inhibitors.  Although it has long been recognized that the intracellular concn. of ATP is very different from the concns. utilized in biochem. enzyme assays, little thought has been devoted to incorporating this discrepancy into our understanding of translation from enzyme inhibition to cellular function.  Significant work has been dedicated to the discovery of JAK kinase inhibitors; however, a disconnect between enzyme and cellular function is prominently displayed in the literature for this class of inhibitors.  Herein, we demonstrate utilizing the four JAK family members (JAK1, JAK2, JAK3, and TYK2) that the difference in the ATP Km of each individual kinase has a significant impact on the enzyme to cell inhibition translation.  We evaluated a large no. of JAK inhibitors in enzymic assays utilizing either 1 mM ATP or Km ATP for the four isoforms as well as in primary cell assays.  This data set provided the opportunity to examine individual kinase contributions to the heterodimeric kinase complexes mediating cellular signaling.  In contrast to a recent study, we demonstrate that for IL-15 cytokine signaling it is sufficient to inhibit either JAK1 or JAK3 to fully inhibit downstream STAT5 phosphorylation.  This addnl. data thus provides a crit. piece of information explaining why JAK1 has incorrectly been thought to have a dominant role over JAK3.  Beyond enabling a deeper understanding of JAK signaling, conducting similar analyses for other kinases by taking into account potency at high ATP rather than Km ATP may provide crucial insights into a compd.'s activity and selectivity in cellular contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYiMVl7OpPFLVg90H21EOLACvtfcHk0lidWvlAVyLKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslart7s%253D&md5=c87874cb1748e13eef2aa241ecef3e79</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5002125%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DATP-mediated%2520kinome%2520selectivity%253A%2520the%2520missing%2520link%2520in%2520understanding%2520the%2520contribution%2520of%2520individual%2520JAK%2520kinase%2520isoforms%2520to%2520cellular%2520signaling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1552%26epage%3D1558%26doi%3D10.1021%2Fcb5002125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lidWvlAVyLKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lidWvlAVyLKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maragakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindorff-Larsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bank, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jumper, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wriggers, W.</span></span> <span> </span><span class="NLM_article-title">Atomic-level characterization of the structural dynamics of proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1126/science.1187409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1126%2Fscience.1187409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20947758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OisL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=341-346&author=D.+E.+Shawauthor=P.+Maragakisauthor=K.+Lindorff-Larsenauthor=S.+Pianaauthor=R.+O.+Drorauthor=M.+P.+Eastwoodauthor=J.+A.+Bankauthor=J.+M.+Jumperauthor=J.+K.+Salmonauthor=Y.+Shanauthor=W.+Wriggers&title=Atomic-level+characterization+of+the+structural+dynamics+of+proteins&doi=10.1126%2Fscience.1187409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic-Level Characterization of the Structural Dynamics of Proteins</span></div><div class="casAuthors">Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6002</span>),
    <span class="NLM_cas:pages">341-346</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) simulations are widely used to study protein motions at an at. level of detail, but they have been limited to time scales shorter than those of many biol. crit. conformational changes.  We examd. two fundamental processes in protein dynamics-protein folding and conformational change within the folded state-by means of extremely long all-atom MD simulations conducted on a special-purpose machine.  Equil. simulations of a WW protein domain captured multiple folding and unfolding events that consistently follow a well-defined folding pathway; sep. simulations of the protein's constituent substructures shed light on possible determinants of this pathway.  A 1-ms simulation of the folded protein BPTI reveals a small no. of structurally distinct conformational states whose reversible interconversion is slower than local relaxations within those states by a factor of more than 1000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnwCEGvUFVELVg90H21EOLACvtfcHk0ljzMviTemrnfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OisL%252FN&md5=85c9d897881e8684fc39d69b2b6b2fad</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1126%2Fscience.1187409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1187409%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DMaragakis%26aufirst%3DP.%26aulast%3DLindorff-Larsen%26aufirst%3DK.%26aulast%3DPiana%26aufirst%3DS.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DBank%26aufirst%3DJ.%2BA.%26aulast%3DJumper%26aufirst%3DJ.%2BM.%26aulast%3DSalmon%26aufirst%3DJ.%2BK.%26aulast%3DShan%26aufirst%3DY.%26aulast%3DWriggers%26aufirst%3DW.%26atitle%3DAtomic-level%2520characterization%2520of%2520the%2520structural%2520dynamics%2520of%2520proteins%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D341%26epage%3D346%26doi%3D10.1126%2Fscience.1187409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barducci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrinello, M.</span></span> <span> </span><span class="NLM_article-title">Linking well-tempered metadynamics simulations with experiments</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">L44</span>– <span class="NLM_lpage">L46</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2010.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2Fj.bpj.2010.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=20441734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2010&pages=L44-L46&author=A.+Barducciauthor=M.+Bonomiauthor=M.+Parrinello&title=Linking+well-tempered+metadynamics+simulations+with+experiments&doi=10.1016%2Fj.bpj.2010.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Linking well-tempered metadynamics simulations with experiments</span></div><div class="casAuthors">Barducci, Alessandro; Bonomi, Massimiliano; Parrinello, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">L44-L46</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Linking expts. with the atomistic resoln. provided by mol. dynamics simulations can shed light on the structure and dynamics of protein-disordered states.  The sampling limitations of classical mol. dynamics can be overcome using metadynamics, which is based on the introduction of a history-dependent bias on a small no. of suitably chosen collective variables.  Even if such bias distorts the probability distribution of the other degrees of freedom, the equil. Boltzmann distribution can be reconstructed using a recently developed reweighting algorithm.  Quant. comparison with exptl. data is thus possible.  Here we show the potential of this combined approach by characterizing the conformational ensemble explored by a 13-residue helix-forming peptide by means of a well-tempered metadynamics/parallel tempering approach and comparing the reconstructed NMR scalar couplings with exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjowMWWV2H7Vg90H21EOLACvtfcHk0ljzMviTemrnfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVansb8%253D&md5=16bc83b663df3e1e2185938102bb8b12</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2010.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2010.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DBarducci%26aufirst%3DA.%26aulast%3DBonomi%26aufirst%3DM.%26aulast%3DParrinello%26aufirst%3DM.%26atitle%3DLinking%2520well-tempered%2520metadynamics%2520simulations%2520with%2520experiments%26jtitle%3DBiophys.%2520J.%26date%3D2010%26volume%3D98%26spage%3DL44%26epage%3DL46%26doi%3D10.1016%2Fj.bpj.2010.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span> <i>Molecular Operating
Environment (MOE)</i>, version <span class="NLM_edition">2015.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
QC, Canada</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%2C+version+2015.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C%0AQC%2C+Canada%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladyshev, V. N.</span></span> <span> </span><span class="NLM_article-title">Analysis and functional prediction of reactive cysteine residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4425</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.275578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1074%2Fjbc.R111.275578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=22157013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFahur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4419-4425&author=S.+M.+Marinoauthor=V.+N.+Gladyshev&title=Analysis+and+functional+prediction+of+reactive+cysteine+residues&doi=10.1074%2Fjbc.R111.275578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis and Functional Prediction of Reactive Cysteine Residues</span></div><div class="casAuthors">Marino, Stefano M.; Gladyshev, Vadim N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4419-4425</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Cys is much different from other common amino acids in proteins.  Being 1 of the least abundant residues, Cys is often obsd. in functional sites in proteins.  This residue is reactive, polarizable, and redox-active; has high affinity for metals; and is particularly responsive to the local environment.  A better understanding of the basic properties of Cys is essential for interpretation of high-throughput data sets and for prediction and classification of functional Cys residues.  We provide an overview of approaches used to study Cys residues, from methods for investigation of their basic properties, such as exposure and pKa, to algorithms for functional prediction of different types of Cys in proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4WM1o3L2LTrVg90H21EOLACvtfcHk0ljzMviTemrnfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFahur0%253D&md5=87691c160b33b4896e06ece905bccbc8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.275578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.275578%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DS.%2BM.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26atitle%3DAnalysis%2520and%2520functional%2520prediction%2520of%2520reactive%2520cysteine%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4419%26epage%3D4425%26doi%3D10.1074%2Fjbc.R111.275578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. R.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometry in the analysis of glutathione conjugates</span>. <i>Biol. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1002/bms.1200220602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fbms.1200220602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=8329460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK3sXltFams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=319-25&author=T.+A.+Baillieauthor=M.+R.+Davis&title=Mass+spectrometry+in+the+analysis+of+glutathione+conjugates&doi=10.1002%2Fbms.1200220602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometry in the analysis of glutathione conjugates</span></div><div class="casAuthors">Baillie, Thomas A.; Davis, Margaret R.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Mass Spectrometry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">319-25</span>CODEN:
                <span class="NLM_cas:coden">BIMSEH</span>;
        ISSN:<span class="NLM_cas:issn">1052-9306</span>.
    </div><div class="casAbstract">A review with 42 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jRrl5L795bVg90H21EOLACvtfcHk0ljzMviTemrnfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFams7k%253D&md5=2e946c5aebae5c3907e09be1b4359bf5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fbms.1200220602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbms.1200220602%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DDavis%26aufirst%3DM.%2BR.%26atitle%3DMass%2520spectrometry%2520in%2520the%2520analysis%2520of%2520glutathione%2520conjugates%26jtitle%3DBiol.%2520Mass%2520Spectrom.%26date%3D1993%26volume%3D22%26spage%3D319%26epage%3D25%26doi%3D10.1002%2Fbms.1200220602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kheffache, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guemmour, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benaboura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouamerali, O.</span></span> <span> </span><span class="NLM_article-title">Conformational analysis and intramolecular hydrogen bonding of cis-3-aminoindan-1-ol: a quantum chemical study</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1007/s00894-013-1989-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1007%2Fs00894-013-1989-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=24026578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOktLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4837-4847&author=D.+Kheffacheauthor=H.+Guemmourauthor=A.+Dekhiraauthor=A.+Benabouraauthor=O.+Ouamerali&title=Conformational+analysis+and+intramolecular+hydrogen+bonding+of+cis-3-aminoindan-1-ol%3A+a+quantum+chemical+study&doi=10.1007%2Fs00894-013-1989-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational analysis and intramolecular hydrogen bonding of cis-3-aminoindan-1-ol: a quantum chemical study</span></div><div class="casAuthors">Kheffache, Djaffar; Guemmour, Hind; Dekhira, Azzedine; Benaboura, Ahmed; Ouamerali, Ourida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4837-4847</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the present work, we carried out a conformational anal. of cis-3-aminoindan-1-ol and evaluated the role of the intramol. hydrogen bond in the stabilization of various conformers using quantum mech. DFT (B3LYP) and MP2 methods.  On the basis of relative energies, we have found nine conformational min., which can interchange through the ring-puckering and the internal rotation of the OH and NH2 groups on the five-membered ring.  The intramol. hydrogen bonds such as OH····π, NH····π, NH····OH and HN····HO are expected to be of crit. importance for the conformational stabilities.  The intramol. interactions of the min. have been analyzed by calcn. of electron d. (ρ) and Laplacian at the bond crit. points (BCPs) using atoms-in-mol. (AIM) theory.  The existence or absence of OH····π and NH····π in cis-3-aminoindan-1-ol remains unclear since the geometrical investigation has not been confirmed by topol. criteria.  The results of theor. calcns. demonstrate that this compd. exists predominantly in one ring-puckering form stabilized by strong hydrogen bond HN····HO interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGta-4ZOzs7Vg90H21EOLACvtfcHk0lhaAyUGiYrq-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOktLfO&md5=11cea9aa3db017cf4cddbca409b85e67</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs00894-013-1989-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-013-1989-3%26sid%3Dliteratum%253Aachs%26aulast%3DKheffache%26aufirst%3DD.%26aulast%3DGuemmour%26aufirst%3DH.%26aulast%3DDekhira%26aufirst%3DA.%26aulast%3DBenaboura%26aufirst%3DA.%26aulast%3DOuamerali%26aufirst%3DO.%26atitle%3DConformational%2520analysis%2520and%2520intramolecular%2520hydrogen%2520bonding%2520of%2520cis-3-aminoindan-1-ol%253A%2520a%2520quantum%2520chemical%2520study%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2013%26volume%3D19%26spage%3D4837%26epage%3D4847%26doi%3D10.1007%2Fs00894-013-1989-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lhaAyUGiYrq-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995–1998</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>576</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1016/S0022-328X(98)01055-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+advances+in+the+cross-coupling+reactions+of+organoboron+derivatives+with+organic+electrophiles%2C+1995%E2%80%931998&doi=10.1016%2FS0022-328X%2898%2901055-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0lhaAyUGiYrq-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520cross-coupling%2520reactions%2520of%2520organoboron%2520derivatives%2520with%2520organic%2520electrophiles%252C%25201995%25E2%2580%25931998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168%26doi%3D10.1016%2FS0022-328X%2898%2901055-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y.</span>; <span class="NLM_string-name">Wang, T.</span>; <span class="NLM_string-name">Salituro, F.</span>; <span class="NLM_string-name">Duffy, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tricyclicheteroaryl Derivatives for Use as Janus Kinase Inhibitors</span>. <span class="NLM_patent">WO2008079521A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Bennani&author=T.+Wang&author=F.+Salituro&author=J.+Duffy&title=Preparation+of+Tricyclicheteroaryl+Derivatives+for+Use+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennani%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Tricyclicheteroaryl%2520Derivatives%2520for%2520Use%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span>; <span class="NLM_string-name">Matsunaga, N.</span>; <span class="NLM_string-name">Ohra, T.</span>; <span class="NLM_string-name">Ohyabu, N.</span>; <span class="NLM_string-name">Hasui, T.</span>; <span class="NLM_string-name">Motoyaji, T.</span>; <span class="NLM_string-name">Siedem, C. S.</span>; <span class="NLM_string-name">Tang, T. P.</span>; <span class="NLM_string-name">Demeese, L. A.</span>; <span class="NLM_string-name">Gauthier, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Heterocycles as Mineralocorticoid Receptor Antagonists</span>. <span class="NLM_patent">WO2007077961A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Fukumoto&author=N.+Matsunaga&author=T.+Ohra&author=N.+Ohyabu&author=T.+Hasui&author=T.+Motoyaji&author=C.+S.+Siedem&author=T.+P.+Tang&author=L.+A.+Demeese&author=C.+Gauthier&title=Preparation+of+Fused+Heterocycles+as+Mineralocorticoid+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Fused%2520Heterocycles%2520as%2520Mineralocorticoid%2520Receptor%2520Antagonists%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrig, S.</span>; <span class="NLM_string-name">Pohlmann, J.</span>; <span class="NLM_string-name">Arndt, S.</span>; <span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Perzborn, E.</span>; <span class="NLM_string-name">Gerdes, C.</span>; <span class="NLM_string-name">Schlemmer, K.-H.</span>; <span class="NLM_string-name">Tuch, A.</span>; <span class="NLM_string-name">Lobell, M.</span>; <span class="NLM_string-name">Nell, P.</span>; <span class="NLM_string-name">Burkhardt, N.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Imino-3-phenyloxazolidines and Related Compounds for the Treatment of Thromboembolic Diseases</span>. <span class="NLM_patent">WO2006058630A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+Roehrig&author=J.+Pohlmann&author=S.+Arndt&author=M.+Jeske&author=M.+Akbaba&author=E.+Perzborn&author=C.+Gerdes&author=K.-H.+Schlemmer&author=A.+Tuch&author=M.+Lobell&author=P.+Nell&author=N.+Burkhardt&title=Preparation+of+2-Imino-3-phenyloxazolidines+and+Related+Compounds+for+the+Treatment+of+Thromboembolic+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrig%26aufirst%3DS.%26atitle%3DPreparation%2520of%25202-Imino-3-phenyloxazolidines%2520and%2520Related%2520Compounds%2520for%2520the%2520Treatment%2520of%2520Thromboembolic%2520Diseases%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">A simple method for the electrophilic cyanation of secondary amines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1021/ol403245r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol403245r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=247-249&author=C.+Zhuauthor=J.-B.+Xiaauthor=C.+Chen&title=A+simple+method+for+the+electrophilic+cyanation+of+secondary+amines&doi=10.1021%2Fol403245r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fol403245r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol403245r%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DJ.-B.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520electrophilic%2520cyanation%2520of%2520secondary%2520amines%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D247%26epage%3D249%26doi%3D10.1021%2Fol403245r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maulik, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S.</span></span> <span> </span><span class="NLM_article-title">Sodium hydride mediated cascade reaction towards the synthesis of 1,5-disubstituted uracil from cyanamides derived from Baylis-Hillman adducts</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">917</span>, <span class="refDoi"> DOI: 10.1055/s-2007-965931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-2007-965931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=911-917&author=S.+Nagauthor=G.+P.+Yadavauthor=P.+R.+Maulikauthor=S.+Batra&title=Sodium+hydride+mediated+cascade+reaction+towards+the+synthesis+of+1%2C5-disubstituted+uracil+from+cyanamides+derived+from+Baylis-Hillman+adducts&doi=10.1055%2Fs-2007-965931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-965931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-965931%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DG.%2BP.%26aulast%3DMaulik%26aufirst%3DP.%2BR.%26aulast%3DBatra%26aufirst%3DS.%26atitle%3DSodium%2520hydride%2520mediated%2520cascade%2520reaction%2520towards%2520the%2520synthesis%2520of%25201%252C5-disubstituted%2520uracil%2520from%2520cyanamides%2520derived%2520from%2520Baylis-Hillman%2520adducts%26jtitle%3DSynthesis%26date%3D2007%26volume%3D2007%26spage%3D911%26epage%3D917%26doi%3D10.1055%2Fs-2007-965931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Burns, D. M.</span>; <span class="NLM_string-name">Feng, H.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Mei, S.</span>; <span class="NLM_string-name">Pan, J.</span>; <span class="NLM_string-name">Vechorkin, O.</span>; <span class="NLM_string-name">Ye, H. F.</span>; <span class="NLM_string-name">Zhu, W.</span>; <span class="NLM_string-name">Rafalski, M.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Xue, C.-B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Furo- and Thieno-Pyridine Carboxamide Compounds Useful as Pim Kinase Inhibitors</span>. <span class="NLM_patent">WO2015027124A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.-L.+Li&author=D.+M.+Burns&author=H.+Feng&author=T.+Huang&author=S.+Mei&author=J.+Pan&author=O.+Vechorkin&author=H.+F.+Ye&author=W.+Zhu&author=M.+Rafalski&author=A.+Wang&author=C.-B.+Xue&title=Preparation+of+Furo-+and+Thieno-Pyridine+Carboxamide+Compounds+Useful+as+Pim+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3DPreparation%2520of%2520Furo-%2520and%2520Thieno-Pyridine%2520Carboxamide%2520Compounds%2520Useful%2520as%2520Pim%2520Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larraufie, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maestri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ollivier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensterbank, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacote, E.</span></span> <span> </span><span class="NLM_article-title">The cyanamide moiety, synthesis and reactivity</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1289749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-0031-1289749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1CjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1279-1292&author=M.-H.+Larraufieauthor=G.+Maestriauthor=M.+Malacriaauthor=C.+Ollivierauthor=L.+Fensterbankauthor=E.+Lacote&title=The+cyanamide+moiety%2C+synthesis+and+reactivity&doi=10.1055%2Fs-0031-1289749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The cyanamide moiety, synthesis and reactivity</span></div><div class="casAuthors">Larraufie, Marie-Helene; Maestri, Giovanni; Malacria, Max; Ollivier, Cyril; Fensterbank, Louis; Lacote, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1279-1292</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  The cyanamide moiety provides many opportunities as a building block for the synthesis of nitrogen-contg. heterocycles.  This review discusses the reported methods for the prepn. of alkyl- and N-acylcyanamides and illustrates their reactivity vis-a-vis nucleophilic addns., cycloaddns., radical chem. and coordination chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopc4w-uJKc-rVg90H21EOLACvtfcHk0lgbDmwGwxqM_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1CjsL8%253D&md5=7d10094d0e3a1be29c48f8018b932a09</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1289749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1289749%26sid%3Dliteratum%253Aachs%26aulast%3DLarraufie%26aufirst%3DM.-H.%26aulast%3DMaestri%26aufirst%3DG.%26aulast%3DMalacria%26aufirst%3DM.%26aulast%3DOllivier%26aufirst%3DC.%26aulast%3DFensterbank%26aufirst%3DL.%26aulast%3DLacote%26aufirst%3DE.%26atitle%3DThe%2520cyanamide%2520moiety%252C%2520synthesis%2520and%2520reactivity%26jtitle%3DSynthesis%26date%3D2012%26volume%3D44%26spage%3D1279%26epage%3D1292%26doi%3D10.1055%2Fs-0031-1289749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span>; <span class="NLM_string-name">Baldwin, E. T.</span>; <span class="NLM_string-name">Beck, J. T.</span>; <span class="NLM_string-name">Hughes, R.</span>; <span class="NLM_string-name">John, V.</span>; <span class="NLM_string-name">Pulley, S. R.</span>; <span class="NLM_string-name">Tenbrink, R.</span></span> <span> </span><span class="NLM_article-title">Preparation of Ring-containing N-Acetyl 2-hydroxy-1,3-diaminoalkanes as β-Secretase Inhibitors for Treating Alzheimer’s Disease and Other Diseases Characterized by Deposition of Aβ-Peptide</span>. <span class="NLM_patent">WO2004024081A2</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Maillard&author=E.+T.+Baldwin&author=J.+T.+Beck&author=R.+Hughes&author=V.+John&author=S.+R.+Pulley&author=R.+Tenbrink&title=Preparation+of+Ring-containing+N-Acetyl+2-hydroxy-1%2C3-diaminoalkanes+as+%CE%B2-Secretase+Inhibitors+for+Treating+Alzheimer%E2%80%99s+Disease+and+Other+Diseases+Characterized+by+Deposition+of+A%CE%B2-Peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMaillard%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Ring-containing%2520N-Acetyl%25202-hydroxy-1%252C3-diaminoalkanes%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%2520for%2520Treating%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Other%2520Diseases%2520Characterized%2520by%2520Deposition%2520of%2520A%25CE%25B2-Peptide%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, H. M.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjaneyulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, J. S.</span></span> <span> </span><span class="NLM_article-title">An expedient and highly selective conversion of alcohols to azides using a NaN<sub>3</sub>/BF<sub>3</sub>.Et<sub>2</sub>O system</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">7385</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)01602-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0040-4039%2898%2901602-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=7385-7388&author=H.+M.%0AS.+Kumarauthor=B.+V.+S.+Reddyauthor=S.+Anjaneyuluauthor=J.+S.+Yadav&title=An+expedient+and+highly+selective+conversion+of+alcohols+to+azides+using+a+NaN3%2FBF3.Et2O+system&doi=10.1016%2FS0040-4039%2898%2901602-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2901602-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252901602-5%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DH.%2BM.%2BS.%26aulast%3DReddy%26aufirst%3DB.%2BV.%2BS.%26aulast%3DAnjaneyulu%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520expedient%2520and%2520highly%2520selective%2520conversion%2520of%2520alcohols%2520to%2520azides%2520using%2520a%2520NaN3%252FBF3.Et2O%2520system%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D7385%26epage%3D7388%26doi%3D10.1016%2FS0040-4039%2898%2901602-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of tert-butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+applications+of+tert-butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0lgqvxqk0ncDxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520tert-butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.-H.</span></span> <span> </span><span class="NLM_article-title">SmI2-promoted imino-Reformatsky reaction for facile synthesis of enantioenriched β-amino acid esters</span>. <i>Sci. China: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s11426-010-4180-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1007%2Fs11426-010-4180-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Giuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=61-65&author=L.+Wangauthor=C.+Shenauthor=M.-H.+Xu&title=SmI2-promoted+imino-Reformatsky+reaction+for+facile+synthesis+of+enantioenriched+%CE%B2-amino+acid+esters&doi=10.1007%2Fs11426-010-4180-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">SmI2-promoted imino-Reformatsky reaction for facile synthesis of enantioenriched β-amino acid esters</span></div><div class="casAuthors">Wang, Li; Shen, Chun; Xu, Ming-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">SCCCCS</span>;
        ISSN:<span class="NLM_cas:issn">1869-1870</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">A facile and efficient method for the stereoselective synthesis of β-amino acid esters via SmI2-promoted imino-Reformatsky reaction is described.  Asym. addn. of tert-Bu bromoacetate to N-tert-butanesulfinyl aldimines afforded β-amino acid esters in moderate to high yields with excellent diastereoselectivities.  The synthetic utilities of the tert-Bu β-amino acid esters were expanded by the prepn. of β-lactams and 3-aminoindan-1-ones derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO7HjntKVVWbVg90H21EOLACvtfcHk0lgqvxqk0ncDxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Giuw%253D%253D&md5=9f7e69095b65332e4e94981e644baad6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs11426-010-4180-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-010-4180-z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DM.-H.%26atitle%3DSmI2-promoted%2520imino-Reformatsky%2520reaction%2520for%2520facile%2520synthesis%2520of%2520enantioenriched%2520%25CE%25B2-amino%2520acid%2520esters%26jtitle%3DSci.%2520China%253A%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D61%26epage%3D65%26doi%3D10.1007%2Fs11426-010-4180-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doughan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, D. J.</span></span> <span> </span><span class="NLM_article-title">Scalable synthesis of β-amino esters via Reformatsky reaction with N-tert-butanesulfinyl imines</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1087964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1055%2Fs-0028-1087964" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=991-993&author=K.+Brinnerauthor=B.+Doughanauthor=D.+J.+Poon&title=Scalable+synthesis+of+%CE%B2-amino+esters+via+Reformatsky+reaction+with+N-tert-butanesulfinyl+imines&doi=10.1055%2Fs-0028-1087964"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1087964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1087964%26sid%3Dliteratum%253Aachs%26aulast%3DBrinner%26aufirst%3DK.%26aulast%3DDoughan%26aufirst%3DB.%26aulast%3DPoon%26aufirst%3DD.%2BJ.%26atitle%3DScalable%2520synthesis%2520of%2520%25CE%25B2-amino%2520esters%2520via%2520Reformatsky%2520reaction%2520with%2520N-tert-butanesulfinyl%2520imines%26jtitle%3DSynlett%26date%3D2009%26volume%3D2009%26spage%3D991%26epage%3D993%26doi%3D10.1055%2Fs-0028-1087964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span>; <span class="NLM_string-name">Fliri, H.
G.</span>; <span class="NLM_string-name">Keats, A.
J.</span>; <span class="NLM_string-name">Lazarides, L.</span>; <span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Pettit, S. N.</span>; <span class="NLM_string-name">Poullennec, K. G.</span>; <span class="NLM_string-name">Sanvoisin, J.</span>; <span class="NLM_string-name">Steadman, V. A.</span>; <span class="NLM_string-name">Watt, G. M.</span></span> <span> </span><span class="NLM_article-title">Preparation of Macrocyclic Peptides as Inhibitors of Flaviviridae Viruses for Treating particularly Hepatitis C Infections</span>. <span class="NLM_patent">WO2012078915A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Appleby&author=H.%0AG.+Fliri&author=A.%0AJ.+Keats&author=L.+Lazarides&author=R.+L.+Mackman&author=S.+N.+Pettit&author=K.+G.+Poullennec&author=J.+Sanvoisin&author=V.+A.+Steadman&author=G.+M.+Watt&title=Preparation+of+Macrocyclic+Peptides+as+Inhibitors+of+Flaviviridae+Viruses+for+Treating+particularly+Hepatitis+C+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAppleby%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Macrocyclic%2520Peptides%2520as%2520Inhibitors%2520of%2520Flaviviridae%2520Viruses%2520for%2520Treating%2520particularly%2520Hepatitis%2520C%2520Infections%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, L. D.</span>; <span class="NLM_string-name">Moyer, M. P.</span>; <span class="NLM_string-name">Sobolov-Jaynes, S. B.</span></span> <span> </span><span class="NLM_article-title">Fused Bicyclic Pyrimidine Derivatives Useful as Antihyperproliferative Agents</span>. <span class="NLM_patent">WO9823613A1</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=L.+D.+Arnold&author=M.+P.+Moyer&author=S.+B.+Sobolov-Jaynes&title=Fused+Bicyclic+Pyrimidine+Derivatives+Useful+as+Antihyperproliferative+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DFused%2520Bicyclic%2520Pyrimidine%2520Derivatives%2520Useful%2520as%2520Antihyperproliferative%2520Agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span>; <span class="NLM_string-name">Janne, P.</span>; <span class="NLM_string-name">Eck, M.
J.</span></span> <span> </span><span class="NLM_article-title">Substituted Heteroaryl Derivatives as EGFR and HER Kinase Modulators and Their Preparation and Use for the Treatment of Diseases</span>. <span class="NLM_patent">WO2010129053A2</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=N.+S.+Gray&author=P.+Janne&author=M.%0AJ.+Eck&title=Substituted+Heteroaryl+Derivatives+as+EGFR+and+HER+Kinase+Modulators+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSubstituted%2520Heteroaryl%2520Derivatives%2520as%2520EGFR%2520and%2520HER%2520Kinase%2520Modulators%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahearn, S. P.</span>; <span class="NLM_string-name">Christopher, M.</span>; <span class="NLM_string-name">Jung, J.</span>; <span class="NLM_string-name">Pu, Q.</span>; <span class="NLM_string-name">Rivkin, A.</span>; <span class="NLM_string-name">Scott, M. E.</span>; <span class="NLM_string-name">Witter, D. J.</span>; <span class="NLM_string-name">Woo, H. C.</span>; <span class="NLM_string-name">Cash, B.</span>; <span class="NLM_string-name">Dinsmore, C.</span>; <span class="NLM_string-name">Guerin, D.</span></span> <span> </span><span class="NLM_article-title">Preparation of Pyrrolopyrimidines as Janus Kinase Inhibitors</span>. <span class="NLM_patent">WO2013085802A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+P.+Ahearn&author=M.+Christopher&author=J.+Jung&author=Q.+Pu&author=A.+Rivkin&author=M.+E.+Scott&author=D.+J.+Witter&author=H.+C.+Woo&author=B.+Cash&author=C.+Dinsmore&author=D.+Guerin&title=Preparation+of+Pyrrolopyrimidines+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhearn%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Pyrrolopyrimidines%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span>; <span class="NLM_string-name">Casimiro-Garcia, A.</span>; <span class="NLM_string-name">Che, Y.</span>; <span class="NLM_string-name">Coe, J.
W.</span>; <span class="NLM_string-name">Flanagan, M. E.</span>; <span class="NLM_string-name">Gilbert, A. M.</span>; <span class="NLM_string-name">Hayward, M. M.</span>; <span class="NLM_string-name">Langille, J. D.</span>; <span class="NLM_string-name">Montgomery, J. I.</span>; <span class="NLM_string-name">Telliez, J.-B.</span>; <span class="NLM_string-name">Thorarensen, A.</span>; <span class="NLM_string-name">Unwalla, R. J.</span></span> <span> </span><span class="NLM_article-title">Pyrrolo[2,3-d]pyrimidinyl-, Pyrrolo[2,3-b]pyrazinyl- and Pyrrolo[2,3-d]pyridinylacrylamides as JAK Inhibitor and Their Preparation</span>. <span class="NLM_patent">WO2015083028A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+F.+Brown&author=A.+Casimiro-Garcia&author=Y.+Che&author=J.%0AW.+Coe&author=M.+E.+Flanagan&author=A.+M.+Gilbert&author=M.+M.+Hayward&author=J.+D.+Langille&author=J.+I.+Montgomery&author=J.-B.+Telliez&author=A.+Thorarensen&author=R.+J.+Unwalla&title=Pyrrolo%5B2%2C3-d%5Dpyrimidinyl-%2C+Pyrrolo%5B2%2C3-b%5Dpyrazinyl-+and+Pyrrolo%5B2%2C3-d%5Dpyridinylacrylamides+as+JAK+Inhibitor+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BF.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidinyl-%252C%2520Pyrrolo%255B2%252C3-b%255Dpyrazinyl-%2520and%2520Pyrrolo%255B2%252C3-d%255Dpyridinylacrylamides%2520as%2520JAK%2520Inhibitor%2520and%2520Their%2520Preparation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segmuller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ybarra, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of acrylophenones and 2-alkyl indanones utilizing hexamethylenetetramine as an inexpensive Mannich reagent</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1775</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1080/00397919608002617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1080%2F00397919608002617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK28XitlWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1775-1784&author=A.+Bhattacharyaauthor=B.+Segmullerauthor=A.+Ybarra&title=Preparation+of+acrylophenones+and+2-alkyl+indanones+utilizing+hexamethylenetetramine+as+an+inexpensive+Mannich+reagent&doi=10.1080%2F00397919608002617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of acrylophenones and 2-alkyl indanones utilizing hexamethylenetetramine as an inexpensive Mannich reagent</span></div><div class="casAuthors">Bhattacharya, Apurba; Segmuller, Brigitte; Ybarra, Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1775-84</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">Hexamethylenetetramine/acetic anhydride-promoted α-methylenation of aryl alkyl ketones I (R1 = Me, Et, n-Bu, n-octyl, n-Pr, Ph, R1 = H, Cl, R3 = H, Br, Cl, R4 = H, OMe) followed by acid-catalyzed cyclization of the resulting acrylophenones produce 2-alkylindanones II in excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjNjGDuWPILVg90H21EOLACvtfcHk0lgYAMEiJXkXLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlWhsLk%253D&md5=5d2899ba26931b6c21068311f14ccf5c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F00397919608002617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919608002617%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DSegmuller%26aufirst%3DB.%26aulast%3DYbarra%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520acrylophenones%2520and%25202-alkyl%2520indanones%2520utilizing%2520hexamethylenetetramine%2520as%2520an%2520inexpensive%2520Mannich%2520reagent%26jtitle%3DSynth.%2520Commun.%26date%3D1996%26volume%3D26%26spage%3D1775%26epage%3D1784%26doi%3D10.1080%2F00397919608002617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span>; <span class="NLM_string-name">Minor, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>. In  <i>Macromolecular Crystallography, Part A</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, C. W.,  Jr.</span>, <span class="NLM_string-name">Sweet, R. M.</span></span>, Eds.; Methods in Enzymology, Vol. 276; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; pp  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lgYAMEiJXkXLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhCouqYaVF3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>D53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhCouqYaVF3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P.</span>; <span class="NLM_string-name">Smart, O.
S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T. O.</span></span> <i>BUSTER</i>, version <span class="NLM_edition">2.8.0</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.%0AS.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>D66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhCouqYaVF3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4','PDB','6DA4'); return false;">PDB: 6DA4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD','PDB','6DUD'); return false;">PDB: 6DUD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3','PDB','6DB3'); return false;">PDB: 6DB3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4','PDB','6DB4'); return false;">PDB: 6DB4</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i153"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01308">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04124"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01308">10.1021/acs.jmedchem.8b01308</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystallographic data collection and structure refinement statistics for structures of JAK3 bound to <b>10</b>, <b>12</b>, <b>23</b>, or <b>34</b>; single molecule X-ray crystallography for <b>13</b>, <b>105</b>, and <b>114</b>; <sup>1</sup>H NMR data for <b>90</b> and <b>91</b>; electron density of <b>10</b>, <b>12</b>, <b>23</b>, and <b>34</b> in complex with JAK3; determination of preferred tautomer form of <b>12</b> using 2D NMR; <sup>1</sup>H NMR and HPLC data for <b>34</b> and <b>35</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_001.pdf">jm8b01308_si_001.pdf (1.96 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01308/suppl_file/jm8b01308_si_002.csv">jm8b01308_si_002.csv (2.58 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factor amplitudes for JAK3 complexes with compounds <b>10</b>, <b>12</b>, <b>23</b>, and <b>34</b> have been deposited with the Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">http://www.rcsb.org</a>) with the following accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DA4">6DA4</a> (<b>10</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DUD">6DUD</a> (<b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB3">6DB3</a> (<b>23</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DB4">6DB4</a> (<b>34</b>). The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01308&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-23%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01308%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01308" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f2670b812290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
